text:
download Reclamo
With the participation of the ESC Working Group on e-Cardiology and in conjunction with
the 39th Annual Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology
Building Floor Plan
To Level 2
Function Function
To Mezzanine
Levels 0 & 2
Consult the
The PACE
The EHRA Key Messages Mobile App is supported in the form of an unrestricted educational grant by:
www.escardio.org/EHRA
Welcome Address................................................................................................................................................................................................................................................................................................................................................................................................................................................................1
Special Events..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................2
Organising Committees....................................................................................................................................................................................................................................................................................................................................................................................................................................3
Congress Resources........................................................................................................................................................................................................................................................................................................................................................................................................................................................4
Congress Timetable.........................................................................................................................................................................................................................................................................................................................................................................................................................................................5
EHRA Members' Benefits.........................................................................................................................................................................................................................................................................................................................................................................................................................6
Highlights On...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................7
Useful Information.................................................................................................................................................................................................................................................................................................................................................................................................................................................................8
Programme at a Glance.....................................................................................................................................................................................................................................................................................................................................................................................................................................9
Contact Details.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................14
Acknowledgements.......................................................................................................................................................................................................................................................................................................................................................................................................................................................15
Morning Sessions......................................................................................................................................................................................................................................................................................................................................................................................................................................................17
Lunchtime Sessions...........................................................................................................................................................................................................................................................................................................................................................................................................................................27
Afternoon Sessions..........................................................................................................................................................................................................................................................................................................................................................................................................................................29
Evening Sessions..........................................................................................................................................................................................................................................................................................................................................................................................................................................................38
Poster Sessions.................................................................................................................................................................................................................................................................................................................................................................................................................................................................39
Lunchtime Sessions........................................................................................................................................................................................................................................................................................................................................................................................................................................107
Afternoon Sessions.......................................................................................................................................................................................................................................................................................................................................................................................................................................109
Poster Sessions...............................................................................................................................................................................................................................................................................................................................................................................................................................................................119
Morning Sessions...................................................................................................................................................................................................................................................................................................................................................................................................................................................131
Poster Sessions..............................................................................................................................................................................................................................................................................................................................................................................................................................................................137
Sessions by topic....................................................................................................................................................................................................................................................................................................................................................................................................................................................................145
Chairpersons & Judges.....................................................................................................................................................................................................................................................................................................................................................................................................................................146
Speakers...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................148
Authors...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................151
I am delighted to welcome you to EHRA EUROPACE – CARDIOSTIM 2015, organised by the European Heart Rhythm
Association (EHRA) in collaboration with Cardiostim and the Working Groups on Cardiac Cellular Electrophysiology
and e-Cardiology.
The scientific content throughout the congress is exciting to say the least. The programme committee, expertly lead
by Prof. Cecilia Linde, Prof. Michael Glikson and Dr. Philippe Ritter, worked from a comprehensive list of topics that
really highlight the multidisciplinary and translational approach in modern electrophysiology, diagnosis of arrhythmias
and conduction disturbance. This excellent programme has been put together by leading experts from around the
world, and has been augmented by its alignment to the strategy of EHRA through the inclusion of sessions from the
Innovation, Young EP and Women in EP communities.
For the third edition in a row we have received more than 1 500 abstract submissions, and to celebrate this remarkable
result we have put a real emphasis on abstract presentations. The "Best Abstracts" have been given the visibility they
deserve by being on display for the whole congress, as well as a new format for the presentation of oral abstracts to
facilitate communication and encourage discussion. Also, there will be two Young Investigator Award sessions, with
winners announced during the Awards and Closing Ceremony. These sessions are a great opportunity to network
and exchange knowledge with both the abstract presenters and the rest of the audience.
The EHRA - ESC stand (B300) in the exhibition area is well worth a visit. EHRA membership gives delegates benefits
such as exclusive access to EHRA Members only sessions, entry to the Members' Lounge where you can stop
for a coffee and meet with the EHRA Executive Board and get discounts on the congress registration fees. More
information is available on the EHRA - ESC stand as well as from the EHRA booths located throughout the congress
centre, including one in the registration area.
We also have a great selection of industry partners attending the congress, bringing with them examples of cutting
edge technology and medical advancements. Make sure to go and see them in the exhibition area.
As well as taking in all that the congress has to offer, allow yourself some time to explore Milan. Dating back 26
centuries, it is one of the oldest cities in Europe; it really is a fascinating city.
Thank you for being here with us in Milan, I wish you all a great congress and hope that you are able to make the most
of all the opportunities it brings you to learn and share.
Professor Karl-Heinz Kuck
EHRA President, 2013 - 2015
All participants are personally invited by the President
of the European Heart Rhythm Association (EHRA) to the
18:15 - 19:15 in room Milano
Welcome addresses
EHRA EUROPACE - CARDIOSTIM 2015 Highlights
Opening Address
The European Heart Rhythm Association is pleased
to invite you to the Networking reception
in the exhibition area directly after the Inaugural session.
All attendees are encouraged to view the "Best Abstracts" which will be on display
in the poster area during the Networking reception and will remain in place throughout the whole congress.
EHRA General Assembly
Tuesday 23 June, 15:30 - 16:30 in room Firenze
Welcome address
Prof. K.H. Kuck, President
Parting salutation of EHRA Board Chairs
Report on EHRA's activities
Prof. C. Leclercq, Secretary
Election results of new EHRA Board
Prof. A. Auricchio,
Nominating Committee Chairperson
Financial update FY2014-15
Prof. B. Merkely, Treasurer
Result of the selection of the new Editor-in-Chief
Prof. P. Vardas, Task force Chairperson
Introduction of new President
Words from new President
Prof. G. Hindricks
All EHRA members are welcome and encouraged to attend.
EHRA Executive Board
Prof. K.H. Kuck
Editor-in-Chief of EP-Europace
Prof. A.J. Camm
President-Elect Prof. G. Hindricks
Past President Prof. A. Auricchio
Secretary Prof. C. Leclercq
Representative of the ESC Working Group
on Cardiac Cellular Electrophysiology Prof. P. Volders
Treasurer Prof. B. Merkely
Grown-Up Congenital Heart Disease Prof. G. Diller
on e-Cardiology Prof. M. Malik
Prof. Cecilia Linde, EHRA Chairperson
Dr. Philippe Ritter, Cardiostim Chairperson
Prof. Michael Glikson, EHRA Vice-Chairperson
Prof. Pierre Jais, Cardiostim Vice-Chairperson
Prof. Jean-Jacques Blanc
Prof. Jesper Hastrup Svendsen
Prof. Luigi Padeletti
Prof. Carina Blomström-Lundqvist
Dr. David Hayes
Dr. Renato Pietro Ricci
Dr. Lucas Boersma
Prof. Hein Heidbuchel
Dr. Alessandro Proclemer
Dr. Maria Grazia Bongiorni
Dr. Meleze Hocini
Prof. Vincent Probst
Dr. Giovanni Luca Botto
Assoc. Prof. Carsten Israel
Dr. Eric Rosenthal
Prof. Giuseppe Boriani
Prof. Tiny Jaarsma
Dr. Frederic Sacher
Dr. Michele Brignole
Prof. Jan Janousek
Dr. Andrea Sarkozy
Prof. Josep Brugada
Prof. Werner Jung
Dr. Magnus Settergren
Prof. Jean-Claude Daubert
Prof. Rose Anne Kenny
Dr. Win Kuang Shen
Dr. Tom de Potter
Dr. Valentina Kutyifa
Prof. Georg Schmidt
Prof. Jean-Claude Deharo
Prof. Gregory Y.H. Lip
Prof. Christian Sticherling
Dr. Paolo Della Bella
Prof. Ignacio Fernandez Lozano
Prof. Isabel van Gelder
Prof. Joachim Ehrlich
Prof. Marek Malik
Dr. Sami Viskin
Dr. Maurizio Gasparini
Prof. Bela Merkely
Dr. Paul Volders
Dr. Peter Geelen
Prof. John Morgan
Prof. Hein J.J. Wellens
Prof. Andreas Goette
Dr. Francis Murgatroyd
Prof. Christian Wolpert
Prof. Bulent Gorenek
Dr. Carlo Napolitano
Prof. Douglas Zipes
Dr. Moti Haim
Dr. Jonas Oldgren
Dr. Franck Halimi
Dr. Mark O'Neill
CME Accreditation
The EHRA EUROPACE - CARDIOSTIM
2015 Congress is accredited by the
European Board for Accreditation in
Cardiology (EBAC) for 21 hours of
external CME credits.
Each participant should claim only those hours of
credit that have actually been spent in the educational
activity. EBAC works in cooperation with the European
Accreditation Council for Continuing Medical Education
(EACCME) which is an institution of the European
Union of Medical Specialists (UEMS). EBAC credits
are recognised by the American Medical Association
towards the Physician's Recognition Award (PRA).
Detailed instructions for converting these credits to
AMA PRA category 1 credits are available on the AMA
EBAC Certificates will be available at the Registration
desk on Tuesday 23 June and Wednesday 24 June.
EHRA Certification Exams
Please note that you must be pre-registered to
participate: no on-site registration available.
Full day examination:
• Tuesday 23 June:
Certification for Allied Professionals in Cardiac
Pacing and ICDs
Certification in Invasive Cardiac Electrophysiology
• Wednesday 24 June:
Certification in Cardiac Pacing and Implantable
Cardioverter Defibrillators (ICDs)
All slide presentations, abstracts and posters are
available for electronic consultation on-site in the
e-Library located in the poster area.
Industry Programme
Consult this new document to find:
•List of industry partners,
Exhibition Floor Plan and
Satellite Symposia Programmes
•Venue Floor Plan and General
•A Notepad
EHRA EUROPACE-CARDIOSTIM 2015 in
the palm of your hand!
The "EHRA 2015" Mobile App is available now!
This free Mobile App will be your guide before, during
and after the congress.
Download the app now!
Scan the QR Code or search for "EHRA
2015" in the App Store or Google Play
Anywhere, at any time, find EHRA EUROPACE CARDIOSTIM 2015 essentials on your mobile device.
Manage and prepare your
congress experience:
•View the entire scientific
•Receive frequent updates
•Search for the key opinion
leaders, international experts,
•Create your personal schedule
•Don't miss the key deadlines!
•NEW! Ask questions and
vote during "Mobile App
interactive sessions!"
Please note this Mobile App is tailored to be your
personal guide before and during the congress, no printed
programme book will be provided to congress attendees.
EHRA EUROPACE - CARDIOSTIM 2015 Mobile App is supported
by Medtronic in the form of an unrestricted
educational grant
Scientific Programme & Planner
The online version of the scientific programme allows
you to plan your personal congress schedule and review
abstracts online.
•Make your own selection according to your needs
and interests
•Search sessions by:
 Session title
 Topic

 Presenter
Available on www.escardio.org/EUROPACE
Saturday 20 June
Sunday 21 June
Monday 22 June
Moderated Posters
EHRA MEMBERS'
EHRA MEMBERSHIP
EHRA membership is open to specialist cardiologists with expertise in arrhythmias and electrophysiology, as well as
to basic scientists, members of allied professions, and general cardiologists.
Join EHRA on www.escardio.org/EHRA to get access!
The benefits of EHRA membership:
•Exclusive access to dedicated scientific sessions
during EHRA EUROPACE - CARDIOSTIM 2015 and to online resources
•Access to the EHRA Lounge level 1 providing all
members the opportunity to meet with EHRA
•Discount on EHRA education including:
 Special rate on registration fee for EHRA courses
 Free online webinars
 Reduced fees on EHRA booklets
•Registration discount on the annual congress
•Reduced fee for the EP Europace Journal
•Exclusive access to EHRA Training Fellowships and a
selection of EHRA Educational Content Online
(including access to the ESC eLearning platform)
•Quarterly e-Newsletter
•Automatic ESC membership and benefits
•10% off on all cardiology publications from Oxford
University Press (OUP)
EHRA DEDICATED SCIENTIFIC SESSIONS
EHRA members attending this year's congress will benefit from members only sessions:
• Programming a primary prevention implantable cardioverter defibrillator
Sunday 21 June 16:30-18:00, Torino - lecture room
Management of channellopathies in children, adolescents & young adults.
Monday 22 June 16:30-18:00, Cagliari - lecture room
Devices may not be forever? Can ongoing ICD or CRT therapy become unnecessary?
Tuesday 23 June 11:00-12:30, Torino - lecture room
EHRA MEMBERS' LOUNGE
The EHRA Members' Lounge is an exclusive area at level 1 providing all EHRA members 2015 with a pleasant and
intimate environment to meet with the EHRA Executive Board (Profs. Kuck, Hindricks, Auricchio, Camm, Merkely
and Leclercq). This allows you to address specific but also more general questions to the EHRA leadership team as
well as to meet with colleagues, check emails or simply enjoy a cup of coffee.
Visit us on the EHRA - ESC stand (B300)
• Find out more about EHRA membership, upcoming educational courses & webinars, grants,
EP Europace journal and ESC general activities
• Pick up a copy of the EHRA White Book
HIGHLIGHTS ON
LIVE AND RECORDED SESSIONS
Live case transmissions will be broadcast allowing the audience to closely follow the procedures and benefit from the
experience of the experts.
On Monday 22 and Tuesday 23 June in room Milano
Recorded case sessions will be presented in a discussion format where real life challenging cases will be:
• Demonstrated by the experts
• Examined with the audience
• Concluded with recommendations and take-home messages
On Sunday 21, Monday 22 and Tuesday 23 June in room Milano
Uncover your topic of choice by following a congress
Atrial Fibrillation track
Topics:Atrial Fibrillation - AF ablation - Anticoagulants
Nurses and Allied Professional track
Pacing track
Topics:Cardiac Pacing - Lead management New implantable and nonimplantable devices
Noninvasive and e-cardiology track
Topics:ECG and e-cardiology - Remote monitoring ECG interpretation
Basic and genetic track
Topics:Genetics - Basic Electrophysiology
Device track
Topics:ICD - CRT
Ablation track
Topics:Traditional ablation - VT ablation
HONORARY LECTURES
Come and listen to world renowned experts in our
community talk on their chosen subject:
Intercontinental Lecture
Professor Melvin Scheinman
On Sunday 21 June in room Milano
Einthoven Lecture
Professor Guenther Breithardt
Pioneer in clinical Electrophysiology Lecture
Professor Jean-Claude Daubert
On Wednesday 24 June in room Napoli
NEW! POSTER SESSION
"BEST ABSTRACTS"
Research will be presented in the poster session entitled
"Best Abstracts". The abstracts with the highest grades
will be given full visibility for the entire congress. The
presenters will be by the poster during the Networking
Reception that follows the Inaugural session on the
evening of Sunday 21 June, between 19:00 and 20:00.
NEW! ORAL ABSTRACT SESSIONS
These sessions will be held in the purposely designed area "AGORA" next to the poster area. Each presenter will
have 5 minutes to present their work followed by a Question & Answer period of 3 minutes animated by experts
chairing the session.
Access to Lecture rooms
Seating is on a "first come-first served" basis. We
recommend you go to the lecture room well before
the session begins. Due to safety regulations, we are
required to close the access to the session if the room
fills to capacity.
An ATM is available on level 1.
A business centre is available on level 1.
The cloakroom is located in the registration area and is
For information on Milan, visit the City Information desk
in the registration area.
Charging points for charging of mobile devices are
available on levels 0, 1 and 2.
Congress Badge
The congress badge gives access to the congress from
Sunday 21 June to Wednesday 24 June 2015.
For security reasons, please ensure your badge is visible
at all times during the congress.
Delegate Bag
Each delegate is entitled to a bag to be collected from
the dedicated desk in the registration area. It contains
the Programme at a Glance, the Industry Programme
and a pen.
Participants in need of medical treatment should refer to
the ESC staff in the registration area.
Information desks are available on levels 0, 1 and 2.
Delegates registered at the Standard fee (EHRA
members or non EHRA members) are offered a
complimentary subscription to the EP Europace Journal
for 1 year (2016).
@ Internet Corner
Computers with internet are available in the exhibition
area.
The official language of the congress is English. With the
exception of two Nurse and Allied Professional sessions
in Italian, all lectures and presentations will be held in
English only.
Lost and found items can be recovered from the
registration area.
EHRA EUROPACE - CARDIOSTIM 2015 is a non
smoking congress. Smoking is strictly prohibited
throughout the building.
A prayer room is available. For more information please
ask at any information point.
The congress Mobile App contains the most up to date
programme and is the fastest way to search sessions,
speakers and topics.
There is no printed Final Programme.
iPads to consult the programme via the Mobile
App are available on levels 0, 1 and 2.
Registration to EHRA EUROPACE - CARDIOSTIM
2015 entitles delegates to the following:
•A copy of the Programme at a Glance and the
•Access to the scientific sessions (with the exception
of three EHRA Members only sessions)
•Access to the exhibition and The PACE
•Refreshment breaks each day from Sunday 21 to
Wednesday 24 June.
All delegates are cordially invited by the President of the
European Heart Rhythm Association (EHRA) to attend
the Inaugural session and Networking reception on
Sunday 21 June.
Visual Reproduction
Photographing or filming scientific sessions or meetings
is strictly prohibited (except with prior permission
of the ESC). The ESC reserves the right to video all
presentations of the EHRA EUROPACE - CARDIOSTIM
2015 Congress.
Atrial fibrillation and heart failure: advances
and gaps in knowledge in the elderly.................................................................................................................................ROMA
Cardiac pacing troubleshooting I: indications........................................................................NAPOLI
Reducing shocks in implantable
cardioverter-defibrillator recipients.......................................................................................................................TORINO
Difficult accessory pathway ablations....................................................................................................... PALERMO
Management of catecholaminergic
polymorphic ventricular tachycardia..................................................................................................................GENOVA
Antiarrhythmic gene and pharmacological
therapy...............................................................................................................................................................................................................................................................................BOLOGNA
Novel aspects of ventricular repolarisation
assessment..........................................................................................................................................................................................................................................................................FIRENZE
Global approach to heart rhythm management.................................................. VENEZIA
Allied professionals (Italian): Remote monitoring
and remote treatment................................................................................................................................................................................................................................BARI
Cancer treatment and cardiotoxicity......................................................................................................... CAGLIARI
Who said there's nothing new in 12-LEAD-ECG?
New lessons....................................................................................................................................................................................................................................................................AGORA
Recorded
session - Robotics and technologies
to facilitate atrial fibrillation ablation and device
implantation.................................................................................................................................................................................................................................................................MILANO
The role of LAA occlusion to prevent
thromboembolism in atrial fibrillation..........................................................................................................................ROMA
How to minimise risk for infection during
device implantation?........................................................................................................................................................................................................................NAPOLI
Risk stratification a decade on from SCD-HeFT.............................................. TORINO
How to decrease fluoroscopy exposure
during electrophysiology procedure?.........................................................................................................PALERMO
One gene, different phenotypes: how is it
possible? Lessons from mixed phenotypes
in Brugada syndrome..........................................................................................................................................................................................................GENOVA
Oxidative stress and membrane excitability.........................................................BOLOGNA
Renaissance of Holter monitoring?............................................................................................................................... FIRENZE
Differences in electrophysiology between Europe
and Japan: do they really matter? An update
of clinically relevant information...........................................................................................................................................VENEZIA
Nursing issues and skills in arrhythmia care......................................................................................................BARI
Antiarrhythmic drugs for prevention of atrial
fibrillation - what is new?................................................................................................................................................................................CAGLIARI
Modern treatment of arrhythmias: data from
clinical practice and registries.................................................................................................................................................................AGORA
Transcatheter
Pacing Systems: From development
to clinical results
Sponsored by Medtronic........................................................................................................................................................................................................ROMA
How to optimise the mitral regurgitation treatment
of your heart failure patients with TMVR?
Sponsored by Abbott Vascular..............................................................................................................................................................NAPOLI
AF - New Tools for an Old Disease
Sponsored by Biosense Webster..........................................................................................................................................GENOVA
Present and future of advanced mapping
Sponsored by St.Jude Medical................................................................................................................................................BOLOGNA
lecture..................................................................................................................................................................................................................................MILANO
of atrial fibrillation: time for
something completely different?..........................................................................................................................................................ROMA
Why and how to implant a leadless pacemaker..........................................................NAPOLI
The subcutaneous defibrillator in practice.................................................................................. TORINO
AVNRT ablation.................................................................................................................................................................................................................................PALERMO
Advanced pharmacological and molecular
therapies for inherited arrhythmias.......................................................................................................................GENOVA
Post-extrasystolic potentiation and
myocardial Ca2+ homeostasis..........................................................................................................................................................FIRENZE
Atrial fibrillation and stroke in 2015...................................................................................................................... VENEZIA
Four interesting cases (interactive session)
in implantable cardioverter defibrillator care.............................................................................................BARI
From bench to personalised therapy with
antiarrhythmic drugs........................................................................................................................................................................................................CAGLIARI
Atrial fibrillation: risk factors, fibrosis and
outcomes.....................................................................................................................................................................................................................................................................................AGORA
Honorary
Management
Upstream
treatment of atrial fibrillation:
myth or reality?...........................................................................................................................................................................................................................................................ROMA
MRI of patients with pacemaker – what are
the challenges?........................................................................................................................................................................................................................................................NAPOLI
Programming a primary prevention
implantable cardioverter defibrillator..............................................................................................................TORINO
Focal atrial tachycardia ablation......................................................................................................................................... PALERMO
Beyond Mendelian Inheritance in arrhythmias:
impact for management...........................................................................................................................................................................................GENOVA
Novel modulators of cardiac ion channel..........................................................................BOLOGNA
The ECG in cardiac resynchronisation
therapy (CRT)......................................................................................................................................................................................................................................................FIRENZE
Guidelines: what is in it for me?............................................................................................................................................................................BARI
Ventricular arrhythmias, devices and
Ablation therapy and bail out strategies in
complex arrhytmias.........................................................................................................................................................................................................................AGORA
Inaugural session............................................................................................................................................................................................................................MILANO
Management of atrial fibrillation – new ideas for 2015............................ROMA
The pericardium and the electrophysiologist........................................................................NAPOLI
Troubleshooting stored data in ICDs: is it VT,
SVT, both or neither? Part 1..................................................................................................................................................................TORINO
Arrhythmogenic right ventricular cardiomyopathy
(ARVC) from genes to bedside.................................................................................................................................................GENOVA
Cardiac ion channels and their macromolecular
complexes: electrophysiology and beyond...................................................................BOLOGNA
Emerging smartphone application for cardiac
evaluation.................................................................................................................................................................................................................................................................................FIRENZE
New developments in technology for arrhythmia
nursing...........................................................................................................................................................................................................................................................................................................................BARI
Antiarrhythmic drugs and devices during pregnancy................. CAGLIARI
Risk predictors beyond LVEF + ECG.......................................................................................................................AGORA
State-of-the-art: ablation in patients on NOACs
Sponsored by Boehringer Ingelheim................................................................................................................................AGORA
Live session.....................................................................................................................................................................................................................................................................MILANO
Rotors and atrial fibrillation: experimental
and clinical aspects.........................................................................................................................................................................................................................................ROMA
Lead extraction in practice................................................................................................................................................................................NAPOLI
SVT, both, or neither? Part 2...............................................................................................................................................................TORINO
Catheter ablation of complex ventricular arrhythmias.... PALERMO
Hypertrophic cardiomyopathy: from genetics
to electrical therapies......................................................................................................................................................................................................GENOVA
Integrating remote monitoring of cardiac implantable
electronic devices into daily clinical practice.........................................................................FIRENZE
Remote monitoring to impact morbidity
and mortality.........................................................................................................................................................................................................................................................VENEZIA
Professional and training issues for nurses
and allied professionals..............................................................................................................................................................................................................................BARI
Practical approach to devices and ablation in adults
with repaired congenital heart disease.................................................................................................CAGLIARI
ICD therapy: clinical data and new concepts..........................................................................AGORA
Improving outcomes in Paroxysmal and Persistent
AF Ablation - Sponsored by Medtronic................................................................................................................ROMA
Atrial high rate episodes and stroke prevention - An update.
Organised by AFNET, supported by an unrestricted
educational grant from Daiichi Sankyo Europe......................................................................NAPOLI
Can the new Generation of Contact Force catheter
make AF Ablation more simple?
Sponsored by Biosense Webster.............................................................................................................................................TORINO
Leadless pacing, Advancing Standard of Care
Sponsored by St.Jude Medical.......................................................................................................................................................PALERMO
The subcutaneous defibrillator: are we ready for
a paradigm shift?
Sponsored by Boston Scientific....................................................................................................................................................GENOVA
Extending the Boundaries in Managing Heart Failure
Patients - Sponsored by Sorin Group CRM................................................................BOLOGNA
Left atrial appendage closure: which of your AF patients
benefit most? - Sponsored by Boston Scientific............................................................FIRENZE
Controversies and advances in management of Atrial
Fibrillation - Special session organised by EPIC Alliance,
supported by an unrestricted educational grant from
BIOTRONIK..............................................................................................................................................................................................................................................................VENEZIA
Breaking Trial...........................................................................................................................................................................................................................MILANO
Achieving permanent lesions in atrial fibrillation...............................................................ROMA
Unanswered questions in lead management.............................................................................NAPOLI
Cardiac resynchronisation therapy (CRT)
in the near future: what developments?..................................................................................................TORINO
Defining the outcome of a VT ablation............................................................................................. PALERMO
Troubleshottoting in surface ECG..............................................................................................................................GENOVA
Carmeliet-Coraboeuf-Weidmann lecture......................................................................BOLOGNA
Health technology assessment of device remote
monitoring...........................................................................................................................................................................................................................................................................FIRENZE
Arrhythmias and device problems in acute
cardiac care..................................................................................................................................................................................................................................................................VENEZIA
Organising care for arrhythmia patients:
what can we learn from different models?..............................................................................................................BARI
New approaches to arrhythmias in repaired
congenital heart disease.....................................................................................................................................................................................CAGLIARI
How to improve procedural outcomes following
atrial fibrillation ablation................................................................................................................................................................................................AGORA
Late
on CCE General Assembly.............................................................................................................................BOLOGNA
WG
session - Basic ablation and complex
implantable cardioventer-defibrillator therapy
in paediatric practice...............................................................................................................................................................................................................MILANO
Persistent atrial fibrillation ablation: the quest
for a tailored approach to each patient...................................................................................................................ROMA
Managing infected devices......................................................................................................................................................................................NAPOLI
What is needed to provide cardiac resynchronisation
therapy for all European patients?...................................................................................................................................TORINO
Non-ischaemic cardiomyopathies............................................................................................................................ PALERMO
EHRA activities in the field of EP Wires, patient
and snap-shot surveys. Up-to-date 2015.........................................................................................GENOVA
Evolving picture of cardiac arrhythmias.....................................................................................BOLOGNA
Patient management systems - best use of medical
technologies..................................................................................................................................................................................................................................................................FIRENZE
TRP channels and cardiac electric activity................................................................................... VENEZIA
Psychosocial care of patients with arrhythmia........................................................................................BARI
Management of channellopathies in children,
adolescents & young adults...................................................................................................................................................................CAGLIARI
New ablation technology: ready for prime time?..................................................AGORA
ablation management: Therapy, stroke
prevention and monitoring
Sponsored by Medtronic..................................................................................................................................................................................PALERMO
AF
Management of atrial fibrillation in patients
with left ventricular systolic dysfunction.............................................................................................................ROMA
Start up of a lead extraction program at my center....................................NAPOLI
in heart failure: indication or not?...................................................................................................................................TORINO
How to approach the unstable ventricular
tachycardia patient.....................................................................................................................................................................................................................PALERMO
Argue with experts - case based discussions...................................................................GENOVA
Device registries - quality of care in daily
clinical practice?..............................................................................................................................................................................................................................BOLOGNA
New understanding of syncope..................................................................................................................................................... FIRENZE
Myocardial ischaemia, necrosis and arrhythmias................................................ VENEZIA
Quality of life in living with a device......................................................................................................................................................BARI
Innovation in EP: achievements and pitfalls........................................................................... CAGLIARI
Lead management and syncope........................................................................................................................................................AGORA
session.......................................................................................................................................................................................................................................................................MILANO
Post atrial fibrillation ablation management............................................................................................ROMA
Devices may not be forever? Can ongoing ICD
or CRT therapy become unnecessary?........................................................................................................TORINO
VT ablation in ischaemic cardiomyopathies....................................................................... PALERMO
Best of young research in 2014...................................................................................................................................................GENOVA
Clinical value of registries related to sudden death...................BOLOGNA
New management strategies of syncope................................................................................................ FIRENZE
The right ventricle in arrhythmogenic remodelling................................. VENEZIA
Monitoring arrhythmias in-hospital: Are we getting
it right?............................................................................................................................................................................................................................................................................................................................BARI
EHRA and Cardiostim inventors Awards................................................................................... CAGLIARI
Molecular pathology and therapy of arrhytmias:
novel insights from experimental studies.................................................................................................AGORA
Live
Improving
CRT response: Patient selection,
implantation and therapy
Sponsored by Medtronic..........................................................................................................................................................................................................ROMA
Device infection: prevention & treatment
Sponsored by Spectranetics & Medtronic..................................................................................... PALERMO
Redefining electrophysiology: high resolution
mapping & ablation
Sponsored by Boston Scientific.....................................................................................................................................................GENOVA
Patient optimization with MultiPoint Pacing
Sponsored by St.Jude Medical.................................................................................................................................................BOLOGNA
1 in 14 Patients require arrhythmia intervention:
Remote Patient Management with the Wearable
Cardioverter Defibrillator
Sponsored by ZOLL....................................................................................................................................................................................................................VENEZIA
aspects on stroke prevention in atrial
fibrillation - what to do in 2015?
This session is supported by Boehringer Ingelheim
in the form of an unrestricted educational grant.......................................................................ROMA
Transcatheter aortic valve implantation induced
conduction disorders - How to manage?..................................................................................................NAPOLI
Tips and tricks at CRT implant.......................................................................................................................................................TORINO
The ECG in arrhythmogenic syndromes............................................................................................GENOVA
Atrial fibrillation registries - of clinical use
in daily clinical practice?.................................................................................................................................................................................BOLOGNA
Postural orthostatic tachycardia syndrome,
inappropriate sinus tachycardia and vasovagal syncope:
toward a consensus on diagnosis and therapy.................................................................FIRENZE
Re-remodelling by cardiac resynchronisation................................................................. VENEZIA
Treatment of arrhythmias in female patients..................................................................................................BARI
Young Investigator Award session Basic Science.......................................... CAGLIARI
It's not all about ablation: electrophysiological
insights from left atrial intervention...............................................................................................................................AGORA
Practical
EHRA General Assembly...........................................................................................................................................................................FIRENZE
session..................................................................................................................................................................................................................................MILANO
Stroke prevention for atrial fibrillation – Europe,
Far East or USA, nice or not?..........................................................................................................................................................................ROMA
New devices for heart failure - when, which device
and in whom...................................................................................................................................................................................................................................................................NAPOLI
Antithrombotic management of patients
undergoing electrophysiological procedures.......................................................................TORINO
International CRT implantation practice:
are we in Sync? Rationale for the CRT Survey II
a HFA EHRA initiative..............................................................................................................................................................................................PALERMO
Special ECG diagnostics..........................................................................................................................................................................................GENOVA
Update of registries and EP wire in heart
rhythm management................................................................................................................................................................................................BOLOGNA
Syncope and sudden death prevention:
special considerations in the elderly.........................................................................................................................FIRENZE
Sinus node dysfunction: how can basic science
improve clinical management?........................................................................................................................................................VENEZIA
Challenges in ablation of complex arrhythmias...................................................................................BARI
Young Investigator Award session - Clinical................................................................... CAGLIARI
Who said there's nothing new in cardiac pacing?!...............................................AGORA
New EHRA Scientific Documents-1..........................................................................................................................NAPOLI
Emerging molecular strategies in antiarrhythmic
therapy..............................................................................................................................................................................................................................................................................................TORINO
Opportunities to prevent sudden death
in sports...............................................................................................................................................................................................................................................................................PALERMO
The art of the ECG. Part 1........................................................................................................................................................................GENOVA
Prediction of response to crt and patient
Cardiac resynchronisation therapy (CRT):
difficult decisions in complex patients............................................................................................................TORINO
Non-lethal arrhythmic challenges in athletes............................................................ PALERMO
Complications of af ablation: avoidance,
recognition and management...................................................................................................................................................................AGORA
and Closing Ceremony............................................................................................................................................NAPOLI
 Awards
SUNDAY IN THE POSTER AREA
"Best Abstracts" Poster session
Coffee break - Moderated Posters & Poster session 1
Poster session 1 - WG on Cardiac Cellular Electrophysiology
"Best Abstracts" Poster presentations
MONDAY IN THE POSTER AREA
TUESDAY IN THE POSTER AREA
WEDNESDAY IN THE POSTER AREA
O˜ cial peer-reviewed highlights from EHRA EUROPACE-CARDIOSTIM 2015
As a congress participant, you will receive this publication post congress.
(Please check your mailing address in your My ESC account)
Scan this QR code for more
info or visit us on EHRA-ESC
stand B300
Read the o˜ cial
EHRA EUROPACE-CARDIOSTIM
2013 highlights here:
EHRA EUROPACE Secretariat
EUROPEAN SOCIETY OF CARDIOLOGY
Website: www.escardio.org/europace
MEETING OF
THE EUROPEAN HEART RHYTHM ASSOCIATION (EHRA)
A Registered Branch of the ESC
Website: www.escardio.org/EHRA
CARDIOSTIM
A subsidiary of Reed Expositions France
Website: www.cardiostim.com
JOINT WITH
ESC Working Group on Cardiac Cellular Electrophysiology
Website: www.escardio.org/ewgcce
ESC Working Group on e-Cardiology
Website: www.escardio.org/e-cardiology
MiCo Milano Congressi
Piazzale Carlo Magno, 1
20149 Milano, IT
Website: www.micomilano.it
Speaker Service Centre (SSC)
The SSC is located in level 2 of the venue.
Highly experienced and skilled technicians will assist you to transfer and to confirm your presentation(s).
Once uploaded to the respective lecture room, presentations will be played locally.
Peak hours of operation in the SSC are during coffee breaks and lunch breaks.
In order to maximise your time in the SSC, and the attention that we are able to give you, we highly recommend visiting early
in the morning or during the sessions.
Speaker Service Centre opening hours*
*Hours may be subject to change
Rehearsal: in the SSC, a demonstration computer will be representative of what is supplied in the lecture room.
We strongly recommend that all speakers familiarise themselves with the mouse control.
(AS OF 12/05/2015)
The European Heart Rhythm Association (EHRA) wishes to express its sincere appreciation to all exhibitors, industry
partners and sponsors mentioned below, who have contributed to the success of EHRA EUROPACE - CARDIOSTIM
2015 in a variety of ways and initiatives.
Abbott Electrophysiology
Finapres Medical Systems B.V.
Fysicon B.V.
Access Point Technologies
HAGMED
Arrhythmia Alliance
Hansen Medical
Asia Pacific Heart Rhythm Society
Heart Rhythm Society
Imricor Medical Systems
Baylis Medical
MEDICO SPA
BIOTRONIK SE & Co.KG
MicroPort EP MedTech
Brazilian Society of Arrhythmias
OSYPKA AG
Cardiac Rhythm News
CardioFocus, Inc.
Schwarzer Cardiotek
CIRCA Scientific, LLC
SOLAECE (Sociedad Latino Americana de
Estimulación Cardíaca y Electrofiología)
CVRx, Inc.
Sorin Group CRM
Daiichi Sankyo Europe GmbH
Spectranetics International B.V.
St.Jude Medical
EBR Systems Inc.
Stereotaxis Inc.
EHRA Plaza
Tyche MedTech, Inc.
ERCULES
Vitatron The Pacemakers
Eumaco Srl
Wisepress Medical Bookshop
European Heart Rhythm Association (EHRA)
World Society of Arrhythmias
European Society of Cardiology (ESC)
Zoll CMS GmbH
FIAB SPA
Atrial fibrillation and heart failure: advances and gaps in knowledge in the elderly
Chairpersons: W.K. Shen (Scottsdale, US); P. Mabo (Rennes, FR)
How-to Session
Participants should learn how to apply the ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy in difficult situations where
different options may apply.
Pacing indication in sinus node disease: symptom-rhythm correlation, drug-induced bradycardia, bradycardia at night.
G. Marinskis (Vilnius, LT)
How to distinguish between intrinsic and extrinsic AV block.
J.-C. Deharo (Marseille, FR)
What to do in syncope and bundle branch block.
M. Brignole (Lavagna, IT)
What to do with rate-response function in pacing.
S. Tzeis (Maroussi, GR)
Cardiac pacing troubleshooting I: indications
Chairpersons: E. Tahirovic (Sarajevo, BA); C.W. Israel (Bielefeld, DE)
08:30 State of the art lecture: atrial fibrillation: why age matters, from mechanism to practice guidelines.
C. Torp-Pedersen (Aalborg, DK)
08:52 Case 1: 82 year-old woman has HTN, Diabetic, cr 1.9 with paroxysmal atrial fibrillation; what would you recommend for
anticoagulation?
G.Y.H. Lip (Birmingham, GB)
09:15 Case 2: 87 year-old man has persistent atrial fibrillation with rapid ventricular rate, HTN, class II-III HF and COPD:
would you ablate the AVN? What pacemaker would you recommend?
J.C. Daubert (Rennes, FR)
09:37 Case 3: 85 year-old man runs marathon, has HTN, sinus bradycardia, and symptomatic recurrent persistent atrial fibrillation;
wants a cure: what would you recommend, ablation, anticoagulation?
P. Friedman (Rochester, US)
Upon conclusion of this Europace - Cardiostim Joint Symposium, participants should be able to:
• Assess and manage older patients with atrial fibrillation for stroke prevention using warfarin and new oral anticoagulants
• Describe the current practice in managing elderly patients with heart failure and atrial fibrillation, particularly recognizing the role of AVN
ablation and pacemaker therapy
• Recognize the advances and knowledge gaps in atrial fibrillation ablation in the very elderly
Reducing shocks in implantable cardioverter-defibrillator recipients
Chairpersons: G. Breithardt (Munster, DE); P. Mitkowski (Poznan, PL)
To review the latest advances and techniques for the reduction of inappropriate and unnecessary shocks in patients with ICDs.
Are shocks harmful, or just a marker of risk?
P.A. Scott (London, GB)
When and how to program ATP to prevent shocks.
I. Anguera Camos (Barcelona, ES)
When and how to use drugs to prevent shocks.
J.R. Ehrlich (Frankfurt, DE)
When and how to ablate to prevent shocks.
A. Oto (Ankara, TR)
Difficult accessory pathway ablations
Chairpersons: F. Halimi (Le Chesnay, FR); F. Gaita (Turin, IT)
Ablation techniques for difficult accessory pathways
Parahisian accessory pathways.
A. Sarkozy (Edegem, BE)
Coronary sinus associated pathways.
S. Ammar (Munich, DE)
Permanent junctional reciprocating tachycardia.
Atrio-fascicular and ventricular pathways (Mahaim fibers).
P.P. Adragao (Carnaxide, PT)
Management of catecholaminergic polymorphic ventricular tachycardia
Chairpersons: M. Borggrefe (Mannheim, DE); M. Eldar (Ramat-Gan, IL)
The management of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is complex. The objective is to guide practicing cardiologists
in taking the most rationale approach to prevent sudden death while preserving quality of life.
The role of beta-blockers.
A. Leenhardt (Paris, FR)
The role of flecainide.
C. Van Der Werf (Amsterdam, NL)
The role of ICD.
J. Till (London, GB)
Role of left cardiac sympathetic denervation and renal denervation.
J. Schwartz (Milan, IT)
Antiarrhythmic gene and pharmacological therapy
39th Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology
Chairpersons: T. Christ (Hamburg, DE); C.A. Remme (Amsterdam Z0, NL)
Antiarrhythmic gene therapy - (when) will biologicals replace catheters and drugs?
D. Thomas (Heidelberg, DE)
Genetic and pharmacological rescue of LQT syndrome in hiPSC-derived cardiomyocytes.
L. Sala (Leiden, NL)
Antiarrhythmic principle of SK channel inhibition in atrial fibrillation.
T. Jespersen (Copenhagen, DK)
The pentamidine analogue PA-6 selectively blocks inward rectifier potassium current IK1 in human atrial myocytes.
A.P. Khan (Essen, DE)
Correlating the effect of dofetilide derivatives in HEK cells and in human induced pluripotent stem cell derived cardiomyocytes.
P. Saxena (Vienna, AT)
Novel aspects of ventricular repolarisation assessment
Chairpersons: F. Lombardi (Milan, IT); G. Schmidt (Munich, DE)
Non invasive and eCardiology track
To provide the electrophysiological basis and the clinical utility of established and new techniques for the evaluation of ventricular repolarisation
and its abnormalities, for both experimental and clinical cardiologists
The ionic and genetic bases of ventricular repolarisation.
S.G. Priori (Pavia, IT)
QT interval and its rate and autonomic control.
M. Malik (Purley, GB)
Beat to beat T wave changes.
H.V. Huikuri (Oulu, FI)
Sympathetic activity-associated periodic repolarisation dynamics
A. Bauer (Munich, DE)
European vs. American AF Guidelines.
P. Kirchhof (Birmingham, GB)
European vs. U.S. CIED indications.
M.R. Gold (Charleston, US)
Is there a global strategy for lead extraction?
C.E.H. Kennergren (Goteborg, SE)
European vs. American management of WPW.
G. Van Hare (Saint Louis, US)
Is there a global strategy for VT management?
V. Reddy (New York, US)
Monitoraggio remoto e trattamento remoto - Allied professionals (Italian):Remote monitoring and remote treatment
Chairpersons: C. Giannessi (Pisa, IT); S. Colosio (Brescia, IT)
Local Track
Global approach to heart rhythm management
Joint session with Heart Rhythm Society (HRS)
Chairpersons: J.D. Day (Murray, US); G. Hindricks (Leipzig, DE)
Joint Session
Discutere i nuovi sviluppi nel monitoraggio remoto e nel trattamento remoto
To discuss new development in remote monitoring and remote treatment (this will be an Italian session)
Miglioramento delle cure mediante il monitoraggio remoto, esperienza di un ospedale italiano
Improving care using remote monitoring, experiences of an Italian hospital.
R. Cervellione (Milan, IT)
Vivere con il monitoraggio remoto per i pazienti con ICD
Life with remote monitoring for ICD's patients.
N. Simonelli (Novi Ligure, IT)
E-health per l'istruzione dei pazienti portatori di device: una messa a punto
E-health for education of device patients: a review.
A. Zorzin (Trieste, IT)
Processi organizzativi ed effetti favorevoli sul risparmio del monitoragggio remoto gestito dal personale infermieristico
Workflow and improveements in cost-saving of nurse-led remote monitoring.
L. Morichelli (Roma, IT)
Cancer treatment and cardiotoxicity
Chairpersons: Y.S. Makaryan (Yerevan, AM); M.J. Schalij (Voorschoten, NL)
Cancer treatment may lead to cardiotoxicity. More and more data become available on type of drugs, their influence on cardiac function, the
prevalence and possible surveillance during and after cancer treatment.The same holds for radiotherapy.
Cardiovascular toxicity of chemotherapeutic agents.
P. Van Der Meer (Groningen, NL)
Prediction, prevention and surveillance of cardiac toxicity during cancer treatment.
M.Z. Khawaja (London, GB)
Radiotherapy and cardiotoxicity.
F. Lohr (To Be Confirmed, DE)
An update on radiotherapy in patients treated with a pacemaker or defibrillator.
A.H. Maass (Groningen, NL)
Oral Abstract Session
Who said there's nothing new in 12-LEAD-ECG? New lessons Chairpersons: P.G. Platonov (Lund, SE); J. Atie (Rio De Janeiro, BR)
Each speaker will present and discuss their research during the session.
After the session finishes each speaker will have a dedicated screen next to the Agora in the «Abstract Discussion Zone» in order to further
discuss and display their presentation and facilitate in-depth dialogue with interested parties.
The features of cardiac electrical and structural remodeling in elite soccer athletes.
J.B. Kim, M.S. Ahn, J.S. Woo, H.S. Kim, W. Kim, W.S. Kim, K.S. Kim (Seoul and Wonju, KR)
Electrocardiographic findings in unselected Chinese adolescents during preparticipation screening
L. Wenling, W. Liu, Y. Zhou, G. Zhou (Beijing, CN)
Prognostic significance of an automated ECG QRS score quantifying myocardial scar burden in patients presenting with
symptoms suggestive of acute myocardial infarction
T. Reichlin, R. Twerenbold, R. Abaecherli, C. Sticherling, S. Osswald, C. Mueller (Basel, CH)
The usefulness of a fragmented QRS complex in patients with myocardial ischemia
(W) 46
M.H. Bae, C.Y. Kim, N.K. Kim, J.H. Kim, S.Y. Jang, S.H. Park, W.S. Choi, J.H. Lee, D.H. Yang, Y. Cho (Daegu, KR)
Clinical importance of lead aVR in arrhythmogenic cardiomyopathy.
S. Peters (Salzgitter, DE)
Fragmented QRS complexes in patients with hypertrophic cardiomyopathy: a marker of myocardial fibrosis detected by cardiac
magnetic resonance imaging with gadolinium enhancement 48
E. Tulumen, P. Ehlermann, C. Doesch, B. Rudic, V. Liebe, S. Roeger, J. Kuschyk, H.A. Katus, T. Papavassiliu, M. Borggrefe
(Mannheim and Heidelberg, DE)
09:24 Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia
A.M. Saguner, S.H. Baldinger, L.M. Haegeli, T. Wolber, J. Steffel, N. Krasniqi, S.A. Mueller-Burri, C. Brunckhorst, F. Duru
(Zurich and Bern, CH)
09:33 Prevalence and prognosis role of wide QRS and of QRS narrower than normal
P. Maury, E. Lematte, J.B. Ruidavet, A. Rollin, A. Duparc, P. Mondoly, C. Cardin, M. Sadron, V. Bongard, J. Ferrieres (Toulouse, FR)
09:42 Electrocardiographic features in patients presenting with non-ischaemic cardiomyopathy and ventricular tachycardias
G. Santagostino, T. Oloriz, G. Peretto, H.J.J. Wellens, P. Della Bella (Milan, IT; Maastricht, NL)
09:51 Electrocardiographic criteria and outcome in patients with arrhythmogenic right ventricular cardiomyopathy.
Posters on display for the whole congress
The outstanding quality of the following abstracts meant they received the highest grades; accordingly they have
been given full visibility for the entire congress.
(The "Best Abstracts" are listed page 39 to 41)
POSTER AREA
ICD with and without lead: outcomes and complications
Chairpersons: A. Arenal Maiz (Madrid, ES); I. Mavrakis (Heraklion, GR)
Temporal changes in patient characteristics and comorbidities in primary and secondary prevention ICD implantations - Insight
from nationwide Danish registries
A.C. Huth Ruwald, M. Vinther, G.H. Gislason, J.B. Johansen, J.C. Nielsen, H.H. Petersen, O.D. Joergensen, S. Riahi, C. Jons
(Gentofte, Odense, Aarhus, Copenhagen and Aalborg, DK)
Ventricular antitachycardia pacing therapy in heart failure patients with cardiac resynchronization therapy defibrillator:
efficacy, safety and impact on heart failure hospitalizations and mortality.
R.P. Ricci, M. Landolina, M. Lunati, G. Boriani, E. Daleffe, R. Rordorf, M. Maines, A. Rossillo, M. Gasparini, A. Proclemer
(Rome, Crema, Milan, Bologna, Udine, Pavia, Rovereto, Mestre-Venice and Rozzano, IT)
Fragmented left bundle branch block predicts efficacy of antithachycardia pacing theraphy in implantable cardioverter
desfibrillator carriers E. Rodriguez Gonzalez, C. Pham Trung, V. Castro Urda, J. Toquero Ramos, M. Sanchez Garcia, A. Ragab, J. Goirigolzarri Artaza,
M.A. Restrepo Cordoba, J. Vazquez Lopez Ibor, I. Fernandez Lozano (Madrid, ES)
Incidence of Slow Ventricular Tachycardia, ATP efficacy and clinical outcome in CRT-D population
A. Bauer, F. Bode, F. Legal, F. Francesci, A. Duparc, J. Sahu, D. Mueller, R. Luise, M. Martino, A. Deplagne (Schwäbisch Hall,
Luebeck, Bad Bevensen and München, DE; Poitiers, Marseille, Toulouse and Bordeaux, FR; Sheffield, GB; Chieti, IT)
Baroreflex activation therapy (BAT) safely coexists with cardiac rhythm management devices in patients with heart failure and
reduced ejection fraction
J. Mueller-Ehmsen, C. Butter, M. Halbach, R. Wachter, M. Senni, D. Klug, A. Ducharme, N. Madershahian, E. Lovett, V. Swarup
(Hamburg, Bernau bei Berlin, Cologne and Gottingen, DE; Bergamo, IT; Lille, FR; Montreal, CA; Minneapolis and Phoenix, US)
Evaluation of implantable cardioverter-defibrillator leads: a long term follow-up study
L. Leite, R. Providencia, N. Antonio, M. Ventura, J. Cristovao, L. Elvas, M. Pego (Coimbra, PT; London, GB)
Eligibility of hypertrophic cardiomyopathy patients for subcutaneous ICD: results of postural & exercise ECG screening
N.T. Srinivasan, K. Patel, P.D. Lambiase (London, GB)
Twelve-month CIED infection rate in ICD and CRT replacements using the antibacterial envelope: results of the CITADEL
and CENTURION studies
C. Henrikson, M.R. Sohail, G.R. Simons, D.J. Lerner, S. Sisk (Portland, Rochester, Englewood, NJ and Monmouth Junction, NJ, US)
The subcutaneous-ICD for patients with Brugada syndrome: a viable option for everybody?
N. Monteforte, A. Mazzanti, N. Maurizi, R. Bloise, M. Morini, P. Gambelli, C. Napolitano, S.G. Priori (Pavia, IT)
Longevity of the subcutaneous implantable defibrillator: long-term follow-up of the European Regulatory Trial cohort
D.A.M.J. Theuns, I.G. Crozier, G.S. Barr, M.A. Hood, R. Cappato, R.E. Knops, A.H. Maass, L.V.A. Boersma, L. Jordaens (Rotterdam,
Amsterdam, Groningen and Nieuwegein, NL; Christchurch and Auckland, NZ; Dudley, GB; San Donato Milanese, IT; Ghent, BE)
Moderated Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from 08:30 until 12:30. The
presenter should be present throughout the coffee break (10:00 - 11:00) in order to discuss the poster.
The following abstracts were chosen for their high quality and will be discussed during the Moderated Poster session animated by two
Chairpersons between 10:00 - 11:00. Each presenter will have 5 minutes to present and discuss their research in front of the audience and the
08:30 - 18:00 "Best Abstracts" Poster on display in the poster area
Recorded session-Robotics and technologies to facilitate atrial fibrillation ablation and device implantation
Chairpersons: J.L. Merino (Madrid, ES); C. Blomstrom-Lundqvist (Uppsala, SE)
- To be familiar with technologies which reduce fluoroscopic exposure during ablation and device implantation procedures.
- To learn the basic principles of second generation remote navigation systems, specially for ablation in patients with complex anatomical
peculiarities.
Robotic AF ablation with the Amigo Remote Navigation system.
J.L. Merino (Madrid, ES)
Retroaortic AF ablation with the Magnetecs Remote Navigation system after atrial septal occluder device implantation.
Reducing radiation exposure in the EP lab: Fluoroscopy-free ICD implantation.
The role of LAA occlusion to prevent thromboembolism in atrial fibrillation
Chairpersons: A. Romanov (Novosibirsk, RU); L.V.A. Boersma (Nieuwegein, NL)
Patient selection for LAA occlusion.
T. Lewalter (Munich, DE)
Tips and tricks for successful LAA occlusion. B. Schmidt (Frankfurt, DE)
Innovation in cardiac imaging to optimise selection and positioning of LAA occluders.
Y. Blaauw (Groningen, NL)
LAA occlusion: what lies ahead.
C. Tondo (Milan, IT)
How to minimise risk for infection during device implantation?
Chairpersons: M.G. Bongiorni (Pisa, IT); V. Pretorius (San Diego, US)
Which routines will help minimising device related infections both acutely and long term . Putting patient safety in focus
What do registries tell us on risk factors for infection?
R. Kirkfeldt (Aarhus, DK)
As simple as soap and water? Patient, operation theatre and operators as well as setting up a protocol for prevention of infection. 71
D. Klug (Lille, FR)
Surgical technique and center volume – Does it matter?
F. Gadler (Stockholm, SE)
What is the documentation of antibiotics to prevent device infections?
I.E. Ovsyshcher (Beer-Sheva, IL)
Risk stratification a decade on from SCD-HeFT
Chairpersons: J. Healey (Hamilton, CA); I. Zupan (Ljubljana, SI)
To provide an up to date perspective on risk stratification for sudden cardiac death in patient being considered for primary prevention ICDs
Are the results of SCD-HeFT and MADIT-2 applicable to today's primary prevention patients?
M. Zabel (Gottingen, DE)
How to approach risk in patient groups when there's no trial data?
H.U. Klein (Munich, DE)
Can we prevent SCD in the first 6 weeks after MI?
G. Steinbeck (Starnberg, DE)
Can biomarkers be useful for risk stratification?
I. Goldenberg (Ramat Gan, IL)
The session proposal aims at providing an update to the best medical practice of fluoroscopy reduction in the EP lab.
One gene, different phenotypes: how is it possible? Lessons from mixed phenotypes in Brugada syndrome.
Chairpersons: S. Viskin (Tel Aviv, IL); S.G. Priori (Pavia, IT)
Biophysical effect of ionising radiation during invasive electrophysiological procedures.
M.G. Andreassi (Pisa, IT)
Radiation in the EP lab: how can we use our XRay systems properly?
T.J.R. De Potter (Aalst, BE)
3D mapping systems: with or without fluoroscopy?
S. Ernst (London, GB)
To use the old tools or change the concept: intracardiac echocardiography in the EP lab.
L. Saghy (Szeged, HU)
How to decrease fluoroscopy exposure during electrophysiology procedure?
Chairpersons: F. Aliyev (Baku, AZ); C. Piorkowski (Dresden, DE)
This section will provide fascinating data on "mixed phenotypes." Different members of unique families carrying the same mutation present with
different phenotypes. How is this possible?
Brugada syndrome and atrioventricular-conduction disease.
V. Probst (Nantes, FR)
Brugada syndrome and CPVT.
C. Napolitano (Pavia, IT)
Brugada syndrome and LQT3.
E. Nof (Tel Hashomer, IL)
Brugada syndrome and early repolarisation.
G. Conte (Lugano, CH)
Oxidative stress and membrane excitability 39th Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology
Chairpersons: P.G.A. Volders (Maastricht, NL); A. Gomez (Chatenay-Malabry, FR)
How mitochondrial ROS production triggers arrhythmias in hypertrophic cardiomyopathy.
C. Maack (Homburg/Saar, DE)
Beat-to-beat variability of action potential duration in canine ventricular myocytes is influenced by extracellular redox
potential and pH.
N. Szentandrassy (Debrecen, HU)
Intracellular milieu during acute myocardial ischemia: the role of the late Na+ current.
C. Ronchi (Milan, IT)
The serine carboxypeptidase cathepsin a increases atrial fibrillation susceptibility
D. Linz, M. Hohl, A. Nickel, S. Ruf, C. Maack, U. Schotten, T. Sadowski, M. Boehm (Homburg and Frankfurt/Main, DE; Maastricht, NL)
Loss of nNOS is sufficient to provide substrate of AF by retrieving AF electrical remodelling.
X. Liu (Oxford, GB)
Renaissance of Holter monitoring?
Chairpersons: I. Cygankiewicz (Lodz, PL); D. Francis (London, GB)
To learn clinical and research possibilities offered by novel Holter analyses including the possibilities of simultaneous recordings of different signals.
Post-extrasystolic cardiovascular response analysis.
G. Schmidt (Munich, DE)
Ventricular repolarisation analysis.
From Holter to loop recorder.
F. Lombardi (Milan, IT)
Respiratory signals from Holter.
D. Sinnecker (Muenchen, DE)
Differences in electrophysiology between Europe and Japan: do they really matter? An update of clinically relevant information
Joint session with the Japanese Heart Rhythm Society (JHRS)
Chairpersons: K. Okumura (Hirosaki, JP); A. Goette (Paderborn, DE)
Rhythm control strategies in AF patients.
K. Inoue (Osaka, JP)
Anticoagulation with old and new drugs.
Strategies in device implantation.
T. Mitsuhashi (Saitama-City, JP)
Genetic background of Channelopathies.
S. Kaab (Munich, DE)
Problemi e competenze di interesse infermieristico nella cure delle Aritmie - Nursing issues and skills in arrhythmia care
Chairpersons: P. Raffagnato (Rovigo, IT); A. Porfili (Roma, IT)
Discutere e migliorare lo sviluppo della cura delle aritmie in Italia
To discuss and enhance development of professional care in arrhythmia care in Italy
Aspettative future, associazioni ed opportunità nella formazione degli infermieri dedicati gestione di PM/ICD in Italia.
Future expectations, associations and possibilities in training of PM/ICD nurses in Italy.
C. Giannessi (Pisa, IT)
La gestione del paziente a fine vita,portatore di un dispositivo cardiaco: quali sono i problemi ? Quando devono essere
interrotte le terapia?
Taking care of a End-of-Life patient with a cardiac device: what are the issues? When should we stop the therapies?
N. Draoli (Grosseto, IT)
11:45 Autogestione delle cure per i pazienti portatori di un dispositivo cardiaco: problemi, miglioramenti e prospettive future.
Self care for patients with a cardiac device: problems, advances and perspectives.
A. Durante (Rho, IT)
12:07 Pacemaker senza fili ed ICD sottocutaneo: cosa posso e dovrei sapere ?
Leadless pacing and S-ICD: what can and should I know?
S. Colosio (Brescia, IT)
Antiarrhythmic drugs for prevention of atrial fibrillation - what is new?
Chairpersons: A. Capucci (Bologna, IT); P. Kourtellaris (Nicosia, CY)
Mechanisms of atrial fibrillation - potential targets for prevention of AF and practical tips.
H.J.G.M. Crijns (Maastricht, NL)
Upstream therapies for AF including lifestyle - is there really evidence
P. Sanders (Adelaide, AU)
New antiarrhythmic drugs - will they really replace the old one's
I.C. Van Gelder (Groningen, NL)
Does the genotype influence response to antiarrhythmic drugs?
D. Dawood (Nashville, US)
Antiarrhythmic drugs still are the cornerstone for prevention of AF. Upstream therapies still are incompletely studied and the role of the
genotype and efficacy of antiarrhythmic drugs is still in its infancy
Modern treatment of arrhythmias: data from clinical practice and registries
Chairpersons: M. Antz (Oldenburg, DE); J.M. Almendral Garrote (Madrid, ES)
Rivaroxaban and dabigatran versus warfarin in patients with high risk of stroke and embolism undergoing electrical
cardioversion with persistent and long-acting atrial fibrillation
O. Kalejs, A. Strelnieks, M. Kovalova, I. Sime, N. Pontaga, M. Zabunova, M. Berzina, I. Cgojeva, A. Lejnieks, A. Erglis (Riga, Jelgava,
Liepaja and Daugavpils, LV)
Predictive ability of bleeding risk scores for stratification of bleeding events in elderly patients with atrial fibrillation.
L. Fauchier, A. Banerjee, I. Lagrenade, N. Clementy, A. Bernard, D. Angoulvant, D. Babuty, G.Y.H. Lip (Tours, FR; Birmingham, GB)
A multicentre experience of percutaneous left atrial appendage occlusion (LAAO) using different device technologies,
with focus on long term outcome T.R. Betts, M. Leo, S. Panikker, P. Kanagaratnam, D. Hildick-Smith, D. Todd, D. Fox, C. Pepper, J. Foran, T.R. Wong (Oxford, London,
Brighton, Liverpool, Manchester and Leeds, GB)
Early detection and treatment of supraventricular arrhythmia by remote monitoring prevents its progression in pacemaker
patients: the randomized, multicenter SETAM trial
W. Amara, C. Montagnier, S. Cheggour, M. Boursier, C. Barnay, F. Georger, A. Deplagne, S. Fromentin, M. Mlotek, J. Taieb
(Montfermeil, Vannes, Avignon, Ars-Laquenexy, Aix-en-Provence, Béziers, Libourne, Montbéliard and Saint-Etienne, FR)
The influence of remote monitoring on long-term cardiovascular outcomes after cardioverter-defibrillator implantation
G. Portugal, M. Oliveira, P.S. Cunha, B. Valente, A. Lousinha, S. Alves, A.S. Delgado, R. Pimenta, J. Feliciano, R. Ferreira (Lisbon, PT)
Radiation exposure during cardiac device implantation: the RayPace registry
P. Bru, A. Dompnier, W. Amara, G. Haddad, G. Galuscan, P. Sagnol, M. Steinbach, C. Montagnier, J. Taieb, A. Milhem
(La Rochelle, Annecy, Montfermeil, La Roche sur Yon, versailles, Chalon s/Saône, Haguenau, Vannes and Aix-en-Provence, FR)
Is early reoperation after a CIED procedure associated with mortality after 6 months? Results from a complete, nationwide
cohort in Denmark
R. Kirkfeldt, J.B. Johansen, E.A. Nohr, O.D. Joergensen, J.C. Nielsen (Aarhus and Odense, DK)
Polish registry of electrical storm and recurrent ventricular tachycardia RECOVERY- preliminary results. R. Sierpinski, J. Stepinska, Z. Kalarus, G. Opolski, K. Wranicz, S. Stec, P. Derejko, P. Urbanek, M. Bilinska, L. Szumowski
(Warsaw, Zabrze, Lodz and Rzeszow, PL)
Predictors of mortality following ventricular tachycardia ablation: data from the German multicenter ablation registry
R.R. Tilz, J. Senges, L. Eckardt, S. Willems, S. Kaab, T. Deneke, T. Lewalter, C. Reithmann, J. Brachmann, K.H. Kuck (Hamburg,
Ludwigshafen, Münster, Munich, Bad Neustadt a.d. Saale and Coburg, DE)
After-PCI serious arrhythmias associated with worse short-term prognosis in stable patients with NSTE-ACS undergoing
successful early PCI
F. Cordeiro, S. Leao, P. Magalhaes, A. Baptista, C. Ferreira, A. Ferreira, P.S. Mateus, J.I. Moreira (Vila Real, PT)
Satellite SymposiumROMA
Transcatheter Pacing Systems: From development to clinical results
Sponsored by Medtronic
Chairpersons: M.G. Bongiorni (Pisa, IT); T.A. Simmers (Eindhoven, NL)
Learn about how the Medtronic Transcatheter Pacing System was developed, how to implant the device with tips and tricks and finally what the
first clinical results are.
M.G. Bongiorni (Pisa, IT)
Innovation by collaboration between physicians and industry.
P. Ritter (Pessac, FR)
Implantation of a Transcatheter Pacing System.
C. Steinwender (Linz, AT)
First clinical experience and results.
L. Mont (Barcelona, ES)
Conclusions and discussion.
T.A. Simmers (Eindhoven, NL)
Satellite Symposium
How to optimise the mitral regurgitation treatment of your heart failure patients with TMVR?
Sponsored by Abbott Vascular
Chairperson: K.H. Kuck (Hamburg, DE)
- Raise awareness on TMVR for optimizing the treatment of Mitral Regurgitation in Heart Failure patients
- Investigates and discuss current clinical practices
K.H. Kuck (Hamburg, DE)
WHO can benefit from Transcatheter Mitral Valve Repair?
A. Vahanian (Paris, FR)
WHY should you refer your patient to Transcatheter Mitral Valve Repair?
F. Gustafsson (Copenhagen, DK)
WHEN should I consider TMVR for treating my patient?
C. Butter (Bernau/Berlin, DE)
Take home messages.
AF - New Tools for an Old Disease
Sponsored by Biosense Webster
Chairperson: M. Grimaldi (Bari, IT)
Clinical data on efficiency and efficacy of Multi ablation Technology in treating Atrial Fibrillation. Standardized workflow and how it adds value to
your clinical practice.
Clinical Review of Multi Ablation Technology.
M. Grimaldi (Bari, IT)
Versatility of Multipolar Ablation.
G.A. Ng (Leicester, GB)
Efficiency of Standard Workflow.
M. Anselmino (Torino, IT)
Discussion and wrap-up.
Present and future of advanced mapping
Sponsored by St.Jude Medical
Chairpersons: P. Della Bella (Milan, IT); C. Piorkowski (Dresden, DE)
The session will present optimized methods to improve the diagnosis and treatment of complex atrial and ventricular arrhythmias. These methods
include advanced mapping techniques and contact force guided ablation.
Advances in electroanatomical mapping: Atrial applications today and tomorrow.
I. Deisenhofer (Munich, DE)
Advances in ventricular remapping and morphology matching.
P. Della Bella (Milan, IT)
Guiding Contact Force ablation procedures using advanced 3D mapping and navigation techniques.
Honorary lecture
Chairpersons: G. Hindricks (Leipzig, DE); A.J. Camm (London, GB)
Management of atrial fibrillation: time for something completely different?
Chairpersons: C.R. Bezzina (Amsterdam, NL); B. Casadei (Oxford, GB)
Intercontinental Lecture:
Newer diagnostic and treatment options for patients with Arrhythmogenic Right Ventricular dysplasia. M.M. Scheinman (San Francisco, US)
Einthoven Lecture: Atrial fibrillation – from mechanisms to improved care
G. Breithardt (Munster, DE)
To inform on newly discovered mechanisms involved in the pathogenesis of atrial fibrillation and evaluate their translational potential
Atrial fibrillation genomics: Time to take the next step.
MicroRNAs: are they realistic therapeutic targets in atrial fibrillation?
Targeting atrial fibrosis: the holy grail for the treatment of atrial fibrillation?
R.P. Martins (Rennes, FR)
Fat chance: adipose tissue talks to the atrial myocardium.
S. Hatem (Paris, FR)
Why and how to implant a leadless pacemaker Chairpersons: G.Z. Duray (Budapest, HU); V. Reddy (New York, US)
Participants should learn why and how to implant these new devices
Why should I implant a leadless pacemaker? Clinical cases of complications with traditional pacing devices.
How to implant a leadless pacemaker with screw-in fixation?
F.V.Y. Tjong (Amsterdam, NL)
How to implant a leadless pacemaker with fixation by hook-mechanism?
The Future: What can we expect (or hope) will come in leadless pacing.
J.M. Morgan (Southampton, GB)
The subcutaneous defibrillator in practice
Chairpersons: C. Sticherling (Basel, CH); P. Avraamides (Nicosia, CY)
Appropriate and inappropriate shocks from S-ICDs.
Sensing issues in S-ICDs and how to avoid them.
Detecting and Managing Complications from S-ICDs.
L.R.A. Olde Nordkamp (Amsterdam, NL)
Patient experience and quality of life.
S.S. Pedersen (Odense, DK)
AVNRT ablation
Chairpersons: L. Jordaens (Gent, BE); C. Wolpert (Ludwigsburg, DE)
Discuss the atypical forms of AVNRT, the ablation energy choise.
14:00 EP maneuvers to differentiate atypical AVNRT from focal atrial tachycardia originating from the coronary sinus ostium and from
J.M. Almendral Garrote (Madrid, ES)
14:22 AVNRT ablation associated with first degree AV block, clinical risks and solutions.
P. Loh (Utrecht, NL)
14:45 Left sided AVNRT: anatomy and implications for ablation.
15:07 Choosing radiofrequency or cryoenergy for AVNRT ablation?
Advanced pharmacological and molecular therapies for inherited arrhythmias.
Chairpersons: E. Behr (London, GB); C. Napolitano (Pavia, IT)
This section will provide thorough information on the future of therapy in inherited arrhythmogenic disease. Cardiologists will have cutting edge
information on the therapeutic strategies that will be entering in the clinical arena in a near future.
New strategies for cardiac sodium current modulation.
L. Belardinelli (Foster City, US)
Role of late sodium current in drug-induced long QT syndrome.
H. Abriel (Bern, CH)
Gene therapy using viral vectors from basic science to bedside.
Isogenic human pluripotent stem cell pairs to study long-QT syndrome.
M. Bellin (Leiden, NL)
Poster session 1 - WG on Cardiac Cellular Electrophysiology 39th Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology (see page 48 to 50)
Post-extrasystolic potentiation and myocardial Ca2+ homeostasis
Chairpersons: M. Malik (Purley, GB); A. Bauer (Munich, DE)
Myocardial Ca2+ homeostasis.
A. Zaza (Milan, IT)
Post-extrasystolic potentiation: Link between Ca2+ homeostasis, heart failure
M.A. Vos (Utrecht, NL)
Post-extrasystolic potentiation predicts outcome in post-MI patients
Interval-force relationship predicts outcome in atrial fibrillation
Atrial fibrillation detection in cryptogenic stroke patients: clinical evidences.
Anticoagulation in atrial fibrillation - state of the art.
Registries of anticoagulation in atrial fibrillation: a global perspective.
M.J.O. Figueiredo (Campinas, BR)
Alternatives in the era of NOAC: left atrial appendage closure ? AF ablation ?
E. Saad (Rio De Janeiro, BR)
Discussion.
P. Kirchhof (Birmingham, GB); G.Y.H. Lip (Birmingham, GB); M.J.O. Figueiredo (Campinas, BR); E. Saad (Rio De Janeiro, BR)
Atrial fibrillation and stroke in 2015
Joint session with the Sociedad Brasileira de Arritmias Cardiacas (SOBRAC)
Chairpersons: L. Magalhaes (Salvador, BR); K.H. Kuck (Hamburg, DE)
To understand how the physiology and pathophysiology of myocardial Ca2+ homeostasis is linked to post-extrasystolic potentiation, which can
be easily measured in patients to assess the contractile status of their heart.
Four interesting cases (interactive session) in implantable cardioverter defibrillator care
Chairpersons: T.M. Norekval (Bergen, NO); T. Jaarsma (Norrkoping, SE)
To hear about and discuss patient cases within ICD care
Clinical case: ICD for life? Decisions at device- and patient end-of-life
J.B. Johansen (Odense M, DK)
Clinical case: Brugada Syndrome and ICD
D.H. Lau (Adelaide, AU)
Clinical case: explantation of LVAD and ICD.
T. Ben Gal (Ramat Hasharon, IL)
Clinical case: implantable cardioverter defibrillator shocks, what do people feel.
I. Morken (Stavanger, NO)
From bench to personalised therapy with antiarrhythmic drugs
Chairpersons: A. Goette (Paderborn, DE); M. Rienstra (Groningen, NL)
Antiarrhythmic drugs are still the cornerstone for treatment of arrhythmias. However, ablation is performed more and more. In this session we
will discuss the mechanism of antiarrhytmhic drugs and the role of antiarrhythmic drugs
Basics of antiarrhythmic drugs.
U. Schotten (Maastricht, NL)
Antiarrhythmic drugs in patients with heart failure
A. Capucci (Bologna, IT)
Antiarrhythmic drugs in adults with congenital heart disease
N.M.S. de Groot (Beinsdorp, NL)
Antiarrhythmic drugs in clinical practice - is patient tailored therapy an option?
J.-Y. Le Heuzey (Paris, FR)
Atrial fibrillation: risk factors, fibrosis and outcomes
Chairpersons: A. Rillig (Hamburg, DE); J. Healey (Hamilton, CA)
14:00 Type of atrial fibrillation and pre-existing heart failure: impact on adverse clinical outcomes
K. Senoo, G. Lip, D. Lane, H. Buller, D. Kotecha (Birmingham, GB; Amsterdam, NL)
14:09 The dangerous embrace between atrial fibrillation and diabetes mellitus: the EURObservational Research Programme - Atrial
Fibrillation (EORP-AF) General Pilot Registry
S. Fumagalli, S. Said, C. Laroche, D. Gabbai, N. Marchionni, G. Boriani, A. Maggioni, M. Popescu, H. Crijns, G. Lip (Florence and
Bologna, IT; Hengelo and Maastricht, NL; Sophia-Antipolis, FR; Oradea, RO; Birmingham, GB)
14:18 Functional remodeling of both atria is associated with occurrence of stroke in patients with atrial fibrillation: lessons from
dynamic computed tomographic analysis of cardiac chamber
(W) 175
H.-M. Tsao, W.C. Hu, P.-H. Tsai, C.-L. Lee, H.-H. Wang, S.-A. Chen (Yi-Lan, Chung-Li and Taipei, TW)
14:27 Cerebral blood flow is improved after cardioversion of atrial fibrillation
M. Gardarsdottir, S. Sigurdsson, T. Aspelund, V.A. Gardarsdottir, V. Gudnason, D.O. Arnar (Reykjavik and Kopavogur, IS)
14:36 Pattern of left atrial remodeling at computed tomography in patients with paroxysmal, persistent and without atrial fibrillation 177
M. Brunelli, A. Grosse, S. Raffa, A. Madaffari, A. Cima, M. Frommhold, T. Daehne, J.C. Geller (Bad Berka, DE)
14:45 Comparison of atrial low voltage extent between persistent and paroxysmal atrial fibrillation
J. Sorrel, H. Lehrmann, J. Schiebelling, R. Weber, J. Allgeier, T. Arentz, A. Jadidi (Bad Krozingen, DE)
14:54 Relationship between diastolic ventricular dysfunction and subclinical sleep-disordered breathing in atrial fibrillation ablation
K. Kaitani, N. Onishi, Y. Hayama, H. Kondo, C. Izumi, Y. Nakagawa (Tenri, JP)
15:03 Obstructive respiratory events and premature atrial contractions after cardioversion 180
D. Linz, M. Hohl, K. Wirth, H.R. Neuberger, M. Boehm (Homburg, DE)
15:12 Modelling the effects of fibrosis-associated electrical heterogeneity in atrial fibrillation
R. Morgan, M.A. Colman, H. Chubb, M. Varela, O.V. Aslanidi (London and Manchester, GB)
15:21 Effects of different fibrotic patterns in the maintenance of atrial fibrillation: a simulation study.
M. Mase, S. Pelloni, A. Cristoforetti, F. Ravelli (Trento, IT)
Contemporary technologies for af ablation
Chairpersons: J. Mansourati (Brest, FR); G.A. Ng (Leicester, GB)
PVI by an endoscopically guided laser balloon: learning curve results after 12-month evaluation in 110 patients
D.Q. Nguyen, S. Wilke, L. Lichtenberg, W. Fehske (Cologne, DE)
Superiority of irrigated multipolar catheter over conventional catheters in atrial fibrillation ablation
S.H. Chin, S.S. Varanasi, G.S. Chu, S. Siddiqui, S.H. Man, R. Somani, A.J. Sandilands, P.J. Stafford, G.A. Ng (Leicester, GB)
Pulmonary vein isolation for symptomatic atrial fibrillation with 2nd generation cryoballoon in patients over 75 years of age P185
A. Pott, C. Bothner, M. Iturbe, M. Messemer, K. Petscher, W. Rottbauer, T. Dahme (Ulm, DE)
Comparison of cooled-tip radiofrequency vs laser balloon for pulmonary vein isolation in patients with atrial fibrillation,
a prospective evaluation
J. Osca Asensi, O. Cano, A. Andres, P. Alonso, M.J. Sancho Tello, J. Olague, L. Martinez Dolz, A. Salvador (Valencia, ES)
12-month clinical outcomes following pulmonary vein isolation using the arctic front advance second-generation cryoballoon:
results from the multi-center STOP AF post approval study
B.P. Knight, P.G. Novak, R. Sangrigoli, J. Champagne, M. Dubuc, S.W. Adler, V. Essebag, S.K. Jain, R.M. John, M. Mansour (Chicago,
Doylestown, St Paul, Pittsburgh and Boston, US; Victoria, Quebec and Montreal, CA)
A single four-minutes freeze with adenosine provocation versus standard procedure with bonus freeze for cryoballoon ablation:
15-months follow-up in 192 patients
J. Tebbenjohanns, C. Hoefer, L. Bergmann, M. Dedroogh, D. Gaudin, A. Von Werder, K. Ruehmkorf (Hildesheim, DE)
Reliable, fast and safe: the first results with the novel gold multi-electrode ablation catheter for atrial fibrillation
P. Gal, T. Buist, J.J.J. Smit, A. Adiyaman, A.R. Ramdat Misier, P.P.H.M. Delnoy, A. Elvan (Zwolle, NL)
Pilot results of independent approach to rotor targeted catheter ablation of persistent atrial fibrillation
P. Kuklik, B. Schaeffer, B.A. Hoffmann, D. Schreiber, J.M. Moser, R.O. Akbulak, D. Steven, L. Pison, U. Schotten, S. Willems
(Hamburg and Cologne, DE; Maastricht, NL)
Pulmonary vein orientation significantly impacts pulmonary vein isolation results in multi-electrode ablation
T.J. Buist, P. Gal, J.J.J. Smit, A.R. Ramdat Misier, P.P.H.M. Delnoy, J.P. Ottervanger, P.L. Jager, A.R. Elvan (Zwolle, NL)
Nine months outcomes following focal impulse and rotor modulation for the treatment of atrial fibrillation using the novel
64-electrode basket catheter
R.R. Tilz, T. Lin, A. Rillig, L. Scholz, C.H. Heeger, A. Metzner, S. Mathew, E. Wissner, F. Ouyang, K.H. Kuck (Hamburg, DE)
Moderated Posters must be set up between 13:30 and 14:00, removed between 18:00 and 18:30 and be on display between 14:00 and 18:00.
The presenters should be present throughout the break (15:30 - 16:30) in order to discuss the poster.
chairpersons.
Upstream treatment of atrial fibrillation: myth or reality?
Chairpersons: P.E. Vardas (Heraklion, GR); W. Galal (Cairo, EG)
Review of clinical trials targeting signalling pathways upstream of the atrial ionic/structural changes that provide a substrate for AF
n-3 Polyunsaturated fatty acids.
A.P. Maggioni (Florence, IT)
Statins.
B. Casadei (Oxford, GB)
Angiotensin receptor blockers.
I. Savelieva (London, GB)
Anti-inflammatory agents.
M. Imazio (Torino, IT)
MRI of patients with pacemaker – what are the challenges?
Chairpersons: D. Zizek (Ljubljana, SI); To be announced
Which strategies should be used when MRI is performed in pacemaker (and ICD) patients
MRI conditional IED
A. Silva Ferreira (Lisbon, PT)
MRI of patients with conventional non-MRI conditional devices.
H. Hoegh Petersen (Copenhagen, DK)
The lead factor in MRI: active and abandomed leads.
W. Jung (Villingen-Schwenningen, DE)
A practical approach.
Debate Session
Programming a primary prevention implantable cardioverter defibrillator
Chairpersons: F.D. Murgatroyd (London, GB); A.N. Hovhannesyan (Yerevan, AM)
EHRA Members only session
DFT testing at the time of ICD implant for primary prevention is obsolete - Pro.
J. Healey (Hamilton, CA)
DFT testing at the time of ICD implant for primary prevention is obsolete - Contra.
DFT testing at the time of ICD implant for primary prevention is obsolete - Rebuttal Pro.
DFT testing at the time of ICD implant for primary prevention is obsolete - Rebuttal Contra.
J. Healey (Hamilton, CA); J.M. Morgan (Southampton, GB)
Programming ATP at the time of ICD implant for primary prevention is obsolete and may even be harmful - Pro.
P. Lambiase (London, GB)
Programming ATP at the time of ICD implant for primary prevention is obsolete and may even be harmful - Contra.
M. Gasparini (Rozzano, IT)
Debate Session (continued)
Programming ATP at the time of ICD implant for primary prevention is obsolete and may even be harmful - Rebuttal Pro.
Programming ATP at the time of ICD implant for primary prevention is obsolete and may even be harmful - Rebuttal Contra.
P. Lambiase (London, GB); M. Gasparini (Rozzano, IT)
Focal atrial tachycardia ablation
Chairpersons: M. Efremidis (Athens, GR); A. Russo (Moorestown, US)
Discuss practical and rare cases of atrial tachycardia ablation
P- wave morphology to localise the site of origin of focal atrial tachycardia.
S.P. Fynn (Cambridge, GB)
Focal atrial tachycardia: what are the most common sites of origin?
J.M. Kalman (Victoria, AU)
Atrial tachycardia ablation from the noncoronary aortic cusp.
R. Pap (Szeged, HU)
Integrating body surface mapping into imaging to identify atrial tachycardia origin.
P. Jais (Bordeaux, FR)
This section will offer practical information on the role of new genetic knowledge for risk stratification. The speaker will provide a critical
assessment of the possibilities and limitation of genetic association studies and next generation sequencing.
Genetics of the normal human electrocardiogram.
C.R. Bezzina (Amsterdam, NL)
Genetic association studies in rare diseases: do we have enough power?
Genetic modifiers for risk stratification and therapy.
The role of next generation sequencing in the clinical setting.
E. Behr (London, GB)
Beyond Mendelian Inheritance in arrhythmias: impact for management.
Chairpersons: C. Napolitano (Pavia, IT); V. Probst (Nantes, FR)
Novel modulators of cardiac ion channels
Chairpersons: A. Barbuti (Milan, IT); F. Charpentier (Nantes, FR)
Transcription factors and microRNAs are novel modulators of ion channel expression in the sinoatrial node.
H. Dobrzynski (Manchester, GB)
The role of CTGF in cardiac remodeling upon pressure overload.
M.S.C. Fontes (Utrecht, NL)
Suberoylanilide Hydroxamic acid (SAHA) affect functional properties of HL-1 cardiomyocytes.
S. Suffredini (Bozen, IT)
Exosomes from human cardiac progenitor cells preserve cardiac function after long-term myocardial infarction.
L. Barile (Lugano, CH)
Thyroid stimulating hormone directly modulates cardiac electrical activity.
O. Casis (Vitoria, ES)
The ECG in cardiac resynchronisation therapy (CRT)
Chairpersons: A. Abd El Wahab (Halifax, CA); A.S. Revishvili (Moscow, RU)
To understand complex CRT ECGs: Lead location, lead dislodgement, fusion, pseudofusion, oversensing, undersensing, etc.
The paced QRS in CRT: RV and LV pacing sites.
H. Burri (Geneva, CH)
Loss of RV and LV capture, anodal capture.
B. Herweg (Tampa, US)
Arrhythmias in the CRT ECG.
The ECG in CRT algorithms: Tracking recovery, sensing reaction, negative AV hysteresis, etc.
C. Kolb (Muenchen, DE)
Guidelines: what is in it for me?
Chairpersons: T.M. Norekval (Bergen, NO); To be announced
Discuss new ESC guidelines and see what is relevant for Nurses and Allied Professionals
Guideline implementation;: how to do this in daily practice.
D. Fitzsimons (Belfast, GB)
What should nurses and allied professionals know from the HF guideline.
T. Jaarsma (Norrkoping, SE)
What is interesting for nurses and allied professionals in the CRT guidelines?
C. Linde (Stockholm, SE)
What should we know about the AF guideline?
J.M.L. Hendriks (Sittard, NL)
Ventricular arrhythmias, devices and antiarrhythmic drugs
Chairpersons: I.C. Van Gelder (Groningen, NL); A. Khachatryan (Yerevan, AM)
Ventricular arrhythmias occur predominantly in the setting of (non)ischaemic cardiomyopathy but may also occur in patients with a normal left
ventriular function in the setting of a channelopathy. In patients with ICDs and CRTs antiarrhythmic drugs wwarrant special.
Antiarrhythmic drugs for ventricular arrhythmias in patients with electrical heart disease.
N.A.M. Estes (Boston, US)
Antiarrhythmic drugs for ventricular arrhythmias in patients with structural heart disease.
S.H. Hohnloser (Frankfurt, DE)
Effect of antiarrhythmic drugs on stimulation and defibrillation threshold.
Optimised antiarrhythmic drug therapy in CRT patients.
K. Vernooy (Valkenburg Aan De Geul, NL)
The role of fractionated potentials in non-macro reentrant atrial tachycardia post atrial fibrillation ablation
Y.C. Wang, L.B. Shi, A. De Bortoli, L.Z. Sun, P.I. Hoff, E. Solheim, P. Schuster, O.J. Ohm, J. Chen (Bergen, NO)
Does left atrial appendage closure improve the success of pulmonary vein isolation? results of a randomized clinical trial
A. Romanov, E. Pokushalov, S. Artemenko, A. Yakubov, I. Stenin, E. Kretov, O. Krestianinov, I. Grazhdankin, D. Risteski, A. Karaskov
(Novosibirsk, RU; Skopje, MK)
16:48 Radiofrequency ablation of intra-atrial reentrant tachycardia in lateral tunnel Fontan circuits: the isthmus is often within
A. Porta Sanchez, K. Viswanathan, B. King, N. Jackson, V. Ezzat, A. Alqubany, L. Harris, E. Downar, K. Nair (Toronto, CA)
16:57 Determining the optimal ablation site for outflow tract ventricular arrhythmia in patients with and without a discrete
coronary cusp prepotential
H. Hachiya, K. Hirao, Y. Yamauchi, H. Taniguchi, S. Miyazaki, H. Nakamura, T. Takagi, J. Iwasawa, N. Ichihara, Y. Iesaka (Tsuchiura-shi,
Ibaraki-ken, Tokyo and Musashino-shi, Tokyo, JP)
17:06 Isolated epicardial RVOT scar: A typical substrate for VT in endurance athletes without evidence for inherited cardiomyopathy 240
J. Venlet, S.R.D. Piers, G.F.L. Kapel, M. De Riva Silva, M.J. Schalij, K. Zeppenfeld (Leiden, NL)
17:15 Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic
J. Acosta Martinez, J. Fernandez-Armenta, D. Penela, D. Andreu, R. Borras, R.J. Perea, T. De Caralt, L. Mont, J. Brugada, A. Berruezo
(Barcelona, ES)
17:24 Ablation of ventricular tachycardia with extracorporeal membrane oxygenation hemodynamic support
F. Baratto, G. Santagostino Baldi, F. Pappalardo, G.D.angelo, M. Evangelista, A. Di Prima, S. Silvietti, P. Della Bella (Milan, IT)
17:33 Short- and long-term outcome after ventricular fibrillation ablation
K. Masuda, A. Nogami, K. Kuroki, T. Machino, M. Igarashi, Y. Sekiguchi, K. Aonuma (Tsukuba, JP)
17:42 Technological, procedural and patient characteristics determine the risk for silent cerebral events in patients undergoing atrial
fibrillation ablation
T. Deneke, P. Mueller, P. Halbfass, A. Szoelloesi, M. Roos, A. Schade, J. Krug, R. Schmitt, G. Christopoulos, K. Nentwich
(Bad Neustadt a.d. Saale, DE)
17:51 Resolution of inconsistent local activation time determination from bipolar electrograms using novel omnipolar catheter
technology and signal processing
R. Balachandran, D.C. Deno, S. Masse, K. Nanthakumar (St Paul, US; Toronto, CA)
Ablation therapy and bail out strategies in complex arrhythmias
Chairpersons: K. Zeppenfeld (Leiden, NL); F. Halimi (Le Chesnay, FR)
Inaugural session
Welcome address by the EHRA President
Welcome address by the ESC President.
F.J. Pinto (Lisbon, PT)
Welcome address by the Local hosts.
G.L. Botto (Como, IT); L. Padeletti (Florence, IT)
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the Chairperson Scientific Programme Committee.
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the Vice-Chairperson Scientific Programme Committee.
M. Glikson (Ramat Gan, IL)
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the ESC Working Group on e-Cardiology.
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the ESC Working Group on Cardiac Cellular Electrophysiology.
P.G.A. Volders (Maastricht, NL)
EHRA EUROPACE - CARDIOSTIM 2015 Highlights from the Chairperson Cardiostim.
Opening Address.
Poster must be set up on Sunday between 08:00 and 12:30 and should remain on display for the whole congress
The presenter is required by the poster during the Networking reception that follows the Inaugural session on the evening of Sunday 21 June,
between 19:00 and 20:00
Removed on Wednesday between 12:30 and 13:00
The outstanding quality of the following abstracts meant they received the highest grades; accordingly they have been given full visibility for the
entire congress.
Mechanisms & Computer modelling (Atrial Fibrillation)
Technical challenges of rotor identification during atrial fibrillation using phase singularity detection P. Kuklik, A. Van Hunnik, S. Zeemering, B. Maesen, L. Pison, H.J. Crijns, S. Willems, U. Schotten (Maastricht, NL; Hamburg, DE)
Catheter ablation (Atrial Fibrillation)
Ablation scar recovery is significantly stronger in atrial fibrillation free patients. P258
P. Gal, C.F. Pacchia, A. Morris, J. Cates, G. Kaur, E. Kholmovski, R. Ranjan, N. Akoum, N.F. Marrouche (Zwolle, NL; Salt Lake City, US)
Clinical experieince with a novel fetal heart monitor approach to preventing phrenic nerve injury during cyroballoon ablation of atrial
fibrillation P259
A. Patel, R.S. Banker (Orange, US)
Extent of atrial low voltage predicts outcomes after ablation for persistent atrial fibrillation P260
Feasibility and safety of uninterrupted peri-procedural apixaban administration in patients undergoing radiofrequency catheter ablation
for atrial fibrillation: results from a multicenter study P261
L. Di Biase, D. Lakkireddy, C. Trivedi, T. Deneke, M. Martinek, S. Mohanty, P. Mohanty, J. Sanchez, J.D. Burkhardt, A. Natale (Austin and
Kansas City, US; Bad Neustadt a.d. Saale, DE; Linz, AT)
Is TEE mandatory in patients undergoing ablation of AF with uninterrupted NOACs? Results from a prospective multicenter registry P262
L. Di Biase, J.D. Burkhardt, C. Trivedi, S. Mohanty, P. Mohanty, D. Lakkireddy, J. Sanchez, G.J. Gallinghouse, S. Beheiry, A. Natale (Austin,
Kansas City and San Francisco, US)
Mid-term results of mIBG guided modulation of ganglionated plexi in addition to PV isolation P263
S. Ernst, N. Roth, R. Baavour, S. Babu-Narayan, S. Ban-Haim (London, GB; Caesarea, IL)
One Shot technologies TO Pulmonary vein isolation (1STOP) project: the standard clinical practice. P264
A. Curnis, G. Arena, L. Padeletti, P. De Filippo, G. Cattafi, L. Leoni, D. Catanzariti, R. Verlato, S. Porcellini, C. Tondo (Brescia, Massa,
Florence, Bergamo, Milan, Padova, Rovereto, Camposampiero and Paderno Dugnano, IT)
Recurrence of atrial fibrillation during follow up. What makes the difference? Data from the German ablation registry (W) P265
A. Sultan, J.L. Luker, L.E. Eckardt, D.A. Andresen, K.H.K. Kuck, E.H. Hoffmann, S.W. Willems, M.H. Hochadel, J.S. Senges, D.S. Steven
(Cologne, Münster, Berlin, Hamburg, Munich and Ludwigshafen, DE)
Tools: catheters, sources, mapping, navigators (Catheter ablation / except atrial fibrillation)
Cross mapping can identify the mechanisms of atrial tachycardia post atrial fibrillation ablation Y.C. Wang, L.B. Shi, A. De Bortoli, L.Z. Sun, P.I. Hoff, E. Solheim, P. Schuster, O.J. Ohm, J. Chen (Bergen, NO)
Substrate dependence of ventricular fibrillation rotors D.E. Krummen, A.B. Bender, S.P. Vampola, J. Hayase, G. Ho, A.A. Schricker, G.G. Lalani, T. Baykaner, W.-J. Rappel, S.M. Narayan
(San Diego and Palo Alto, US)
The substrate analysis using fast-Fourier transform of the local ventricular signals in patients with postinfarction ventricular
tachycardia K. Kuroki, A. Nogami, M. Igarashi, Y. Komatsu, S. Kowase, K. Kurosaki, T. Machino, N. Murakoshi, Y. Sekiguchi, K. Aonuma (Tsukuba and
Yokohama, JP)
Clinical and epidemiological aspects (Atrial Fibrillation)
Accuracy comparison of cardiac computed tomography with transesophageal echocardiography for detecting left atrial appendage
thrombus in patients with atrial fibrillation Y. Toyoshima, K. Inoue, Y. Koyama, K. Tanaka, T. Oka, N. Tanaka, Y. Sotomi, Y. Orihara, K. Iwakura, K. Fujii (Osaka, JP)
Atrial fibrillation in hypertrophic cardiomyopathy: is a hypertrophied septum important? S.I. Im, K.M. Park, E.K. Kim, S.C. Lee, S.J. Park, J.S. Kim, Y.K. On (Busan and Seoul, KR)
Results (Catheter ablation / except atrial fibrillation)
Clinical and electrocardiographic characteristics of idiopathic ventricular arrhythmias originating from apical crux area -A comparison
with VA originating from posteroseptal left ventricle- M. Kawamura, Y. Munetsugu, Y. Kobayashi (Tokyo, JP)
Devices (Pacing)
Cardiac implantable electronic devices adverse events reporting system (CIED_AERS): rationale and preliminary results P270
K.R. Silva, L.B.A. Alves, T.S. Kawauchi, C.M.M. Albertini, J.V. Barros, I.C. Maurino, G. Melo, M. Martinelli, R. Costa (São Paulo and
Sao Paulo, BR)
Early electrical performance of a novel leadless transcatheter pacemaker system. Data from the Micra clinical study P271
C. Steinwender, P. Ritter, G. Duray, K. Soejima, L. Chinitz, O. Razali, L. Mont, T. Sheldon, K. Stromberg, D. Reynolds (Linz, AT; Bordeaux, FR;
Budapest, HU; Tokyo, JP; New York, Mounds View, MN and Oklahoma City, Oklahoma, US; Kuala Lumpur, MY; Catalonia, ES)
Minimized ventricular pacing to prevent the first onset of AF in pacemaker patients without atrial arrhythmia history: results from the
ANSWER study P272
S. Boveda, P. Defaye, J. Moreno, G. Macaluso, G. Jauvert, M. Burban, J. Noack, E. Garcia Campo, P.H. Siot, M.O. Stockburger
(Toulouse, Grenoble, Marseille, Neuilly sur Seine, Nantes and Clamart, FR; Madrid and Vigo, ES; Hamburg and Berlin, DE)
Indications & Results (Pacing)
Heart rhythm conduction disturbances in patients who underwent transcatheter aortic valve implantation - TAVI B. Sredniawa, K. Mitrega, P. Chodor, Z. Kalarus, M. Zembala (Zabrze, PL)
Prevalence and clinical significance of LBBB according to classical or strict definition criteria in permanent pacemaker patients. A. Mazza, M.G. Bendini, M. Lovecchio, S. Valsecchi, U. Riva, M. Leggio, R. De Cristofaro (Orvieto, Milan and Rome, IT)
Prevalence of indication for cardiac resynchronization therapy: effect of evolving clinical guidelines M. Stahlberg, B. Svennblad, C. Linde, F. Braunschweig, U. Dahlstrom, M. Edner, L.H. Lund (Stockholm, Uppsala and Linkoping, SE)
The effect of using floseal on reducing the incidence of pocket hematoma formation in patients requiring pacemaker or implantable
cardioverter-defibrillator with concomitant dual antiplatelet therapy. O. Al-Razo, E. Gonzalez, J.A. Blazquez, L. Sartor, A. Hurtado, J. Silvestre, J.M. Mesa (Madrid, ES)
Use of CoreValve and prolonged PQ and QRS times are associated with pacemaker dependence in patients with a new LBBB after
transcatheter aortic valve implantation V.J. Nijenhuis, S.M. Chaldoupi, J.C. Balt, M.C.E.F. Wijffels, L.V.A. Boersma, J.M. Ten Berg (Nieuwegein, NL)
Leadless (Pacing)
How robust is the Micra transcatheter pacemaker fixation? P278
T.A. Simmers, M.D. Bonner, F.A.L.E. Bracke, M.D. Eggen, P. Ritter, D. Reynolds (Eindhoven, NL; Mounds View MN and Oklahoma City, US;
Bordeaux, FR)
Technical and imaging aspects (Resynchronisation therapy)
Imaging guided left ventricular lead placement improves clinical response in cardiac resynchronization therapy: a randomized
controlled trial (W) P279
A. Sommer, M.B. Kronborg, B.L. Norgaard, S.H. Poulsen, H.K. Jensen, J.M. Jensen, J. Kristensen, C. Gerdes, P.T. Mortensen, J.C. Nielsen
(Aarhus, DK)
Service life of implantable cardioverter-defibrillators for cardiac resynchronization therapy: an analysis of determinants in current
clinical practice. P280
M. Landolina, A. Curnis, G. Morani, A. Vado, E. Ammendola, A.D. Onofrio, G. Stabile, M. Crosato, M. Gasparini (Crema, Brescia, Verona,
Cuneo, Naples, Treviso and Rozzano, IT)
Indications & Results (Resynchronisation therapy)
Left ventricular endocardial pacing across the interventricular septum - medium-term results J.H.P. Gamble, M. Ginks, K. Rajappan, Y. Bashir, T.R. Betts (Oxford, GB)
Left ventricular lead position and outcome in CRT - a large nationwide cohort study. M.B. Kronborg, J.B. Johansen, S. Riahi, H.H. Petersen, J. Haarbo, O.D. Jorgensen, J.C. Nielsen (Aarhus, Odense, Aalborg and
Copenhagen, DK)
Lead management - extractions and recalls
Characteristics and failure rate of the Biotronik Linox implantable cardioverter defibrillator lead F. Demirel, A. Adiyaman, P.P. Delnoy, J.J.J. Smit, A.R. Ramdat Misier, A. Elvan (Zwolle, NL)
Mechanism (Basic Science in Arrhythmias)
Spatio-temporal organization of APD-alternans in the in-vivo human heart and interactions with APD-restitution properties M. Orini, P. Taggart, B. Hanson, M. Hayward, P. Lambiase (London, GB)
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc score = 1 in a community based cohort study. L. Fauchier, C. Lecoq, N. Clementy, D. Angoulvant, D. Babuty, G.Y.H. Lip (Tours, FR; Birmingham, GB)
Registries and surveys
Long-term survival following ICD and CRT-D implant in a large unselected population J. Sims, S. Charlton, A. Patel, S. Liu (Mounds View, US)
Non-compaction cardiomyopathy. Risk stratification for prophylactic indication of implantable cardiac defibrillator. Long term single
centre registry. N. Galizio, A. Palazzo, L. Favaloro, H. Casabe, A. Fernandez, E. Guevara, G. Carnero, F. Robles, H. Fraguas, J. Gonzalez
(Capital Federal, AR)
ECG and eCardiology (Cardiac arrhythmias, non invasive)
Useful electrocardiographic features to help identify the mechanism of atrial tachycardia after persistent atrial fibrillation ablation P. Pascale, L. Roten, A.J. Shah, D. Scherr, Y. Komatsu, N. Derval, F. Sacher, M. Hocini, M. Haissaguerre, P. Jais (Lausanne and Bern, CH;
Different outcomes between high and low volume centres performing transvenous lead extraction in the ELECTRa registry M.G. Bongiorni, C. Kennergren, C. Butter, J.C. Deharo, A. Kutarski, C.A. Rinaldi, A.P. Maggioni, C. Blomstrom-Lundqvist, A. Auricchio,
K.H. Kuck (Pisa, IT; Gothenburg and Uppsala, SE; Bernau bei Berlin and Hamburg, DE; Marseille and Sophie Antipolis, FR; Lublin, PL;
London, GB; Lugano, CH)
Transvenous removal of pacing and ICD leads: single italian referral center experience. M.G. Bongiorni, E. Soldati, L. Segreti, G. Zucchelli, A. Di Cori, S. Viani, L. Paperini, G. Branchitta, D. Andreini (Pisa, IT)
Poster session 1
Posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to be on display between 08:30 - 12:30.
The presenter should be available by the poster during the coffee break (10:00 to 11:00) in order to discuss the research with the audience.
Cost and efficiency benefits of a single modality imaging strategy for pre-procedural workup of atrial fibrillation catheter ablation P291
P. Bhagirath, A.W.M. Van Der Graaf, E. Van Dongen, S. Ghoerbien, V.J.H.M. Van Driel, H. Ramanna, N.M.S. De Groot, M.J.W. Gotte
(The Hague and Rotterdam, NL)
Left atrial appendage closure using the novel Coherex Wavecrest device - initial single center experience P292
K.J. Chun, S. Bordignon, L. Perrotta, A. Fuernkranz, D. Dugo, A. Konstantinou, B. Schmidt (Hamburg and Frankfurt am Main, DE)
Neuropreventive effect of sitagliptin after atrial fibrillation related ischemic stroke in type 2 Diabetic Patients: a nationwide cohort
study P293
T.H. Chen, L.S. Lin, D.Y. Chen, S.H. Wang (Taipei, TW)
Arrhythmia progression is associated with development of cardiovascular disease in a population of patients with idiopathic atrial
fibrillation: a 5-year follow-up study P294
E.A.M.P. Dudink, B. Weijs, R.J. Haest, J.A. Kragten, B.L. Kietselaer, J.E. Wildberger, H.J.G.M. Crijns (Maastricht, Geldrop and Heerlen, NL)
Effect on sleep and sleep apnea with cardioversion of atrial fibrillation (W) P295
N. Hoglund, C. Sahlin, M. Kesek, S. Jensen, K. Franklin (Umea, SE)
Assessment of p wave signal-averaged ECG in patients with hypertension to investigate the preventive effect of eplerenone on atrial
fibrillation M. Kawasaki, T. Yamada, T. Morita, Y. Furukawa, S. Tamaki, Y. Iwasaki, A. Kikuchi, T. Kondo, M. Fukunami (Osaka, JP)
Categorizating patients with long-standing atrial fibrillation by evaluating exercise capacity helped in determining treatment strategy P297
T. Haruna, M. Funasako, I. Tanaka, M. Okano, T. Sekihara, Y. Kimura, H. Hayashi, M. Kimura, M. Inoko (Osaka, JP)
Hyperglycemia and oxidative stress stimulate abnormal proliferation of atrial fibroblast through NADPH oxidase/MAPK/MMP9
signal pathway T. Liu, Q. Zhang, X. Wang, X. Liang, G. Li (Tianjin, CN)
Antiarrhythmic drugs (Atrial Fibrillation)
Effect of QT interval prolongation following antiarrhythmic drug therapy on left ventricular systolic and diastolic function. K. Chouchoulis, J. Chiladakis, N. Koutsogiannis, P. Davlouros, D. Alexopoulos (Patras, GR)
Utility of adenosine testing in pulmonary vein isolation P300
G. Lima Da Silva, N. Cortez-Dias, A. Mata, C. Barata, A. Magalhaes, M. Nobre Menezes, S. Magalhaes, L. Carpinteiro, A. Bernardes,
J. De Sousa (Lisbon, PT)
Insight into referral patterns for pulmonary vein isolation. a dutch questionnaire among cardiologists and electrophysiologists J.R. Folkeringa, N. Veeger, B.A. Schoonderwoerd, H.J.G.M. Crijns (Leeuwarden and Maastricht, NL)
Impact of the second-generation cryoballoon on procedural efficiency: results from the STOP AF post approval study four year status
report P302
(W) P303
The outcome of catheter ablation and predictors of AF recurrence in lone AF patients M. Takigawa, A.T. Takahashi, T.K. Kuwahara, K.O. Ohkubo, K.Y. Yamao, E.N. Nakashima, J.N. Nakajima, K.T. Takagi, K.H. Hirao, M.I. Isobe
(Suita, Osaka, Yokosuka and Tokyo, JP)
Rotormapping and -ablation in redo-cases of persistent atrial fibrillation: procedural data P304
S.G. Spitzer, L. Karolyi, C. Raemmler, F. Scharfe, T. Weinmann, T. Otto, A. Langbein (Dresden, DE)
One-year clinical outcome second-generation 28-mm cryoballoon ablation using a single 3-minutes approach P305
G. Ciconte, C. De Asmundis, Y. Saitoh, G. Mugnai, V. Velagic, G. Irfan, B. Hunuk, E. Stroker, P. Brugada, G.B. Chierchia (Brussels, BE)
First versus second-generation 28-mm cryoballoon ablation: one-year follow-up P306
G. Ciconte, G.B. Chierchia, G. Di Giovanni, Y. Saitoh, G. Mugnai, G. Irfan, G. Conte, J. Sieira, C. De Asmundis, P. Brugada (Brussels, BE)
Comparison of long-term success rate between single-shot technologies for paroxysmal atrial fibrillation ablation. P307
G.M. Fassini, S. Conti, S. Riva, A. Dello Russo, M. Moltrasio, F. Tundo, B. Majocchi, V. Marino, E. Russo, C. Tondo (Milan, IT)
Surgery & Pacing (Atrial Fibrillation)
Bleeding risk in patients on novel oral anticoagulants (NOAC) undergoing CIED procedures: a comparison study with uninterrupted
warfarin F. De Sensi, G. Miracapillo, G. Savarese, T. Infusino, M. Breschi, L. Addonisio, S. Severi (Grosseto, Foligno and Catanzaro, IT)
Feasibility of minimal fluoroscopy approach for catheter ablation of atrial fibrillation P308
C. Brodt, L. Norton, M. Shah, M. Turakhia, P. Zei (Palo Alto, US)
Multicenter safety of focal impulse and rotor modulation (FIRM) ablation P309
D.E. Krummen, T. Baykaner, V. Swarup, J.P. Daubert, J.M. Miller, G. Tomassoni, S. Park, M. Viswanathan, P.J. Wang, S.M. Narayan
(San Diego, Phoenix, Durham, Indianapolis, Lexington and Palo Alto, US)
Antiarrhythmic treatment before and after AF ablation. Long-term results. P310
O. Sapelnikov, A. Partigulova, Y.U. Shuvalova, D. Cherkashin, P. Mezentsev, A. Kulikov, I. Grishin, R. Latypov, A. Chapurnikh, R. Akchurin
(Moscow, RU)
Low force vs. high force atrial RF ablation in a chronic porcine model: effective lesion assessment by voltage, pathology and cardiac MR P311
S.E. Williams, H. Chubb, J. Harrison, R. Karim, K. Rhode, T. Schaeffter, W.Y. Kim, H. Jensen, R. Razavi, M.O.neill (London, GB)
Combining stroke prevention and arrhythmia reduction in a single procedure: a novel, safe and effective treatment for persistent atrial
S. Panikker, J.W.E. Jarman, S.K. Haldar, L. Mantziari, W. Hussain, J.P. Foran, V. Markides, T. Wong (London, GB)
Induced self-terminating shortlasting AF before PVI excludes extra-PV substrate in patients with PAF P313
M. Namdar, P. Gentil-Baron, H. Sunthorn, H. Burri, D. Shah (Geneva, CH)
Derivative of catheter contact force over time (df/dt) correlates with measures of left atrial appendage flow velocity and spontaneous
echo contrast in patients with non-valvular atrial fibrillation P314
C. Teres, M. Namdar, S. Marcelino, H. Muller, P. Gentil-Baron, H. Sunthorn, H. Burri, D. Shah (Geneva, CH)
Left atrial voltage map after atrial fibrillation ablation decreased recurrence of atrial fibrillation in patients of persistent atrial
fibrillation in spite of size of low voltage area P315
N. Watanabe, K. Inoguchi, Y. Chiba, Y. Onishi, Y. Munetsugu, T. Onuki, T. Adachi, M. Kawamura, T. Asano, Y. Kobayashi (Tokyo, JP)
Novel experience of irrigated multipolar catheter in stepwise approach for atrial fibrillation ablation P316
The impact of intracardiac echocardiographic image directly acquired from the left atrium for CT image integration in atrial fibrillation
ablation P317
K. Kaseno, K.H. Hisazaki, N.A. Naoki, K.N. Nakamura, D.A. Aoyama, Y.S. Shiomi, K.H. Hasegawa, M.Y. Yokokawa, H.U. Uzui, H.T. Tada
(Fukui and Maebashi, JP)
The efficiency and safety of Dabigatran periprocedural therapy in patients undergoing percutaneous ablation of atrial fibrillation
substrate. P318
K. Zawada-Rapacz, B. Binkowski, T. Grycewicz, W. Grabowicz, E. Wonko, A. Szwedzinska, T. Kucejko, A. Lubinski (Lodz, PL)
Distribution of rotational activation in the left atrium in patients with persistent atrial fibrillation: Relationship to low-voltage areas and
fractionated electrograms P319
S. Nakahara, Y. Hori, N. Tsukada, N. Nishiyama, A. Nakagawa, S. Kobayashi, T. Komatsu, Y. Sakai, I. Taguchi (Koshigaya City, JP)
Dramatic reduction in procedure duration using the 3. generation magnetic navigation system for catheter ablation of atrial fibrillation P320
S. Deiss, A. Metzner, F. Ouyang, S. Mathew, C. Lemes, T. Maurer, C. Heeger, R. Tilz, K.H. Kuck, E. Wissner (Hamburg, DE)
The use of deflectable sheath improves stable catheter contact and results in less arrhythmia recurrences P321
J. Kautzner, S.R. Dukkipati, G.F. Michaud, J. Petru, J.P. Albenque, F. Marchlinski, S.R. Mahapatra, D. Harari, H. Lambert, V.Y. Reddy
(Prague, CZ; New York, Boston, Philadelphia and Plymouth, US; Toulouse, FR; Geneva, CH)
Spot diagnosis by means of an ECG pattern: Inferior axis and positive concordant R pattern in the precordial leads are pathognomonic
for ventricular arrhythmias arising from the great cardiac vein P323
H. Bogossian, G. Frommeyer, I. Ninios, F. Hasan, Q.S. Nguyen, Z. Karosiene, D. Mijic, B. Lemke, M. Zarse (Lüdenscheid/ Witten-Herdecke,
Münster and Luedenscheid, DE)
Assessment of ventricular tachycardia scar substrate by intracardiac echocardiography : comparison with contrast-enhanced cardiac MRI ( W) P324
I. Watanabe, Y. Okumura, K. Takahashi, K. Sonoda, A. Hirayama (Tokyo, JP)
A novel technique for simultaneous representation of multiple EP datasets with equivalent accuracy to color surface shading P325
J. Whitaker, S. Williams, H. Chubb, M. Gabrawi, M.O.neill (London, GB)
Peri-mitrotricuspid annulus atrial flutter: reentrant circuit delineation by entrainment mapping E. Falconi, A. Bittner, M. Arceluz, R. Delgado, R. Altamirano, F. Cruz, M. Ortega, F. Larraya, J.L. Merino (Madrid, ES; Santiago, CL)
3D transcatheter cryoablation of slow pathway for treatment of atrio-ventricular nodal reentry tachycardia in children: acute success
obtained by a single focus cryolesion predicts a better outcome P327
M.S. Russo, D. Righi, C. Di Mambro, M.S. Silvetti, R. Remoli, F.A. Saputo, F. Drago (Rome, IT)
Outcomes with AV nodal ablation from the pacemaker pocket M.C. Giudici, N.E. Worden, L. Joseph, R.B. Arteaga, S.R. Mickelsen, G. Goldsmith (Iowa City, US)
Comparison of acute ablation results to non invasive programmed stimulation after catheter ablation of ventricular tachycardia F. Baratto, G. Paglino, G. Santagostino, M. Yamase, P. Vergara, A. Radinovic, P. Della Bella (Milan, IT)
The guidance of cavo-tricuspid isthmus ablation using a contact force ablation catheter and novel parameters C.R.P. Booth, K. Ng, K. Dauber, G. Kaye, P. Gould (Brisbane, AU)
Results of catheter ablation of ventricular ectopy from the papillary muscle guided by intracardiac echocardiography P. Peichl, D. Wichterle, R. Cihak, B. Aldhoon, J. Kautzner (Prague, CZ)
Assessment of clockwise cavotricuspid isthmus block based on conduction time during transient entrainment in common atrial flutter:
a prospective study E. Castellanos Martinez, T. Barrio, J. Salas, S. Madero, R. Peinado, M. Ortiz, J.E.S.U.S. Almendral (Madrid, ES)
New easy used ECG-algorithm for patients with WPW syndrome D.S. Novikov, M.L. Kandinsky, A.S. Samoilov, Z.A. Kidakoev, M.S. Druzhko (Krasnodar, RU)
Primary & Secondary prevention (Sudden cardiac death and implantable defibrillators)
Long-term clinical outcomes after primary prevention ICD implantation in women and men. Results from a multicenter study. P. Cabanas-Grandio, L. Gaztanaga, T. Barrio, M. Rodriguez-Manero, J. Fernandez-Armenta, V. Exposito-Garcia, J.M. Sanchez-Gomez,
J. Jimenez-Lopez, J. Moreno Arribas, E. Garcia Campo (Vigo, Bilbao, Granada, Santiago de Compostela, Cadiz, Santander, Valencia, Toledo
and Alicante, ES)
Chagas cardiomyopathy patients with pacemaker: factors associated with sudden death G. Peixoto, S.F. Siqueira, M.M. Lensi, S.A.D. Nishioka, R.A. Teixeira, A.A.A. Pedrosa, R. Costa, M. Martinelli (Sao Paulo, BR)
Implantable cardioverter defibrillator in patients with Brugada syndrome J. Hernandez Ojeda, E. Arbelo, A. Gomez Juanatey, R. Borras, M. Matas, J.M. Tolosana, L. Mont (Barcelona, ES)
Difference of cycle length between appropriate and inappropriate therapy in patients with Brugada syndrome, early repolarization
syndrome and idiopathic ventricular fibrillation W.S. Lee, J. Kim, C.H. Kwon, J.H. Choi, U. Jo, Y.R. Kim, G.B. Nam, K.J. Choi, Y.H. Kim (Seoul, KR)
Technical aspects (Sudden cardiac death and implantable defibrillators)
Results of an automatic algorithm predictor of successful antitachycardia pacing therapy and the need of shock in patients with
implantable defibrillator P338
R. Matia Frances, A.H.Madrid, G. Sanchez-Huete, J. Martinez-Ferrer, J. Alzueta, J. Vinolas, J. Rubio, J.M. Porres (Madrid, Vitoria, Malaga,
Barcelona, Valladolid and Donostia, ES)
Timing of ICD /CRT-D replacement in real-world practice: need for a behavioral change? P339
M. Biffi, E. Ammendola, G. Ciaramitaro, D. Potenza, M. Santamaria, M. Iori, C. Baiocchi, F. Lissoni, M. Malacrida, F. Zanon (Bologna, Naples,
Palermo, San Giovanni Rotondo, Campobasso, Reggio Emilia, Siena, Lodi, Milan and Rovigo, IT)
Subcutaneous ICD
Ventricular arrhythmias in patients supported with ventricular assist devices and the role of implantable cardioverter defibrillators A. Gkouziouta, A. Kostopoulou, G. Theodorakis, S. Adamopoulos (Athens, GR)
Positive effect of the novel multi point pacing modality in cardiac resynchronization therapy: early follow-up data from a multicenter
experience G. Forleo, R. Massaro, M. Giammaria, F. Zanon, V. Calabrese, G. Senatore, A. Curnis, C.D.agostino, L. Calo', L. Santini (Rome, San Giovanni
Rotondo, Turin, Rovigo, Ciriè (Turin), Brescia and Bari, IT)
Atrial preference pacing in patients with sinus node dysfunction who have paroxysmal AF P. Kasem-Suwan (Bangkok, TH)
long term follow up of primary and secondary prevention implantable cardioverter defibrillator patients:real-world data from the
island of crete E. Kanoupakis, J. Fanourgiakis, H. Mavrakis, E. Kallergis, S. Petousis, M. Vernardos, M. Touloupaki, M. Stauvroulaki, G. Chlouverakis,
P. Vardas (Heraklion, GR)
Complications related to cardiac rhythm management devices therapy and their financial implication: a prospective single-center
two years survey J. Fanourgiakis, E. Simantirakis, E. Kanoupakis, S. Chrysostomakis, M. Stauvroulaki, A. Daskalakis, M. Vernardos, M. Touloupaki,
G. Chlouverakis, P. Vardas (Heraklion, GR)
A single-centre cohort study on long-term results of triventricular pacing in patients with advanced heart failure R.A. Providencia, D. Rogers, V. Cobb, P. Lambiase, S. Ahsan, O. Segal, M. Lowe, E. Rowland, F. Khan, A.W. Chow (London, GB)
Prognostic implication of functional mitral regurgitation in patients undergoing cardiac resynchronization therapy. A. Proclemer, M. Gasparini, M. Cipriani, R. Rordorf, A. Curnis, G.B. Perego, R.P. Ricci, G. Boriani, M. Landolina, M. Lunati (Udine,
Rozzano, Milan, Pavia, Brescia, Rome, Bologna and Crema, IT)
Vectorcardiographic QRS area predicts delayed left ventricular lateral wall activation in patients undergoing cardiac resynchronization
therapy M. Mafi Rad, G.W.M. Wijntjens, E. Engels, Y. Blaauw, J.G.L.M. Luermans, T. Dinh, L. Pison, H.J. Crijns, F.W. Prinzen, K. Vernooy
(Maastricht, NL)
Semi-invasive determination of interventricular conduction delays in CRT patients in sinus rhythm (SR) or atrial fibrillation (AF)
in comparison with healthy subjects B. Ismer, A. Nagel, K. Kroll, T. Haber, L. Perez Escobar, J. Haertig, J. Melichercik (Offenburg and Lahr/Baden, DE)
Arrhythmic events and outcome differences in a large quadripolar CRT-D post-approval study M. Cao, D. Martin, S. Beau, S. Allison, D. Schleinkofer, T.G. Farazi, S. Zhang, R. Corbisiero (Rosemead, Burlington, Little Rock, Huntsville,
Fort Wayne, Sylmar and Browns Mills, US)
Change of electrical QRS axis after cardiac resynchronization L.F. Pava, P. Perafan, D.C. Carrillo, J. Jimenez, J. Hernandez, S. Loaiza (cali, CO)
Good relation between left ventricular electrical activation and contraction in patients undergoing cardiac resynchronization therapy P350
M. Mafi Rad, J. Van T Sant, J. Blaauw, F.J. Meijboom, P.J. Doevendans, M.J. Cramer, H.J. Crijns, F.W. Prinzen, M. Meine, K. Vernooy
(Maastricht and Utrecht, NL)
Basal basal multi point pacing improves electrical characteristics more than basal apical lead positioning P351
A. Pokawattana, H. Sugumar, K. Zibell, L. Odgers, H.S. Lim, A. Teh, D.O.donnell (Melbourne, AU)
Neurohormonal response to cardiac resynchronization therapy in heart failure patients with impaired or preserved right ventricular
function P352
C. Valzania, F. Fallani, G. Gavaruzzi, M. Biffi, C. Martignani, I. Diemberger, M. Ziacchi, J. Frisoni, C. Rapezzi, G. Boriani (Bologna, IT)
DDD pacing mode survival in patients with dual-chamber pacemaker during the long-term follow-up. M. Debski, M. Ulman, A. Zabek, K. Haberka, J. Lelakowski, B. Malecka (Krakow and Niepolomice, PL)
Outcome of septal/parahisian vs apical right ventricular pacing in children. S. Placidi, M.S. Silvetti, A. Ammirati, L.M. Santucci, M. Prosperi, L. Rava, F. Drago (Rome, IT)
Influence of pacing mode on mortality and cardiovascular hospitalization during follow-up of patients with permanent pacemaker A. Bonet Basiero, P. Sanchez Chamero, A. Cabestrero De Diego, J. Padro Dalmau, R. Freixa Pamias (Sant Joan Despí, Barcelona, ES)
Leads (Pacing)
Intra-Hisian block: Stable distal His-Purkinje conduction at 3 years during permanent His bundle pacing P. Vijayaraman, A. Naperkowski, G. Dandamudi, K.A. Ellenbogen (Wilkes Barre and Richmond, US)
Electrical performance and lead handling evaluation of a new active fixation left ventricular lead: results of an italian multicenter
experience M. Biffi, R. Rordorf, G. Giannola, G. Luzzi, M.G. Bongiorni, G. Maglia, L. Bontempi, M. Ziacchi, M. Landolina, M. Lunati (Bologna, Pavia,
Cefalu, Bari, Catanzaro, Brescia and Milan, IT)
Long term follow up of patients without reimplantation of a cardiac internal electronic device following transvenous lead extraction ( W) P359
S. Gomes, G. Cranney, M. Bennett, R. Giles (Sydney, AU)
CIED infections - how many patients are managed improperly and which mistakes are most frequent? The lesson from lead extraction. P360
A. Kutarski, M. Czajkowski, M. Polewczyk, A.M. Polewczyk, A. Polewczyk (Lublin and Kielce, PL)
Prevalence and reassessment of device re-implantation after a pacemaker or defibrillator extraction P361
G.D.D.angelo, P. Mazzone, F. Melillo, T. Oloriz, F. Guarracini, G. Paglino, A. Marzi, N. Sora, P. Della Bella (Milan, IT)
Laser lead extraction allows for safe and effective removal of single- as well as dual coil ICD leads P362
S. Hakmi, S. Pecha, Y. Yildirim, L. Conradi, B. Sill, N. Gosau, M.A. Aydin, S. Willems, H. Reichenspurner, H. Treede (Hamburg and
Reinbek, DE)
Implantable loop recorder: a syncope unit experience M. Rafanelli, A. Ceccofiglio, F. Tesi, G. Toffanello, V.M. Chisciotti, G. Rivasi, N. Marchionni, A. Ungar (Florence, IT)
Importance of coronary vasospasm in unexplained syncope D.H. Shin, C.K. Lee, G.H. Sohn, J.W. Kim, S.Y. Yoo, S.S. Cheong (GangNeung, KR)
Waveform characteristics of ventricular fibrillation in relation to clinical parameters and shock success: An electrocardiographic
study in ICD-patients J.L. Bonnes, J. Thannhauser, M. Hermans, J. Nas, S.W. Westra, M.J. De Boer, M.A. Brouwer, J.L.R.M. Smeets (Nijmegen and Enschede, NL)
Measurement of ventricular effective refractory period by the extrastimulus technique: effect of baseline ventricular pacing versus
sinus rhythm. S. Rossi, F. Cacciani, M. Zaniboni, S. Callegari, L. Carnevali, A. Sgoifo, M. Miragoli, E. Macchi (Parma, IT)
A microRNA blueprint for early atrial remodeling in a porcine model of paroxysmal atrial fibrillation M. Torrado, D. Franco, E. Lozano-Velasco, F. Hernandez-Torres, R. Calvino, G. Aldama, A. Centeno, A. Castro-Beiras, A. Mikhailov
(La Coruna and Jaen, ES)
Galectin 3 in patients with atrial fibrillation and metabolic syndrome V.A. Ionin, O.V. Listopad, S.E. Nifontov, A.V. Soboleva, D.I. Jatsuk, E.L. Zaslavskaya, O.D. Belyaeva, E.I. Baranova, E.V. Shlyakhto
(Saint Petersburg and Saint-Petersburg, RU)
Pharmacology (Basic Science in Arrhythmias)
Magnesium, an old but still fascinating antiarrhythmic: a comparative study of two doses S. Myftiu, I. Sharka, A. Shkoza, G. Sulo, E. Sulo, X.H. Belshi, E. Saja (Tirana, AL; Bergen, NO)
Magnetocardiography provides beat-to-beat monitoring of fetal rhythm in unshielded clinical ambulatory setting at the 28th week of
gestation D. Brisinda, A.R. Sorbo, A. Venuti, F. Fioravanti, R. Fenici (Rome, IT)
Clinical mechanisms (Cardiac arrhythmias, non invasive)
Electrophysiological observations of acute His bundle injury during permanent His bundle pacing A. Naperkowski, G. Dandamudi, K.A. Ellenbogen, P. Vijayaraman (Wilkes Barre and Richmond, US)
Insight into the role of environmental triggers in J wave syndrome: results of 15 year-follow up. A. Talib, N. Sato, K. Sumitomo, T. Nishiura, N. Sakamoto, Y. Tanabe, T. Takeuchi, Y. Kawamura, N. Hasebe (Asahikawa, JP)
Corrected PR interval after treatment optimisation: does it matter? T. Nikolaidou, P. Pellicori, J. Zhang, A.L. Clark (Hull, GB)
Correlation between electrocardiographic abnormalities and scar location in patients with non-ischaemic cardiomyopathy and
ventricular tachycardia G. Santagostino, T. Oloriz, G. Peretto, H.J.J. Wellens, P. Della Bella (Milan, IT; Maastricht, NL)
The lewis lead for P-wave detection during ventricular tachycardia M. Huemer, H. Meloh, A. Wutzler, A.S. Parwani, P. Attanasio, H. Matsuda, F. Blaschke, L.H. Boldt, W. Haverkamp (Berlin, DE)
High risk electrocardiographic markers in Brugada syndrome S. Georgopoulos, P. Korantzopoulos, M. Efremidis, K. Vlachos, N. Fragakis, P. Arsenos, K. Gatzoulis, A. Sideris, T. Liu, K. Letsas (Athens,
Ioannina and Thessaloniki, GR; Tianjin, CN)
Novel galvanised titanium-based ECG technology can reliably detect arrhythmias F. Ara, C. Crockford, I. John, R.A. Kaba (Ashford and London, GB)
Autonomic nervous system (Cardiac arrhythmias, non invasive)
The effect of sympatho-vagal interaction and beta-blocker on heart rate and ventricular refractoriness in isolated rabbit hearts S.H. Chin, E. Wake, K.E. Brack, G.A. Ng (Leicester, GB)
Others (Cardiac arrhythmias, non invasive)
Complementary automated patch clamp, extracellular field potential and impedance recordings of cardiomyocytes: the safety
screening tool box for the future E. Dragicevic, N. Becker, S. Stoelzle-Feix, U. Thomas, L. Doerr, M. Rapedius, M. Beckler, M. George, A. Brueggemann, N. Fertig
(Munich, DE)
Effectiveness of a management program for outpatient clinic or remote titration of beta-blockers in CRT patients: the RESTORE study. A.D. Onofrio, P. Palmisano, E. Ammendola, L. Calo', A. Ruocco, A. Rapacciuolo, G. Del Giorno, V. Bianchi, M. Campari, M. Accogli
(Naples, Tricase, Rome and Milan, IT)
Long-term outcomes of the patients with frequent atrial premature contractions: results from retrospective single center study K.J. Chun, J.K. Hwang, S.J. Park, K.M. Park, Y.K. On, J.S. Kim (Seoul, KR)
Malfunction of cardiac devices after radiotherapy without direct exposure to ionizing radiation: experimental data M. Zecchin, G. Morea, E. Sergi, M. Severgnini, E. Bianco, A. De Luca, A. Zorzin Fantasia, V. Milan, G. Giannini, G. Sinagra (Trieste, IT)
Initial european experience with a novel percutaneous epicardial suture delivery device for LAA exclusion. R.R. Tilz, J. Foran, K. Bartus, T. Wong, S. Gafoor, T. Fink, J. Myc, R. Lee, H. Sievert, K.H. Kuck (Hamburg and Frankfurt am Main, DE;
London, GB; Krakow, PL; San Francisco, US)
Suitable PT-INR in Japanese is different from Caucasian from the base of coagulat and fibrinolytic makers Y. Kobayashi, A. Ochi, K. Inokuchi, Y. Nakamura, K. Ogawa, Y. Onishi, Y. Munetsugu, Y. Minoura, N. Watanabe, E. Uchida (Tokyo, JP)
Intermediate term outcome of thoracic sympathectomy in patients with diseased hearts and refractory ventricular tachycardia storms P380
P. Barwad, S. Devidutta, M. Shah, S. Joshi, S. Vichare, S. Shastri, M. Venkat, R. Motwani, S. Moolgaonkar, Y. Lokhandwala (Chandigarh
and Mumbai, IN)
Risk assessment in hypertrophic cardiomyopathy: the role of the emerging sudden cardiac death risk factors P381
M.F. Mezni, A. Haggui, S. Mzoughi, H. Mahfoudhi, B. Jdaida, N. Ben Mansour, D. Lahidheb, N. Hajlaoui, W. Fehri, H. Haouala (Tunis, TN)
Poster session 1 - WG on Cardiac Cellular Electrophysiology 39th Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology
The presenter should be available by the poster (14:00-15:30) in order to discuss the research with the audience.
Effects of mutations in HCN4 assessed with the Inada et al. human sinus node action potential model. 48
Modelling of Bradycardia Due to Pacemaker Cell Apoptosis In the Mouse. R.K. Sanjay (Manchester, GB)
If current and its role in rate modulation: a "funny" investigation by Dynamic Clamp technique. C. Bartolucci (Cesena, IT)
Piecewise-linear approximation for a quantitative analysis of cardiac action potential. S. Severi (Cesena, IT)
From rabbit to man: towards a computational model of human sinoatrial node action potential.
A. Fabbri (Cesena, IT)
Cellular mechanisms promoting automaticity and delayed afterdepolarizations in paroxysmal atrial fibrillation: A Computational Study. J.T. Koivumaeki (Kuopio, FI)
Late sodium and sodium-calcium exchanger current block as a combined anti-arrhythmic approach in human hypertrophic
cardiomyopathy E. Passini, B. Rodriguez, A. Minchole, R. Coppini, E. Cerbai, S. Severi, A. Bueno-Orovio (Bologna and Florence, IT; Oxford, GB)
Computational model to explain the origin of diastolic micro-signals observed in intracardiac electrograms from implantable
cardioverter defibrillator recipients. P. Rossi, A. Casaleggio, M. Migliore (Genova and Palermo, IT)
Effect of different chronotropic interventions on the source-sink properties of simulated sinoatrial-atrial cell pairs F. Cacciani, M. Zaniboni (Parma, IT)
A validation study of the dynamic clamp technique for the L-type Ca2+ current in rabbit atrial myocytes S. Kettlewell, J. Dempster, G.L. Smith, A.J. Workman (Glasgow, GB)
Experimentally calibrated population of human atrial cell models mimicking action potential and voltage clamp recordings from a
specific cell group. A. Muszkiewicz (Oxford, GB)
Hypersensitive RyRs underlies synchronous systolic secondary Ca2+ release and early afterdepolarizations: A simulation study
in a ventricular myocyte. N. Gaur (Lysaker, NO)
Cardiac electrophysiological properties of Hey2+/- mice. P399
S. Podliesna (Amsterdam, NL)
Alteration of membrane distribution of Cav3 T78M induces cardiac arrhytmias by modulating ion channel properties. A. Barbuti (Milan, IT)
A new KCNQ1 mutation that impairs its association with KCNE1 is responsible for short QT syndrome. P401
C. Valenzuela (Madrid, ES)
Role of common polymorphism Q2958R on RyR2 function and propensity to cardiac arrhythmias. P402
C. Valdivia (Ann Arbor, US)
Functional characterization of a mutation in KCNT1 gene related to non familial Brugada Syndrome. P403
I. Rivolta (Monza, IT)
Functional characterization of a new cpvt-1 ryr2 mutation (r420q) in mouse ventricular myocytes P404
R. Rizzetto, Y.Y. Wang, A. Zahradnikova Jr, F. Lefebvre, J.P. Benitah, A.M. Gomez (Chatenay-Malabry, FR)
In vivo modulation of the cardiac sodium channel by overexpression of a Brugada syndrome SCN5A mutation in mice using
viral vectors P405
N. Doisne, M. Grauso, N. Mougenot, M. Clergue, A. Coulombe, P. Guicheney, N. Neyroud (Paris, FR)
Scn5a+/deltaQKP mice present late sodium current associated with long QT syndrome, dilated cardiomyopathy and ranolazine-sensitive
spontaneous ventricular arrhythmias P406
N. Belbachir, J. Montnach, F. Chizelle, A. Carcouet, I. Baro, F. Charpentier (Nantes, FR)
Basic mechanisms of cardiac excitation
Sarcolemmal Ca2+-entry via Cav1.2 channels controls the profile of calcium-activated chloride current in ventricular myocytes. K. Vaczi (Debrecen, HU)
Electrophysiological Organization of the Pacemaker and Conduction systems cells in the Avian Heart. V. Prosheva (Syktyvkar, RU)
Effects of miRNAs modulated by endurance training on cardiomyocyte excitability. M. Bonzanni (Carvico, IT)
Optical manipulation of electrical activity of whole mouse heart. L. Sacconi (Sesto Fiorentino, IT)
The unique Ion channel transcriptome of the transitional cells between Purkinje fibres and ventricular muscle. X.J. Cai (Manchester, GB)
Quantifying natural variability in the kinetics of cardiac INa. M. Clerx (Maastricht, NL)
Are the membrane and Ca2+ clocks involved in atrioventricular nodal conduction in young and aged rats? Y. Saeed, I. Temple, Z. Borbas, A. Atkinson, J. Yanni, M.R. Boyett, C. Garratt, H. Dobrzynski (Manchester, GB)
The role of ß-adrenoceptor activation in the frequency-dependence of triggered activity in catecholaminergic polymorphic
ventricular tachycardia. M.K. Stokke (Oslo, NO)
Effect of hypercholesterolemia and ageing on TdP arrhythmia incidence in methoxamine sensitized rabbits. L. Nalos (Pilsen, CZ)
Optical mapping sutdy of atrial fibrillation-induced reentry on perfused whole heart preparation in a large mammalian species. C.E. Cros (Pessac, FR)
Cardiac remodeling in rat model volume overload. D. Jarkovska (Plzen, CZ)
Heart rate variability in sepsis. M. Stengl (Pilsen, CZ)
Not hypoxia alone but obstructive respiratory events disturb ventricular repolarisation by sympathatic activation D. Linz, M. Hohl, K. Wirth, J.C. Reil, M. Boehm (Homburg, DE)
The study of EADs and the relation to Torsade de Pointes N.V. Vandersickel, A.V.P. Panfilov (Ghent, BE)
Asymptomatic ventricular fibrillation in patient with implanted left ventricle assist device. A case report. E. Gadula-Gacek, M. Tajstra, J. Pacholewicz, A. Kurek, M. Zakliczynski, P. Nadziakiewicz, M. Gasior, M. Zembala (Zabrze, PL)
Defective sinoatrial node function causes cardiac arrhythmias in diabetic mice A.F. Lubberding, E. Soltysinska, T. Speerschneider, M. B Thomsen (Copenhagen, DK)
Pro-arrhythmic electrical rate of atrial conduction and distinct cardiac Cxs contribution in HL-1 cell line M. Constantin, S. Dupuis, S. Chaigne, T. Desplantez (Bordeaux, FR)
Pulmonary vein isolation by laser balloon ablation: is energy delivered too deep into the vein? M.R. Arceluz, F. Cruz, E. Falconi, O. Salvador, J. Figueroa, M. Ortega, R. Delgado, J. Caro, C. Vasquez, J.L. Merino (Madrid, ES)
The lack of Hemopexin causes cardiac heme retention and oxidative stress in C57BL/6 mice, resulting in reduction of fractional
shortening. G. Ingoglia (Turin, IT)
Determined factors of long- term efficacy of persistent atrial fibrillation radiofrequency ablation: 5 years of follow-up S.H.G. Nardaia, Z.R. Mustapaeva, F.G. Rzaev, A.S.H. Revishvili (Moscow, RU)
Electrical isolation of the superior vena cava by laser balloon ablation in patients with atrial fibrillation: initial experience. M.R. Arceluz, P.F. Cruz, E. Falconi, O. Salvador, J. Figueroa, M. Ortega, R. Delgado, J. Caro, C. Vasquez, J.L. Merino (Madrid, ES)
Lower loop reentry. Entreintment characterization and ablation validation P.F. Cruz, M. Arceluz, E. Falconi, S. Castrejon Castrejon, O. Salvador, J. Caro, R. Delgado, M. Ortega, C. Vazquez, J.L. Merino Llorens
(Madrid, ES)
Malignant mitral valve prolapse mixes up features of primary electrical disorder and mild structural heart disease L. Bisch, S. Di Bernardo, P. Monney, P. Pascale, C.I. Park, E. Pruvot (Lausanne, CH)
Association of initial and terminal ventricular activation velocity ratio on 12-leads electrocardiography with myocardial scar presence S. Priyantoro, K. Priyantoro, Y. Yuniadi, M. Kasim, A.M. Soesanto (Jakarta, ID)
Assessment of cardiac electrophysiology during deep hypothermia and rewarming in isolated Langendorff perfused rabbit hearts K. Mcglynn, E.S. Dietrichs, A. Allan, F. Burton, T. Tveita, G.L. Smith (Glasgow, GB; Tromso, NO)
Panoramic measurements of ventricular activation and repolarisation in isolated rabbit hearts during bi-ventricular pacing A. Allan, R. Myles, G. Smith, F. Burton (Glasgow, GB)
The TRPM4 non-selective cation channel participates in the rabbit Purkinje fiber action potential T. Hof, R. Rouet, A. Manrique, L. Salle, R. Guinamard (Caen, FR)
Accurate co-expression ratio of Cx43:Cx45: influence on the gap junction channels make-up and properties S. Dupuis, S. Chaigne, M. Constantin, T. Desplantez (Bordeaux, FR)
Electrical properties of gap junction channels: dependence on the ratio of co-expressed connexin 43 and connexin 40. S. Chaigne, S. Dupuis, M. Constantin, T. Desplantez (Bordeaux, FR)
TRPM4 over-expression in HEK-293 cell line: comprehensive interpretation of functional data. L.C. Ozhathil, V. Sottas, N. Syam, J.S. Rougier, B. Bianchi, H. Abriel (Bern, CH; Leuven, BE)
Bridging integrator 1 (BIN1) initiates t-tubule growth during cardiac development and disease D.B. Lipsett, M. Frisk, N. Singh, J.M. Aronsen, W. Marszalec, O.M. Sejersted, I. Sjaastad, J.A. Wasserstrom, G. Christensen, W.E. Louch
(Oslo, NO; Chicago, US)
Slices of human neonatal and infantile myocardium: a novel experimental platform to study (patho)physiological properties at
a cellular level T. Hannes, M. Haustein, M. Khalil, J. Hescheler, A. Kroener, G. Bennink, K. Brockmeier (Cologne and Giessen, DE)
Multiple roles of TRPM4 cation channel in cardiac electrophysiology R. Guinamard, T. Hof, P. Bouvagnet, L. Salle (Caen and Lyon, FR)
The effect of beta3-adrenoceptors on Na/K pump modulation in noradrenaline-incubated cardiomyocytes G. Kayki Mutlu, M. Rocchetti, V.M. Altan, A. Zaza (Ankara, TR; Milan, IT)
The presenter should be available by the poster during the break (15:30 to 16:30) in order to discuss the research with the audience.
Inhibition of rotors by vernakalant but does not lead to termination of atrial fibrillation A. Van Hunnik, P. Kuklik, S. Zeemering, H.R.M. Kuiper, S. Verheule, U. Schotten (Maastricht, NL)
Quality of life improvement following PVI for paroxysmal AF is sustained during long term follow-up J.-P. Albenque, A. Natale, M. Mansour, K.H. Kuck, W. Saliba, D. Shah, S. Mahapatra, A. Yulzari, D. Harari, V. Reddy (Toulouse, FR; Austin,
Boston, Cleveland, Minneapolis and New York, US; Hamburg, DE; Geneva, CH)
A combination of epicardial and endocardial catheter ablation approaches to atrial arrhythmias after multiple failed atrial fibrillation
ablations Y. Huo, T. Gaspar, M. Christoph, M. Forkmann, M. Pohl, J. Mayer, J. Salmas, J. Sitzy, C. Wunderlich, C. Piorkowski (Dresden, DE)
Second-generation cryoballoon ablation for persistent atrial fibrillation: single centre experience G. Ciconte, C. De Asmundis, Y. Saitoh, G. Irfan, G. Mugnai, V. Velagic, B.U.R.A.K. Hunuk, E. Stroker, P. Brugada, G.B. Chierchia
(Brussels, BE)
Cryoballoon temperature monitoring during pulmonary vein isolation as a surrogate marker for acute procedural success M. Botros, A. Metzner, C. Heeger, P. Wohlmuth, C. Lemes, T. Maurer, R. Tilz, K.H. Kuck, F. Ouyang, E. Wissner (Hamburg, DE)
Efficacy of intracardiac ultrasound-guided catheter ablation for durable pulmonary vein isolation in patients with paroxysmal atrial
fibrillation S. Fukamizu, T. Kitamura, R. Hojo, Y. Aoyama, A. Nakada, I. Kawamura, S. Miyazawa, M. Nishizaki, H. Sakurada, M. Hiraoka (Tokyo,
Yokohama and Ibaraki, JP)
Radiofrequency catheter ablation versus balloon cryoablation of atrial fibrillation: markers of myocardial damage, inflammation and
thrombogenesis B. Antolic, A. Pernat, M. Cvijic, D. Zizek, L. Klemen, M. Sinkovec (Ljubljana, SI)
Initial experience with a novel laser catheter balloon for paroxismal and short lasting persistent atrial fibrillation ablation J. Osca Asensi, O. Cano, A. Andres, P. Alonso, M.J. Sancho Tello, B. Igual, J. Olague, L. Martinez Dolz, A. Salvador (Valencia, ES)
Clinical use of lesion size index during pulmonary vein isolation with contact force sensing catheters S. Madero, J. Salas, M.T. Barrio, E. Castellanos, R. Peinado, M. Ortiz, J. Almendral (Madrid, ES)
Left atrial remodeling in patients with atrial fibrillation is related to left ventricular myocardial fibrosis M.S. Dzeshka, E. Shantsila, G.Y.H. Lip (Grodno, BY; Birmingham, GB)
Validation of conventional thromboembolic risk factors in Korean AF population: suggestion for new scoring system,
CHA2DS2-VAK (W) P441
M.J. Cha, S.R. Lee, W.H. Lim, S.H. Kang, Y.J. Cho, I.Y. Oh, E.K. Choi, S. Oh (Seoul, KR)
Ventricular rate is not related to survival in patients with heart failure and atrial fibrillation P442
S. Hawkey, D. Levin, M. Mohan, F. Baig, L. Rutherford, C.C. Lang, A.M. Choy (Dundee, GB)
The occurence of cardiovascular disease in apparently idiopathic AF patients and the role of early cardiac CT angiography
(a 5yr follow-up study) P443
E.A.M.P. Dudink, B. Weijs, R.J.P. Haest, J.A. Kragten, B.L. Kietselaer, J.E. Wildberger, H.J.G.M. Crijns (Maastricht, Geldrop and Heerlen, NL)
Yield of electrophysiolocal study to unmask supraventricular tachycardia in patients < 45 years scheduled for pulmonary vein isolation
due to symptomatic atrial fibrillation. P444
S.-M. Chaldoupi, L.V.A. Boersma, M.C.E.F. Wijffels, J. Balt (Nieuwegein, NL)
Left ventricular fibrosis is associated with kidney dysfunction in patients with atrial fibrillation P445
M.S. Dzeshka, E. Shantsila, G.Y.H. Lip (Grodno, BY; Birmingham, GB)
Clinical outcomes of atrial fibrillation ablation according to technological step-up of CARTO mapping systems: a single center
experience P446
A. Nakada, S. Fukamizu, T. Kitamura, R. Hojo, Y. Aoyama, K. Komiyama, T. Tejima, M. Nishizaki, M. Hiraoka, H. Sakurada (Tokyo,
Sequential unipolar and bipolar radiofrequency versus repeated unipolar radiofrequency ablation of paroxysmal atrial fibrillation
by nMARQ catheter P457
P. Vergara, L. Capulzini, G. Paparella (Milan, IT; Brussels, BE)
Atrial fibrillation ablation with Amigo robotic arm: a comparison with manual navigation P458
F. Moscoso Costa, R. Candeias, P. Adragao, D. Cavaco, P. Santos, E. Vaz, P. Carmo, F. Morgado, M. Mendes (Lisbon, PT)
Characteristics and efficacy of radiofrequency catheter ablation for symptomatic atrial premature contractions P459
S. Aita, K. Kuroki, M. Igarashi, Y. Sekiguchi, A. Nogami, K. Aonuma (Ibaraki, JP)
Three-minute single shot versus three-minute double shot cryoballoon ablation for the treatment of atrial fibrillation P460
J. Marti Almor, E. Valles, B. Benito, P. Ramos, S. Cabrera, A. Fageda, V. Bazan (Barcelona, ES)
Feasibility and safety of nurse-directed deep sedation (W) P461
M. Namdar, L. Varotto, F. Mattey-Prevot, J. Lyvet, D. Marcelot, A. Eichenberger, P. Gentil-Baron, H. Sunthorn, H. Burri, D. Shah
(Geneva, CH)
FIRM only ablation in patients with persistent atrial fibrillation: acute and medium term results. P462
A. Schade, P. Halbfass, P. Mueller, K. Nentwich, M. Roos, F. Steinborn, G.A. Szoelloesi, P. Pavlov, T. Deneke
(Erfurt and Bad Neustadt/ Saale, DE)
Does the size of isolation area after pulmonary vein isolation with balloon-based techniques really matter for the long term outcome? P463
G.M. Fassini, L. Cipolletta, G. Del Giorno, S. Conti, G. Vettor, A. Dello Russo, F. Tundo, B. Majocchi, V. Marino, C. Tondo (Milan, IT)
Feasibility of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices P464
C.H. Heeger, A. Rillig, T. Lin, S. Mathew, M. Botros, A. Metzner, E. Wissner, K.H. Kuck, F. Ouyang, R.R. Tilz (Hamburg, DE)
Activation mapping during pulmonary vein pacing allows precise localization of conduction gaps in the wide circumferential ablation
lines to complete pulmonary vein isolation P465
G. Monir, S. Pollak, E. Bassily, J. Pepe (Orlando, US)
Relationship between reduced left atrial function and electro-anatomical remodeling in patients undergoing atrial fibrillation ablation. P466
A.S. Parwani, D.A. Morris, N. Smolny, M. Huemer, A.S. Wutzler, P. Attanasio, F. Blaschke, W. Haverkamp, L.-H. Boldt (Berlin, DE)
Incidence and characteristics of pulmonary vein stenosis following catheter ablation of atrial fibrillation: insights from the
contemporary multicenter ADVICE trial (W) P467
S. Gomes, P. Khairy, F.P. Mongeon, Z. Galvan, J. Andrade, S. Nattel, M. Talajic, S. Levesque, D. Roy, L. Macle (Montreal, CA)
Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation P468
J. Kornej, J. Schmiedl, L. Ueberham, S. John, B. Dinov, G. Hindricks, V. Adams, D. Husser, A. Bollmann (Leipzig, DE)
Optimal settings of VisiTag module for contact force-guided circumferential pulmonary vein isolation of atrial fibrillation K. Nakamura, S. Naito, K. Minami, T. Sasaki, E. Goto, M. Nakano, S. Shimizu, T. Yano, K. Kumagai, S. Oshima (Maebashi, JP)
Characterization of endocardial voltage attenuation and pulmonary vein isolation following convergent epicardial ablation for
persistent atrial fibrillation P470
B.G. Hook, T. Fitton (Burlington MA, US)
Excellent outcomes at long term follow-up following minimally invasive surgical ablation for stand-alone atrial fibrillation C. Muneretto, G. Bisleri, F. Rosati, L. Di Bacco, L. Bontempi, M. Cerini, A. Curnis (Brescia, IT)
An automated algorithm for the segmentation of the left atrial blood pool as a key step in the assessment and display of left atrial wall
thickness P472
J. Whitaker, R. Karim, T. Fastl, R. Rajani, H. Chubb, S. Williams, M. Gabrawi, M. Wright, S. Niederer, M.O.neill (London, GB)
Stereotactic radiosurgery in threatment of ventricular tachycardias R. Neuwirth, J. Cvek, L. Knybel, L. Molenda, B. Otahal, J. Pindor, M. Fiala, D. Feltl, M. Branny (Trinec and Ostrava, CZ)
Experience with non-invasive mapping system (ECVUE) to guide ablation P474
F. Gomez, K. Roy, L. Mantziari, D. Valeron, I. Horduna, J.R. Clague, S. Ernst (London, GB)
Direct pulmonary vein ablation with stenosis prevention therapy (W) P475
C. Desimone, E. Ebrille, F. Syed, D. Ladewig, S. Suddendorff, E. Gilles, A. Danielsen, S. Kapa, D. Holmes, S. Asirvatham (Rochester and
Ann Arbor, US; Turin, IT)
Use of electrical coupling index in typical atrial flutter ablation M. Maines, D. Catanzariti, C. Angheben, M. Del Greco (Rovereto, IT)
The non-fluoroscopic navigation reduces significantly not only the x-ray exposure but the cumulative radiofrequency time as well
during radiofrequency catheter ablation of the cavo-tricuspid isthmus T.N. Shalganov, M.K. Stoyanov, B.T. Kunev (Sofia, BG)
Early impacts of right ventricular pacing on left ventricular strain and dyssynchrony A. Algazzar, M.A. Moharram, A.A. Katta, G. Soltan, W. Abdelaziz (Cairo and Shebin El-kom, EG)
Intra-individual comparison of two algorithms for the reduction of ventricular pacing percentage in sick sinus syndrome:
twelve-month results from the VIPERS study V. Calvi, E.C.L. Pisano', M. Brieda, V. Giudici, D. Melissano, B. Castaldi, G. Nigro, C. Guastaferro, M. Madalosso, A. Capucci (Catania,
Lecce, Pordenone, Seriate, Casarano, Isernia, Naples, Castellammare, Mestre-Venice and Ancona, IT)
Long-term single-center experience with subaxillary approach in cardiac defibrillators implantation in young patients population M. Morosato, G. Morani, G. Silvestre, L. Tomasi, B. Bolzan, G. Mugnai, C. Vassanelli (Verona, IT)
Follow up cost of patients subjected to cardiac rhythm management device implantation J. Fanourgiakis, E. Simantirakis, E. Kanoupakis, S. Chrysostomakis, N. Maniadakis, G. Kourlaba, G. Mpantouvakis, M. Touloupaki, E. Kouvidis,
P. Vardas (Heraklion and Athens, GR)
Long-term performance of a MRI-conditional ventricular lead: Beflex MRI RF46D (Ventricular) and RF45D (atrial). J.A. Lapuerta Irigoyen, R. Bangueses, P. Vigil, J. Casares, C. Fernandez Cimadevilla, J. Garcia-Rubio (Gijon and Aviles, ES)
Low dislodgement and phrenic nerve stimulation (PNS) incidences observed in new straight quadripolar LV leads M. Biffi, D. Gras, D. Exner, W.B. Johnson, A.C. Lin, A. Hussin, G. Giannola, S. Li, K. Holloman, G. Crossley (Bologna and Cefalu, IT;
Nantes, FR; Calgary, CA; Des Moines, Chicago, Minneapolis and Nashville, US; Kuala Lumpur, MY)
Prevalence of subcutaneous implantable defibrillator (S-ICD) related complications in patients with congenital heart disease:
results from a pooled analysis from the IDE study and EFFORTLESS registry B.D.souza, Y.Y. Kim, M. Burke, J.M. Morgan, A.R. Leon, K.K. Patton, S.C. Agarwal, P.H. Belott, A.E. Epstein, M.J. Shah (Philadelphia,
Chicago, Atlanta, Seattle and La Mesa, US; Southampton and Newcastle upon Tyne, GB)
Manufacturer change at the time of ICD replacement: italian survey and preliminary data from the DECODE study M. Biffi, E. Ammendola, A. Vado, Q. Parisi, M.L. Narducci, A. Campana, A. Pierantozzi, G. Zingarini, M. Malacrida, P. De Filippo
(Bologna, Naples, Cuneo, Campobasso, Rome, Salerno, Pesaro, Perugia, Milan and Bergamo, IT)
long term follow up of victims of out of hospital cardiac arrest with first rhythm ventricular fibrillation treated with an ICD in
secondary prevention M. Caputo, B. Adjibodou, F. Regoli, G. Conte, A. Del Bufalo, T. Moccetti, C. Klersy, M. Curti, A. Auricchio (Lugano, CH; Pavia, IT)
Prognostic value of the epinephrine test following thoracoscopic left cardiac sympathetic denervation in patients with inherited
arrhythmia syndrome S.Y. Jang, Y. Cho, N.K. Kim, C.Y. Kim, J.H. Kim, M.H. Bae, J.H. Lee, D.H. Yang, H.S. Park, S.C. Chae (Daegu, KR)
Re-evaluation of the left ventricular ejection fraction before ICD generator replacement: time for a systematic approach? J. Nas, D. Jilesen, J.L. Bonnes, S.W. Westra, J.L.R.M. Smeets, M.A. Brouwer, M.J. De Boer (Nijmegen, NL)
Outcomes of patients with valvular cardiomyopathy after prophylactic defibrillator implantation. M. Rodriguez Manero, R.A.A.S. Rosa Alba Abellas-Sequellas, J.J.L. Jesus Jimenez-Lopez, J.F.A. Juan Fernandez-Armenta,
J.B.M. Juan Benezet-Mazuecos, A.F.C. Agustin Fernandez-Cisnal, J.M.A. Jose Moreno-Arribas, V.B.G. Vicente Bertomeu-Gonzalez,
R.F. Rafael Peinado, L.M.S. Luis Martinez-Sande (Santiago de Compostela, Toledo, Cadiz, Madrid, Seville and Alicante, ES)
Are patients with Wolff-Parkinson-White pattern with syncope as the single symptom different from those completely symptom-free? P478
M.S. Ait Messaoudene, Y. Aoudia, R. Benkouar, F. Ahlouche, T. Boumedien, A. Boudrifa, T. Delassi, M.T. Chentir (Algiers, DZ)
Impact of automated template matching during PVC ablation: results of a randomized controlled trial (W) P479
J. Luker, A. Sultan, K. Furst, H. Servatius, R.O. Akbulak, B. Schaffer, D. Schreiber, B.A. Hoffmann, S. Willems, D. Steven (Cologne and
Hamburg, DE; Bern, CH)
Efficacy of the renal denervation in patients with resistant hypertension and atrial fibrillation P480
L. Plashchinskaya, D. Goncharik, A. Chasnoits, V. Barsukevich, A. Savchenko, V. Golenischa, A. Mrochek (Minsk, BY)
Distance to the origin, not the earliness activation or pacemap, determines a cure of ventricular tachyarrhythmias: a distinct
subgroup of outflow tachyarrhythmias. P481
K. Hisazaki, K. Kaseno, D. Aoyama, K. Hasegawa, M. Yokokawa, N. Amaya, K. Ishida, K. Arakawa, H. Uzui, H. Tada (Fukui, JP)
The transseptal or transaortic approach for pediatric left sided accessory pathway ablation in era of NavX/Ensite? Comparison
of four apporaches. P482
A. Baszko, K. Czyz, S. Stec, A. Lazniak, K. Deutch, J. Siedz, W. Bobkowski (Poznan, Rzeszow and Kielce, PL)
Permanent cardiac pacing in infants and neonates. Long-term experience of a single center P495
K. Bieganowska, M. Miszczak-Knecht, A. Kaszuba, M. Posadowska, K. Pregowska, M. Birbach, W. Lipinski (Warsaw, PL)
optimization of rate-adaptive pacing in patients with hear failure P496
M.V. Kuznetsova, D.A. Andreev, O.N. Ganeeva, I.V. Drozdov, A.A. Aleksandrov, I.V. Samoylenko, Y.S. Sazonova, A.A. Bikova, V.P. Sedov,
A.L. Syrkin (Moscow, RU)
Long lasting ventricular pacing in patients with SSS increases left ventricle diastolic dysfunction and myocardial fibrosis even after
DDD pacing upgrade. (W) P497
L. Checinski, A. Slawuta, J. Moszczynska-Stulin, J. Gajek (Wroclaw, PL)
Incidence of pneumonia following pacemaker implantation in the elderly P498
S.A. Edroos, M.H. Mahmoud, K. Mitrousi, M. Addawe, O. Al-Sharef, A. Owusu-Ansah, H. El-Gendi, R. Jagathesan, J. Sayer, D. Roy
(Harlow, GB)
Influence of types of heart rhythm disorders into sexuality and sexual behaviors among men after pacemaker implantation P499
A. Mlynarska, R. Mlynarski, M. Sosnowski, K.S. Golba (Katowice, PL)
Cardiac resynchronization therapy: left ventricular lead placement guided by coronary venous electroanatomic mapping M. Maines, C. Angheben, D. Catanzariti, M. Marini, A. Coser, M. Del Greco (Rovereto and Tretno, IT)
LV lead revision of anteroseptal and apical postions - it can make a difference S.T. Sivakumaran, M. Shanks, S. Kimber, J. Choy, H. Becher (Edmonton, CA)
Ventricular lead position and mechanical dyssynchrony in response to cardiac resynchronization therapy V. Lebedeva, T. Lubimceva, M. Trukshina, E. Lyasnikova, D. Lebedev (Saint-Petersburg, RU)
Anatomical and electrical interlead distance predict outcome in cardiac resynchronization therapy patients P503
G. Stabile, A.D. Onofrio, P. Pepi, A. De Simone, M. Santamaria, A. Rapacciuolo, S.I. Caico, D. Pecora, M. Malacrida, G.L. Botto (Naples,
Mantova, Maddaloni, Campobasso, Gallarate, Brescia, Milan and Como, IT)
Does CRT benefit heart failure patients with long PR-interval but no ventricular dyssynchrony by reducing mitral regurgitation? P504
J. Walmsley, F. Prinzen, T. Delhaas, J. Lumens (Maastricht, NL)
Usefulness of ventricular sense response in last-generation CRT devices P505
D.F. Ortega, L.D. Barja, E.M.I.L.I.O. Logarzo, N. Mangani, A. Paolucci (buenos aires, Pilar and Buenos Aires, AR)
Multiple BiV stimulation combinations by using two RV leads improve potential for response to CRT: Results of the TriV HF ICD study P506
W. Kranig, R.G. Grove, E.W. Wolff, M.K. Kowalski, J.T. Thale (Bad Rothenfelde, DE)
Response to cardiac resynchronisation therapy correlates with less appropriate ICD interventions and lower mortality P507
B.A. Schaer, S. Frey, T. Reichlin, M. Kuehne, S. Osswald, C. Sticherling (Basel, CH)
Association between right ventricular lead position and clinical outcome in cardiac resynchronization therapy: validation by cardiac
computed tomography P508
C. Stephansen, A. Sommer, M.B. Kronborg, C. Gerdes, P.T. Mortensen, B.L. Noergaard, J.C. Nielsen (Aarhus, DK)
Small-caliber lead failure after generator exchange R. Salgado Aranda, J. Martin Gonzalez, J. Martinez Ferrer, J. Alzueta, X. Vinolas, J. Fernandez De La Concha, M. Molina Lerma, L. Perez,
D. Calvo, J. Garcia Fernandez (Burgos, Vitoria, Malaga, Barcelona, Madrid, Granada, A Coruña and Oviedo, ES)
Lead extraction experience with high frequency 80 Hz laser sheaths S. Hakmi, S. Pecha, Y. Yildirim, L. Conradi, B. Sill, N. Gosau, M.A. Aydin, S. Willems, H. Reichenspurner, H. Treede (Hamburg and
Device explantation due to infection - What are the causative microorganisms? V. Moeller, M. Seifert, F. Hoelschermann, C.H. Butter (Bernau bei Berlin, DE)
Safety and effectiveness of transvenous extraction of pacemaker and implantable cardioverter-defibrillator leads in patients under
or over 80 years of age. M. Nagashima, Y. An, K. Hiroshima, M. Fukunaga, S. Touhoku, K. Kourai, K. Ando (Kitakyushu, JP)
Relations between syncope-induced brain injury and coagulation changes during positive head-up tilt test in patients with vasovagal
syncope A.Z. Pietrucha, M. Wnuk, I. Bzukala, E. Konduracka, R. Mariankowski, B. Szloszarczyk, R. Rychlak, J. Nessler (Cracow, PL)
Exercise-induced syncope: mechanism and clinical outcomes F. Rodriguez Entem, V. Exposito, S. Gonzalez Enrriquez, L. Ruiz Guerrero, C. Sorto, J.J. Olalla (Santander, ES)
Positive inotropic support in acute cardiac decompensation - haemodynamic and arrhythmogenic effects of levosimendan and
catecholamines combined treatment in experimental heart failure K.V. Nagy, B. Sax, E.M. Vegh, A. Kosztin, N. Turi-Kovats, G. Szucs, E. Zima, V. Kekesi, B. Merkely (Budapest, HU)
Bundle branch blocks are due to longitudinal dissociation in the His bundle: Resolution of BBB by permanent His bundle pacing P. Vijayaraman, A. Naperkowski, P. Sharma, J.N. Koneru, K.A. Ellenbogen, G. Dandamudi (Wilkes Barre and Richmond, US)
Age and gender features in pediatric patients with paroxysmal supraventricular tachycardia T. Kruchina, I. Vinogradova, D. Egorov, O. Laur, G. Novik, B. Tatarsky (Saint-Petersburg, RU)
Effect smoothness priors regularization on quantitative estimate of heart rate variability parameters of normal subjects D. Brisinda, A.R. Sorbo, A. Venuti, F. Fioravanti, R. Fenici (Rome, IT)
Utilization of echocardiographic tissue deformation imaging to differentiate idiopathic VT from ARVC B. Al Mogheer, H. Kassem, E. Baligh, Z. Ashour, A. Abdelwahab (Cairo, EG)
Usefulness of 7-days Holter monitoring in patients after pulmonary vein isolation- assessment of silent atrial fibrillation recurrences. K. Szydlo, M. Wita, I. Wozniak-Skowerska, A. Wnuk-Wojnar, A. Hoffmann, S. Nowak, M. Faryan, K. Mizia-Stec (Katowice, PL)
Clinical profile and electrophysiological abnormalities of Adult Ebsteins anomaly M.T. Rahman (Dhaka, BD)
Exercise stress test in diagnostics of long QT syndrome in young athletes L.A. Balykova, L.M. Makarov, S.A. Ivyanskij, A.A. Shirokova, Y.U.O. Soldatov, N.V. Shchekina (Saransk and Moscow, RU)
Pre-existing right axis deviation in patients with verapamil sensitive idiopathic left ventricular tachycardia K. Higuchi, H. Muramoto, A. Suzuki, T. Sasaki, M. Goya, K. Hirao (Kanagawa and Tokyo, JP)
Incidence and characteristics of tachyarrhythmias in young patients presented with acute myocarditis A. Gkouziouta, G. Karavolias, A. Kostopoulou, G. Theodorakis, S. Adamopoulos (Athens, GR)
Advancement in engineering technology with the potential to replace the 12 Lead ECG for rhythm management F. Ara, C. Crockford, I. John, R.A. Kaba (Ashford and London, GB)
Time course and characteristics of tachyArrhythmias. A. Yaksh, C. Kik, P. Knops, K. Zwiers, M.J.B. Van Ettinger, P. Van De Kemp, O.C. Manintveld, A.A. Constantinescu, A.J.J.C. Bogers,
N.M.S. De Groot (Rotterdam, NL)
The lung impedance monitoring in treatment of chronic heart failure: results of the LIMIT-CHF study G. Domenichini, T. Rahneva, I. Diab, O. Dhillon, V. Baker, R.J. Hunter, M.J. Earley, R.J. Schilling (London, GB)
Genetics (Basic Science in Arrhythmias)
A novel mutation in beta-myosin heavy chain gene in a family with hypertrophic cardiomyopathy E. Komurcu-Bayrak, D.F. Bayrak, G. Kahveci, A. Buturak, F. Guclu-Geyik, N. Erginel-Unaltuna (Istanbul, TR)
LQT syndrome: a new tool for risk stratification V. Novelli, A. Malovini, N. Monteforte, R. Bloise, M. Memmi, A. Mazzanti, R. Bellazzi, C. Napolitano, S.G. Priori (Pavia, IT)
Evidence of transmural activation recovery interval gradients in intact human cardiac restitution studies P515
N.T. Srinivasan, M. Orini, R.D.B. Simon, R. Providencia, C. Torrinha, F. Khan, O.R. Segal, A.W. Chow, M.D. Lowe, P.D. Lambiase (London, GB)
Electrophysiological markers that can guide high rate pacing to avert occurrence of Torsade de Pointes in the chronic atrioventricular
block dog model P516
S.C. Wijers, A. Dunnink, H.D.M. Beekman, R. Varkevisser, A. Bossu, A. Aranda Hernandez, M. Meine, M.A. Vos (Utrecht and Maastricht, NL)
Effect of myocardial ischemia on inferolateral early repolarization P517
M. Stoller, C. Seiler, J. Seiler, H. Servatius, F. Noti, N. Tran, A. Medeiros-Domingo, J. Fuhrer, H. Tanner, L. Roten (Bern, CH)
Bleeding risk in patients treated with dabigatran or vitamin K antagonist for non-valvular atrial fibrillation : a meta analysis of
matched analysis in routine care settings L. Fauchier, W. Darwiche, T. Bejan Angoulvant, N. Clementy, D. Angoulvant, D. Babuty, F. Dievart (Tours, FR)
Influence of rivaroxaban in comparison to warfarin on the laboratory measurements of coagulation assays and the circadian variation
in patients with non-valvular atrial fibrillation Y. Hitaka, M. Ogawa, S. Goto, Y. Nagata, J. Morii, S. Imaizumi, T. Yasuda, N. Matsumoto, A. Matsunaga, K. Saku (Fukuoka, JP)
Respirate Project-2: a telemedicine-based project for ICD-CRTD patients involving HF specialist and general practitioner P. Rocca, L. Viscardi, P. Neri, A. Locatelli, M. Tespili, V. Giudici (Seriate, IT)
Gender differences in antithrombotic therapy in Europe: observations from the GLORIA-AF registry program G.Y.H. Lip, H.-C. Diener, S.J. Dubner, J.L. Halperin, C.S. Ma, K.J. Rothman, K. Zint, A. Elsaesser, C. Teutsch, M.V. Huisman
(Birmingham, GB; Essen and Ingelheim, DE; Buenos Aires, AR; New York and Research Triangle Park NC, US; Beijing, CN;
Burlington, CA; Leiden, NL)
Management of atrial fibrillation – new ideas for 2015
Chairpersons: P. Kirchhof (Birmingham, GB); S. Levy (Marseille, FR)
Insights from the EORP registry on AF.
L. Fauchier (Tours, FR)
PREFER in atrial fibrillation: an update.
L.M. Rincon (Madrid, ES)
Post marketing reporting: update on Xantus.
A.J. Camm (London, GB)
Detection of AF: Focus on stroke survivors.
J. Brachmann (Coburg, DE)
ORBIT-AF: A view from the US.
B.A. Steinberg (Durham, US)
The pericardium and the electrophysiologist Joint session with the ESC Working group on Myocardial & Pericardial disease on EP pericardium
Chairpersons: K.H. Kuck (Hamburg, DE); A.D. Ristic (Belgrade, RS)
To study the interface between pericardium and invasive electrophysiology , and the risk of pericardial complications of EP procedures
Management of cardiac tamponade – the position statement.
Pacemaker related pericardial disease – acute and chronic.
Contemporary management of recurrent pericarditis.
Y. Adler (Rannana, IL)
Pericardial anatomy - relevance to ablation performance and complications
Y.-M. Cha (Rochester, US)
Troubleshooting stored data in ICDs: is it VT, SVT, both or neither? Part 1
Case Based Session
Chairpersons: F.D. Murgatroyd (London, GB); P. Ritter (Pessac, FR)
Principles of interpreting ICD EGMs.
Discussion & questions from the audience.
S. Richter (Leipzig, DE)
D.J. Wright (Liverpool, GB)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) from genes to bedside Chairpersons: G. Thiene (Padova, IT); J.-Y. Le Heuzey (Paris, FR)
This section is aimed at update on ARVC with a specific focus on the pathophysiology and clinical management of ventricular arrhythmias. The
session has a translational approach that will walk the audience to gather a mechanistic approach to the disease phenotype.
Genetics and genotyping in ARVC.
P. Van Tintelen (Amsterdam, NL)
Desmosomes, sodium channels and the genesis of the arrhythmogenic substrate in ARVC.
C.A. Remme (Amsterdam Z0, NL)
The clinical role of mapping and ablation in ARVC.
C. Bisceglia (Milan, IT)
Prophylactic implantable defibrillator in patients with ARVC.
D. Ward (Dublin, IE)
Cardiac ion channels and their macromolecular complexes: electrophysiology and beyond
Chairpersons: G. Antoons (Maastricht, NL); D. DiFrancesco (Milan, IT)
The cardiac sodium channel interactomes: results from genetically-modified mouse models.
Impact of DPP10 on native cardiac Ito and action potential in rat epicardial myocytes.
K. Metzner (Leipzig, DE)
Super-resolution imaging of Ryanodine Receptor cluster organization in normal and failing rat cardiac myocytes.
T. Kolstad (Oslo, NO)
End-Binding protein 1 is a modulator of cardiac conduction.
V. Portero (Amsterdam, NL)
Determinants of altered atrial Na+-Ca2+ exchanger function in patients with chronic atrial fibrillation
S. Ghezelbash, C. E Molina, L. Badimon, N. Voigt, J. Heijman, D. Dobrev (Essen, DE; Barcelona, ES)
Emerging smartphone application for cardiac evaluation
Chairpersons: M. Malik (Purley, GB); F. Braunschweig (Stockholm, SE)
To provide insight into the most relevant application that have been proposed to evaluate cardiovascular function from arrhythmias detection to
Pocket view ECG.
J. Oster (Oxford, GB)
Smartphone cardiac rhythm monitoring.
Symptom evaluation and patient education.
F. Braunschweig (Stockholm, SE)
Safety, accuracy and validation of medical smartphone applications.
E.G. Caiani (Milan, IT)
New developments in technology for arrhythmia nursing
Chairpersons: N. Simonelli (Novi Ligure, IT); J. Elders (Nijmegen, NL)
To discuss developments and practical application of technology in arrhythmia nursing
News in rhythm management devices, ablation systems and EP recording.
F.W. Prinzen (Maastricht, NL)
Nurses roles in implanting loop recorders and performing generator box changes.
A. Newham (Middlesbrough, GB)
Ongoing management of Sprint Fidelis and Riata defibrillator leads.
I.A. Fazal (Newcastle Upon Tyne, GB)
Practical issues in remote monitoring.
N. Sadoul (Vandoeuvre Les Nancy, FR)
Arrhythmias during pregnancy occur seldom. This session will give an overview on the types of arrhythmias, which drug can be instituted during
pregnancy and which drug not and gives some practical advised how to treat these patients.
Risk predictors beyond LVEF + ECG Chairpersons: M.A. Vos (Utrecht, NL); J. Poole (Seattle, US)
Arrhythmias in structural congenital heart disease during pregnancy.
C. Berul (Washington, US)
Arrhythmias in electrical heart disease during pregnancy.
A.C.P. Wiesfeld (Groningen, NL)
Antiarrhythmic drugs during pregnancy.
Cardioversion and devices during pregnancy: practical tips.
N. Rueb (Tubingen, DE)
Antiarrhythmic drugs and devices during pregnancy
Chairpersons: H. Malmborg (Uppsala, SE); K.H. Haugaa (Oslo, NO)
Can serologic markers of fibrosis predict future shocks in icd recipients with dilated cardiomyopathy?
E. Kanoupakis, J. Fanourgiakis, E. Kallergis, H. Mavrakis, G. Chlouverakis, P. Vardas (Heraklion, GR)
Left atrial fibrosis quantification by late gadolinium enhancement MRI: can we find the optimal normalized thresholds
E. Benito, A. Carlosena-Remirez, E. Guasch, A. Berruezo, R.J. Perea, S. Prat, J. Brugada, L. Mont (Barcelona, ES)
Identification of the arrhythmogenic substrate in acute phase of STEMI
J. Acosta, D. Penela, D. Andreu, J. Fernandez-Armenta, T. De Caralt, L. Mont, J.T. Ortiz, X. Bosch, J. Brugada, A. Berruezo
Prognostic value of 18-fluorodeoxyglucose positron emission computed tomography scan in patients with unexplained
atrioventricular conduction block
A. Shelke, T. Danwade, D. Saggu, S. Yalagudri, C. Sridevi, C. Narasimhan (Hyderabad, IN)
Noninvasive epi/endocardial mapping of ventricular arrhythmias
A. Tsyganov, M. Chaykovskaya, M. Chmelevsky, S. Deiss, T. Maurer, M. Yakovleva, K.H. Kuck, E. Wissner (Moscow and Saint Petersburg, RU; Hamburg, DE)
Oral Abstract Session (continued)
Focal hypermetabolic left ventricular cardiomyopathy: an underdiagnosed life-threatening arrhythmogenic disease
C.I. Park, P. Pascale, L. Bisch, J. Schlaepfer, S. Di Bernardo, G. Buss, J. Prior, E. Pruvot (Geneva and Lausanne, CH)
'islets' of heterogenous myocardium within the scar predict ventricular tachycardia after myocardial infarction
K. Malaczynska-Rajpold, K. Blaszyk, M. Wasniewski, W. Seniuk, A. Gwizdala, M. Pyda, P. Mitkowski, S. Grajek (Poznan, PL)
Predictive role of circulating endothelial-derived apoptotic microparticles in chronic heart failure with atrial fibrillation
A. Berezin, A. Kremzer (Zaporozhye, UA)
MRI based whole-heart inverse potential mapping of idiopathic ventricular ectopy
P. Bhagirath, A.W.M. Van Der Graaf, J. De Hooge, V.J.H.M. Van Driel, H. Ramanna, N.M.S. De Groot, M.J.W. Gotte (The Hague
and Rotterdam, NL)
Exploring mechanisms of Brugada syndrome using noninvasive electrocardiographic imaging M. Chaykovskaya, B. Rudic, A. Tsyganov, E. Fetisova, V. Kalinin, E. Zaklyazminskaya, A. Shestak, M. Yakovleva, R. Schimpf,
M. Borggrefe (Moscow, RU; Mannheim, DE)
Effects and results of various pacing modalities
Chairpersons: B. Lamp (Bad Oeynhausen, DE); J.-J. Blanc (Brest, FR)
Temporary transvenous pacing - results and complications in clinical practice
M. Faustino, F. Costa, S. Baptista, L. Marques, H. Vasconcelos, F. Madeira, C. Morais (Amadora, PT)
Predictors of death in pacemaker chagas cardiomyopathy patients: first results of PACINCHAGAS study
G. Peixoto, S.F. Siqueira, M.M. Lensi, S.A.D. Nishioka, A.A.A. Pedrosa, R.A. Teixeira, R. Costa, M. Martinelli (Sao Paulo, BR)
Effectiveness of right ventricular septal pacing to prevent the occurrence of new-onset atrial fibrillation
S. Kuroda, A. Mizukami, Y. Matsue, Y. Naruse, K. Kurosaki, M. Suzuki, A. Matsumura, A. Nogami, K. Aonuma, Y. Hashimoto
(Chiba, Tsukuba and Yokohama, JP; Groningen, NL)
Cardiac contractility modulation with the optimizer system in patients with symptomatic heart failure despite optimal medical
therapy and cardiac resynchronization therapy
J. Kuschyk, H. Naegele, K.H. Kuck, C. Butter, T. Lawo, D. Wietholt, S. Roeger, D. Burkhoff, B. Rousso, M. Borggrefe
(Mannheim, Reinbek, Hamburg, Bernau bei Berlin, Bochum and Uelzen, DE; New York, US; Hod Hasharon, IL)
Pacemaker longevity in patients implanted for sinus node disease or atrio-ventricular block: a post-hoc analysis of the
ANSWER study J. Moreno Planas, M. Stockburger, S. Boveda, P. Mabo, F. Bode, J. Rodriguez Garcia, G. Carreras, D. Bukart-Kuttner,
A. Rousseau-Plasse, P. Defaye (Madrid, ES; Berlin and Lübeck, DE; Toulouse, Rennes, Clamart and Grenoble, FR;
Terni, IT; Vienna, AT)
Evaluation and long term performance of novel right ventricular and atrial automatic capture control algorithms: results
from the essential registry
M. Biffi, M. Bertini, D. Saporito, G. Belotti, F. Quartieri, C. Tomasi, A. Pucci, D. Giorgi, D. Grassini, A. Gargaro (Bologna, Ferrara,
Rimini, Treviglio, Reggio Emilia, Ravenna, Carrara, Lucca and Milan, IT)
Long term performance of the tendril MRI leads: results from the tendril MRI lead observational study
R. Breedveld, J. Sperzel, G. Paulussen, M. Alberio, E. Pisano, D. Sergi, K. Timmermans, A. Oza (Leeuwarden and Heerlen, NL;
Bad Nauheim, DE; Como, Lecce and Rome, IT; Zaventem, BE; Sylmar, US)
Assessing response to biventricular pacing: non-invasive cardiac monitoring does not consistently detect acute response
J.H.P. Gamble, N. Herring, R. Khiani, P.W.X. Foley, M.R. Ginks, K. Rajappan, Y. Bashir, T.R. Betts (Oxford, Milton Keynes
and Swindon, GB)
Prognostic role of right ventricular function in patients with heart failure undergoing cardiac resynchronization therapy S. Maffe', A. Rapacciuolo, E. Bertaglia, A.D. Onofrio, F. Esposito, U. Parravicini, A. Agresta, P. Paffoni, M. Campari, G. Stabile
(Borgomanero (NO), Naples, Padua and Milan, IT)
Characteristics of regions with poor acute hemodynamic response in cardiac resynchronization therapy
S. Ross, H.H. Odland, T. Edvardsen, T. Haaland, T. Fischer, L.O. Gammelsrud, R. Skaardal, E. Kongsgaard (Oslo, NO)
Satellite Symposium - Experts on the Spot
Moderated Posters (continued)
State-of-the-art: ablation in patients on NOACs
Sponsored by Boehringer Ingelheim
State-of-the-art: ablation in patients on NOACs.
S. Willems (Hamburg, DE); R. Schilling (London, GB)
Chairpersons: J.C. Silberbauer (London, GB); F. Leyva-Leon (Sutton Coldfield, GB)
Parallel case 1
Accurate substrate analysis during SR
Relation of SR findings and documented/induced VT to guide the selection of the ablation targets
Substrate ablation
VT ablation efficacy validation.
Presenting CRT candidate (preop echo)
Identify LV lead adequate location
Choosing LV lead (bipolar vs multipolar vs multipoint)
Evaluating inter and intraLV delays, and programming
Parallel Case 1 - A case of substrate related VT ablation.
P. Della Bella (Milan, IT); N. Trevisi (Milan, IT)
Parallel case 2 - A case of CRT.
M. Gasparini (Rozzano, IT); P. Galimberti (Rozzano, IT)
During this interactive session, speakers and attendees will discuss the current guidelines for performing ablation in NVAF patients on NOACs,
and how the safety and efficacy profile of NOACs demonstrated in clinical trials and in real-world practice relates to ablation. Delegates will then
be encouraged to explore how new clinical trials may impact on future practice.
Rotors and atrial fibrillation: experimental and clinical aspects
Chairpersons: R. Schilling (London, GB); A. Goette (Paderborn, DE)
Basic electrophysiology of rotors and reentry circuits.
J. Jalife (Ann Arbor, US)
Role of rotors in experimental persistent AF.
Mechanisms in paroxysmal and persistent AF using non contact mapping
Mechanisms in paroxysmal and persistent AF using contact mapping
P. Wang (Stanford, US)
Lead extraction in practice
Chairpersons: J.-C. Deharo (Marseille, FR); M.G. Bongiorni (Pisa, IT)
Extraction with unpowered sheaths.
A. Kutarski (Lublin, PL)
Extraction with powered sheaths.
Extraction of a free-floating lead.
P. Defaye (Grenoble, FR)
Extraction of a damaged lead.
E. Soldati (Pisa, IT)
Troubleshooting stored data in ICDs: is it VT, SVT, both, or neither? Part 2
Chairpersons: M.R. Gold (Charleston, US); S. Ploux (Pessac, FR)
To develop a systematic approach to the interpretation of stored data (especially electrogram) in troubleshooting ICDs from each of the major
manufacturers.
Cases 1.
C.W. Israel (Bielefeld, DE)
B.A. Schaer (Basel, CH)
Catheter ablation of complex ventricular arrhythmias
Joint session with the Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia.(SOLAECE)
Chairpersons: L. Mont (Barcelona, ES); G. Fenelon (Sao Paulo, BR)
Challenges of ablating outflow tract PVCS/VT.
L.E. Aguinaga Arrascue (Tucuman, AR)
Catheter ablation of post myocardial infarction vt should be performed after the first episode of sustained VT/VF?
J. Kautzner (Prague, CZ)
Epicardial approach to mapping and ablation of VT. State of the art.
M. Scanavacca (Sao Paulo, BR)
Trigger ablation for VF: fact or fancy?
S. Knecht (Brugge, BE)
Hypertrophic cardiomyopathy: from genetics to electrical therapies
Chairpersons: F. Gadler (Stockholm, SE); K.H. Haugaa (Oslo, NO)
Genetic testing in patient and family management.
L. Monserrat (Oleiros, ES)
The role of MRI in diagnosis and risk stratification of HOCM.
E.J. Rowin (Boston, US)
Risk-stratification for sudden death.
P.M. Elliott (London, GB)
Place of electrical therapies: pacing and ICD.
N. Behar (Rennes, FR)
Septal reduction therapies (percutaneous ans surgical ) and the risk for SCD.
S. Ommen (Rochester, Minnesota, US)
Catheter ablation of ventricular arrhythmias is among the most frequent indications for catheter ablation. In symptomatic patients ablation may be
performed as first line therapy. Thus, the procedure should be effective but also very safe. In this highly practical session the ablation procedure of
VT is explained in different types of substrates, showing the different techniques and approach in different pathologies (outflow tract, idioapathic,
ischaemic heart disease and Chagas disease). In their presentations the experts will particularly focus on potential problems and pitfalls and of
course give their recommendations how to prevent and handle
Integrating remote monitoring of cardiac implantable electronic devices into daily clinical practice
Chairpersons: F. Braunschweig (Stockholm, SE); L. Guedon-Moreau (Lille, FR)
To focus on practical aspects of remote monitoring in standard clinical practice: current use in different European countries; technology issues;
organisational models and patient acceptance; effectiveness of remote monitoring in patient management
Implementing remote monitoring in Europe: where do we stand today?
C. Piorkowski (Dresden, DE)
Commonalities and differences in technology among manufacturers. Implications on patient management.
P. Mabo (Rennes, FR)
Workflow, time and patient acceptance and satisfaction. The role of Allied Professionals.
Effectiveness of remote monitoring in detection and treatment of clinical and device-related cardiovascular events
in daily practice.
A.D.Onofrio (Naples, IT)
Remote monitoring to impact morbidity and mortality
Joint session with the Asia Pacific Heart Rhythm Society (APHRS)
Chairpersons: J.M. Kalman (Victoria, AU); G. Hindricks (Leipzig, DE)
Impact on mortality of remote monitoring.
G. Hindricks (Leipzig, DE)
Stroke risk in device detected AF
R. Mahajan (Adelaide, AU)
Screening for AF in cryptogenic stroke.
Device management using remote monitoring.
H.-F. Tse (Hong Kong, HK)
Professional and training issues for nurses and allied professionals
Chairpersons: U. Walfridsson (Linkoping, SE); J. Mudd (Middlesbrough, GB)
To present and discuss training and professional developments for nurses and allied professionals
The EHRA exam in cardiac pacing and ICDs for allied professionals.
J. Elders (Nijmegen, NL)
Advance practice roles for nurses and allied professionals; state of the art in Europe.
E. Kletsiou (Athens, GR)
Ethical issues in arrhythmia care.
J. Tagney (Bristol, GB)
Publishing by nurses and allied professionals.
Practical approach to devices and ablation in adults with repaired congenital heart disease
Chairpersons: J. Janousek (Prague, CZ); R. Fogelman (Petah Tikva, IL)
Practical approach to the management of arrhythmias in adults with repaired congenital heart disease.
This will include medical management, use of implanted devices and catheter ablation.
Recognition & management of acute arrhythmia in the adult congenital heart disease population
A. Stuart (Bristol, GB)
Catheter ablation of incisional atrial arrhythmias after congenital heart disease repair. J. Hebe (Bremen, DE)
Transvenous pacemaker & defibrillator implantation in complex congenital heart disease. E. Rosenthal (St Albans, GB)
Anatomical substrates and ablation for re-entrant ventricular tachycardias in repaired congenital heart disease.
K. Zeppenfeld (Leiden, NL)
ICD shocks. Risk factor or risk marker. Association between ICD intervention and mortality.
V. Castro Urda, M. Sanchez Garcia, J. Martinez Ferrer, A. Barrera Cordero, X. Vinolas Prat, A. Arenal Maiz,
J. Fernandez De La Concha, J.C. Rodriguez Perez, J.C. Villacastin Dominguez, I. Fernandez Lozano (Madrid, Vitoria, Malaga,
Barcelona, Badajoz and Las Palmas De Gran Canaria, ES)
Incidence of appropriate therapy after elective replacement of an uneventful first ICD.
B. Vandenberk, C. Garweg, G. Voros, V. Flore, T. Marynissen, J. Ector, R. Willems (Leuven, BE)
Prognostic significance of Non-sustained Ventricular Tachycardias occurring early after ICD implant among patients with left
ventricular dysfunction.
J. Jimenez-Candil, O. Duran, E. Garcia-Piney, J. Hernandez, J.L. Morinigo, P. Perdiguero, A. Martin, P.L. Sanchez (Salamanca, ES)
Atrial fibrillation and outcomes of patients implanted with cardioverter defibrillator or cardiac resynchronization therapy
in a real world setting
N. Teodorovich, Y. Kogan, I. Goldenberg, M. Swissa (Rehovot and Ramat Gan, IL)
Long-term follow-up of the Brugada syndrome: a single-centre experience
B. Rudic, E. Tueluemen, S. Roeger, K. Stach, C. Doesch, R. Schimpf, C. Veltmann, J. Kuschyk, T. Papavassiliu, M. Borggrefe
(Mannheim and Hannover, DE)
The shortening of the short refractory periods in short QT syndrome
A. Rollin, A. Duparc, P. Mondoly, C. Cardin, M. Sadron, E. Lematte, A. Bennadji, E. Thomson, P. Maury (Toulouse, FR)
Identifying patients with less potential to benefit from implantable cardioverter-defibrillator therapy
A. Kaura, I. Mann, R. Kamdar, E. Petzer, E. Silberbauer, N. Gall, F. Murgatroyd, P. Scott (London, GB)
Morphology of myocardial infarction scar, assessed by magnetic resonance imaging, is a better predictor of ventricular
arrhythmia than left ventricular ejection fraction
D. Voilliot, F. Odille, M. Andronache, B. Brembilla-Perrot, D. Mandry, P.Y. Marie, J. Felblinger, E. Aliot, N. Sadoul, C. De Chillou
(Nancy, FR)
Long term follow up of post-MI patients with relatively preserved left ventricular ejection fraction and non sustained VT:
Role of ce-CMR in identification of arrhythmogenic substrate
K. Yalin, E. Golcuk, A.K. Bilge, K. Adalet (Istanbul, TR)
Left cardiac sympathetic denervation made by a video assisted thoracoscopic approach could terminate electrical storm in
icd patients with brugada syndrome.
E. Hatzinikolaou-Kotsakou, M. Konstantinidou, E. Reppas, G. Moschos, T.H. Beleveslis (Thessaloniki, GR)
ICD therapy: clinical data and new concepts Chairpersons: V. Kutyifa (Rochester, US); I. Goldenberg (Ramat Gan, IL)
Improving outcomes in Paroxysmal and Persistent AF Ablation
Chairpersons: K.H. Kuck (Hamburg, DE); M. Hocini (Pessac, FR)
Learn about the clinical results with the second generation Cryoballoon in both paroxysmal and persistent atrial fibrillation ablation. Learn about
the technology of the second generation multi-electrode ablation catheters and the clinical results obtained with this technology.
M. Hocini (Pessac, FR)
Dosing considerations with the second generation Cryoballoon.
K.J. Chun (Frankfurt, DE)
Second-generation multi-electrode ablation technology: clinical results and future directions.
L.V.A. Boersma (Nieuwegein, NL)
Cryoballoon ablation for persistent atrial fibrillation.
S. Boveda (Toulouse, FR)
Atrial high rate episodes and stroke prevention – An update
Organised by AFNET, supported by an unrestricted educational grant from Daiichi Sankyo Europe
Chairpersons: G. Breithardt (Munster, DE); G. Hindricks (Leipzig, DE)
To highlight achievements and current challenges of anticoagulation
To highlight current challenges of NOACs in clinical practice
To review recent developments in pathophysiology of thrombogenesis in AF
To review current evidence on relation of atrial high rate episodes (AHRE) to AF
To explain the NOAH -AFNET 6 trial investigating edoxaban in AHRE
Clinical use of non vitamin K antagonists – An update.
A. Goette (Paderborn, DE)
Thrombogenesis in atrial fibrillation – Virchows triad in 2015.
Atrial high rate episodes as markers for stroke risk.
Non vitamin K antagonist oral anticoagulants in patients with atrial high rate episodes. Design and rationale of the
NOAH – AFNET 6 trial.
Can the new Generation of Contact Force catheter make AF Ablation more simple?
Chairperson: R. Schilling (London, GB)
Discuss the combination of Porous Tip with Contact Force Technology and its potential clinical impacts in the treatment of AF. Does an efficient
tracking of the ablation strategy adds value to your clinical practice?
Clinical benefits of Fluid Reduction during treatment of AF.
M. Scaglione (Asti, IT)
Optimized ablation strategy and reproducibility.
M. Duytschaever (Gent, BE)
AF Toolbox - How does all come together.
Leadless pacing, Advancing Standard of Care
Chairpersons: P. Defaye (Grenoble, FR); C. Tondo (Milan, IT)
Leadless pacing - Technology Overview and future opportunities.
Leadless pacing - Where do we stand on clinical perspective?
R. Knops (Amsterdam, NL)
Leadless pacing - Retrievability data.
J. Sperzel (Johannesberg, DE)
Q&A.
The subcutaneous defibrillator: are we ready for a paradigm shift?
Sponsored by Boston Scientific
Chairpersons: C. Leclercq (Rennes, FR); R. Cappato (San Donato Milanese, IT)
1) Learn about latest clinical data on the entirly subcutaneous implantable defibrillator to better understand the benefit for patients.
2) Learn about the evolution of subcutaneous defibrillator technology in the way we are protecting patients from sudden cardiac death.
3) Learn about risk stratification factors to guide patient selection for the subcutaneous defibrillator.
12:45 Introduction - Welcome.
C. Leclercq (Rennes, FR)
12:48 Real-world experience with the subcutaneous defibrillator: what have we learnt?
13:03 Evolution in subcutaneous defibrillator technology: is there room for improvement?
L. Eckardt (Munster, DE)
13:18 Subcutaneous defibrillator patient selection: how does it fit my daily clinical practice? M.G. Bongiorni (Pisa, IT)
13:43 Conclusion & Closing.
R. Cappato (San Donato Milanese, IT)
Extending the Boundaries in Managing Heart Failure Patients
Sponsored by Sorin Group CRM
Chairpersons: A. Auricchio (Lugano, CH); M. Lunati (Milan, IT)
Understand the clinical impact of the latest developments in device therapy for the prevention and treatment of HF and Central Sleep Apnea −
Pacemakers, CRT and Phrenic Nerve Stimulation (PNS).
How important is it to adapt ventricular pacing in patients with intermittent AV block? What additional benefits do we expect from using multipoint or multi-lead stimulation in CRT? How to screen for Sleep Apnea?
How can PNS be used to treat Central Sleep Apnea in HF patients?
AV block is not always AV block – AV management & heart failure prevention.
G.L. Botto (Como, IT)
Multi-point or multi-lead? The future of CRT.
Innovative solutions to screen, diagnose and treat CSA in heart failure patients.
W.T. Abraham (Columbus, US)
Left atrial appendage closure: which of your AF patients benefit most? Sponsored by Boston Scientific
Chairperson: S.K. Doshi (Santa Monica, US)
1) To learn which patients may benefit from left atrial appendage closure.
2) To understand how to best balance the risk of stroke and bleeding in specific patient groups.
3) To know the latest clinical evidence, guidelines and expert consensus recommendations on left atrial appendage closure.
Session objectives and introduction.
S.K. Doshi (Santa Monica, US)
Case 1: "My patient suffered a hemorrhagic stroke and cannot take Warfarin."
T.R. Betts (Oxford, GB)
Discussion and audience interaction
Case 2: "My renal failure patient is at high risk for stroke but does not want to take long-term oral anticoagulation."
Discussion and audience interaction.
Case 3: "My patient had pulmonary vein isolation and now recurrence of AF."
J.P.M. Foran (Sutton, GB)
Key learnings and session evaluation.
Controversies and advances in management of Atrial Fibrillation
Organised by EPIC Alliance, supported by an unrestricted educational grant from BIOTRONIK
Chairpersons: J. Poole (Seattle, US); A. Alonso Martin (Barcelona, ES)
1) The participant will understand the role of risk factor modulation in AF patients
2) The participant will understand the studies regarding AF detection through remote monitoring and the implications for therapy
3) The participant will understand the risks and benefits of different approaches to AF ablation
Risk factor modification of AF: Are we missing the boat?
U. Birgersdotter-Green (La Jolla, US); C. Linde (Stockholm, SE)
Preventing stroke: Role of remote monitoring and indication of oral anticoagulation.
L. Guedon-Moreau (Lille, FR); G. Pelargonio (Rome, IT)
Point by point or single shot PAF ablation?
E. Hoffmann (Munich, DE); C. Herrera Siklody (Ludwigsburg, DE)
Pushing the boundaries: New technology for ablation of persistent AF.
I. Deisenhofer (Munich, DE); A. Russo (Moorestown, US)
Late Breaking Trial
Chairpersons: G. Hindricks (Leipzig, DE); K.H. Kuck (Hamburg, DE)
Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes
Discussant: Pacing for reflex syncope
ENHANCED ICD programming to reduce therapies and improve quality of life in Implantable Cardioverter Defibrillator
patients: a prospective, single-arm safety monitoring study M.H. Mastenbroek (Utrecht, NL)
Discussant: ENHANCED-ICD study
F.D. Murgatroyd (London, GB)
Big data Characterization of Sex-Specific Survival Following CIED Implant
N. Varma (Cleveland, US)
Discussant: sex-specific survival following CIED implant C. Linde (Stockholm, SE)
Cardiorespiratory Fitness Predicts Arrhythmia Recurrence in Patients with Symptomatic Atrial Fibrillation-CARDIO-FIT Study
R. Pathak (Adelaide, AU)
Discussant:.CARDIO-FIT Study
C. Herrera Siklody (Ludwigsburg, DE)
Early Performance of a Miniaturized Leadless Cardiac Pacemaker: The Micra Transcatheter Pacing Study
Discussant:.Micra Transcatheter Pacing Study: Early Performance V. Reddy (New York, US)
Achieving permanent lesions in atrial fibrillation
Chairpersons: C. Pappone (Cotignola, IT); C. Piorkowski (Dresden, DE)
Creating permanent pulmonary vein isolation or bidirectional block of lines with a single ablation is still not guaranteed. This session would
investigate strategies to improve transmural lesion creation, to ultimately benefit patients.
How I try to improve lesion permanence with current tools: role of visi tag, contact force, adenosine, pacing the RF lesions…
G. Michaud (Boston, US)
Real time ultrasound for creation of permanent lesions.
M.J. Wright (London, GB)
Energies, technologies, that may be associated with more durable lesions V. Reddy (New York, US)
Lesion assessment using MRI.
R. Beinart (Ramat Gan, IL)
Visually guided laser ablation a single center experience.
Unanswered questions in lead management
Chairpersons: J.M. Larsen (Aalborg, DK); C. Love (New York, US)
When to abandon or extract non-functioning leads?
Managing recalled leads.
R. Parkash (Halifax, CA)
Impact of lead type and placement on extraction.
C.A. Rinaldi (London, GB)
Future directions in lead technology.
L. Wilkoff (Cleveland, US)
To approach innovation in the field of CRT
No lead in the coronary sinus?
More imaging and less ECG for eligibility?
V. Delgado (Leiden, NL)
Fully automatic programming?
G.Z. Duray (Budapest, HU)
Remote monitoring with remote programming?
Biological pacing?
M. Eldar (Ramat-Gan, IL)
Defining the outcome of a VT ablation Chairpersons: P. Della Bella (Milan, IT); Y. Karpenko (Odessa, UA)
Programmed stimulation results and their relation to long term survival.
P. Maury (Toulouse, FR)
How to prove substrate modification as an additional endpoint of an ablation.
J.C. Silberbauer (London, GB)
Complete elimination of endo- and epicardial LAVAS: how to achieve and how to prove.
Non-invasive assessment of the success late after the procedure: role of the NIPS (non-invasive programmed stimulation
via the ICD.
T. Oloriz (Zaragoza, ES)
Cardiac resynchronisation therapy (CRT) in the near future: what developments? Chairpersons: L. Padeletti (Florence, IT); B. Merkely (Budapest, HU)
Troubleshottoting in surface ECG
Educative session by RETAC group
Chairpersons: A. Curnis (Brescia, IT); T. Arentz (Bad Krozingen, DE)
Interactive discussion on Case Reports
14:00 Narrow QRS tachycardias-Part 1 L. De Roy (Wavre, BE)
14:15 Narrow QRS tachycardias-Part 2. C.I. Park (Meyrin, CH)
14:30 Broad QRS tachycardias-Part 1 B. Guy-Moyat (Couzeix, FR)
14:45 Broad QRS tachycardias-Part 2. E. Rodriguez Font (Barcelona, ES)
15:00 Device implanted patients-Part 1 P. Defaye (Grenoble, FR)
15:15 Device implanted patients-Part 2. S. Boveda (Toulouse, FR)
Carmeliet-Coraboeuf-Weidmann lecture
Chairpersons: A. Zaza (Milan, IT); G.L. Smith (Glasgow, GB)
14:00 Atrial fibrillation: a dystrophinopathy of the heart
Health technology assessment of device remote monitoring
Chairpersons: A. Auricchio (Lugano, CH); M. Santini (Rome, IT)
To have an overview on Health Technology assesment of device remote monitoring as a new standard for patient follow-up.
Benefits on device monitoring and disease management: what is the evidence?
M. Lunati (Milan, IT)
Role of remote monitoring in stroke prevention and anticoagulation management
Key issues and challenges with current CIED remote monitoring reimbursement solutions.
G. Boriani (Bologna, IT)
Ethical and legal issues in process planning and management.
M. Landolina (Crema, IT)
Arrhythmias and device problems in acute cardiac care
Joint session with ACCA
Chairpersons: F. Leyva-Leon (Sutton Coldfield, GB); G.Y.H. Lip (Birmingham, GB)
Management of atrial fibrillation complicated by acute heart failure.
C.J.M. Vrints (Edegem, BE)
Optimal antithrombotic treatment in patients with an acute coronary syndrome and atrial fibrillation news from the joint
position paper from EHRA, ACCA and EAPCI task force.
M. Lettino (Milan, IT)
Management of electrical storm (EHRA).
Management of sepsis in an ICD patient (EHRA).
S. Faerestrand (Bergen, NO)
To review different models of organising care and to discuss what migth be relevant for organisation of care in the arrhythmia patient
The AF clinic improves patients outcomes.
How does the patient benefit from device clinics?
A. Metzner (Hamburg, DE)
How is a 'black out' clinic organised?
J. Mudd (Middlesbrough, GB)
Is partnership between EP and HF clinics feasible?
New approaches to arrhythmias in repaired congenital heart disease
Chairpersons: E. Rosenthal (St Albans, GB); J. Hebe (Bremen, DE)
Organising care for arrhythmia patients: what can we learn from different models?
Chairpersons: J. Tagney (Bristol, GB); L. Morichelli (Roma, IT)
This symposium should give the audience an overview of recent advances in understanding the mechanism of arrhythmias, sudden cardiac death
prevention and cardiac resynchronisation in these complex patients
Anatomical and pathological substrate for arrhythmias after repair of congenital heart disease
Primary ICD implantation in repaired congenital heart disease: Is it ever indicated? T. Paul (Gottingen, DE)
Non-transvenous ICDs in congenital heart disease: techniques and results
F. Roses Noguer (Barcelona, ES)
Cardiac resynchronisation for the failing subpulmonary right ventricle: Is there a role?
J. Janousek (Prague, CZ)
How to improve procedural outcomes following atrial fibrillation ablation Chairpersons: H.J.G.M. Crijns (Maastricht, NL); J.C. Nielsen (Aarhus N, DK)
Comparison of contact force sensing radiofrequency catheter and new generation cryoballoon ablation of pulmonary veins
in patients with paroxysmal atrial fibrillation. 1 year follow up.
A. Kardos, Z. Kis, Z. Som, Z. Nagy, C. Foldesi (Budapest, HU)
Adenosine in atrial firillation ablation: does it improve the outcome?
F. Moscoso Costa, D. Cavaco, P. Carmo, P. Santos, S. Carvalho, T. Teixeira, A. Soares, M. Marques, L. Parreira, P. Adragao (Lisbon, PT)
Ipsilateral pulmonary vein isolation using new force-power-time formula in atrial fibrillation patients
P. Taghji, M. Duytschaever, Y. Vandekerckhove, T. Phlips, R. Choudhury, R. Tavernier, H. Nakagawa (Bruges, BE; Oklahoma City, US)
Tissue contact monitoring with an electrical coupling index during radiofrequency energy pulmonary venous isolation
- a prospective randomised control trial
M.A. Jones, K.C.K. Wong, C. Hayes, D. Webster, M. Ginks, Y. Bashir, K. Rajappan, T.R. Betts (Oxford, GB)
Robotic catheter ablation provides stable contact force during pulmonary vein isolation
B. Kreidieh, S. Ibarra, P. Schurmann, A.S. Dave, M. Valderrabano (Houston, US)
Good 2 year outcomes in patients with adverse features undergoing convergent hybrid AF ablation for persistent AF
S.B.L. Claridge, N. Child, C.A. Rinaldi, J. Gill, P. Taggart (London, GB)
Simultaneous renal sympathetic denervation and pulmonary veins isolation in patients with paroxysmal atrial fibrillation and
A.S. Vorobyoff, V.N. Bibikov, S.V. Korolev, A.V. Geraschenko, A.V. Sveshnikov (Moscow, RU)
Pulmonary vein reconnection: is contact force the main problem?
P. Adragao, F. Moscoso Costa, D. Cavaco, L. Parreira, P. Santos, P. Carmo, S. Carvalho, T. Teixeira, A. Soares, M. Abecasis
(Lisbon, PT)
Appropriate waiting time to confirm dormant pulmonary vein conduction in patients with atrial fibrillation
K. Kato, K. Ejima, M. Shoda, T. Manaka, D. Yagishita, R. Henmi, K. Suwa, T. Mizuki, M. Imai, N. Hagiwara (Tokyo, JP)
Differences in the prevalence, characteristics, and predictors of pulmonary vein reconnections between contact force-guided
and conventional circumferential pulmonary vein isolation
K. Nakamura, S. Naito, T. Sasaki, E. Goto, K. Minami, M. Nakano, S. Shimizu, T. Yano, K. Kumagai, S. Oshima (Maebashi, JP)
WG on CCE General Assembly
Clinical aspects of risk prediction and etiology in atrial fibrillation
Chairpersons: T. Potpara (Belgrade, RS); M. Duytschaever (Gent, BE)
Risk prediction in atrial fibrillation. comparison between the CHADS2, CHA2DS2-VASC score in a large contemporary
cohort of patients with incident non-valvular atrial fibrillation
M. Haim, M. Hoshen, O. Reges, Y. Rabi, M. Leibowitz, R. Balicer (Beer Sheva and Tel Aviv, IL)
Causes of death and influencing factors in unselected patients with atrial fibrillation. L. Fauchier, O. Villejoubert, N. Clementy, B. Pierre, A. Bernard, D. Angoulvant, D. Babuty (Tours, FR)
New onset of atrial fibrillation following transcatheter aortic valve replacement: the prevalence, predictive factor and
prognostic value W. Kong, E. Tay, J. Yip (Singapore, SG)
Association between serum parathyroid hormone and prevalent atrial fibrillation in a Korean population: the Dong-gu study
K.H. Lee, H.W. Park, N.S. Yoon, J.G. Cho, J.S. Kim, M.H. Shin, S.S. Kweon, Y.H. Lee, S.S. Kim (Gwangju and Iksan, KR)
The impact of free thyroxine on the outcomes of left atrial ablation procedures
P. Sousa, R. Providencia, S. Combes, N. Combes, S. Boveda, J.P. Albenque (Toulouse, FR)
Natriuretic propeptides as markers of atrial fibrillation burden and recurrence: insights from the AMIO-CAT trial
S. Darkner, J.P. Goetze, X. Chen, K. Henningsen, S. Pehrson, J.H. Svendsen (Copenhagen, DK)
Atrial fibrillation in patients with obstructive sleep apnea: triggers and atrial structural remodeling J. Li, F. Contreras Valdes, C. Tschabrunn, E. Anter (Boston, US)
Relationship between elft atrial wall thickness and intracardiac electrogram characteristics during atrial fibrillation and sinus
I. Watanabe, Y. Okumura, K. Takahashi, A. Hirayama (Tokyo, JP)
Relation of biomarkers of inflammation, oxidative stress and endothelial dysfunction with the development of cardiovascular
disease in lone atrial fibrillation
M. Polovina, M.C. Ostojic, T. Potpara (Belgrade, RS)
Twenty-four hours holter monitoring predictors for new onset atrial fibrillation in a non-selected population
S. Cabrera, E. Valles, B. Benito, P. Ramos, J. Bruguera, J. Marti-Almor (Barcelona, ES)
The presenter should be present throughout the break (15:30 - 16:30) in order to discuss the poster.
Recorded session - Basic ablation and complex implantable cardioverter-defibrilator therapy in paediatric practice.
Chairpersons: J.M. Morgan (Southampton, GB); A. Goette (Paderborn, DE)
SubQ ICD in a young child with Brugada syndrome.
Endovenous ICD in a 12 year old post SubQ ICD removal.
Simple ablation in a 10 year old child.
Persistent atrial fibrillation ablation: the quest for a tailored approach to each patient
Chairpersons: M. O'Neill (London, GB); J. Steinberg (New York, US)
The session proposal aims at providing an update on the recent developments on the methods and techniques for substrate characterisation in
AF. The audience will learn the different approaches targeting AF substrate thus improving ablation outcome.
Phase mapping: principle and comparison to activation mapping, results in surgery patients
P. Kuklik (Maastricht, NL)
Contact phase mapping to guide persistent AF ablation: methods, end point, results
Non contact phase mapping to guide persistent AF ablation: methods, end point, results
Origin of CFAE: a marker of arrhythmogenic substrate or something else?
MRI imaging in AF ablation.
N. Marrouche (Salt Lake City, US)
Managing infected devices
Chairpersons: C. Stellbrink (Bielefeld, DE); C.E.H. Kennergren (Goteborg, SE)
Pocket and endovascular infection: is there a difference?
F. Regoli (Lugano, CH)
Antibacterial envelopes: how effective are they?
S. Mittal (New York, US)
Reimplantation: when and how?
V. Pretorius (San Diego, US)
Prevention of infection: patient or intervention.
What is needed to provide cardiac resynchronisation therapy for all European patients? Chairpersons: R. Hatala (Bratislava, SK); A. Raviele (Mestre, IT)
To give a picture of implementation of CRT in daily practice from education to financing
CRT training: courses, proctorship, simulators.
New leads and delivery systems for LV pacing.
Organisation: few or many implanting centres?
Cost effectiveness and appropriate reimbursement.
Full CRT availability across Europe.
B. Merkely (Budapest, HU)
Non-ischaemic cardiomyopathies Chairpersons: T. Oloriz (Zaragoza, ES); A. Grace (Cambridge, GB)
ECG and the assessment of scar localisation: mechanistic and prognostic implications.
Electrocardiographic imaging to enhance substrate localisation.
F. Sacher (Bordeaux Pessac, FR)
Multimodality imaging.
Should myocardial biopsy become part of the standard pre-operative assessment of patients undergoing ablation?
S. Sala (Milan, IT)
EHRA activities in the field of EP Wires, patient and snap-shot surveys. Up-to-date 2015
Chairpersons: M.G. Bongiorni (Pisa, IT); H. Estner (Munchen, DE)
Evolving picture of cardiac arrhythmias 39th Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology
Chairpersons: M.B. Thomsen (Copenhagen, DK); D. Dobrev (Essen, DE)
Arrhythmogenic mechanisms in catecholaminergic polymorphic ventricular tachycardia.
H. Valdivia (To Be Confirmed, US)
Sodium channel haploinsufficiency and structural changes in ventricular arrhythmogenesis - effect of age and sex.
K. Jeevaratnam (Guildford, GB)
Cardiac inward rectifier potassium current IK1 is inhibited by acetaldehyde at clinically relevant concentrations: a role in
arrhythmogenesis related to alcohol consumption?
M. Bebarova, P. Matejovic, M. Simurdova, J. Simurda (Brno, CZ)
Mechanism of induction of LQT syndrome in HIV patients.
C. Lamoureux (Montreal, CA)
Is electromechnical window negativity required for Torsades de Pointes?
H.J. van der Linde (Beerse, BE)
Atrial fibrillation: clinical approaches and therapeutic strategies.
J. Chen (Bergen, NO)
Cardiac pacing, resyncronization and icd therapy in europe.
A. Proclemer (Udine, IT)
Clinical management of common arrhythmic scenario's in europe.
A.H. Madrid (Madrid, ES)
New aspects of ep procedures in europe.
E. Sciaraffia (Uppsala, SE)
Patient and snap-shot surveys.
T. Potpara (Belgrade, RS)
Patient management systems - best use of medical technologies
Chairpersons: To be announced; A. Katz (Ashkelon, IL)
To explore the use of monitoring technologies for prevention of heart failure hospitalisations and sudden cardiac death
The tools and how to use them.
L. Chinitz (New York, US)
Technology review - how do we evaluate these technologies?
Major studies in remote monitoring technology - where are we now and what's coming?
Reimbursement for remote monitoring technologies - where are we failing?
R.P. Ricci (Rome, IT)
TRP channels and cardiac electric activity
Chairpersons: A. Anic (Zadar, HR); P.G.A. Volders (Maastricht, NL)
Many transient receptor potential (TRP) channels are expressed in cardiac cells. The main learning objective of this symposium is to review the
roles of some of them in normal and pathological electrophysiology.
Role of TRPM4 channels in cardiac inotropy and repolarisation.
R. Vennekens (Leuven, BE)
TRPM4 in human genetic conduction disorders.
TRPC channels and their relevance to cardiovascular physiology and disease.
Calcium-activated nonselective cation channels in mammalian cardiomyocytes.
M. Demion (Montpellier, FR)
Psychosocial care of patients with arrhythmia
Chairpersons: A.H. Mansour (Ramat Gan, IL); J. Tagney (Bristol, GB)
To describe psychological issues that are relevant in patients with arrhtymia
Psychosocial assessments: who does it and what should we measure?
How to live a good life with arrhythmia; perspectives of patients.
T. Lobban (Shipston On Stour, GB)
Empowering ICD patients towards improved quality of life.
L. Hinterbuchner (Salzburg, AT)
Deactivation ICD in deactivation of ICDs both for theatre and in end of life situations.
P. Nolan (Galway, IE)
Chairpersons: R.-G. Vatasescu (Bucharest, RO); F. Roses Noguer (Barcelona, ES)
Management of channelopathies remains contentious in the adolescent and young adult population – 2 debates will highlight these issues
EP studies are mandatory in children & adolescents with Brugada syndrome - Pro
J. Brugada Terradellas (Barcelona, ES)
EP studies are mandatory in children & adolescents with Brugada syndrome - Contra
N. Blom (Leiden, NL)
EP studies are mandatory in children & adolescents with Brugada syndrome - Rebuttal Pro.
EP studies are mandatory in children & adolescents with Brugada syndrome - Rebuttal Contra.
J. Brugada Terradellas (Barcelona, ES); N. Blom (Leiden, NL)
Sports restrictions are no longer needed in all young patients with LQTS - Pro.
S. Viskin (Tel Aviv, IL)
Sports restrictions are no longer needed in all young patients with LQTS - Contra.
R. Fogelman (Petah Tikva, IL)
Sports restrictions are no longer needed in all young patients with LQTS - Rebuttal Pro.
Sports restrictions are no longer needed in all young patients with LQTS - Rebuttal Contra.
S. Viskin (Tel Aviv, IL) ; R. Fogelman (Petah Tikva, IL)
New ablation technology: ready for prime time?
Chairpersons: T.J.R. De Potter (Aalst, BE); N. Rueb (Tubingen, DE)
Non-septal localization of late potentials in post-myocardial infarction patients undergoing ventricular tachycardia ablation
D. Tsiachris, J. Silberbauer, G. Maccabelli, T. Oloriz, H. Mizuno, C. Bisceglia, A. Marzi, N. Sora, S. Sala, P. Della Bella (Milan, IT)
Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy
F. Pizzamiglio, M. Casella, A. Dello Russo, C. Carbucicchio, G. Fassini, S. Riva, P.F. Notarstefano, M. Pieroni, L. Bolognese,
C. Tondo (Milan and Arezzo, IT)
Electroanatomic mapping system allows zero fluoroscopy in cryo and radiofrequency ablation of accessory pathways
in children
E. Ebrille, C. Raimondo, R. De Vito, F. Di Clemente, D. Caponi, P. Di Donna, F. Gabbarini, M. Morosato, F. Gaita, M. Scaglione
(Turin, Siena, Asti and Verona, IT)
Usefulness of contact force maps to predict ablation gaps in catheter ablation of atrial fibrillation
D. Andreu, F. Gomez-Pulido, M. Calvo, E. Benito, A. Carlosena-Remirez, E. Arbelo, J.M. Tolosana, A. Berruezo, J. Brugada, L. Mont
Needle-based intracardiac echocardiography for transseptal puncture guidance 806
M.C. Finlay, C.A. Mosse, R. Colchester, S. Noimark, E. Zhang, D. Nikitichev, I. Papakonstantinou, P. Beard, R.J. Schilling,
A. Desjardins (London, GB)
Real-time magnetic resonance-guided ablation of typical right atrial flutter using active catheter tracking and passive catheter
S. Hilbert, P. Sommer, G. Hindricks, M. Gutberlet, M. Grothoff (Leipzig, DE)
Epicardial impedance mapping in surgical theater : pilot study for fat detection to facilitate epicardial radiofrequency catheter
ablation for ventricular tachycardia
H. Mizuno, G. Maccabelli, F. Alamanni, P. Della Bella (Suita, JP; Milan, IT)
Feasibility of fully MR-guided ablation with active tracking: from pre-clinical to clinical application 809
H. Chubb, J. Harrison, S.E. Williams, J. Whitaker, S. Weiss, S. Krueger, G. Stenzel, T. Schaeffter, R. Razavi, M.O. Neill (London, GB)
Resynchronization therapy implant procedures with a novel sensor-based electromagnetic tracking system: more
than just reduction in radiation exposure. 810
B. Thibault, B. Montdesert, M. Dubuc, K. Dyrda, L. Rivard, D. Roy, M. Talajic, S. Venier, R. Tadros, L. Macle (Montreal, CA)
Cardiac radiosurgery: non-invasive ablation and initial patient outcomes
P.C. Zei, P.J. Maguire, R. Schilling, D.W. Davies, E.A. Gardner, T.J. Fogarty, J.M. Assad (Stanford, California and Mountain View, US;
London, GB; Monterrey, MX)
AF ablation management: Therapy, stroke prevention and monitoring
Chairpersons: A.J. Camm (London, GB); C. Blomstrom-Lundqvist (Uppsala, SE)
Learn about atrial fibrillation ablation using the latest Cryoballoon technologies. Learn how to prevent atrial fibrillation related stroke using novel
oral anticoagulation. Learn how continuous monitoring for atrial fibrillation around the ablation procedure can help to optimize treatment
C. Blomstrom-Lundqvist (Uppsala, SE)
Individualising OAC for stroke prevention in AF: What factors are important?
AF ablation results with the second generation Cryoballoon.
G.B. Chierchia (Jette, BE)
State of the art monitoring around AF ablation.
J. Schreieck (Tuebingen, DE)
Phenotypic profiling to determine individuals at risk for atrial fibrillation: A latent class clustering analysis of the PREVEND cohort M. Rienstra, B. Geelhoed, J.E. Siland, R.A. Vermond, P. Van Der Harst, H.L. Hillege, I.C. Van Gelder (Groningen, NL)
P wave duration/morphology and left atrial volume at computed tomography in patients without and with (paroxysmal or persistent)
atrial fibrillation A. Cima, M. Brunelli, S. Raffa, A. Grosse, M. Frommhold, T. Daehne, A. Madaffari, C. Lindemann, J.C. Geller (Bad Berka, DE)
Prediction of atrial arrhythmia after transcatheter closure of atrial septal defect J.K. Hwang, K.M. Park, S.J. Park, Y.K. On, J.S. Kim, S.W. Park, I.S. Kang, J.Y. Song, J. Huh (Seoul, KR)
Clincial response predictors in patients undergoing Cardiac Resyncrhonization Therapy (CRT): 7 years follow up. R. Ramirez Rodriguez, A.M. Ramirez Rodriguez, A. Delgado Espinosa, A. Medina Fernandez-Aceytuno, E. Hernandez Ortega,
A. Garcia Quintana, M. Blanco Nuez (Las Palmas G.C. ES)
Investigation of the frequency of spontaneous echo contrast and the predictors of left atrial appendage sludge or thrombus formation
in patients with atrial fibrillation/flutter. R. Takeuchi, M. Ishida, K. Kodama, N. Hosoya, S. Kageyama, H. Sugiyama, Y. Watanabe, K. Murata, R. Nawada, T. Onodera (Shizuoka, JP)
Cardiovasal interconnections depending on Cystatin C in CHF patients with permanent atrial fibrillation N. Koziolova, Y. Shilova, E. Polyanskaya, J. Nikonova (Perm, RU)
Association between red blood cell distribution width and postoperative atrial fibrillation after cardiac surgery: a prospective
observational study P. Korantzopoulos, N. Sontis, T. Liu, S. Siminelakis, E. Apostolakis (Ioannina, GR; Tianjin, CN)
No efficacy of antiarrhythmic drugs during the first 3-months after pulmonary vein isolation in patients with paroxysmal atrial fibrillation P824
S. Hirose, K. Miyamoto, M. Wada, I. Nakajima, K. Ishibashi, H. Okamura, T. Noda, T. Aiba, S. Kamakura, K. Kusano (Suita, JP)
Is CHA2DS2-VASc score predictive of long-term outcome of catheter ablation of atrial fibrillation evaluated with implantable
ECG loop recorder? A. Vachulova, H. Cerna, L. Urban, P. Hlivak, M. Svetlosak, P. Margitfalvi, M. Sasov, K. Gladisova, V. Bernat, R. Hatala (Bratislava, SK)
Non-fluoroscopic sensor-based catheter navigation in ablation of atrial fibrillation: a randomized comparison with electroanatomic
standard procedures. S. Rolf, K. Schoene, S. Richter, C. Piorkowski, T. Gaspar, Y. Huo, A. Arya, A. Bollmann, G. Hindricks, P. Sommer (Leipzig and Dresden, DE)
Totally nonfluoroscopic atrial fibrillation ablation approach. Single centre experience. E. Kropotkin, E.A. Ivanitskiy (Krasnoyarsk, RU)
Decrease in asymptomatic cerebral lesions during left atrial ablation due to improved workflow: a single center comparison M. Derndorfer, E. Sigmund, S. Winter, W. Jauker, M. Gschwendtner, J. Aichinger, H. Puererfellner, M. Martinek (Linz, AT)
Stiffening of the left atrium immediately after pulmonary vein isolation R. Pap, G. Agoston, J. Szilagyi, G. Bencsik, G. Klausz, L. Saghy, A. Varga, T. Forster (Szeged, HU)
Spatial relationship of focal impulses, rotors and low voltage zones in patients with persistent atrial fibrillation A. Schade, P. Mueller, P. Halbfass, M. Roos, K. Nentwich, G.A. Szoelloesi, L.C. Costello-Boerrigter, T. Deneke (Erfurt and
Bad Neustadt/ Saale, DE)
Impact of esophageal temperature monitoring-guided ablation during pulmonary vein isolation on pulmonary vein reconnection M. Leo, M. Pedersen, K. Rajappan, M. Ginks, Y. Bashir, T.R. Betts (Oxford, GB)
Effect of arrhythmia burden and arrhythmia-related events on quality of life in patients undergoing ablation for atrial fibrillation:
a substudy of the AMIO-CAT trial S. Darkner, X. Chen, J. Hansen, S. Pehrson, A. Johannessen, J.H. Svendsen (Copenhagen, DK)
Is combined ablation for paroxysmal atrial fibrillation using balloon cryoablation and radiofrequency ablation superior to either
technique alone? Long-term follow up and cost analysis. A. Opel, M.A. Akhtar, S. Hadjivassilev, R. Ang, M. Finlay, M. Dhinoja, M. Earley, R. Schilling, R. Hunter, S. Sporton (London, GB)
Successful endoscopic surgical ablation in patients with persistent atrial fibrillation is associated with recovery of atrial transport function P847
C. Muneretto, G. Bisleri, F. Rosati, E. Gorga, A. Curnis, E. Chiari (Brescia, IT)
Catheter ablation for paroxysmal atrial fibrillation improves sleep-disordered breathing P834
S. Mito, Y. Muraoka, N. Shiode (Hiroshima, JP)
Catheter ablation of paroxysmal and persistent atrial fibrillation: long-term outcome of a pulmonary vein isolation-based strategy
as index procedure P835
M.M. Oliveira, M.N. Silva, P.S. Cunha, A. Lousinha, B. Valente, T. Silva, A. Monteiro, R. Pimenta, A.S. Delgado, R.C. Ferreira (Lisbon, PT)
Low vulnerability of the right phrenic nerve for electroporation ablation P836
K.G.E.J. Neven, V.J.H.M. Van Driel, H. Van Wessel, A. Vink, P.A.F.M. Doevendans, F.H.M. Wittkampf (Utrecht, NL)
Visualization of electrophysiologically defined junction between the right atrium and the superior vena cava P837
N. Nishiyama, S. Takatsuki, K. Nakajima, S. Kashimura, Y. Katsumata, T. Nishiyama, T. Kimura, K. Fukumoto, Y. Aizawa, K. Fukuda (Tokyo, JP)
Left atrial size is only one predictor for mid-term outcome after ablation of atrial fibrillation using second-generation cryoballoon P838
A. Berkowitsch, E. Akkaya, D. Pajitnev, H. Greiss, N. Deubner, S. Zaltsberg, H. Moellmann, H.F. Pitschner, T. Neumann, M. Kuniss
(Bad Nauheim, DE)
Impact of power on impedance drops with stable and unstable points under the same force-time integral in atrial fibrillation ablation. P839
L.B. Shi, W.Y.C. Wang, P.S. Schuster, B.A. Bortoli, S.L.Z. Sun, P.I.H. Per Ivar, E.S. Solheim, O.L.O. Ohm, C.J. Chen (Bergen, NO)
Head to head comparison between radiofrequency and second generation cryoballon catheter ablation for paroxismal atrial
fibrillation. A prospective controlled study. P840
S. Ferretto, L. Leoni, C. Dalla Valle, F. Migliore, M. De Lazzari, M. Siciliano, M. Silvano, A. Zorzi, S. Iliceto, E. Bertaglia (Padua, IT)
Comparison between direct injection of adenosine in the pulmonary vein and the conventional intravenous method for determining
dormant conduction after pulmonary vein isolation (W) P841
E.-K. Choi, S.R. Lee, S.H. Kang, W.H. Lim, M.J. Cha, Y.J. Cho, I.Y. Oh, S. Oh (Seoul, KR)
Linear ablation of box isolation with biatrial isthmuses ablation as an initial therapy for the persistent and longstanding persistent atrial
S. Takatsuki, T. Kimura, N. Nishiyama, K. Nakajima, A. Kunitomi, S. Kashimura, K. Fukumoto, Y. Tanimoto, Y. Aizawa, K. Fukuda
(Tokyo, Japan, JP)
Less than two minutes, second generation cryoballoon applications achieves acute PVI in 79% without phrenic nerve palsy:
preliminary results of the 1-2-3 study P843
M.M.D. Molenaar, M.F. Scholten, T. Hesselink, Y.J. Stevenhagen, J.M. Van Opstal (Enschede, NL)
Predictive value of atrial remodeling of atrial tachyarrhythmia recurrence after catheter ablation of atrial fibrillation during the
long-term follow K. Ejima, K. Kato, K. Arai, K. Fukushima, R. Henmi, D. Yagishita, T. Manaka, K. Ashihara, M. Shoda, N. Hagiwara (Tokyo, JP)
Impact of catheter tip-tissue contact on left atrial geometries: relationship between the external structures and anatomic distortion
of 3D fast anatomical mapping and high contact force guided images (W) P845
N. Tsukada, S. Nakahara, Y. Hori, N. Nishiyama, A. Nakahara, T. Komatsu, S. Kobayashi, Y. Sakai, I. Taguchi (Koshigaya City, JP)
AF ablation with the new circular, irrigated multipolar ablation catheter nMARQTM catheter: a single center experience M. Gwechenberger, B. Richter, M. Marx, C. Gangl, H. Goessinger (Vienna, AT)
Initial experience with a new image integration module designed for reducing radiation exposure during electrophysiological ablation
procedures P848
O. Cano Perez, P. Alonso, J. Osca, A. Andres, M.J. Sancho-Tello, J. Olague, A. Salvador, L. Martinez-Dolz (Valencia, ES)
A novel tool for mapping multiple rhythms from a single mapping procedure P849
L. Ptaszek, B. Moon, F. Sacher, P. Jais, S. Mahapatra, M. Mansour (Boston and Minneapolis, US; Bordeaux-Pessac, FR)
Catheter ablation of ventricular tachycardia in the presence of an old endocavitary thrombus: the role of intracardiac echocardigraphy P850
P. Peichl, D. Wichterle, R. Cihak, B. Aldhoon, J. Kautzner (Prague, CZ)
Omnipolar ablation catheter technology with unique capacity for beat by beat conduction velocity and direction display D.C. Deno, R. Balachandran, D. Morgan, S. Masse, K. Nanthakumar (St. Paul, US; Toronto, CA)
Distinct and wide variations exist in the morphology of the cavo-tricuspid isthmus:utility of real-time intracardiac echocardiography. P852
K. Hisazaki, K. Kaseno, N. Amaya, D. Aoyama, M. Yokokawa, T. Morishita, K. Ishida, K. Arakawa, H. Uzui, H. Tada (Fukui, JP)
Waiting time after cavo-tricuspid isthmus ablation for typical atrial flutter and long term procedural success P853
S. Marchandise, C. Scavee, C. Barbraud, C. De Meester, M.C. Gonzalez, C. Goesaert, Y. Reis-Pinheiro, J.B. Le Polain De Waroux (Brussels, BE)
Success and limitation of epicardial VT ablation procedures in a large single centre cohort M. Roos, A. Schade, K. Nentwich, J. Krug, P. Halbfass, P. Mueller, G.A. Szoelloesi, T. Deneke (Bad Neustadt a.d. Saale, DE)
Ablation of frequent pvc in primary prevention patients meeting criteria for icd implant. safety and appropriateness of withholding
the implant. D. Penela, J. Acosta, L. Aguinaga, L. Tercedor, J. Fernandez-Armenta, D. Andreu, P. Sanchez, J. Brugada, L. Mont, A. Berruezo
(Barcelona and Granada, ES; Argentina, AR)
Contact force-guided versus contact force-blinded catheter ablation of typical atrial flutter: a prospective study. S. Venier, J.G. Andrade, M. Dubuc, K. Dyrda, P. Guerra, P. Khairy, B. Mondesert, L. Rivard, B. Thibault, L. Macle (Montreal, CA)
Outcomes after multiple catheter ablations of ventricular tachycardia in patients with structural heart disease B. Dinov, C. Stevanello, A. Bollmann, S. Rolf, P. Sommer, G. Hindricks, A. Arya (Leipzig, DE)
Ablation of tachyarrhythmias in early childehood S. Krivolapov, R. Batalov, S. Popov, L. Svintsova, I. Kovalev (Tomsk and Moscow, RU)
Effect of Non-sustained ventricular tachycardias burden on electrical therapies among ICD patients with left ventricular dysfunction. J. Jimenez-Candil, P. Perdiguero, E. Garcia-Piney, J. Morinigo, J. Hernandez Hernandez, A. Martin, P.L. Sanchez (Salamanca, ES)
Primary prevention in ischemic cardiomyopathy in Brazil: should we really do this? G. Peixoto, M.S. Rocha, S.F. Siqueira, M.M. Lensi, S.A.D. Nishioka, R.A. Teixeira, W.A. Hueb, L.A. Machado Cesar, R. Costa, M. Martinelli
(Sao Paulo, BR)
Newly detected atrial arrhythmic episodes in single lead ICD with atrial sensor and early clinical interventions triggered by remote
monitoring V. Calzolari, M. Crosato, L. De Mattia, P. Squasi, M. Mastropietro, A. Tronchin, D. Giacopelli, Z. Olivari (Treviso and Milan, IT)
The impact of age on clinical outcomes patients with primary prevention ICD/CRT-Ds D.G. Wilson, H.M. Zeljko, G. Leventopoulos, A. Yue, P.R. Roberts, P.J. Roderick, J.M. Morgan (Southampton, GB)
Defibrillator patients should not be denied a peaceful death P863
A. Kinch Westerdahl, R.S. Sutton, V.F. Frykman (Stockholm, SE; London, GB)
Percutaneous placement of prototypical epicardial defibrillation coils: a novel approach towards delivery of less painful shocks (W) P864
C. Desimone, F. Syed, P. Gaba, J. Wolf, P. Leinveber, Z. Starek, T. Kara, C. Bruce, P. Friedman, S. Asirvatham (Rochester and Ann Arbor, US;
Brno, CZ)
The subcutaneous implantable cardioverter-defibrillator: first single-center experience with concomitant implantable pulse generators J. Kuschyk, K. Stach, E. Tulumen, B. Rudic, V. Liebe, R. Schimpf, M. Borggrefe, S. Roeger (Mannheim, DE)
Defibrillation testing for right-sided implantable cardioverter-defibrillators (ICD) S. Venier, P. Khairy, M. Dubuc, K. Dyrda, P. Guerra, L. Rivard, D. Roy, M. Talajic, L. Macle, B. Thibault (Montreal, CA)
Electromagnetic interference between smartphones and current cardiac implantable electronic devices: rare but present C. Lennerz, H. Pavaci, C. Grebmer, H. Vrazic, V. Semmler, M. Kottmaier, M. Kornmayer, G. Von Olshausen, I. Deisenhofer, C. Kolb
(Munich and Landshut-Achdorf, DE; Zagreb, HR)
Pacemaker replacement in nonagenarians: procedural safety and long-term follow-up A. Godot, D. Feneon, A. Behaghel, N. Behar, A. Le Helloco, P. Mabo, J.C. Daubert, C. Leclercq, R.P. Martins (Rennes, FR)
Determining the safety of magnetic resonance imaging in cardiac pacemaker patients, results from the Infinite MRI study. V.F. Van Dijk, P.P.H.M. Delnoy, J.J.J. Smit, A.R. Ramdat Missier, A. Elvan, H.W. Van Es, B.J.W.M. Rensing, L.V.A. Boersma (Nieuwegein and
Zwolle, NL)
The evaluation of tricuspid regurgitation following implantation of right ventricular septal and apex pacing leads by 3D echocardiography P870
T. Hirai, T. Nakagomi, K. Mamiya, K. Okamoto, K. Iwase, M. Niwa, K. Miki, N. Suzuki, T. Tanaka (Okazaki, JP)
Activation of coagulation cascade in patients with implantable devices P871
M. Sepsi, P. Scheer, G. Chlupova, T. Novakova, J. Spinar (Brno, CZ)
Long-term follow-up of transvenous cardiac pacing in children: single-center experience in 161 patients B. Kircanski, N. Radovanovic, P. Stojanov (Belgrade, RS)
Acute transitory atrio ventricular blockage in African; consider sickle cell anemia P.H. Gacon (Dijon FR)
Early repolarization in unexplained syncope S. Loebe, J. Kornej, A. Arya, H. Hindricks, A. Bollmann, D. Husser (Leipzig, DE)
The role of QT intervals in prognosis of syncope of unknown origin A. Fotoglidis, C. Papadopoulos, N. Fragakis, E. Pagourelias, D. Tanos, V. Skeberis, P. Kyriakou, V. Vassilikos (Thessaloniki, GR)
Right ventricular diastolic dysfunction in children with WPW syndrome: invasive hemodynamic study I.A. Khamnagadaev, S.A. Termosesov, M.A. Shkolnikova, L.S. Kokov, I.L. Ilich, R.S. Garipov, Y. Volkova (Moscow, RU)
Acute right ventricular apex pacing with an altered activation pattern reduces electrical parameters but does not modify torsade
de pointes incidence in the anesthetized chronic complete AV-block dog A. Dunnink, R. Varkevisser, A. Bossu, S.C. Wijers, A. Oros, V.J.A. Bourgonje, T.R.G. Stams, H.D.M. Beekman, M.A. Vos (Utrecht, NL)
Incidence and predictors of subclavian vein obstruction following biventricular ICD implantation: a contrast venography study O. Beton, E. Saricam, Z. Kucuksu, M. Yaman, A. Zorlu, H. Kaya, H. Yucel, M.B. Yilmaz, I. Tandogan (Sivas, Ankara, Erzincan, Samsun
and Malatya, TR)
Lead to lead mutual connection during extraction with strong connecting tissue scar -interaprocedurally recognised technical
problem and its significance. A. Kutarski, M. Polewczyk, A.M. Polewczyk, A. Polewczyk (Lublin and Kielce, PL)
Complete extraction of abdominal pacing and ICD leads- A unique case series G. Ganesha Babu, V. Cobb, S. Ahsan, R. Providencia, V. Posdziech, A. Chow (London, GB)
Transvenous extraction of very old (over 20-year-old) leads using mechanical systems - effectiveness and safety A. Zabek, K. Boczar, K. Haberka, M. Debski, R. Pfitzner, J. Lelakowski, B. Malecka (Krakow, PL)
A simple score for predicting CRT-Response based on data from a Multicentric Registry. R.A. Providencia, E. Marijon, A. Bouzeman, P. Defaye, C. Leclercq, L. Fauchier, O. Piot, D. Klug, N. Sadoul, S. Boveda (Toulouse, Paris,
Grenoble, Rennes, Tours, Lille and Nancy, FR)
targeting the latest activated region is the best strategy for optimizing response to CRT: fact or fiction? M. Pluijmert, J. Lumens, P. Bovendeerd, K. Vernooy, T. Delhaas, F. Prinzen (Maastricht and Eindhoven, NL)
Effect of stem cell therapy on electrical and mechanical activation in heart failure patients F. Maffessanti, D. Suerder, W. Kroon, M. Potse, F. Regoli, R. Murzilli, T. Moccetti, F.W. Prinzen, R. Krause, A. Auricchio (Lugano, CH;
Maastricht, NL)
Effects of cardiac resynchronization therapy on functional capacity and neurocognitive profile, a possible role on the slowing of frailty
development M. Nesti, S. Fumagalli, L. Pandolfini, M. Beltrami, G. Ricciardi, P. Pieragnoli, L. Padeletti (Florence, IT)
Triple-site ventricular (TRIV) pacing is superior to conventional biventricular pacing: a prospective observational trial with minimum
invasive hemodynamic assessment M. Nobre Menezes, P. Marques, G. Lima Da Silva, A. Bernardes, A. Magalhaes, N. Cortez Dias, L. Carpinteiro, J. De Sousa, F.J. Pinto
Clinical response and reverse remodeling after cardiac resynchronisation therapy in patients with right ventricular dysfunction P. Pinto-Teixeira, M. Oliveira, A. Galrinho, P. Cunha, L. Branco, J. Feliciano, R. Pimenta, A. Lousinha, M. Nogueira-Silva, R. Ferreira
Electromechanical characterization of left ventricular pacing vectors in CRT P876
L. Lambrakos, E. Bunting, H. Garan, E. Konofagou (New York, US)
Feature-tracking cardiovascular magnetic resonance to predict response following cardiac resynchronisation therapy. P877
R.J. Taylor, F. Umar, E.L.S. Lin, G. Mankaryous, B. Stegemann, F. Leyva (Birmingham, GB; Maastricht, NL)
Agreement analysis between QuickOpt and echocardiographic-based methods in optimizating cardiac resynchronization therapy devices P878
A. Adel Mohamed Elamragy, R.H. Deyab, H.H. Rizk, A.M. Abdelwahab (Cairo, EG)
Undecided about getting a pacemaker? Take one for a test drive M. Giudici (Iowa City, US)
Effect of heart rate on the intrinsic and the ventricular-paced QRS duration I. Chiladakis, A. Kalogeropoulos, F. Zagkli, K. Chouchoulis (Patras, GR)
Expression of miRNAs and morphological changes in myocardium of patients with atrial fibrillation M.V. Eremeeva, T.V. Sukhacheva, A.G. Ibragimova, V.S. Rudomanova, V.A. Vaskovskiy, A.S.H. Revishvili (Moscow, RU)
Spectrum of long qt gene mutations in the republic of ireland. D.P. Moran, S. Touhy, B. Noonan, J.O.O.neill, D. Ward, C. Mcgorrian, A. Green, S.A. Lynch, W. Reardon, J. Galvin (Dublin, IE)
Cardiomyopathies associated with mutations in SCN5A gene E. Zaklyazminskaya, A. Revishvili, I. Pronicheva, A. Shestak, S. Dzemeshkevich (Moscow, RU)
Xanthine oxidase inhibitor prevents atrial fibrillation susceptibility by inhibition of oxidative CaMKII in Dahl salt-sensitive rats D.Z. Xu, N. Murakoshi, T. Kimura, K. Tajiri, A. Nogami, K. Aonuma (Tsukuba, JP)
Results of clinical testing of a cloud computing based ambulatory ecg monitoring and arrhythmia detection system I. Crozier, D. Hooks, M. Daly, I. Melton, C. Cruickshank, K. Morgan, L. Minarsch (Christchurch, NZ)
Clinical and electrophysiological characteristics of children with chronic sinus tachycardia I. Vinogradova, T. Kruchina, A. Adrianov, O. Gordeev, D. Egorov (Saint-Petersburg, RU)
The value of anticardiac antibodies and cardiovascular magnetic resonance findings and in patients with dilated cardiomyopathy
and conduction disturbances with structurally normal heart E.M. Gupalo, O.V. Stukalova, T.A. Malkina, T.V. Sharf, E.E. Efremov, N.A. Mironova (Moscow, RU)
Do ectopic supraventricular premature beats predict early new onset AF after CABG? A. Yaksh, C. Kik, E.A.H. Lanters, U. Chigharoe, P. Knops, M.J.B. Van Ettinger, M.C.J. De Wijs, P. Van De Kemp, A.J.J.C. Bogers, N.M.S.
De Groot (Rotterdam, NL)
Influence of electrode placement on localization of accessory pathway in patients with WPW syndrome S.H. Moon, Y.R. Kim, J.P. Yun, J.H. Kwon, M.S. Kim, U. Jo, G.B. Nam, K.J. Choi, Y.H. Kim, J. Kim (Seoul, KR)
Description of extrasystoles in healthy pediatric subjects C. Bautista, G. Sarquella Brugada, S. Cesar, L. Marzo, A. Berruezo, J. Brugada (Esplugues de Llobregat, ES)
Arrhythmogenic right ventricular cardiomyopathy with epsilon waves in peripheral and precordial leads F. Candelmo, F. Rotondi, F. Alfano, F. Manganelli, T. Lanzillo, G. Amoroso, A. Caccavale, E. Ragno, M.R. Pagliuca (Avellino, IT)
Repolarisation abnormalities in patients with alternant hemiplegia: a peculiar ECG for a rare entity. G. Sarquella Brugada, C. Fons, S. Cesar, J. Campistol, L. Marzo, C. Bautista, J. Brugada (Esplugues de Llobregat, ES)
Clinical usefulness of baroreflex sensitivity test in the detection of cardiovascular autonomic neuropathy in patients with type 2
diabetes mellitus. E. Borowik, W. Grabowicz, A. Lubinski (Lodz, PL)
Cardiac sodium shannel variants are differentially tuned via tyrosine phosphorylation S.M. Iqbal, R. Lemmens-Gruber (Vienna, AT)
Risk factors, incidence and efficacy of pharmacotherapy of ventricular arrhythmias and its impact on clinical outcomes in patients
with acute coronary syndrome O. Kalejs, A. Maca, I. Zakke, K. Trusinskis, M. Zabunova, I. Mintale, S. Jegere, V. Stirna, A. Erglis (Riga, LV)
The prevalence of arrhythmias and conduction disorders in children with congenital heart disease undergone cardiac surgery
correction A. Adrianov, A.V. Adrianov, L. Teslinova, I. Vinogradova (Saint-Petersburg, RU)
Effects of worsening renal function on fibrin clot structure in atrial fibrillation patients receiving warfarin. Y.C. Lau, Q. Xiong, A. Blann, G.Y.H. Lip (Birmingham, GB; Nanchang, CN)
Left atrial appendage occluder for stroke prevention - the institut Jantung Negara (The national heart institute of Malaysia) watchman
registry Z. Muhammad, S. Khalea, A. Hussein, Z. Ali, N. Mohd Saad, K.W. Koh, G.S. Tay, R. Rebo, R. Omar (Kuala Lumpur, MY)
Patterns of newly detected atrial fibrillation and antithrombotic treatment in Europe (GLORIA-AF Phase II) G.Y.H. Lip, H.C. Diener, S.J. Dubner, J.L. Halperin, C.S. Ma, K.J. Rothman, K. Zint, A. Elsaesser, C. Teutsch, M.V. Huisman (Birmingham, GB;
Essen and Ingelheim, DE; Buenos Aires, AR; New York and Research Triangle Park, US; Beijing, CN; Burlington, CA; Leiden, NL)
ICD therapies in the era of remote monitoring : follow-up of 881 patients with a very low rate of inappropriate therapies P. Jacon, N. Pellet, A. Martin, H. Rekik, J.J. Ndjessan, F. Dujenet, P. Defaye (Grenoble, FR)
Circadian rhythms in ECG parameters in mice with and without heart failure. L.A. Gottlieb (Koebenhavn N, DK)
Remodeling of distinct sodium channel pools in the murine failing heart. M. Rivaud (Amsterdam, NL)
Adverse Remodelling of the Cardiac Conduction System (CCS) in Heart Failure Could be the Result of Up and Down Regulation of
MicroRNAs. J. Yanni (Manchester, GB)
Electrical remodelling in heart failure M. Liu, G.B. Shi, H. Liu, S.C. Dudley (Providence, US)
Identification of two native Nav1.5 phosphorylation sites as potential determinants of the increased late Na+ current in heart failure S. Burel, F. Coyan, M.R. Meyer, C.F. Litchi, J.H. Brown, F. Charpentier, J.M. Nerbonne, R.R. Townsend, L.S. Maier, C. Marionneau
(Nantes, FR; Saint Louis, Galveston and San Diego, US; Regensburg, DE)
Pacemaker-induced cardiomyopathy in the sheep: RVA but not RVOT pacing results in a heart failure cellular phenotype G. Kirkwood, M. Lawless, C. Pearman, E. Radcliffe, A.W. Trafford (Manchester, GB)
The association between tenascin-c and nt-proBNP levels and arrhythmia prevalence in heart failure C. Ozmen, A. Deniz, O.S. Deveci, C.E. Caglayan, A.I. Celik, I. Yildiz, P. Ozmen Yildiz, M. Demir, M. Kanadasi (Adana and Osmaniye, TR)
Effect of ethanol on inward rectifier potassium current sensitive to acetylcholine in rat atrial myocytes and on expressed Kir3.1/3.4
channels. Z. Horakova (Prerov, CZ)
A Novel, Potent, and Selective Inhibitor of Cardiac Late Sodium Current Reduces Transmural Dispersion of Repolarization and
Suppresses Experimental Arrhythmias. S. Rajamani (Fremont, US)
Paradoxical effects of IKs blockade during nNOS inhibition. J. Bernardi (Milan, IT)
Mode of action of TMYX on the pacemaker activity of freely moving mice. C. Piantoni (Milan, IT)
Effects of the Traditional Chinese Medicine drug TMYX on action potential parameters of SAN cells. M. Paina (Milan, IT)
Molecular aspects of ivabradine binding to hHCN4 and hHCN1 channel pores. A. Bucchi (Milan, IT)
DIfferent lidicaine, nifedipine and oubaine sensitivity SAN cells in rabbit and mouse. A. Golovko (Syktyvkar, RU)
Rabbit and mouse sino-auricular node cells with similar maximal upstroke velocity of the potential exhibit different sensitivity to
lidocaine, nifedipine and ouabain. E. Lebedeva (Syktyvkar, RU)
Pharmacological analysis of transmembrane action potential's morphology in the spontaneously beating heart of ascidia Styela rustica
in vitro. A. Golovko (Syktyvkar, RU)
Selective pharmacologic block demonstrates contribution of L-type Cav1.3 calcium channel over the full diastolic depolarization
phase of cardiac pacemaker cells. P. Mesirca (Montpellier, FR)
Inhibition of the inward rectifier current IK1 by PA-6 restores sinus rhythm in goats with atrial fibrillation, but does not induce
ventricular arrhythmias in dogs with chronic AV block M.A.G. Van Der Heyden, R. Varkevisser, Y. Ji, A. Bossu, D. Opacic, J. Beekman, S. Yang, M. Wang, S. Verheule, M.A. Vos (Utrecht and
Maastricht, NL; Lawrence, US)
Molecular determinants of dronedarone inhibition of the hERG K+ channel Y. Zhang, C. Colenso, C. Dempsey, J. Hancox (BRISTOL, GB)
Calcium handling and mechano-electric transduction
Is Electromechnical Window Negativity Required for Torsades de Pointes? H.J. van der Linde (Beerse, BE)
NOD1, a new player in the cardiac calcium handling. M. Fernandez-Velasco (Madrid, ES)
Does flecainide have effect on Ca handling in the absence of sodium current? Y. Li (Manchester, GB)
Histone deacetylases (HDAC) inhibition modulates cardiac calcium dynamic by promoting Serca2 acetylation. C. Florio (Bolzano, IT)
The effects of vagal nerve stimulation on calcium handling in the failing heart. E. Radcliffe (Manchester, GB)
Stem cell-derived cardiomyocyte models
Novel Evaluation of Cardiac Kinematics Parameters for beating human induced-pluripotent stem cells derived cardiomyocytes and
for in-situ heart by a High-Speed Bright-field Video Mapping: a Contactless and Electrodeless Approach. M. Miragoli (Rozzano, IT)
Using Cardiomyocytes Differentiated From Urine-derived Pluripotent Stem Cells To Recapitulate Electrophysiological Characteristics
of LQT2 syndrome. N. Gaborit (Nantes, FR)
Electrophysiological Characterization of a Novel SCN5A Mutation Causing Brugada Syndrome, Using Cardiomyocytes Differentiated
From hiPSCs. M. Jouni (Nantes, FR)
Electrophysiological characterization of hiPSC-derived cardiomyocytes from Brugada syndrome patients without SCN5A mutations. C. Veerman (Amsterdam, NL)
Mechanism of induction of LQT syndrome in HIV patients. Z. Es-Salah-Lamoureux (Nantes, FR)
Human iPS-derived cardiomyocytes from AF patients show altered If current independently of the maturation stage. G. Campostrini (Milan, IT)
E-c coupling and drug sensitivity differences between human induced pluripotent stem cells derived cardiomyocytes
in 3d microtissues and 2d culture. M. Hortigon-Vinagre (Glasgow, GB)
Analysis of electrical excitability of human induced pluripotent stem cells derived cardiomyocytes using optogenetic stimulation. V. Zamora-Rodriguez (Glasgow, GB)
Altered electrical signal propagation and slowed conduction in mixed cultured strands of primary ventricular cells and stem
cell-derived cardiomyocytes. N.D. Ullrich, Y. Prudat, I.C. Marcu, J.P. Kucera (Heidelberg, DE; Bern, CH)
A novel Duchenne Muscular Dystrophy model: human iPS-csrdiomyocytes for mechanistic studies. J.M. Pioner (Florence, IT)
Electrophysiological effects of long term exposure of hiPSC-derived cardiomyocytes to the late sodium current inhibitor GS967.
S. Casini (Leiden, NL)
Ivabradine prolongs action potential duration but has no significant effect on spontaneous rate in cardiomyocytes derived from
human-induced pluripotent stem cells. A. Costa (Glasgow, GB)
Employing Cardiac Myocyte Progenitor Cells to Fabricate Biological Pacemakers. L. Cocera Ortega (Amsterdam, NL)
Electrophysiological charecterization of the human induced pluripotent stem cell derived cardiomyocytes obtained from hypertrophic
cardiomyopathy C.K. Prajapati, K. Larsson, M. Ojala, R.P. Polonen, K. Aalto-Setala (Tampere, FI)
Regulation of L-type Ca2+-currents in human induced pluripotent stem cell-derived cardiomyocytes A. Uzun, I. Vollert, K. Breckwoldt, C. Neuber, A. Hansen, T. Eschenhagen, T. Christ (Hamburg, DE)
Electrophysiological properties of human induced pluripotent stem cell derived cardiomyocytes isolated from engineered heart tissues A. Horvath, A. Uzun, I. Vollert, K. Breckwoldt, C. Neuber, A. Hansen, A. Varro, T. Eschenhagen, T. Christ (Hamburg, DE; Szeged, HU)
channels Z. Horakova, P. Matejovic, J. Hosek, M. Simurdova, J. Simurda, M. Bebarova (Brno, CZ)
Multiple ion channel pharmacology screening at physiological temperature using the CytoPatch automated patch-clamp platform O. Scheel, J. Eisfeld, S. Frech, B. Amuzescu, S. Wierschke, J. Kudolo, T. Knott (Rostock, DE)
Transverse tubule regulation in the heart: A role for Amphiphysin II? J. Caldwell (Manchester, GB)
Novel insights on the relationship between T-tubular electrical defects and mechanics in cardiac hypertrophy and heart failure. L. Sacconi (Sesto Fiorentino, IT)
Stretch activated ion channels in the human cardiac aortic valve in health and disease. R. Peyronnet (To Be Confirmed, GB)
Characterizing Axial and Longitudinal Mechanics of Individual Cardiomyocytes. A. Desai (To Be Confirmed, US)
Gender differences in the calcium handling in human heart failure. C.E. Molina (Essen, DE)
Stimulation of calcium sparks in both sino - atrial node and ventricular myocytes. L. Miller (Manchester, GB)
Measurement of Ca2+ leak in beating Cardiac myocytes. N. Macquaide (Glasgow, GB)
Development Of A Cell Isolation Method In Large Mammals: Regional Differences In Calcium Signaling Across Left Atrium From Sheep. F. Brette (Pessac, FR)
Atrial myocytes express a cell-specific axial tubule system that confines ultrarapid intracellular Ca2+ signals and excitation-contraction
coupling to the cell center S. Brandenburg, T. Kohl, K. Gusev, E. Wagner, S. Sossalla, G. Hasenfuss, S. Hell, B. Schwappach, J. Lederer, S.E. Lehnart (Gottingen, DE;
Baltimore, US)
Cytosolic calcium changes affect the incidence of early afterdepolarizations in ventricular cardiomyocytes B. Horvath, B. Hegyi, K. Kistamas, K. Vaczi, T. Banyasz, J. Magyar, N. Szentandrassy, P.P. Nanasi (Debrecen, HU)
Elevated ventricular wall stress disrupts cardiomyocyte t-tubular structure and ca2+ homeostasis M. Ruud, M. Frisk, E.K.S. Espe, M. Aronsen, P.A. Norseng, I. Sjaastad, G. Christensen, W.E. Louch (Oslo, NO)
A severity of sleep-disordered breathing with atrial fibrillation ablation candidates is associated with the long-term outcome after
pulmonary vein antrum isolation K. Kaitani, N. Onishi, Y. Hayama, H. Kondo, C. Izumi, Y. Nakagawa (Tenri, JP)
Hybrid approach for persistent atrial fibrillation: a single centre experience A. Curnis, M. Cerini, A. Lipari, F. Vassanelli, G.L. Bisleri, N. Ashofair, L. Inama, F. Rosati, C. Muneretto, L. Bontempi (Brescia, IT)
Catheter ablation vs. rate control for atrial fibrillation in patients with heart failure: a meta-analysis S. Stavrakis, S.S. Po (Oklahoma City, US)
Ipsilateral (superior to inferior and inferior to superior) pulmonary vein capture to demonstrate antral circumferential ablation M. Brunelli, S. Raffa, A. Grosse, M. Frommhold, T. Daehne, A. Cima, A. Madaffari, J.C. Geller (Bad Berka, DE)
Management of tamponade complicating catheter ablation for atrial fibrillation: early removal of pericardial drains is safe, effective
and may reduce pain and hospital stay compared to delayed removal M.E.F. Pedersen, M. Stone, A. Malhotra, M. Leo, K. Wong, M. Ginks, K. Rajappan, T. Betts, Y. Bashir (Oxford, GB)
Electrocardiographic characteristics of atrial fibrillation onset as a predictor of long-term therapy outcome in patients with
paroxysmal atrial fibrillation: A substudy of the MANTRA-PAF trial A.H. Hakalahti, P. Uusimaa, J.C. Nielsen, P.S. Hansen, M.J.P. Raatikainen (Oulu and Jyvaskyla, FI; Aarhus, DK)
Relationship between left atrial wall thickness by computed tomography and voltage amplitude in patients undergoing radiofrequency
catheter ablation of paroxysmal atrial fibrillation E. Goto, K. Nakamura, S. Naito, K. Minami, S. Shimizu, T. Yano, T. Sasaki, K. Kumagai, S. Oshima (Maebashi city, JP)
Analysis of redo-procedures out of the FIRM ONLY study cohort K.M. Nentwich, P. Halbfass, P. Mueller, M. Roos, A. Schade, A. Szoelloesi, S. Kerber, T. Deneke (Bad Neustadt an der Saale, DE)
Increase of power could enhance effectiveness of radio frequency ablation at the same force-time integral level. L.B. Shi, W.Y.C. Wang, P.S. Schuster, B.A. Bortoli, S.L.Z. Sun, P.I.H. Per Ivar, E.S. Solheim, O.J.O. Ohm, C.J. Chen (Bergen, NO)
Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation in patients
with persistent atrial fibrillation T. Kondo, J. Miake, K. Ogura, M. Kato, K. Iitsuka, K. Yamamoto (Yonago, JP)
Semi automated segmentation of the left atrial blood pool for the assessment and display of left atrial wall thickness J. Whitaker, T. Fastl, H. Chubb, S. Williams, M. Gabrawi, R. Karim, A. Sekaran, R. Rajani, S. Niederer, M.O.neill (London, GB)
Relationship between reduction of systolic blood pressure and atrial fibrillation burden after renal denervation and pulmonary vein
isolation E. Pokushalov, A. Romanov, D.G. Katritsis, A. Strelnikov, S. Artemenko, D. Losik, V. Baranova, A. Karaskov, J.S. Steinberg (Novosibirsk, RU;
Athens, GR; New York, US)
A prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients
with incident non-valvular atrial fibrillation M. Haim, M. Hoshen, O. Reges, Y. Rabi, R. Balicer, M. Leibowitz (Beer Sheva and Tel Aviv, IL)
The long-term outcome of carotid endarterectomy in real-world practice: implications of atrial fibrillation A. Banerjee, M. Stoodley, M. Griffith, H. Marshall, M. Lencioni, J. De Bono, D. Ray, F. Leyva (Birmingham, GB)
The role of the parameters of heart rate variability in the patients with different clinical types of nonvalvular atrial fibrillation Y.S. Makaryan, S.V. Grigoryan (Yerevan, AM)
Advantage of preprocedural thrombus evaluation of the left atrial appendages by intracardiac echocardiography in catheter ablation
patients with persistent atrial fibrillation Y. Ikegami, K. Tanimoto, K. Inagawa, K. Miura, T. Fukuda, M. Fukuda, W. Yamada, J. Fuse, M. Sakamoto, Y. Momiyama (Tokyo, JP)
Arrhythmia pattern during follow-up after electrical cardioversion does not correlate with the extent of left atrial anatomical
remodeling at computed tomography M. Brunelli, S. Raffa, A. Grosse, A. Cima, A. Madaffari, T. Daehne, M. Frommhold, J.C. Geller (Bad Berka, DE)
Esophagus temperature monitoring during cryoballoon ablation on left atrium using deflectable probe and fixed sensor probe P983
A. Kobori, Y. Sasaki, T. Yamane, K. Kim, N. Ehara, M. Kinoshita, S. Kaji, Y. Furukawa (Kobe, JP)
Robotic navigation system nullifies the benefit of general anesthesia during pulmonary vein isolation: results from a randomized
single-center study. P984
A. Dello Russo, S. Conti, G. Fassini, M. Casella, E. Russo, F. Pizzamiglio, L. Cipolletta, G. Vettor, G. Del Giorno, C. Tondo (Milan, IT)
Early ablation in paroxysmal atrial fibrillation demonstrates significant benefit in atrial function and reverse remodelling: a study
with 3D strain P985
M. Agelaki, J. Grapsa, D. Dawson, C. Papadopoulos, A. Katsivas, P. Nihoyannopoulos (London, GB; Athens, GR)
Apixaban is a safe alternative to uninterrupted warfarin during catheter ablation of atrial fibrillation P986
K.R. Nilsson, B. Pye, A. Lorrain, J. Murrow (Augusta, US)
Redo-ablations of atrial fibrillation: procedural characteristics depending on the choice of cryoenergy or radiofrequency ablation
as the first line therapy P987
V. Galand, D. Feneon, N. Behar, A. Behaghel, M. Fournet, J.C. Daubert, P. Mabo, D. Pavin, R.P. Martins (Rennes, FR)
Head-to-head comparison of contact-force sensing catheters: the same benefit on catheter ablation of paroxysmal and persistent atrial
fibrillation? P988
R.A. Providencia, Z. Khoueiry, A. Bouzeman, P. Sousa, S. Combes, N. Combes, S. Boveda, J.P. Albenque (Toulouse, FR)
The incidence and characteristics of right phrenic nerve stimulation from right pulmonary veins P989
Y. Hama, Y. Matsudo, T. Kuwahara, M. Yamamoto, T. Himi (Kisarazu and Yokosuka, JP)
NMARQ survey: results of using a novel irrigated multielectrode mapping and ablation catheter for atrial fibrillation ablation P990
N. Vitulano, A. Di Monaco, F. Quadrini, F. Troisi, G. Katsouras, V. Caccavo, T. Langialonga, M. Grimaldi (Acquaviva Delle Fonti, IT)
Non-fluoroscopic navigation system in atrial fibrillation ablation: reducing reference displacement using active fixation lead. P991
R. Salgado Aranda, J. Garcia Fernandez, J. Martin Gonzalez, S. Mayordomo Gomez, J. Monedero Campo, M. Alvarez Calderon,
A. Mateos Perez (Burgos, ES)
Figure-of-eight suture for vascular hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation P992
U. Lakshmanadoss, R. Khalid, I. Kutinsky, B. Williamson, W. Wong, D.E. Haines (Royal Oak and Rochester, US)
Pulmonary vein anatomy and nadir temperature during cryoballoon ablation for atrial fibrillation. P993
J. Baran, R. Piotrowski, A. Sikorska, T. Krynski, S. Stec, P. Kulakowski (Warsaw and Rzeszów, PL)
Atrial fibrillation cycle length measured in a 12-lead surface ECG predicts intracardiac AF cycle length prior to ablation procedure (W) P994
J. Luker, A. Sultan, D. Schreiber, T. Plenge, S. Willems, D. Steven (Cologne and Hamburg, DE)
Age-specific incidence of recurrent atrial fibrillation and clinical events after catheter ablation in patients with paroxysmal atrial
fibrillation (W) P995
M. Takigawa, A.T. Takahashi, T.K. Kuwahara, K.O. Ohkubo, K.Y. Yamao, E.N. Nakashima, N.J. Nakajima, K.T. Takagi, K.H. Hirao, M.I. Isobe
(Suita, Osaka and Yokosuka, JP)
Predictors of pocket hematoma occurrence in patients on uninterrupted oral anticoagulation undergoing cardiac implantable
electronic device procedures F. De Sensi, G. Miracapillo, L. Addonisio, M. Breschi, T. Infusino, S. Severi (Grosseto and Catanzaro, IT)
Comparison of pulmonary vein isolation guided by remote magnetic navigation in patients with paroxysmal atrial fibrillation using
an irrigated gold-tip and a classical irrigated catheter P997
R. Prisecaru, L. Riahi, Y. De Greef, D. Stockman, P. Van Den Heuvel, B. Schwagten (Antwerp, BE)
Endoscopically detected esophageal thermal lesions are related to the use of esophageal intraluminal temperature probe: Results
from atrial fibrillation ablation using a novel irrigated multipolar abl P998
T. Deneke, P. Halbfass, P. Mueller, P. Fochler, M. Roos, R. Schmitt, G. Christopoulos, A. Szoelloessi, J. Krug, K. Nentwich
Irradiation of the operator and the patient during radiofrequency ablation of common atrial flutter using three different settings
of angiography system P999
M. Granier, X. Brunet, J. Greffier, A. Zedira, J.P. Beregi, P. Messner, P.F. Winum (Nimes, FR)
Cavotricuspid isthmus ablation using a catheter equipped with mini electrodes on the 8mm tip: a prospective comparison with an 8mm
dumbbell shape tip catheter and an 8mm tip cryothermal catheter. P1000
J. Iwasawa, S. Miyazaki, N. Ichihara, T. Takagi, H. Nakamura, H. Taniguchi, H. Hachiya, Y. Iesaka (Tsuchiura, JP)
Characterization of very low voltage/scar areas in patients with left atrial flutter by high density voltage maps P.F. Cruz, S. Castrejon Castrejon, E. Falconi, M. Arceluz, R. Delgado, M. Ortega, O. Salvador, J.L. Merino Llorens (Madrid, ES)
External Defibrillators
Wearable cardioverter defibrillator reduces implantation rate of ICD in patients with high risk for life-threatening cardiac arrhythmias A.M. Sinha, E. Martens, A. Wystrach (Hof, DE)
The subcutaneous implantable defibrillator:global experience in an high volume ICD lead extraction centre S.M. Viani, G. Zucchelli, E. Soldati, L. Paperini, L. Segreti, A. Di Cori, A. Boem, D. Levorato, G. Branchitta, M.G. Bongiorni (Pisa, IT)
Developing a new classification and grading system for pocket hematoma after CIED procedures F. De Sensi, S. Severi, G. Miracapillo, K.E.J. Airaksinen (Grosseto, IT; Turku, FI)
Tricuspid regurgitation associated with pacemaker lead an underestimated problem. A. Rydlewska, A. Zabek, K. Boczar, J. Lelakowski, B. Malecka (Krakow, PL)
Stability of pacing indices in cardiac transplant patients T. Farid, A.R. Moser, B. Austin, A. Magalski, A. Wimmer (Kansas City, US)
Two years experience after decentralization of pacemaker follow-up visit to local especialty care centres using remote transmission. J.J. Ferrer Hita, A. Rodriguez Gonzalez, R.A. Juarez Prera, P. Jorge Perez, F. Bosa Ojeda, M.J. Garcia Gonzalez, E. Gonzalez Cabeza,
B. Mari Lopez, C. Mendez Vargas, I. Laynez Cerdena (Santa Cruz de Tenerife, ES)
Incidence of new externalized conductors and electrical dysfunction in Riata leads: results from a multicenter study P1012
D. Hayes, R. Freedman, M. Niebauer, V. Plumb, J. Dinerman, S. Beau, G. Kim, A. Curtis (Rochester, Salt Lake City, Cleveland, Birmingham,
Huntsville, Little Rock, Sylmar and Buffalo, US)
Transvenous ICD Lead failure: which leads are more likely to fail? a meta-analysis of case-control studies and randomized control trials. P1013
R.A. Providencia, D. Pimenta, G. Babu, A. Ioannou, J. Novak, P.D. Lambiase (London, GB)
Effectiveness of extracorporeal life support for patients with cardiogenic shock due to intractable arrhythmic storm S. Le Pennec-Prigent, R.P. Martins, C. Chabanne, B. Lelong, J.C. Daubert, C. Leclercq, P. Mabo, E. Flecher (Rennes, FR)
Predictive model of the probability of sudden cardiac death of the patients with dilated cardiomyopathy T. Vaikhanskaya, T.M. Kaptsiukh, T.V. Kurushka, O.P. Melnikova, A.V. Frolov (Minsk, BY)
Quality of life, biomarkers and ICD indications in patients with a wearable cardioverter/defibrillator - preliminary results of
a prospective trial with 1 year of follow-up D. Duncker, Y. Kirste, S. Hohmann, T. Koenig, F. Zauner, H. Oswald, C. Veltmann (Hannover, DE)
Role of NT-proBNP in the assessment of clinical outcome and prediction of arrhythmic events E. Menardi, A. Vado, G. Rossetti, M. Landolina, A. Castro, R. Massa, M. Sassara, A. Kheir, M. Malacrida, L.M. Biasucci (Cuneo, Crema,
Rome, Alessandria, Viterbo, Ponte San Pietro and Milan, IT)
Impact of evaluation of epicardial impedance before ablation to determine effective epicardial ablation sites T. Kitamura, S. Fukamizu, R. Hojo, Y. Aoyama, K. Komiyama, T. Tejima, M. Nishizaki, H. Sakurada, M. Hiraoka (Tokyo, Yokohama and
Ibaraki, JP)
Electroanatomical voltage and morphology characteristics in post-infarction patients undergoing ventricular tachycardia ablation:
A pragmatic approach favoring late potentials abolition. D. Tsiachris, J. Silberbauer, G. Maccabelli, T. Oloriz, F. Baratto, H. Mizuno, G. Paglino, P. Mazzone, N. Trevisi, P. Della Bella (Milan, IT)
Safety of anteroseptal atrioventricular accessory pathway catheter ablation: very long-term follow-up results D. Zagari, A. Sanzo, M. Tritto, R. De Ponti, G. Spadacini, P. Moretti, E. Renzullo, A. Santoro, G. Oreto, J.A. Salerno-Uriarte (Castellanza,
Varese and Messina, IT)
Prognosis of atrial flutter-related tachycardiomyopathy did not differ from patients without atrial flutter-related tachycardiomyopathy
after ablation V. Manenti, A. Olivier, J.M. Sellal, N. Girerd, B. Brembilla-Perrot (Vandoeuvre les Nancy, FR)
Radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia with congenital heart disease K. Toyohara, T. Nishimura, K. Miyamoto, T. Wada, Y. Kudoh, D. Takeuchi, M. Shoda, T. Nakanishi (Tokyo, JP)
The impact of NavX in pediatric arrhythmia ablation on safety, procedure duration and number of RF lesions. Is it a time to change
approach? A. Baszko, K. Czyz, A. Lazniak, B. Sprada, A. Bartkowiak-Sniatkowska, W. Bobkowski (Poznan, PL)
Do quadripolar transvenous LV leads have advantages at the time of de novo CRT-D implantation? (W) P1020
C.G. Wollmann, K. Thudt, P. Vock, H. Mayr (St. Polten, AT)
Utility and safety of temporary pacing using active-fixation leads and externalized re-usable pacemakers in transcatheter aortic valve
implantation and other conditions requiring short-term pacing P1021
S. Schwarz, A. Kypta, S. Hoenig, J. Kammler, K. Saleh, T. Lambert, H. Blessberger, V. Gammer, A. Nahler, C. Steinwender (Linz, AT)
Long-term follow up of pacemaker implantation through a persistent left superior vena cava, a safe approach? M.T. Lopez Lluva, J. Jimenez Diaz, J.J. Gonzalez Ferrer, N.G. Uribe Heredia, J. Benezet Penaranda (Ciudad Real, ES)
Patients with atrio-ventricular blocks qualified for pacemaker implantation seem to be more frequent exposed on frailty syndrome A. Mlynarska, R. Mlynarski, M. Sosnowski, K.S. Golba (Katowice, PL)
Long-term follow-up of patients with cardiac implantable electrical devices implanted in childhood M. Sasov, V. Illikova, E. Balazova, P. Margitfalvi, M. Svetlosak, R. Hatala (Bratislava, SK)
LBBB is incomplete in the majority of patients with HF due to systolic LV dysfunction: a simple intraprocedural demonstration D.-A. Radu, C.N. Iorgulescu, S.N. Bogdan, E. Ene, A. Nastasa, G. Malaescu, R.G. Vatasescu (Bucharest, RO)
Initial experience implanting a new intravenous coronary sinus lead with an active fixation mechanism for cardiac resynchronization
therapy. R. Matia Frances, A.H.Madrid, J. Rubio, A. Miracle, G. Sanchez-Huete, E. Franco, J. Moreno, J.L. Zamorano (Madrid, Valladolid and
Mostoles, ES)
Biventricular pacing reduces coronary flow velocity reserve in the left anterior descending artery compared with baseline rhythm
in patients with chronically implanted CRT devices S.B.L. Claridge, Z. Chen, T. Jackson, J. Behar, K. Assress, M. Lumley, R. Williams, J. Bostock, D. Perera, C.A. Rinaldi (London, GB)
Modifying quadripolar left ventricular pacing vectors impacts ventricular activation times in cardiac resynchronisation therapy T.A. Jackson, S. Claridge, J. Behar, R. Razavi, C.A. Rinaldi (London, GB)
Cardiac resynchronization therapy in chagas cardiomyopathy P1029
G. Peixoto, S.F. Siqueira, S.A.M. Martins, J.X. Santos, S.A.D. Nishioka, A.A.A. Pedrosa, R.A. Teixeira, R. Costa, M. Martinelli (Sao Paulo, BR)
Electromechanical coupling in heart failure patients P1030
F. Maffessanti, W. Kroon, M. Potse, F. Regoli, R. Murzilli, D. Suerder, T. Moccetti, F.W. Prinzen, R. Krause, A. Auricchio (Lugano, CH;
Red cell distribution width is superior to the NT-proBNP in the survival prediction of chronic heart failure patients with cardiac
resynchronization therapy P1031
G. Szeplaki, A.M. Boros, P. Perge, Z.S. Jenei, E. Zima, L. Molnar, S.Z. Szilagyi, Z. Prohaszka, L. Geller, B. Merkely (Budapest, HU)
Cardiac resynchronization therapy optimization by ECG P1032
V. Lebedeva, T. Lubimceva, M. Trukshina, E. Lyasnikova, D. Lebedev (Saint-Petersburg, RU)
The utility of biventricular acute hemodynamic optimisation to determine the optimal pacing location for cardiac resynchronisation
therapy. P1033
J.M. Behar, E. Hyde, S. Claridge, T. Jackson, M. Sohal, E. Sammut, J. Webb, R. Razavi, S. Niederer, C.A. Rinaldi (London, GB)
Selvester qrs scoring system and fragmented qrs on a 12-lead ecg : are predictors of arrhyhthmic risk? P1034
M. Nesti, S. Cartei, R. Bani, P. Pieragnoli, G. Ricciardi, L. Checchi, L. Pandolfini, L. Padeletti (Florence, IT)
Usefulness of PET-CT in the diagnostic strategy in infection of cardiac implantable electronic device. P1035
J. Meurice, G. Petyt, J.S. Hermida, P. Milliez, F. Anselme, C. Hossein-Foucher, C. Marquie, D. Klug (Lille, Amiens, Caen and Rouen, FR)
Percutaneous vacuum-assisted thrombectomy device used for removal of large vegetations on infected pacemaker and defibrillator
leads as an adjunct to lead extraction P1036
R. Schaerf, S. Najibi, J. Conrad, R. On, P. Sandhu, B. Larreta (Burbank, US)
Repetitive inappropriate ICD shocks due to insulation failure with externalized conductor cables of a Linox SD ICD lead: a case report. P1037
T. Reichlin, M. Kuehne, S. Knecht, A. Muehl, B. Schaer, S. Osswald, C. Sticherling (Basel, CH)
The diagnostic quality of the new injectable telemedically cardiac monitor Reveal LINQ. M. Christoph, J. Mayer, C. Wunderlich, Y. Huo, M. Forkmann, J. Salmas, M. Pohl, T. Gaspar, C. Piorkowski (Dresden, DE)
Comorbid epilepsy and developmental disorder in congenial long QT syndrome with perinatal arrhythmia A. Miyazaki, H. Sakaguchi, A. Kumakura, T. Aiba, M. Matsuoka, Y. Miyamoto, W. Shimizu, H. Ohuchi (Suita and Osaka, JP)
Levels of cardiac autoantibodies in patients with ventricular premature beats with structurally normal heart. M. Belyaeva, N. Mironova, T. Malkina, M. Sidorova, E. Efremov, T. Sharf, K. Zykov, S. Golitsyn (Moscow, RU)
Electrocardiographic and arrhythmic characterization of severe disorders of serum potassium in hospitalized patients, do we know
all about them? A.R. Rivera Juarez, F. Atienza, S. Zhang, B. Sanchez, A. Tejedor, C. Puertas, A. Arenal, F. Fernandez-Aviles (Madrid, ES)
Multistep electrocardiographic algorithms demonstrate inferior specificity for identifying ventricular tachycardia when applied by
non-cardiologists A.M. May, J.B.S. Brenes-Salazar, V.V. Vaidya, B.T. Ternus, D.K. Kebed, P.B. Brady (Rochester, MN, US)
Electrocardiographic findings in peripartum cardiomyopathy - diagnosis vs. recovery D. Duncker, T. Reinke, A. Haghikia, T. Koenig, S. Hohmann, H. Oswald, D. Hilfiker-Kleiner, J. Bauersachs, C. Veltmann (Hannover, DE)
High prevalence of asymptomatic atrial fibrillation in the North-East Region of Romania M. Grecu, M. Floria, R.E. Moisei, B. Brinza, A. Iliescu, F. Corciova, C. Arsenescu Georgescu, G. Tinica (Iasi, RO)
Interactive 3-dimensional simulation of electrocardiography M.C. Finlay, V. Hurmusiadis (London, GB)
Successful prenatal management of lethal ventricular arrhythmias in fetuses with congenital LQTS. A. Miyake, H. Sakaguchi, A. Miyazaki, T. Miyoshi, T. Aiba (Osaka, JP)
Contact analysis and device leaflet interaction of a nitinol based goretex patch device in the treatment of mitral regurgitation by
finite element analysis M. Arokiaraj, L. Guerrero, R. Levine, I. Palacios (Pondicherry, IN; Boston, US)
Liraglutide, an analog of glucagon-like peptide-1, exerts a direct positive chronotropic effect on rabbit hearts A. Porta Sanchez, P. Lai, S. Masse, M. Kusha, K. Viswanathan, N. Jackson, M.A. Azam, N. Zamiri, J. Asta, K. Nanthakumar (Toronto, CA)
Identification of the CACNA1C gene Gly406Arg mutation causing Timothy syndrome in a newborn with AV block and QT
prolongation using next-generation sequencing P1043
L. Hategan, L. Kornyei, A. Bacsi, Z. Hegedus, I. Nagy, J. Borbas, T. Forster, R. Sepp (Szeged, Budapest and Székesfehérvár, HU)
C34T AMP deaminase-1 gene polymorphism is associated with permanent atrial fibrillation in patients with chronic heart failure. P1044
B. Benito, E. Valles, C. Enjuanes, A. Garcia-Elias, S. Cabrera, P. Ramos, B.A. Perez, D. Bueno, J. Comin-Colet, J. Marti-Almor (Barcelona, ES)
Influence of duration of Atrial Fibrillation on endothelial function. P. Lodzinski, M. Peller, K. Kajurek, P. Balsam, A. Kondracka, M. Kiliszek, E. Kozluk, G. Opolski (Warsaw, PL)
Female rats exposed to high sucrose diet exhibit down-regulation of myocardial Cx43 and increased propensity to inducible VF
that are attenuated by melatonin and Omacor. T. Benova, C. Viczenczova, J. Radosinska, V. Knezl, B. Bacova, B. Obsitnik, J. Slezak, N. Tribulova (Bratislava, SK)
Application of dipole density versus voltage in electrophysiology: a model study L. Dang, G. Beatty, G. Scharf (Zurich, CH; San Diego, US)
The role of beta-blocker treatment in reducing the incidence of fast-VT related syncope in ICD patients with left ventricular
dysfunction: Results from a multicenter study. J. Jimenez-Candil, I. Anguera, J. Fernandez-Portales, J. Morinigo, J. Hernandez, E. Garcia-Piney, P. Perdiguero, P.L. Sanchez (Salamanca,
L'Hospitalet de Llobregat, Barcelona and Caceres, ES)
Vasovagal syncope patient eligibility for prevention of syncope trials IV and V: a single center evaluation T. Kus, E. Tewfik, B. Huang, R.S. Sheldon, G. Becker, M. Sturmer (Montreal and Calgary, CA)
Long runs of non-sustained ventricular tachycardia predict serious arrhythmic events in patients with non-ischemic heart failure M. Pimentel, A. Zimerman, D. Chemello, V. Giaretta, M. Andrades, D. Silvello, L.I. Zimerman, L.E. Rohde (Porto Alegre, BR)
Impact of a wireless probe on ultrasound-guided venous cannulation in the electrophysiology lab: reduction of unsuccessful attempts
and accidental arterial punctures D. Rodriguez Munoz, E. Franco Diez, G. Lumia, T. Segura De La Cal, A. Carbonell San Roman, R. Matia Frances, A. Hernandez-Madrid,
J. Moreno Planas, J.L. Zamorano Gomez (Madrid, ES)
Predicting intracranial bleeding risk in unselected patients with atrial fibrillation: comparison of several bleeding risk scores. P1058
L. Fauchier, A. Banerjee, I. Lagrenade, N. Clementy, D. Angoulvant, A. Bernard, D. Babuty, G.Y.H. Lip (Tours, FR; Birmingham, GB)
Patient-related factors and the quality of oral anticoagulant therapy with vitamin K antagonists for stroke prevention in atrial fibrillation P1059
M. Polovina, J. Savic, M. Vukicevic, G. Mitic, T. Potpara (Belgrade and Novi Sad, RS)
Successive monitoring with seven-day Holter and episodic ECG recorder with automatic transtelephonic ECG transmission for
asymptomatic atrial fibrillation in patients with cryptogenic stroke V. Bulkova, D. Goldemund, Z. Houzarova, M. Novak, S. Sobotkova, D. Kovarikova, L. Ondraskova, J. Gandalovicova, M. Fiala (Brno, CZ)
Effect of high-grade atrioventricular block complicating STEMI in the contemporary era F. Cordeiro, P. Magalhaes, S. Leao, A. Baptista, C. Ferreira, A. Ferreira, P.S. Mateus, J.I. Moreira (Vila Real, PT)
Management of atrial fibrillation in patients with left ventricular systolic dysfunction
Chairpersons: T. Rostock (Mainz, DE); L. Mont (Barcelona, ES)
The session proposal aims to providing an update on the management of patients with atrial fibrillation (both catheter ablation as rhythm control
strategy and AV nodal ablation as rate control strategy) and concomitant LV dysfunction.
Atrial fibrillation ablation in patients with left ventricular hypertrophy
Long term outcome of AF ablation in patients with left venticular systolic dysfunction.
F. Gaita (Turin, IT)
Current indications for AV node ablation in CRT recipients with atrial fibrillation.
Biventricular or right ventricular pacing only in the setting of the ablate-and-pace approach?
Cardiac resynchronisation therapy (CRT) in heart failure: indication or not? Chairpersons: I. Goldenberg (Ramat Gan, IL); J. Sperzel (Johannesberg, DE)
Installation of facilities.
G. Luzzi (Bari, IT)
Optimal training.
Patient selection.
C. Love (New York, US)
Complication management.
Start up of a lead extraction program at my center
Chairpersons: D. Luria (Jerusalem, IL); P. Neuzil (Praha, CZ)
To give a full picture of current indications to CRT
Narrow QRS (< 130 ms) and dyssynchrony.
A. Quesada Dorador (Valencia, ES)
LBBB with a QRS duration of 120-150 ms.
P. Bordachar (Pessac, FR)
Non-LBBB with QRS >150 ms.
J.G.F. Cleland (London, GB)
AV block and LVEF 35-50%.
J.-J. Blanc (Brest, FR)
First degree AV block with long PQ with/without overt HF
How to approach the unstable ventricular tachycardia patient Chairpersons: L.A. Geller (Budapest, HU); A. Proclemer (Udine, IT)
Patient triage: need for pre- and intra-operative cardiocirculatory support.
F. Baratto (Milan, IT)
Intraoperative hemodynamic support for the low output states: does it help?
Substrate based techniques only during sinus rhythm: how reliable is this?
D. Tsiachris (Athens, GR)
VT termination, even under cardio circulatory support, is still the most valuable information.
T. Deneke (Bad Neustadt, DE)
Argue with the experts - case based discussions
Chairpersons: E. Arbelo (Barcelona, ES); T.J.R. De Potter (Aalst, BE)
A broad complex tachycardia in a normal heart
R. Ang (London, GB)
Expert discussant
A rare reason for supraventricular tachycardia in a patient with a pacemaker.
E.E. Ozcan (Izmir, TR)
Ablation of an atrial macro-reentrant tachycardia via unusual vascular access routes 24 years after congenital heart surgery.
M. Pohl (Dresden, DE)
A long RP tachycardia.
S.N. Bogdan (Bucharest, RO)
Device registries - quality of care in daily clinical practice?
Chairpersons: C. Leclercq (Rennes, FR); J.C. Nielsen (Aarhus N, DK)
Implementing results of lead extraction registry to improve quality of care - need for a European registry?
Device registries - can reported complication rates be trusted?
Experience from the ICD and pacemaker registry in UK - has quality of care improved?
D. Todd (Liverpool, GB)
Can registries be used to improve CRT response rates?
M. Stahlberg (Stockholm, SE)
Device registries - financial implications.
New understanding of syncope
Chairpersons: M. Hamdan (Madison, US); M. Khoury (Beirut, LB)
Clinical Seminar
This session will provide insights into greater understanding of reflex syncope, its pathophysiology,outcome and differential diagnosis.
Syncope and falls in older people.
Tales of the fainting heart: genes and biomarkers
A. Fedorowski (Malmo, SE)
New interrpretation of a positive tilt test
R. Sutton (Monte Carlo, MC)
Adenosine sensitive syncope: a distinct clinical entity?
MR imaging before ablation contributes to risk stratification and planning of the procedure. The session will provide a translational view on
contemporary MR imaging, the contribution of structural myocardial substrates to arrhythmogenesis, and potentially useful integrated real-time
imaging with ablation in this setting
Arrhythmogenic consequence of AMI acute / chronic.
O. Aquilina (Attard, MT)
Role of Purkinje fibres and Purkinje arborisation in ischaemia related arrhythmogenesis.
F. Ouyang (Hamburg, DE)
Real time MR imaging in ablation of infarct border zone.
C. Mahnkopf (Coburg, DE)
MR characteristics of arrhythmogenic substrate in post infarct patients.
A. Berruezo Sanchez (Barcelona, ES)
Myocardial ischaemia, necrosis and arrhythmias Chairpersons: H.A. Hauer (Amsterdam, NL); S. Gizurarson (Reykjavik, IS)
Quality of life in living with a device
Chairpersons: T. Lobban (Shipston On Stour, GB); N. Simonelli (Novi Ligure, IT)
To discuss issues in daily life that affect the quality of life of patients living with a device
Sport for ICD patients: how much and how to programme the device.
What can we offer patients in patient teaching programmes?
U. Walfridsson (Linkoping, SE)
Resuming sexual life after a device implantation.
T.M. Norekval (Bergen, NO)
ICD shocks, what do people feel.
Innovation in EP: achievements and pitfalls
Chairpersons: F.W. Prinzen (Maastricht, NL); A. Metzner (Hamburg, DE)
Key innovations in cardiac resynchronisation therapy.
A. Auricchio (Lugano, CH)
Simplify a challenge: novel catheters for pulmonary vein isolation.
E. Wissner (Hamburg, DE)
Technical innovations in VT-ablation.
Funding opportunities for early stage (proof-of-concept) innovative ideas in electrophysiology and related fields.
Lead management and syncope
Chairpersons: J.M. Tolosana (Barcelona, ES); J. Mansourati (Brest, FR)
08:30 The outcomes of patients with lead extraction without subsequent device re-implantation
M. Al-Hijji, O. Yousefian, D. Hodge, S. Hebsur, K. Lewis, M.J. Ackerman, V. Pretorius, P. Friedman, U. Birgersdotter-Green, Y.M. Cha
(Rochester and San Diego, US)
08:39 Single sheath lead extraction, a single center experience of more than 1800 lead extractions
T.M. Knutsen, P. Vanberg, T. Steen, P.T. Skretteberg, Z. Kamal, E.S. Platou (Oslo, NO)
08:48 Conductor externalization and failure rate of the Linox lead
L. Roten, F. Noti, A. Lam, N. Klossner, J. Seiler, H. Servatius, A. Medeiros-Domingo, N. Van Tran, J. Fuhrer, H. Tanner (Bern, CH)
08:57 Lead-dependent infective endocarditis the role of factors predisposing to its development in an analysis of 414 clinical cases
A. Polewczyk, W. Jachec, A. Tomaszewski, W. Brzozowski, M. Janion, A. Kutarski (Kielce, Zabrze and Lublin, PL)
09:06 Transvenous lead extraction in octagenarians.
E.V. Dovellini, L. Giurlani, P. Corsi, A. Michelucci, N. Carrabba, A. Santini, D. Antoniucci (Florence, IT)
09:15 Favorable outcome of gram-negative bacteremia in patients with a cardiovascular implantable electronic device
J. Shimotakahara, N. Yagi, J. Nakazato, T. Miyagi, T. Takahashi, M. Wake, K. Hirata (Uruma, JP)
09:24 The role of the coagulation system in the development and prognosis of syncope in patients with hypertrophic cardiomyopathy. 1114
G.A. Shakaryants, M.V. Kozhevnikova, V.Y.U. Kaplunova, E.V. Privalova, I.S. Chekneva, N.V. Khabarova, Y.N. Belenkov (Moscow, RU)
09:33 Impact of age and medications on risk of recurrent syncope in patients with suspected neurally-mediated syncope
N.R. Petix, A. Del Rosso, V. Guarnaccia, A. Zipoli (Empoli, IT)
09:42 Changes of brain desaturation during head-up tilt test in teenagers with vasovagal syncope
A.Z. Pietrucha, B.J. Pietrucha, M. Wnuk, I. Bzukala, O. Kruszelnicka, E. Konduracka, A. Rudzinski, J. Nessler (Cracow, PL)
09:51 Outcome of patients with early repolarization after an episode of syncope
M. Le Bloa, F. Sacher, J.B. Gourraud, P. Maury, C. Leclercq, D. Babuty, D. Klug, J. Mansourati, M. Haissaguerre, V. Probst
(Bordeaux, Nantes, Toulouse, Rennes, Tours, Lille and Brest, FR)
Focus on early repolarisation
Chairpersons: L. Eckardt (Munster, DE); H.V. Huikuri (Oulu, FI)
A higher prevalence of early repolarization and its characteristics on electrocardiogram in patients with epilepsy
K. Hayashi, R. Kohno, N. Akamatsu, Y. Oginosawa, Y. Otsuji, H. Abe (Kitakyusyu and Fukuoka, JP)
The relationship between J wave and ventricular tachycardia during Takotsubo cardiomyopathy
Y.S. Baek, M.J. Lee, J.H. Park, J.W. Yoon, S.W. Kwon, S.D. Park, S.H. Shin, S.I. Woo, J. Kwan, D.H. Kim (Incheon, KR)
Prevalence of early repolarization in congenital long QT syndrome. A combination of early and delayed repolarization
P. Maury, M. Audoubert, R. Chauvel, J.B. Gourraud, A. Rollin, A. Duparc, P. Mondoly, C. Cardin, F. Sacher, V. Probst (Toulouse,
Bordeaux and Nantes, FR)
Early repolarization pattern: a marker of increased risk in patients with catecholaminergic polymorphic ventricular tachycardia P1121
E. Tulumen, E. Schulze-Bahr, S. Zumhagen, B. Stallmeyer, B.M. Beckmann, S. Kaab, C. Wolpert, B. Rudic, C. Veltmann,
M. Borggrefe (Mannheim, Münster, Munich, Ludwigsburg and Hannover, DE)
Persistence of identical ECG pattern and prevalence of depolarization and repolarization markers in asymptomatic young
individuals with incidentally found prominent J-wave over a period of 4 years. P1122
E. Simeonidou, C. Michalakeas, S. Kastellanos, C. Varounis, C. Dai, J. Lekakis (Athens, GR)
Early repolarisation is associated with sudden death in hypertrophic cardiomyopathy
(W) P1123
G. Mellor, N. Sheikh, K. Prakash, M. Papadakis, S. Sharma, E.R. Behr (London, GB)
Relationship between J-wave and vagal activity in the patients who do not have structural heart disease
Y.S. Baek, J.H. Park, J.W. Yoon, M.J. Lee, S.D. Park, S.W. Kwon, S.H. Shin, S.I. Woo, J. Kwan, D.H. Kim (Incheon, KR)
Electrical remodeling in patients with iatrogenic left bundle branch block
E.B. Engels, T.T. Poels, P. Houthuizen, P. De Jaegere, K. Vernooy, F.W. Prinzen (Maastricht, Eindhoven and Rotterdam, NL)
Utility of T-wave-alternans during night time for risk assessment in patients with Brugada-type electrocardiogram
S. Sakamoto, M. Takagi, J. Kakihara, Y. Hayashi, A. Doi, M. Yoshiyama (Osaka, JP)
Maximal T-wave alternans site on the 12-lead Holter ECG correlates with the late gadolinium enhancement distribution
on cardiac MRI in hypertrophic cardiomyopathy
N. Sakamoto, N. Sato, E. Sugiyama, A. Minoshima, Y. Tanabe, T. Takeuchi, Y. Kawamura, N. Hasebe (Asahikawa, JP)
Chairpersons: To be announced; G. Hindricks (Leipzig, DE)
Accurate CT scan anatomy and CARTO mapping with Stereotaxis catheter
Merging CT and CARTO map, PV mapping with Lasso catheter;
Ablation of PV antrum utilizing the VISITAG CARTO feature
Validation of bidirectional VP isolation (pacing and Adenosin).
Indication to the procedure
General setup (general anesthesia, TEE monitoring)
Choice and sizing if the appropriate device
Post procedure evaluation and patient follow up
Parallel case 1 - A case of AF ablation using magnetic remote control. M. Gasparini (Rozzano, IT); C. Ceriotti (Rozzano, IT)
Parallel case 2 - A case of LAAO
P. Mazzone (Monza, IT); N. Sora (To Be Confirmed, IT)
Post atrial fibrillation ablation management Chairpersons: M. Grimaldi (Bari, IT); H.J.G.M. Crijns (Maastricht, NL)
The session proposal aims to providing an update on post ablation management of atrial fibrillation patients and methods used to reduce
recurrences.
Ablation endpoint guided by pharmacological challenges.
B. Mondesert (Montreal, CA)
Substrate modification by anti-arrhythmic drugs after ablation.
Post ablation management: how to identify atrial fibrillation recurrence and how does that impact anticoagulation and
antiarrhythmic drug prescriptions?
D.L. Packer (Rochester, US)
Non pharmacologic measures to prevent atrial fibrillation recurrence.
Chairpersons: J.C. Daubert (Rennes, FR); I. Goldenberg (Ramat Gan, IL)
EHRA Member session
VT ablation in ischaemic cardiomyopathies Chairpersons: M. Borggrefe (Mannheim, DE); J.L. Merino (Madrid, ES)
Localising the critical isthmus during pacing in postinfarct VTs.
C. de Chillou (Vandoeuvre Les Nancy, FR)
High density mapping of ventricular scar.
H. Nakagawa (Oklahoma City, US)
Epicardial ablation of post infarct VTs.
U. Tedrow (Boston, US)
Endocardial ablation to eliminate epicardial electrograms in scar related VTs.
ICD is superfluous in responders to CRT- Pro.
J. Singh (Boston, US)
ICD is superfluous in responders to CRT- Contra.
F. Ruschitzka (Zurich, CH)
ICD is superfluous in responders to CRT- Rebuttal Pro.
ICD is superfluous in responders to CRT- Rebuttal Contra.
J. Singh (Boston, US); F. Ruschitzka (Zurich, CH)
CRT therapy in patients with < 130 ms is hazardous - Pro.
D. Francis (London, GB)
CRT therapy in patients with < 130 ms widths is hazardous - Contra.
W. Mullens (Genk, BE)
CRT therapy in patients with < 130 ms is hazardous - Rebuttal Pro.
CRT therapy in patients with < 130 ms widths is hazardous - Rebuttal Contra.
D. Francis (London, GB), W. Mullens (Genk, BE)
There is ongoing debate if an initiated CRT D therapy really needs to include an ICD over time . There is evidence to suggest that CRT may
be hazardous in patients with narrow QRS. How do we deal with patients already implanted? Could interruption of ongoing ICD therapy in
responders to CRT be considered? Listen to the debate by experts in the field.
Best of young research in 2014
Chairpersons: To be announced; V. Kutyifa (Rochester, US)
MRI-Guided approach to localize and ablate gaps in repeat AF ablation procedure
F. Bisbal (Barcelona, ES)
Impact of earliest activation site location in the septal right ventricular outflow tract for identification of
left vs right outflow tract origin of idiopathic ventricular arrhythmias. J. Acosta (Barcelona, ES)
Neurohormonal, Structural, and Functional Recovery pattern after premature ventricular complex ablation is independent of
structural heart disease status in patients with depressed left ventricular ejection fraction.
D. Penela (Barcelona, ES)
12:07 Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on
mortality: a systematic review and meta-nalysis
V.H. Tan (Singapore, SG)
Clinical value of registries related to sudden death
Chairpersons: A. Proclemer (Udine, IT); B. Merkely (Budapest, HU)
Sudden cardiac death syndromes - the clinical value of registries.
M. Zoni-Berisso (Genoa, IT)
Sudden cardiac death related to sports or recreational activities - the value of national based registries.
E. Marijon (Paris, FR)
Trends in implantation indications and outcomes - data from ICD registries.
M. Suleiman (Haifa, IL)
The use of periprocedural anticoagulation therapy for patients undergoing device implantation - results of a European snap
shot survey.
Clinical use and benefits of device registries in Europe.
New management strategies of syncope Chairpersons: W.K. Shen (Scottsdale, US); G. Baron Esquivias (Sevilla, ES)
To educate physicians in the new understanding of reflex syncope
Assessing risk in patients who present with syncope/collapse.
D.G. Benditt (Minneapolis, US)
Distinguishing syncope, epilepsy and non-epileptic attack disorder.
A.P. Fitzpatrick (Manchester, GB)
How to improve cost-effectiveness of syncope management.
M. Hamdan (Madison, US)
How to improve the benefit of cardiac pacing in reflex syncope.
The right ventricle in arrhythmogenic remodelling Chairpersons: E. Pruvot (Lausanne, CH); P.G.A. Volders (Maastricht, NL)
This translational study will provide experimental understanding for the specific contribution of the right ventricle to arrhythmogenesis under
various conditions. Clinical perspectives will be given, particularly in relation to antiarrhythmic treatment.
RV versus LV electrophysiology in cardiac remodelling.
D. Dobrev (Essen, DE)
Exercise-related RV arrhythmias and the effect of physical deconditioning.
M. Papadakis (London, GB)
Lessons from arrhythmogenic ventricular cardiomyopathy: electrical and structural phenotypes.
F. Duru (Zurich, CH)
The RV after repair of congenital heart defects, and catheter-based antiarrhythmic treatment.
Describe and discuss monitoring of arrhythmias and discover ways to improve practice
State of the art: 50 years with in-hospital telemetry monitoring – and what is ahead of us?
B.J. Drew (San Francisco, US)
Non-cardiac patients – a challenge to existing telemetry guidelines.
P.A.F.M. Doevendans (Utrecht, NL)
Dedicated monitor watchers – is it really necessary?
Comparison of two teaching methods for cardiac arrhythmia interpretation among nursing students.
T. Xanthos (Athens, GR)
Monitoring arrhythmias in-hospital: Are we getting it right?
Chairpersons: A.H. Mansour (Ramat Gan, IL); L. Hinterbuchner (Salzburg, AT)
EHRA and Cardiostim inventors awards
Chairpersons: F.W. Prinzen (Maastricht, NL); P. Ritter (Pessac, FR)
New approach for anti-bradycardia pacing: left ventricular septum pacing by transvenous approach through the inter-ventricular
septum.
11:22 A method and system for vector analysis of lectrocardiogram in assessment of risk of sudden cardiac death (SCD) due to
arrhythmogenic right ventricular dysplasia/cardiomyopathy by quantifying micro scars (i.e. "bites") in three dimensional
vector loops.
I. Vranic (Belgrade, RS)
11:45 Through-needle intracardiac echocardiography for transseptal puncture using a novel optical pulse-echo ultrasound technique.
M.C. Finlay (London, GB)
12:07 EHRA Inventors Award Winner announcement.
Molecular pathology and therapy of arrhythmias: novel insights from experimental studies
Chairpersons: C. Wolpert (Ludwigsburg, DE); M. Eldar (Ramat-Gan, IL)
Next-generation sequencing in molecular autopsy: potential for clinical application?
(W) 1173
H. Raju, J. Ware, J. Skinner, A. Wilde, J. Tfelt-Hansen, M. Cohen, M. Christiansen, S. Cook, M. Sheppard, E.R. Behr (London and
Sheffield, GB; Auckland, NZ; Amsterdam, NL; Copenhagen, DK)
Isolated reduced expression of desmoplakin manifesting as recurrent ventricular tachycardia originating from the right
ventricle epicardium 1174
S. Rosset, D. Graf, J. Metzger, E. Pruvot (Lausanne and Chêne Bougeries, CH)
SCN10A polymorphisms are associated with the clinical severity of probands with sodium channelopathies
M. Fukuyama, S. Ohno, M. Ichikawa, T. Makiyama, M. Horie (Otsu and Kyoto, JP)
Heritability of conduction disturbances in the pacemaker clinic
H. Steiner, P.B.S. Celestino-Soper, A. Doytchinova, T.C. Lynnes, W.J. Groh, J.M. Miller, P.S. Chen, M. Vatta (Poria, IL; Indianapolis, US)
Post-mortem genetic analysis in juvenile cases of sudden cardiac death. Familial implications.
G. Sarquella Brugada, O. Campuzano, S. Cesar, A. Iglesias, O. Sanchez-Molero, C. Allegue, J. Castella, J. Medallo, R. Brugada,
J. Brugada (Esplugues de Llobregat, Girona and Barcelona, ES)
A novel 'splice site' mutation of the HCN4 gene, encoding for the cardiac pacemaker channel, causes familial bradycardia
B. Csanyi, L. Hategan, J. Borbas, Z. Hegedus, I. Nagy, L. Saghy, M. Csanady, T. Forster, R. Sepp (Szeged, HU)
Efficacy of a biological therapy for recessive catecholaminergic polymorphic ventricular tachycardia in human induced
pluripotent stem cells-derived cardiomyocytes
F. Lodola, E. Di Pasquale, R. Bongianino, M. Denegri, L. Rutigliano, M. Buonocore, R. Bloise, G. Condorelli, C. Napolitano,
S.G. Priori (Pavia, Milan and Rozzano, IT)
Radiofrequency catheter ablation of the left bundle branch guided by left bundle potential and three-dimensional
electroanatomical mapping system in canine models
L. Ding, K. Yin, C. Cai, W. Hua, Y. Jiang, Y. Yao, S. Zhang (Beijing, CN)
LED flash-induced termination of anatomical reentry in optogenetically modified transverse rat ventricular tissue slices
M. Watanabe, I. Feola, A.S. Teplenin, M.J. Schalij, K. Zeppenfeld, D.L. Ypey, A.A.F. De Vries, D.A. Pijnappels (Leiden, NL)
The electrocardiographic J-T interval in models of long QT
S. Rajamani, D. Guo, G. Liu, L. Belardinelli (Fremont, US)
Improving CRT response: Patient selection, implantation and therapy
Chairpersons: A. Auricchio (Lugano, CH); M. Meine (Utrecht, NL)
Learn how to optimise and improve the response of cardiac resynchronisation therapy by selecting the right candidates, applying the right tools
and techniques during implantation and the use of dedicated algorithms that improve hemodynamics while adapting to the individual patient.
M. Meine (Utrecht, NL)
Selection of CRT candidates: Which patients benefit most?
Latest tools for successful CRT implantation.
M. Biffi (Bologna, IT)
AdaptivCRT: Dynamic left ventricular pacing to improve response.
N. Clementy (Tours, FR)
Device infection: prevention & treatment
Sponsored by Spectranetics & Medtronic
Chairperson: C.E.H. Kennergren (Goteborg, SE)
Infection can be a problem.
M.R. Sohail (Rochester, US)
Infection is preventable.
E.C. Ellis (Nashville, US)
Infection is treatable.
An increasing number of CIED are implanted every year. With an aging patient population and increased complexity of the device and leads, the
infection rates are also outgrowing implant rates. In this session, you will hear of the CIED infection problem, how to prevent it and ways to treat
those patients.
Redefining electrophysiology: high resolution mapping & ablation
Chairpersons: P. Della Bella (Milan, IT); A. Bollmann (Leipzig, DE)
1) Learn how high resolution mapping technology enables accurate diagnosis and evaluation of cardiac arrhythmias.
2) Learn how high resolution ablation technology allows for precise localisation of ablation targets in complex arrhythmias.
3) Learn how high resolution ablation technology enables lesion assessment during ablation.
4) Learn how high resolution mapping technology contributes to a tailored ablation strategy in patients indicated for ventricular tachycardia
ablation.
High resolution mapping in AT: clinical impact.
P.B. Lim (London, GB)
High Resolution Ablation: Role of Mini-electrodes in a Pace and Ablate strategy for Atrial Arrhythmias.
High resolution mapping in VT: feasibility and clinical meaningfulness.
Patient optimization with MultiPoint Pacing
Chairpersons: A. Curnis (Brescia, IT); C. Marquie (Lille, FR)
A. Curnis (Brescia, IT)
Vector selection and programming based on electrical conduction.
D.O.Donnell (Victoria, AU)
Clinical evidence demonstrating benefits of MultiPoint Pacing CRT.
A. Kloppe (Bochum, DE)
Management of Non-Responders with MultiPoint Pacing.
Z. Calovic (Belgrade, RS)
Q & A.
1 in 14 Patients require arrhythmia intervention: Remote Patient Management with the Wearable Cardioverter Defibrillator
Sponsored by ZOLL
Chairpersons: J. Sperzel (Johannesberg, DE); J.-C. Deharo (Marseille, FR)
This program will discuss how the Wearable Cardioventer Defibrillator provides protection from Sudden Cardiac Death with a connection
to your patients' changing cardiac condition through the Online Patient Data Management System. Arrhythmic events captured and provide
actionable insights and the opportunity to modify the treatment path for WCD patients.
Discussion of the utility of remotely managed patient clinical and diagnostic markers to effect better outcomes.
J. Steffel (Zurich, CH)
Overview of the online patient management system and clinical scenarios for its use in treating patients in addition
to shocking VT/VF.
O. Przibille (Frankfurt, DE)
Panel discussion / Q&A.
Practical aspects on stroke prevention in atrial fibrillation - what to do in 2015?
This session is supported by Boehringer Ingelheim in the form of an unrestricted educational grant
Chairpersons: G.Y.H. Lip (Birmingham, GB); K.H. Kuck (Hamburg, DE)
Is my patient with 'lone AF' really low risk?
My patient on a oral anticoagulant presents with an ischaemic stroke, and is being considered for thrombolysis.
J. Oldgren (Uppsala, SE)
My patient on oral anticoagulation needs an ablation or device implantation.
S. Willems (Hamburg, DE)
Do we still need antiplatelet therapy? The aspirin conspiracy.
To learn about how to prevent and treat TAVI induced conduction abnormalities and arrhythmias.
Predictors and incidence of conduction abnormalities and arrhythmias after TAVI.
R.M. Van Der Boon (Rotterdam, NL)
Impact of new-onset LBBB or AV-block on clinical outcomes after TAVI.
A.S. Petronio (Pisa, IT)
Indication of permanent PM.
M. Schwerg (Berlin, DE)
Special devices after TAVI (CRT and leadless PM).
Transcatheter aortic valve implantation induced conduction disorders - How to manage?
Joint session with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Chairpersons: M. Settergren (Stockholm/Solna, SE); R. Teles (Carnaxide, PT)
Tips and tricks at CRT implant
Chairpersons: M. Biffi (Bologna, IT); M. Glikson (Ramat Gan, IL)
Practical issues for having an effective CRT in the lab without complications
Cannulation of the difficult coronary sinus.
CS venogram: Which side branch and which lead?
Small and tortuous side branches: Retrograde approach and snaring.
S. Worley (Earleville, US)
Management of occluded veins.
R. Lieberman (Bloomfield Hills, US)
The ECG in arrhythmogenic syndromes
Chairpersons: S.G. Priori (Pavia, IT); S. Viskin (Tel Aviv, IL)
ECG markers of risk in Brugada syndrome.
R. Brugada Terradellas (Girona, ES)
How to differentiate benign from malignant early repolarisation pattern.
J. Tikkanen (Helsinki, FI)
How to make the diagnosis of short and long QT syndromes. Clues from the ECG.
C. Wolpert (Ludwigsburg, DE)
Catecholaminergic arrhythmias. From genetics to ECG.
Atrial fibrillation registries - of clinical use in daily clinical practice?
Chairpersons: C. Blomstrom-Lundqvist (Uppsala, SE); J. Chen (Bergen, NO)
European registries for atrial fibrillation ablation - can outcomes and reported complication rates be trusted?
The use of periprocedural anticoagulation therapy for patients undergoing atrial fibrillation ablation - results of a European
snap shot survey.
The use of patient self assessment questionnaires for educational purposes - experience from a European atrial fibrillation
anticoagulation survey.
14:54 First report from the Thoracoscopic epicardial/hybrid Atrial Fibrillation Ablation Registry (TehAFAR) of EHRA.
L. Pison (Maastricht, NL)
15:12 Atrial fibrillation and device registries - of clinical use in daily clinical practice?
W. Amara (Le Raincy-Montfermeil, FR)
Postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia and vasovagal syncope: toward a consensus on diagnosis
and therapy Chairpersons: R. Sutton (Monte Carlo, MC); H. Haouala (Tunis Montfleury, TN)
When to suspect and how to flow POTS and IST.
W.K. Shen (Scottsdale, US)
Different clinical manifestations of vasovagal syncope.
P. Alboni (Ferrara, IT)
Therapy of POTS, IST and VVS (except pacing).
R. Sheldon (Calgary, CA)
The role of cardiac pacing in VVS.
A. Moya I Mitjans (Barcelona, ES)
Re-remodelling by cardiac resynchronisation
Chairpersons: U. Lendeckel (Greifswald, DE); S. Cazeau (Paris, FR)
Pre-implant echo determinants of responders.
U. Hoke (Leiden, NL)
Cellular alterations underlying systolic heart failure. F.R. Heinzel (Berlin, DE)
Myocyte remodeling after CRT.
M. Vanderheyden (Aalst, BE)
Determination of optimal implant site – can we predict response anatomically at implant?
Treatment of arrhythmias in female patients
Chairpersons: C. Linde (Stockholm, SE); K. Jubele (Riga, LV)
ECG and arrhythmias in female athletes.
N.M. Panhuyzen-Goedkoop (Rozendaal, NL)
Treatment of supraventricular arrhythmias in females.
Gender differnces in inherited arrhythmia syndromes with or without an ICD.
K.H. Haugaa (Oslo, NO)
ICD and CRT therapy in female patients.
U. Birgersdotter-Green (La Jolla, US)
Young Investigator Award session - Basic Science
Chairpersons: B. Casadei (Oxford, GB); P.G.A. Volders (Maastricht, NL)
Judge(s): J.R. Ehrlich (Frankfurt, DE); D. DiFrancesco (Milan, IT)
Full protection from drug-induced torsade de pointes-like arrhythmias by an allosteric Ikr-modulatory mechanism in rat
ventricular monolayers
J. Liu, Z. Yu, J.P. Van Veldhoven, A.P. Ijzerman, D.A. Pijnappels, L.H. Heitman, A.A. De Vries (Leiden, NL)
Is left atrial fibrosis quantified using late Ggadoadolinium enhancement magnetic resonance imaging a specific attribute of atrial
fibrillation?
O. Aparina, O. Stukalova, N. Mironova, E. Butorova, D. Parkhomenko, S.P. Golitsyn (Moscow, RU)
14:30 Creating new trans-species types of myocytes by forced fusion between cardiomyocytes and fibroblasts to counteract
arrhythmias: breaking boundaries with muscular mixtures
S.F. Askar, E.C.A. Nyns, M.C. Engels, M.J. Schalij, W. Jangsangthong, Z. Neshati, A.A.F. De Vries, D.A. Pijnappels (Leiden, NL)
14:45 Conduction disorders in orthotopic heart transplantation: risk factors and clinical relevance
S. Ferretto, E. Tafciu, I. Giuliani, T. Bottio, G. Feltrin, A. Gambino, A. Angelini, S. Iliceto, G. Gerosa, L. Leoni (Padua, IT)
15:00 Value of the frontal QRS-T angle for diagnosis and prognosis in patients with symptoms suggestive of acute myocardial
15:15 Positive chronotropic action of liraglutide on isolated rabbit hearts is not mediated by the beta-adrenergic pathway A. Porta Sanchez, P. Lai, M. Kusha, S. Masse, M.A. Azam, J. Asta, K. Viswanathan, N. Jackson, K. Nanthakumar (Barcelona, ES;
Toronto, CA)
Leading experts are discussing diagnosis and treatment of cardiac arrhythmias in female patients
It's not all about ablation: electrophysiological insights from left atrial intervention
Chairpersons: M. O'Neill (London, GB); M. Duytschaever (Gent, BE)
Electrophysiological findings following surgical thoracoscopic unilateral atrial fibrillation ablation P. Osmancik, P. Budera, J. Zdarska, D. Herman, I. Hoskova, Z. Straka (Prague, CZ)
Congenital atrial septal defect and atrial fibrillation: staged approach in complex endovascular treatment
B. Kravchuk, M. Petkanych, I. Ditkivskyy, B. Cherpak, O. Paratsii (Kyiv, UA)
Reference values for conduction times to identify achievement of bidirectional block after left atrial linear ablation (roof,
inferolateral or superoseptal mitral isthmus) M. Brunelli, A. Grosse, S. Raffa, T. Daehne, M. Frommhold, A. Cima, A. Madaffari, J.C. Geller (Bad Berka, DE)
Rate-dependence of atrial electrogram amplitude
S. Havranek, J. Simek, Z. Fingrova, V. Bulkova, T. Boucek, D. Wichterle (Prague, CZ)
Biatrial and spatial electroanatomical assessments in patients with and without paroxysmal atrial fibrillation: insight into
arrhythmogenic substrates relevant to ablation
T. Yasuda, M. Ogawa, J. Morii, Y. Nagata, Y. Hitaka, N. Kumagai, N. Matsumoto, K. Saku (Fukuoka, JP)
14:45 Spatial relationship between the left atrium anatomical contact area and rotational activity in persistent AF
S. Nakahara, Y. Hori, N. Tsukada, N. Nishiyama, A. Nakagawa, A. Hayashi, T. Komatsu, S. Kobayashi, Y. Sakai, I. Taguchi
(Koshigaya City, JP)
14:54 Development of non-pulmonary vein foci is an increased risk for atrial fibrillation recurrence as revealed by repeated
pulmonary vein isolation
R. Hojo, S. Fukamizu, T. Kitamura, Y. Aoyama, K. Komiyama, T. Tejima, M. Nisizaki, M. Hiraoka, H. Sakurada (Tokyo, Yokohama
and Ibaraki, JP)
15:03 Different energy sources: what can we learn from an early redo of atrial fibrillation ablation?
A. Dello Russo, L. Cipolletta, G.M. Fassini, G. Vettor, G. Del Giorno, S. Conti, M. Zucchetti, F. Pizzamiglio, M. Casella,
15:12 Clinical significance of evaluating bidirectional dormant conduction after pulmonary vein isolation
S. Miyazawa, S. Fukamizu, T. Kitamura, R. Hojo, Y. Aoyama, K. Komiyama, T. Tejima, M. Nishizaki, M. Hiraoka, H. Sakurada
(Tokyo, Yokohama and Ibaraki, JP)
15:21 Catheter based epicardial substrate analysis in patients with refractory atrial fibrillation C. Wunderlich, M. Christoph, Y. Huo, J. Salmas, J. Mayer, M. Forkmann, M. Pohl, T. Gaspar, C. Piorkowski (Dresden, DE)
New technology for CRT
Chairpersons: G.Z. Duray (Budapest, HU); O.A. Breithardt (Kassel, DE)
Capture thresholds and pacing impedances of LV pacing vectors in a large quadripolar CRT-D post approval study
R. Corbisiero, D.T. Martin, S.L. Beau, S. Allison, D. Schleinkofer, T.G. Farazi, S. Zhang, M. Cao (Browns Mills, Burlington,
Little Rock, Huntsville, Fort Wayne, Sunnyvale, Sylmar and Rosemead, US)
Chronic performance of 10 pacing vectors available with a novel quadripolar left ventricular lead compared to bipolar leads
in the MORE CRT trial
G. Boriani, S. Connors, B. Lemke, W. Mullens, Z. Kalarus, J. Osca Asensi, P. Raatikainen, D. Schmitz, L. Calo, C. Leclercq
(Bologna and Rome, IT; St. John's, CA; Ludenscheid and Essen, DE; Genk, BE; Zabrze, PL; Valencia, ES; Tampere, FI; Rennes, FR)
Acute haemodynamics and left ventricular mechanical dyssynchrony improving with multisite left ventricular pacing via
quadripolar lead.
P. Alonso Fernandez, J. Osca Asensi, O. Cano Perez, A. Andres Lahuerta, V. Miro Palau, J. Sanz Sanchez,
M.J. Sancho-Tello De Carranza, J. Olague De Ros (Valencia, ES)
Long term effects of a short-spaced left ventricular quadripolar lead: results from the Per4mer study
M. Ziacchi, D. Saporito, G.L. Morgagni, E. De Maria, F. Quartieri, M. Bertini, M. Zardini, M. Luzi, G. Boriani, M. Biffi (Bologna,
Rimini, Macerata, Carpi, Reggio Emilia, Ferrara, Parma and Ancona, IT)
Quadripolar LV leads are associated with fewer replacements and deactivations than bipolar LV leads in CRT-P
M.P. Turakhia, G.B. Forleo, J. Prillinger, C. Kumar, Y. Nabutovsky, M.R. Gold (Palo Alto, Sunnyvale, Sylmar and Charleston, US;
Rome, IT)
The quadripolar left ventricular lead allows due to basal stimulation an optimized more steady left ventricular activation
D. Mijic, Z. Karosiene, H. Bogossian, B. Lemke, M. Zarse (Ludenscheid, DE)
A new approach to check the left ventricle capture in biventricular devices. Results from DREAM (cardiac resynchronization
therapy device left capture confirmation through an Electrograms analysis Mod
M.S. Baccillieri, D. Ambroso, P. Turrini, E. Dalla Vecchia, R. Verlato (Camposampiero, PD and Marano Vicentino (VI), IT)
A new transvenous active fixation lead provides more options for stable targeted left ventricular lead placement
S. Faerestrand, H. Keilegavlen, T. Hovstad (Bergen, NO)
Failure of optimization algorithm to shorten QRS duration in patients with cardiac resynchronization therapy
D. Wichterle, R. Polasek, H. Jansova, J. Cerny, P. Kucera, K. Sedlacek, J. Kautzner (Prague and Liberec, CZ)
Multi-point pacing in cardiac resynchronization therapy: optimization and effect on QRS
G. Di Stolfo, G. Forleo, L. Santini, M. Giammaria, D. Ricciardi, G. Senatore, A. Curnis, A. Vado, E. Bertaglia, F. Zanon
(San Giovanni Rotondo, Rome, Turin, Ciriè (Turin), Brescia, Cuneo, Padua and Rovigo, IT)
Recorded session
Chairpersons: M. Hocini (Pessac, FR); P. Della Bella (Milan, IT)
Endo–epicardial ablation of VT in a patients with ARVC.
The hunt of AF drivers in persistent AF.
Stroke prevention for atrial fibrillation – Europe, Far East or USA, nice or not?
Chairpersons: U. Birgersdotter-Green (La Jolla, US); P. Kirchhof (Birmingham, GB)
The European guidelines: ESC, Nice.
J.C. Cowan (Leeds, GB)
The Asia Pacific Heart Rhythm Society guidelines.
The AHA/ACC/HRS guidelines.
C. January (Madison, US)
Comparing the guidelines on stroke prevention.
New devices for heart failure - when, which device and in whom Joint session with the Heart Failure Association
Chairpersons: C. Leclercq (Rennes, FR); G.S. Filippatos (Athens, GR)
Monitoring devices in heart failure F. Ruschitzka (Zurich, CH)
Baroreceptor stimulation.
E. Gronda (Sesto S. Giovanni, IT)
Vagal nerve stimulation.
M. Borggrefe (Mannheim, DE)
Cardiac contractility modulation ready for broad use.
Sleep apnoea syndrome.
Antithrombotic management of patients undergoing electrophysiological procedures
Chairpersons: G.Y.H. Lip (Birmingham, GB); F. Marin (Murcia, ES)
16:30 Ablation of atrial fibrillation and left sided lesions arrhythmias.
C. Sticherling (Basel, CH)
16:48 Right atrial ablation procedures (slow pathway ablation, right-sided accessory pathways, right atrial tachycardias, AV-node
ablation).
17:06 Ablation of right sided ventricular tachycardias.
17:24 Antithrombotic management for the implantation of CIED and generator changes.
17:42 What the guidelines say?
International CRT implantation practice: are we in Sync? Rationale for the CRT Survey II a HFA EHRA initiative
Chairpersons: C. Linde (Stockholm, SE); M. Gasparini (Rozzano, IT)
Comparison of International Guidelines for CRT Implementation.
C. Normand (Stavanger, NO)
CRT Survey II: Objectives, design and organisation.
K. Dickstein (Stavanger, NO)
What predicts response: patient selection, implantation technique or follow-up?
C. Stellbrink (Bielefeld, DE)
International benchmarking; what does it tell us and why is it important?
A.K. Gitt (Ludwigshafen, DE)
Practical session, interactive where ECGs are presented and discussed with the audience
Case 1.
J.L.R.M. Smeets (Nijmegen, NL)
B. Belhassen (Tel Aviv, IL)
Update of registries and EP wire in heart rhythm management
Chairpersons: G. Breithardt (Munster, DE); J.C. Nielsen (Aarhus N, DK)
Overview of 4 years of "EP Wire" – a valuable reflection of clinician thought or a gimmick?
Registries in monitoring of implantable device practice – are we in danger of undermining the need for clinical trials?
The most important registries in global cardiac rhythm management practice.
Can an evidence base be developed on the basis of registry data? J.C. Daubert (Rennes, FR)
Gaps in practice – where will registries next contribute?
Special ECG diagnostics
Chairpersons: J. Brugada Terradellas (Barcelona, ES); G. Papiashvili (Tbilisi, GE)
Syncope and sudden death prevention: special considerations in the elderly
Chairpersons: J.-J. Blanc (Brest, FR); A. Oto (Ankara, TR)
Case 1: 82 year-old hypertensive man has cognitive impairment, recurrent syncope and falls, LBBB: what is next, tilt testing,
injectable loop recorder, empirical pacemaker, or nothing of the above?
A. Ungar (Florence, IT)
Panel discussion & questions from the audience.
S.M. Rafla (Alexandria, EG); B. Goronja (Banjaluka, BA)
Case 2: 82 year-old woman has CAD, STEMI 3 yrs ago, EF 40%, 2 syncopes without prodromes while watching TV,
5-sec pause during carotid sinus massage: what would you recommend, EPS, PM, ICD, or nothing of the above?
H. Abe (Kitakyushu, JP)
Case 3: 82 year-old man lives independently has DCM, NYHA II, EF 25%, PM dependent, PM at ERI: what would you
recommend, replacement with PM, ICD, or CRT?
G. Baron Esquivias (Sevilla, ES)
Sinus node dysfunction: how can basic science improve clinical management?
Chairpersons: R. Sutton (Monte Carlo, MC); E. Nof (Tel Hashomer, IL)
Sinus node dysfunction is a common cause of syncope. Mechanisms and genetic determinants of sinus node dysfunction will be presented and
discussed with respect to their impact on patient management.
The basis of pacemaker activity: the funny current.
D. DiFrancesco (Milan, IT)
Biological pacemakers to re-constitute intrinsic cardiac activation.
G.J.J. Boink (Amsterdam, NL)
HCN channel dysfunction in sinus node disease.
Pacing in sinus node disease – are all patients equal?
H. Bonnemeier (Kiel, DE)
Challenges in ablation of complex arrhythmias
Chairpersons: A. Sarkozy (Edegem, BE); S. Ernst (London, GB)
Leading female experts are going to discuss alternative current treatment approaches for complex arrhythmias followed by their own practical
approaches.
Redo paroxysmal atrial fibrillation ablation: my prefered approach.
Current aproaches of persistent atrial fibrillation ablation: my prefered approach.
Current approaches of difficult idiopathic outflow tract ventricular arrhythmias: my favorite case.
Current approaches of ischaemic ventricular tachycardia ablation: my prefered approach.
Young Investigator Award session - Clinical
Chairpersons: M. Glikson (Ramat Gan, IL); To be announced
Judge(s): P.E. Vardas (Heraklion, GR); K.H. Kuck (Hamburg, DE)
Who said there's nothing new in cardiac pacing?!
Chairpersons: P. Ritter (Pessac, FR); J. Sperzel (Johannesberg, DE)
Micra Transcatheter Pacing System: early performance assessment to demonstrate safety for pacemaker dependent patients
L. Mont, D.G. Benditt, G.Z. Duray, P. Ritter, D. Reynolds, T. Sheldon, V. Laager, J. Hayman, K. Stromberg (Barcelona, ES;
Minneapolis, Oklahoma City and Mounds View, MN, US; Budapest, HU; Bordeaux, FR)
Micra delivery system perforation risk assessment
M. Bonner, A. Steingisser, A. Jamous, P. Mcdonnell (Minneapolis and Santa Rosa, US; Galway, IE)
Permanent His bundle pacing in patients with advanced AV block: feasibility and long term follow-up
P. Vijayaraman, A. Naperkowski, G. Dandamudi, K.A. Ellenbogen (Wilkes Barre and Richmond, US)
Clinical benefit of right ventricular mid-septal pacing: 3 years follow-up data of a large consecutive patients cohort
G.H. Mairesse, M. Raepers, A. Moscato, E. Mauel, R. Campagnolo, A. Bartholome, Y. Ernst, B. Marchand (Arlon, BE)
Reversal of chronic right ventricular pacing induced adverse structural and electrical remodeling by permanent
his bundle pacing
P. Vijayaraman, G. Dandamudi, K.A. Ellenbogen (Wilkes Barre and Richmond, US)
Cardiovascular and non-cardiovascular adverse events in sinus node disease and AV block with a ventricular pacing
minimization mode versus standard DDD: A substudy from the ANSWER randomized trial
M. Stockburger, S. Boveda, J. Moreno, A. Da Costa, R. Hatala, J. Brachmann, C. Butter, J. Garcia Seara, M. Rolando, P. Defaye
(Berlin, Coburg and Bernau bei Berlin, DE; Toulouse, Saint-Etienne and Grenoble, FR; Madrid and Santiago de Compostela, ES;
Bratislava, SK; Saluggia, IT)
Complications following cardiac implantable electronic device procedures: results from a 6-month prospective registry
R. Costa, C.M.M. Albertini, T.S. Kawauchi, I.C. Maurino, G. Melo, L.B.O. Alves, E.S. Crevelari, A.I. Fioreli, M. Martinelli, K.R. Silva
Effect on late clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve implantation.
J. Fernandez-Pastor, J.L. Pena-Hernandez, A. Munoz-Garcia, C. Medina-Palomo, A. Ruiz-Salas, A. Barrera-Cordero,
E. De Teresa-Galvan, F.J. Alzueta-Rodriguez (Malaga, ES)
16:30 Esophageal temperature monitoring during atrial fibrillation ablation: sensitivity of a conventional probe to detect significant
temperature increases R. Delgado, E. Falconi, A. Burgos, R. Olivares, M. Arceluz, P.F. Cruz, O. Salvador, M. Ortega, J. Caro, J.L. Merino (Madrid, ES)
16:45 Are the results of cryoballoon ablation more reproducible regards midterm success of paroxysmal atrial fibrillation ablation?
Comparative data vs. radiofrequency from a Multicentric National Survey.
S. Boveda, P. Defaye, D. Pavin, J.P. Cebron, F. Anselme, R.A. Providencia (Toulouse, Grenoble, Rennes, Nantes and Rouen, FR)
17:00 Fibrosis architecture predicts atrial fibrillation recurrences after ablation
P. Gal, C.F. Pacchia, A. Morris, J. Cates, G. Kaur, A. Elvan, N.F. Marrouche (Zwolle, NL; Salt Lake City, US)
17:15 Long- term follow- up after left ventricular endocardial resynchronisation therapy: mortality and thromboembolic complications
Z. Kis, A. Arany, G. Gyori, A. Mihalcz, A. Kardos, C.S. Foldesi, I. Kassai, T. Szili- Torok (Budapest, HU; Rotterdam, NL)
17:30 Predictors of LAA thrombi in patients with atrial fibrillation and Low CHA2DS2-VASc score
S. Nedios, T. Seewoester, E. Koutalas, J. Kornej, S. Rolf, A. Arya, P. Sommer, D. Husser, G. Hindricks, A. Bollmann (Leipzig, DE)
17:45 Electrophysiological insights into site of infra-nodal AV block: lessons from permanent His bundle pacing
A. Naperkowski, G. Dandamudi, K.A. Ellenbogen, P. Vijayaraman (Wilkes Barre and Richmond, US)
Prognostic implication of heart failure with preserved and reduced ejection fraction in patients requiring pacemaker
A. Mizukami, Y. Matsue, Y. Naruse, S. Kowase, K. Kurosaki, M. Suzuki, A. Matsumura, A. Nogami, K. Aonuma, Y. Hashimoto
(Kamogawa, Yokohama and Tsukuba, JP; Groningen and Leiden, NL)
Optimized pacing mode for hypertrophic cardiomyopathy. the impact of ECG-fusion during pacing.
D. Penela, F. Burgos, R. Evertz, J. Roca, M. Sitges, R. Villuendas, R. Brugada, L. Mont, J. Brugada, A. Berruezo (Barcelona and
Girona, ES)
Comparison of segmental peak left atrial longitudinal strain and strain rate in patients with paroxysmal and persistent atrial fibrillation P1327
A.A. Shavarov, A.A. Yusupov, G.K. Kiyakbaev, V.S. Moiseev (Moscow, RU)
A systematic review on the progression of paroxysmal to persistent atrial fibrillation: shedding new light on the effects of catheter
ablation. P1329
R. Proietti, A. Hadjis, A. Alturki, G. Thanassoulis, J.F. Roux, M.L. Bernier, A. Verma, J. Haeley, V. Essebag (Milan, IT; Montreal and Hamilton, CA)
MRI-assessed scar following atrial ablation is a reproducible finding between repeat scans P1330
H. Chubb, R. Karim, J. Harrison, S. Aziz, J. Whitaker, S.E. Williams, M.J. Wright, R.M. Kiedrowicz, R. Razavi, M.O. Neill (London, GB)
Increasing role of AF substrate modification during redo procedures P1331
S. Rolf, M. Kreuzhuber, P. Sommer, S. Richter, A. Bollmann, A. Arya, G. Hindricks (Leipzig, DE)
The impact of the left atrium volume reduction after radiofrequency catheter ablation for persistent atrial fibrillation P1332
N. Onishi, K. Kaitani, Y. Hayama, S. Imamura, C. Izumi, Y. Nakagawa (Tenri, Nara, JP)
Comparison of radiation dose of catheter ablation for atrial fibrillation using three-dimensional computed tomography or using
three-dimensional rotational angiography P1333
S. Fujita, E. Fujii, Y. Kagawa, M. Ito (Tsu, JP)
Catheter ablation of persistent atrial fibrillation: long-term outcomes of the hamburg sequential ablation strategy P1334
S. Brooks, A. Metzner (Hamburg, DE)
Electrogram modification suggesting transmurality during radiofrequency catheter ablation of atrial fibrillation: a comparison
between remote magnetic and contact-force catheters P1335
S.S. Bun, A. Ayari, D.G. Latcu, A. Errahmouni, N. Saoudi (Monaco, MC)
Does the extend of left atrial arrhythmogenic substrate depend on the electro anatomical mapping technique: Impact of electrode
size and inter electrode spacing P1336
M. Huemer, D. Qaiyumi, P. Attanasio, A.S. Parwani, L.H. Boldt, F. Blaschke, W. Haverkamp, A. Wutzler (Berlin, DE)
Idiopathic arrhythmias from left ventricular mid-septum beneath the His bundle - Para-AV nodal origin indicated by accelerated
junctional rhythm during successful radiofrequency ablation P1337
M. Fiala, O. Toman, J. Januska, J. Spinar (Brno and Trinec, CZ)
Predictors factors for events in the association between wpw syndrome and ventricular hypertrophy L. De Paula Van Der Steld, B.R. Brugada, C.O.L. Campuzano, M.S.R. Rocha (Salvador, BR; Girona, ES)
Radiofrequency ablation versus antiarrhythmic drugs for atrial fibrillation: collaborative meta-analysis of quality of life, hospitalization,
and morbidity outcomes D.G. Katritsis, K.C. Siontis, G.D. Katritsis, B.J. Gersh, M.E. Josephson, J.P.A. Ioannidis (Boston, Rochester and Stanford, US; Oxford, GB)
Atrial sphericity and left atrial fibrosis are independent tools for characterisation of atrial structural remodelling H. Chubb, K. Lal, K. Kouranloo, J. Whitaker, M.J. Wright, R.M. Kiedrowicz, R. Razavi, R. Karim, M.J.O. Neill (London, GB)
Left atrial segmentation may be automated using a novel ECG and respiratory gated magnetic resonance angiography (gMRA
technique H. Chubb, K. Lal, J. Whitaker, M. Henningsson, M.J. Wright, R.M. Kiedrowicz, R.M. Razavi, R. Karim, M.O. Neill (London, GB)
Optimisation of late gadolinium enhanced (LGE) MR imaging of atrial ablation scar: contrast-to-noise ratio improves with time S.E. Williams, H. Chubb, J. Whitaker, S. Aziz, J. Harrison, M.J. Wright, R.M. Kiedrowicz, T. Schaeffter, R. Razavi, M.O. Neill (London, GB)
Opportunistic screening for atrial fibrillation in hospitalized geriatric patients R. Tavernier, Y. Vandekerckhove, R. Van Hoeyweghen, T. Phlips, V. Kataria, R. Houben, M. Duytschaever (Bruges, BE; Maastricht, NL)
Atrial fibrillation related to both pulmonary vein and superior vena cava in the same patient D.R. Lin Jiaxiong, D.R. Nie Zhenning, D.R. Lin Jinyi, D.R. Dai Shimo, D.R. Zhang Chunyu, D.R. Ge Junbo (Shanghai, CN)
Efficay and safety of first line cryoablation strategy to treat paroxysmal atrial fibrillation: a large cohort of data derived from
real world multicentric experience. P1338
C. Tondo, C. Ardito, L. Padeletti, L. Leoni, D. Catanzariti, S. Porcellini, A. Curnis, L. Sciarra, R. Verlato, G. Arena (Milan, Florence, Padova,
Rovereto, Paderno Dugnano, Brescia, Rome, Camposampiero and Massa, IT)
Predictors for obtaining favorable results after catheter ablation for patients with post-operative atrial tachycardia P1339
T. Mishima, I. Nakajima, M. Wada, K. Ishibashi, K. Miyamoto, H. Okamura, T. Noda, T. Aiba, S. Kamakura, K. Kusano (Osaka, JP)
Radiofrequency ablation of atrial fibrillation: comparison of success rate of circular ablation vs point-by-point ablation with contact
force in paroxysmal and persistent atrial fibrillation P1340
R. Rosso, Y. Levi, S. Viskin (Tel Aviv, IL)
Radiofrequency af ablation with a new multipolar irrigated catheter (nMARQTM): acute and short-term results and impact on
postablation silent cerebral ischemia P1341
C. Raimondo, E. Ebrille, R. De Vito, D. Caponi, M. Anselmino, F. Ferraris, P. Di Donna, F. Halimi, F. Gaita, M. Scaglione (Turin, Siena and
Asti, IT; Le Chesnay, FR)
Distribution and periprocedural management of different anticoagulation regimen in patients undergoing catheter ablation for atrial
fibrillation in a high volume center P1342
T. Lin, A. Rillig, J. Pleman, C.H. Heeger, A. Metzner, S. Mathew, E. Wissner, F. Ouyang, K.H. Kuck, R.R. Tilz (Hamburg, DE)
Safety and efficacy of single stage atrial fibrillation ablation and left atrial appendage occlusion (W) P1343
R. Colleran, C. Mc Cann, J. Galvin, I.P. Casserly, B. Glover, T. Keelan, K. Walsh (Dublin, IE)
Reduction of fluoroscopy exposure during atrial fibrillation ablation using a novel fluoroscopy image integrated 3-dimensional
electroanatomical mapping system P1344
Y. Huo, M. Christoph, M. Forkmann, M. Pohl, J. Mayer, J. Salmas, J. Sitzy, C. Wunderlich, C. Piorkowski, T. Gaspar (Dresden, DE)
Is it necessary to eliminate adenosine triphosphate induced non-pulmonary vein foci after pulmonary vein and superior vena cava
isolation? P1345
Y. Hama, Y. Matsudo, T. Kuwahara, K. Kamishita, M. Yamamoto, T. Himi (Kisarazu and Yokosuka, JP)
Rhythm control for persistent atrial fibrillation patients contributes to the improvement of exercise tolerability. P1346
R. Matsuoka, T. Hirose, S. Warita, M. Kaneda, R. Watanabe, M. Ishiguro, H. Yagasaki, S. Tanihata, M. Arai, T. Noda (Gifu, JP)
Hybrid therapy for persistent atrial fibrillation P1347
G. Bencsik, A. Benak, M. Kohari, J. Szilagyi, G. Klausz, A. Makai, R. Pap, L. Saghy (Szeged, HU)
Gastroesophageal reflux disease is not more frequently in patient with paroxysmal atrial fibrillation ablation M. Floria, O. Barboi, C. Rezus, M. Grecu, C. Cijevschi Prelipcean, G.H.E. Balan, V.L. Drug (Iasi, RO)
Alignment of periprocedural left atrial rotational angiography with electro-anatomical mapping using sensors on an esophageal
temperature probe is highly accurate and decreases radiation dose P1349
P. Vanduynhoven, I. Romero, P. Koopman, L. Herbots, J. Vijgen (Hasselt, BE; Eindhoven, NL)
Robotic navigation system versus manual pulmonary vein isolation: a novel ablation annotation algorithm. A. Dello Russo, G. Del Giorno, S. Conti, G. Vettor, L. Cipolletta, G.M. Fassini, M. Casella, E. Russo, F. Pizzamiglio, C. Tondo (Milan, IT)
Improving anatomical definition in pulmonary vein isolation with 3D rotational angiography without the need for mapping. K. Morrice, E. Silva, G. Bardhaj, P. Peytchev, P. Geelen, T.J.R. De Potter (Aalst, BE)
The Isochronal map of non-contact mapping system is useful to distinguish the right or left outflow tract origin of idiopathic
ventricular arrhythmias K. Miyazawa, M. Ueda, M. Ishimura, T. Kajiyama, N. Hashiguchi, Y. Kobayashi (Chiba, JP)
Impact of intracardiac echocardiography on electrical storm ablation F. Turreni, A. Castro, M.L. Loricchio, M. Mercurio, F. Messina, G. Altamura (Rome, IT)
Performance of a non-invasive mapping system (ECVUE) for pre-procedural and intra-procedural mapping to guide ablation
in patients with congenital heart disease: a step further. K. Roy, F.P. Gomez, D. Valerone, I.S. Horduna, L. Mantziari, J.R. Clague, S. Ernst (London, GB)
Predictive accuracy of contactless magnetocardiographic mapping to detect ischemic heart disease D. Brisinda, A.R. Sorbo, A. Venuti, F. Fioravanti, R. Fenici (Rome, IT)
Indications (Catheter ablation / except atrial fibrillation)
Predictors of ventricular arrhythmias after left ventricular assist device implantation: a large single-center observational study E. Efimova, M. Dobrovie, B. Dinov, P. Sommer, A. Bollmann, S. Richter, J. Fischer, J. Garbade, G. Hindricks, A. Arya (Leipzig, DE)
Results (Catheter ablation /except atrial fibrillation)
In hospital mortality in patients after ablation of ventricular tachycardia S. Mathew, M. Kamioka, A. Metzner, C. Lemes, S. Deiss, E. Wissner, R. Tilz, K.H. Kuck, F. Ouyang (Hamburg, DE)
Learning curve associated with implantation of the totally subcutaneous implantable defibrillator: results from a pooled analysis
of 882 patients from the ide study and effortless registry P1369
T.F. Brouwer, R.E. Knops, D.A. Theuns, L.V.A. Boersma, R. Weiss, P. Neuzil, P. Lambiase, A.R. Leon, P.W. Jones, M. Burke (Amsterdam,
Rotterdam and Nieuwegein, NL; Columbus, Atlanta, Minneapolis and Chicago, US; Prague, CZ; London, GB)
Eligibility to subcutaneous implantable cardioverter-defibrillator: relationship with ECG suitability in different physiologic conditions P1370
A. Corzani, M. Ziacchi, M. Biffi, I. Diemberger, C. Martignani, A. Marziali, A. Mazzotti, G. Massaro, C. Rapezzi, G. Boriani (Bologna, IT)
Blind axillary vein puncture using fluoroscopic landmarks: a safe and effective approach for implantable cardioverter defibrillator leads P1367
F. Migliore, M. Siciliano, M. De Lazzari, S. Ferretto, C. Dalla Valle, S. Iliceto, E. Bertaglia (Padova, IT)
Device Longevity in a contemporary cohort of ICD/CRT-D patients undergoing device replacement P1368
Q. Parisi, A. Campana, D. Potenza, M.L. Narducci, F. Giofre', G. Stabile, D. Saporito, M. Bertini, C. Tomasi, M. Biffi (Campobasso, Salerno,
San Giovanni Rotondo, Rome, Bergamo, Naples, Rimini, Ferrara, Ravenna and Bologna, IT)
Interference resistance of pacemakers and defibrillators to 60 Hz electric fields. K.M. Dyrda, D.H. Nguyen, M. Plante, A. Turgeon, D. Goulet, R. Kavet, P. Khairy, B. Thibault, G. Ostiguy (Montreal and Varennes, CA;
Palo Alto, US)
A new algorithm for multi-point pacing in cardiac resynchronization therapy: feasibility from a multicenter experience M. Giammaria, L. Santini, G. Forleo, D. Potenza, M. Del Greco, E. Pisano', L. Calo', G. Morani, G. Ansalone, F. Zanon (Turin, Rome,
San Giovanni Rotondo, Rovereto, Lecce, Verona and Rovigo, IT)
Comparison of variability of the paced QRS wave duration caused by right ventricular apex pacing and septal pacing in the cinical
situation M. Tanaka, M. Oi, Y. Motohashi, K. Takahashi, E. Ko, K. Hanazawa, M. Toyofuku, M. Kitada, Y. Yutsuki, T. Tamura (Wakayama, JP)
Single and dual chamber device implantation totally without the use of fluoroscopy. E. Kropotkin, E.A. Ivanitskiy (Krasnoyarsk, RU)
Safety and efficacy of implantable cardioverter-defibrillator programming with long detection interval and high rate cutoff in
secondary prevention population. Y. Hayashi, M. Takagi, J. Kakihara, S. Sakamoto, A. Doi, M. Yoshiyama (Osaka, JP)
Epicardial fibrosis detected with delayed enhancement imaging is more prevalent in patients with nonischemic dilated cardiomyopathy
receiving an ICD for secondary prevention. S. Pedretti, S. Vargiu, P. Pedrotti, A. Roghi, M. Lunati (Milan, IT)
The incidence of appropriate therapies following device replacement in primary prevention ICD patients: is improvement in systolic
function a predictor? W.F. Mcintyre, C.M. Seifer (Winnipeg, CA)
Incidences of ventricular tachyarrhythmias and mortality in patients with ischemic versus non-ischemic left ventricular dysfunction
and implantable cardioverter-defibrillators M. Tham, S.K. Kumar, J. Chan, P.L. Chia (Singapore, SG; Melbourne, AU)
Non invasive programmed stimulation as a predictor of arrhythmia recurrences after catheter ablation of ventricular tachycardia P1358
F. Baratto, G. Paglino, M. Yamase, G. Santagostino Baldi, A. Radinovic, P. Vergara, T. Oloriz, P. Della Bella (Milan, IT)
J-point elevation as a predictor of malignant ventricular arrhythmia triggered by premature ventricular contractions with right
bundle brunch block and superior axis P1359
Y. Munetsugu, M. Kawamura, Y. Kobayashi (Tokyo, JP)
Catheter ablation without the use of fluoroscopy in pediatric patients P1360
M. Jan, K. Rupar, T. Prolic Kalinsek, U. Mazic, D. Kuhelj, B. Gersak (Ljubljana, SI)
Efficacy of a systematic endo and epicardial access in patients with ischemic heart disease who undergo a first ventricular tachycardia
ablation P1361
M. Izquierdo De Francisco, J.M. Sanchez-Gomez, A. Ferrero De Loma-Osorio, A. Martinez Brotons, C. Nunez, J. Nunez, A. Belver,
A. Pelaez, J. Chorro, R. Ruiz Granell (Valencia and Castellon, ES)
Focal radiofrequency ablation for macroreentrant left atrial tachycardias P1362
P.F. Cruz, S. Castrejon Castrejon, M. Arceluz, O. Salvador, E. Falconi, M. Ortega, R. Delgado, J.L. Merino Llorens (Madrid, ES)
Lead-extractions, the zwolle experience with the evolution mechanical sheath P.P.H.M. Delnoy, O.A. Witte, A. Adiyaman, A. Ghani, J.J.J. Smit, A.R. Ramdat Misier, A. Elvan (Zwolle, NL)
Middle term outcomes after left ventricular epicardial lead implantation. V. Cousin, C. Marquie, G. Fayad, W. Escande, L. Wissocque, S. Boule, S. Kacet, D. Klug (Lille, FR)
Routine His bundle pacing (HBP) can be a clinical reality: Incremental improvement in HBP outcomes with procedural experience A. Naperkowski, S.A. Worsnick, A. Pugazhendhi, G. Dandamudi, P. Vijayaraman (Wilkes Barre, US)
The predictor of hospitalization from heart failure after permanent right venticular apical pacing in patients with acquired high-grade
atrioventricular block and normal left ventricular function J. Sohn, Y.S. Lee, J.Y. Choi, K.S. Kim, H.S. Park, S.W. Han, Y.N. Kim (Daegu, KR)
Is transcatheter delivered pacing suitable for all adult sizes and ages? L.V.A. Boersma, P. Ritter, G.Z. Duray, C. Steinwender, K. Soejima, O. Razali, S. Liu, J.H. Hudnall, V. Laager, D. Reynolds
(Nieuwegein, NL; Bordeaux, FR; Budapest, HU; Linz, AT; Tokyo, JP; Kuala Lumpur, MY; Mounds View, MN and Oklahoma City, US)
Safety and diagnostic accuracy of a cardiac resynchronization therapy-defibrillator with a floating atrial bipole in heart failure
patients with permanent atrial fibrillation P1380
C. Sticherling, D. Mueller, B. Schaer, D. Baensch, C. Kolb (Basel, CH; Bad Bevensen, Rostock and Munich, DE)
Multipoint left ventricular pacing improves pre-ejection period and ejection duration assessed with non-invasive radial artery
tonometry measurements in cardiac resynchronization therapy patients P1381
C. Pappone, Z. Calovic, A. Cuko, L.C. Mcspadden, K. Ryu, R. Stutz, D. Winter, M. Saviano, G. Vicedomini, V. Santinelli (Cotignola, IT;
Sylmar, California and Itasca, Illinois, US)
Effect of optimization of cardiac resynchronization therapy on short term outcomes using QuickOpt and tissue synchronization imaging P1382
Impact of body mass index on outcomes and cardiac reverse remodeling in heart failure patients with cardiac resynchronization therapy J. Hosoda, T. Ishikawa, S. Umemura, K. Andoh, M. Nobuyoshi, S. Fujii, S. Shizuta, T. Kimura, T. Isshiki (Yokohama, Kitakyushu, Kurashiki,
Kyoto and Tokyo, JP)
T-wave area as an additional predictor of clinical response to cardiac resynchronization therapy E.B. Engels, E.M. Vegh, C.J.M. Van Deursen, K. Vernooy, J.P. Singh, F.W. Prinzen (Maastricht, NL; Boston, US)
Patients with chronic RV pacing undergoing upgrade to CRT have a similar long-term survival compared to patients with de novo
CRT implantation C.T. Witt, M.B. Kronborg, E.A. Nohr, J.C. Gerdes, P.T. Mortensen, J.C. Nielsen (Aarhus and Odense, DK)
Time course of electrical and mechanical remodelling in cardiac resynchronization therapy M. Cvijic, D. Zizek, B. Antolic, I. Zupan (Ljubljana, SI)
Predictors of clinical deterioration following CRT implantation S.N. Bogdan, A. Sabbag, I. Lipchenca, D. Bar-Lev, O. Gurevitz, R. Beinart, I. Goldenberg, M. Eldar, M. Glikson, E. Nof (Ramat Gan, IL)
Upgrade to tri-ventricular pacemaker in non-responders to biventricular cardiac resynchronization therapy: clinical response,
mortality and procedural complications at five years S.H. Man, M. Jeilan, S. Siddiqui, G.S. Chu, S.H. Chin, S.S. Varanasi, W.B. Nicolson, D. Chin, G.A. Ng (Leicester, GB; Nairobi, KE)
Transvenous coronary sinus and implantable cardioverter defibrillator lead extraction: different difficulties and complications. E.V. Dovellini, L. Giurlani, P. Corsi, A. Michelucci, G.P. Cerisano, R. Valenti, D. Antoniucci (Florence, IT)
Contribution of positron emission tomography to the diagnosis of septic embolism in patients with pacing lead endocarditis S. Amraoui, G. Tlili, M. Sohal, A. Zemmoura, S. Ploux, P. Ritter, L. Bordenave, P. Bordachar (Bordeaux-Pessac, FR; London, GB)
A dedicated paediatric syncope unit M. Courtheix, Z. Jalal, P. Bordachar, X. Iriart, X. Pillois, C. Escobedo, C. Rabot, L. Tribout, J.B. Thambo (Bordeaux-Pessac, FR)
One-day fast track evaluation of patients with syncope A. Naimushin, D. Bar-Lev, G. Rozen, M. Abu Hadba, S. Laufer, R. Mahaina, M. Eldar, J. Or, M. Glikson (Ramat Gan, IL)
Arrhythmogenic ventricular cardiomyopathy with peculiar ventricular aneurysm and TMEM43 mutations M. Ichikawa, S. Ohno, Y. Fuji, J. Ozawa, K. Sonoda, M. Fukuyama, K. Kato, H. Itoh, M. Horie (Otsu, JP)
Detection and prevalence of large PKP2 deletion in arrhythmogenic right ventricular cardiomyopathy (ARVC) using exome
sequencing, qPCR and multiplex ligation-dependent probe amplification (MLPA). J. Fedida, V. Fressart, P. Charron, T. Hery, R. Peat, A. Korniat, F. Hidden-Lucet, E. Villard, E. Gandjbakhch (Paris, FR)
Use of a patient-activated external event recording system in diagnosing the clinical arrhythmia in patients with palpitations and
normal 48h holter ECG. P. Attanasio, M. Huemer, A.S. Parwani, H. Boldt, W. Haverkamp, A. Wutzler (Berlin, DE)
Assessment of ventricular repolarization prolongation and inhomogeneity reflecting parametres in different sleep stages M. Viigimae, D. Karai, P. Pirn, M. Pindmaa, K. Pilt, K. Meigas, J. Kaik (Tallinn, EE)
Electrocardiographic abnormalities and arrhythmic risk markers in patients with beta thalassemia major P. Korantzopoulos, M. Kolios, A.P. Vlahos, E. Kapsali, E. Briasoulis (Ioannina, GR)
Early ventricular tachyarrhythmias after coronary artery bypass grafting surgery: is it a real burden? E.M.J.P. Mouws, A. Yaksh, P. Knops, C. Kik, M.J.B. Van Ettinger, M. De Wijs, P. Van De Kemp, E. Boersma, A.J.J.C. Bogers, N.M.S. De Groot
(Rotterdam and Amsterdam, NL)
The relationship between repolarization parameters and serum electrolytes levels in patients with J wave syndrome N. Sato, R. Sasaki, M. Imahashi, K. Saito, A. Talib, N. Sakamoto, K. Akasaka, Y. Kawamura, S. Fujii, N. Hasebe (Asahikawa, JP)
Time course of dysrhythmia after heart transplantation. A. Yaksh, C. Kik, P. Knops, K. Zwiers, M.J.C. De Wijs, P. Van De Kemp, O. Manintveld, A.A. Constanstinescu, A.J.J.C. Bogers,
48 hour Holter have a high diagnostic gain, and frequent arrhythmia-symptom correlation in palpitations, and low diagnostic gain
in syncope T. Koustrup, H. Molgaard (Aarhus, DK)
Electrophysiological properties in children with symptomatic and asymptomatic Wolff-Parkinson-White syndrome T. Kruchina, I. Vinogradova, D. Egorov, O. Laur, G. Novik, B. Tatarsky (Saint-Petersburg, RU)
Successful evaluation of two novel ECG-based biomarkers of sudden cardiac death in patients with Brugada syndrome S. Siddiqui, W.B. Nicolson, A. Li, E.R. Behr, G.A. Ng (Leicester and London, GB)
The activity of systemic inflammation under complex treatment including antiplatelet therapy at patients with atrial fibrillation
and insulin resistance M.A. Orynchak, M.M. Vasylechko, I.I. Vakalyuk (Ivano-Frankivsk, UA)
Ventricular vulnerability to a single low-intensity premature stimulus in the normal heart P1394
S. Rossi, S. Callegari, D. Corradi, L. Carnevali, A. Sgoifo, M. Miragoli, E. Macchi (Parma and Milan, IT)
Concomitant disease substantially contributes to the induction of adipocyte/adipositas-associated gene expression in the atria during AF P1395
U. Lendeckel, C. Wolke, R. Chilukoti, A. Giese, G. Homuth, A. Bukowska, J. Kanaan, H.-G. Wollert, N. Suffee, S. Hatem (Greifswald,
Magdeburg and Karlsburg, DE; Paris, FR)
Expression and activity of the BMP/TGF signaling pathway in fibrillating atria P1396
U. Lendeckel, A. Bukowska, R.K. Chilukoti, G. Homuth, A. Goette, J. Kanaan, H.-G. Wollert, S. Hatem, N. Suffee, C. Wolke (Greifswald,
Magdeburg, Paderborn and Karlsburg, DE; Paris, FR)
Validation of the San Francisco syncope rule in a Colombian population M. Guillermo, D. Vargas (Bogota, CO)
Ventricular arrhythmias in aortic valve stenosis before and after transcatheter aortic valve implantation P1409
D. Tempio, G.P. Pruiti, S. Conti, S.A. Romano, D. Capodanno, C. Liotta, A. Di Grazia, C. Tamburino, V. Calvi (Catania, IT)
Prolonged frontward p wave duration on magnetcardiogram is associated with atrial recurrence after successful pulmonary vein isolation P1410
K. Ogawa, M. Igarashi, K. Kuroki, Y. Shinoda, E. Sai, Y. Yui, T. Machino, Y. Sekiguchi, A. Nogami, K. Aonuma (Ibaraki, JP)
Cardiac MRI after ventricular tachyarrhythmias increases diagnostic precision and reduces the need for family screening for
inherited cardiac disease P. Marstrand, A. Axelsson, N. Vejlstrup, H. Bundgaard, J. Theilade (Copenhagen, DK)
Left atrial appendage sizing for percutaneous occlusion with Amplatzer cardiac plug: a multumodality imaging approach X. Iriart, W. Selmi, Z. Jalal, J.B. Thambo (Bordeaux-Pessac, FR)
The effects of aging on coagulation fibrinolytic system and endothelial impairment A. Ochi, T. Adachi, K. Inokuchi, Y. Onishi, Y. Munetsugu, T. Onuki, N. Watanabe, Y. Minoura, M. Kawamura, Y. Kobayashi (Tokyo, JP)
Percutaneous left atrial appendage occlusion. clinical indications, management and follow up in a referral center P. Mazzone, F. Guarracini, N. Trevisi, D. Regazzoli, F. Melillo, A. Marzi, N. Sora, E. Agricola, M. Oppizzi, P. Della Bella (Milan, IT)
Impact of remote monitoring system for congenital heart disease patients T. Nishimura, D. Takeuchi, T. Manaka, K. Toyohara, M. Shoda, T. Nakanishi (Tokyo, JP)
Gender, age and and morbidity dependent letality after pacemaker and ICD implantation- Analysis of German quality management data P1416
B. Lemke, D. Panteloglou, D. Mijic, M. Zarse, H. Bogossian, Z. Karosine, A. Muegge (Luedenscheid and Bochum, DE)
Long term outcome of radiofrequency catheter ablation for atrial fibrillation in patients with left ventricular dysfunction P1423
M. Yahata, S. Shizuta, T. Kawaji, K. Nakai, H. Sugiyama, K. Goto, T. Kimura (Kyoto, JP)
Advantages for multi electrodes mapping with the flower catheter for multiple atrial tachycardias in the context of atrial fibrillation
ablation: a comparison with the point-by-point technique P1424
S.S. Bun, T. Delassi, D.G. Latcu, M. Eljamili, N. Saoudi (Monaco, MC)
Mitral isthmus ablation using a circular mapping catheter positioned in the left atrial appendage as a reference for conduction block P1425
T. Nishiyama, K. Nakajima, S. Kashimura, Y. Katsumata, T. Kimura, N. Nishiyama, Y. Tanimoto, Y. Aizawa, K. Fukuda, S. Takatsuki (Tokyo, JP)
Novel ultrasound and dipole density mapping: a study in patients with atrial flutter P1426
M. Duytschaever, S. Willems, R. Tavernier, B. Hoffman, Y. Vandekerckhove (Bruges, BE; Hamburg, DE)
Functional improvement after successful catheter ablation for long-standing persistent atrial fibrillation is comparable in patients
with preserved and impaired left ventricular systolic function P1427
M. Fiala, V. Bulkova, L. Sknouril, R. Nevralova, O. Toman, M. Dorda, J. Januska, J. Spinar, D. Wichterle (Brno, Prague and Trinec, CZ)
Prediction of rhythm outcomes after catheter ablation of atrial fibrillation in low risk patients with CHA2DS2-VASc score 0-1 J. Kornej, G. Hindricks, A. Arya, P. Sommer, D. Husser, S. Rolf, A. Bollmann (Leipzig, DE)
Acute procedural and clinical outcome comparison using the first and second-generation cryoballoon: inside a large cohort of
ata derived from real world multicentric experience. P1429
M. Lunati, G. Arena, C. Tondo, D. Catanzariti, L. Bontempi, L. Leoni, S. Porcellini, R. Verlato, L. Sciarra, L. Padeletti (Milan, Massa,
Rovereto, Brescia, Padova, Paderno Dugnano, Camposampiero, Rome and Florence, IT)
Mid-term results from a French survey on catheter ablation of atrial fibrillation R.A. Providencia, P. Defaye, D. Pavin, J.P. Cebron, F. Anselme, S. Boveda (Toulouse, Grenoble, Rennes, Nantes and Rouen, FR)
Renal function as predictor for electro-anatomical left-atrial substrate in atrial fibrillation P1431
J. Kornej, B. Dinov, G. Hindricks, D. Husser, W. Acou, S. Kircher, J. Kosiuk, A. Bollmann, S. Rolf (Leipzig, DE)
Long-term cerebral thromboembolic/hemorrhagic event rates following transcatheter ablation or rate control strategy in atrial
fibrillation patients: a multicenter retrospective observational report. P1432
C. Gallo, A. Battaglia, M. Anselmino, F. Bianchi, S. Grossi, G. Nangeroni, E. Toso, L. Gaido, M. Scaglione, F. Gaita (Turin and Asti, IT)
Intracardiac echocardiography for exclusion of thrombus in the left atrial appendage. Is it better than routine transesophageal
echocardiography? P1433
J. Baran, S. Stec, E. Pilichowska-Paszkiet, R. Piotrowski, M. Sikora-Frac, A. Sikorska, T. Krynski, M. Soszynska, B. Zaborska, P. Kulakowski
(Warsaw and Rzeszów, PL)
Impact of the esophageal temperature monitoring guided atrial fibrillation ablation preventing the asymptomatic excessive
transmural injury without compromising the clinical outcome: a case-control st K. Kiuchi, K. Okajima, A. Shimane, K. Yokoi, J. Teranishi, K. Aoki, Y. Taniguchi, S. Yamada, Y. Yasaka, H. Kawai (Himeji, JP)
Improving AF detection in patients with cryptogenic stroke. Learning concepts from a prospective cohort with insertable cardiac
monitor. B. Benito, E. Valles, E. Cuadrado, P. Ramos, S. Cabrera, A. Ois, A. Rodriguez-Campelo, J. Roque, J. Marti-Almor (Barcelona, ES)
Relative performance of three different estimated glomerular filtration rates on the prediction for the progression and clinical
outcomes in patients with paroxysmal atrial fibrillation K.H. Lee, H.W. Park, N.S. Yoon, J.G. Cho, Y.K. Ahn, M.H. Jeong, J.C. Park, S.S. Kim (Gwangju, KR)
Analysis of intermittent ecg recordings using lempel-ziv complexity predicts paroxysmal atrial fibrillation while in sinus rhythm. P.J. Howlett, D. Abasolo, V. Alexeenko, F. Hatch, E.W. Leatham, R. Jabr, C.H. Fry (Guildford and Bristol, GB)
Atrial fibrillation is a predictor of short term poor clinical outcomes after transcatheter aortic valve implantation (TAVI) W. Kong, E. Tay, J. Yip, R. Wong, M. Liang, K. Kyu, K.K. Poh (Singapore, SG)
The time interval from the initiation of the p-wave to the start of left atrial appendage ejection flow can predict the occurrence of
postoperative atrial fibrillation after aortic valve replacement Y. Hayama, K. Kaitani, S. Imamura, N. Onishi (Tenri, JP)
Morphological predictors of effective chemical ablation of marshall vein for atrial fibrillation P1434
Y. Sasaki, A. Kobori, Y. Furukawa (Kobe, JP)
Safety and feasibility of excluding fluoroscopy imaging during catheter ablation of atrial fibrillation P1435
A. Bulava, M. Eisenberger, J. Hanis (Ceske Budejovice, CZ)
Left atrial reverse remodeling prevents recurrence of atrial fibrillation after catherter ablation of persistent atrial fibrillation P1436
Y. Kagawa, E. Fujii, S. Fujita, M. Ito (Tsu, JP)
Safety of warfarin and novel oral anticoagulants in atrial fibrillation ablation P1437
M. Fujimoto, T. Ikeda, K. Okeie, M. Yamamoto (Toyama, JP)
Application of electrogram dyssynchrony to guide catheter ablation of persistent atrial fibrillation: acute and long term effect P1438
P. Kuklik, B. Schaeffer, B.A. Hoffmann, D. Schreiber, J.M. Moser, R.O. Akbulak, A. Sultan, J. Luker, D. Steven, S. Willems (Hamburg, DE)
Effect of pulmonary vein anatomy and pulmonary vein diameters on outcome of cryoballoon aatheter ablation for atrial fibrillation P1439
E. Guler, G. Babur Guler, G.G. Demir, F. Kizilirmak, H.M. Gunes, M.O. Omaygenc, B. Cakal, F. Kilicaslan (Istanbul, TR)
Magnetic and contact-force sensing catheters have similar orientation during circumferential pulmonary vein isolation: lessons
from bipolar electrogram morphology analysis (W) P1440
D.G. Latcu, A. Ayari, S.S. Bun, A. Errahmouni, N. Saoudi (Monaco, MC)
The different effect of anticoagulation during catheter ablation of atrial fibrillation according to preablation oral anticoagulant. P1441
J.Y. Kim, S.H. Kim, I.G. Song, T.S. Kim, J.H. Kim, S.W. Jang, M.Y. Lee, T.H. Rho, Y.S. Oh (Seoul, KR)
Radiation-free pulmonary vein isolation in patients with atrial fibrillation and a patent foramen ovale P1442
S. Knecht, C. Sticherling, A. Muehl, T. Reichlin, N. Pavlovic, S. Osswald, M. Kuehne (Basel, CH)
Catheter ablation of atrial fibrillation: three-dimensional transesophageal echocardiography provides an acceptable image quality
for analysing the individual pv anatomy prior to an ablation procedure P1443
K. Kettering, F. Gramley, S.V. Bardeleben (Frankfurt and Mainz, DE)
High output pace capture methodology has poor sensitivity for identifying the location of conduction gaps in the wide
circumferential ablation line during pulmonary vein isolation P1444
S. Pollak, G. Monir, E. Bassily, J. Pepe (Orlando, US)
Myocardial 123I-MIBG scintigraphy in assessing of the cardiac radiofrequency denervation effectiveness Y. Saushkina, V. Evtushenko, A. Evtushenko, S. Minin, I. Efimova, Y. Lishmanov, K. Smishlyaev, O. Nasanova, V. Chernov, N. Efimova
(Tomsk, RU)
Safety of mapping in the sinus of valsalva region under intracardiac echocardiography guidance without angiography K.C. El Tallawi, T. Feghali, M. Refaat, M. Khoury, B. Abi-Saleh (Beirut, LB)
A Novel, efficient method to identify gaps in cavo-tricuspid isthmus ablation line P. Vijayaraman, C.A. Hadadi, A. Naperkowski, G. Dandamudi, K.A. Ellenbogen (Wilkes Barre and Richmond, US)
Zero fluoroscopy direction: going back to 3d mapping system origin A. Pani, F. Ruffa, G. De Vito, R. Brambilla, C. Gerosa, A. Vincenti, G. Rovaris, S. Negroni, S. Foresti, D. Malaspina (Lecco, Monza
and Milan, IT)
An early negative deflection of the bipolar electrogram predicts the site of origin of premature ventricular contractions G. Epicoco, A. Sorgente, H. Ali, G. Bonitta, S. Foresti, G. De Ambroggi, C. Balla, M.M. Ciccone, P. Lupo, R. Cappato
(Bari and San Donato Milanese, IT)
Optimization of left atrial catheterization by selective transseptal puncture. A single center experience. A. Radinovic, P. Mazzone, F. Guarracini, A. Marzi, N. Sora, P. Della Bella (Milan, IT)
Validation of standard and new criteria for the differential diagnosis of narrow QRS tachycardia in children and adolescents K.J. Deutsch, S.M.S. Stec, P.K. Kukla, A.M. Morka, M.J. Jastrzebski, A.B. Baszko, M.P. Pitak, J.S. Sledz, M.M. Mazij, L.S. Szydlowski
(Kielce, Rzeszow, Gorlice, Krakow, Poznan, Wroclaw and Katowice, PL)
Impact of cavotricuspid isthmus morphology on procedural success rate of cryo- or radiofrequency ablation of cavotricuspid
dependent atrial flutter S. Saygi, H. Bastani, C. Wredlert, M. Jensen-Urstad (Stockholm, SE)
Accessory pathway induced asynchrony in children: ablation as healing treatment for heart failure. G. Sarquella Brugada, A. Berruezo, S. Cesar, C. Bautista, L. Marzo, J. Brugada (Esplugues de Llobregat, ES)
Experience of catheter ablation accessory pathways in children Ebstein's anomaly E. Artukhina, A.S.H. Revishvili (Moscow, RU)
Examination about the influence that difference in the sensing filter properties gives to the record of the intracardiac wave pattern. Y. Goseki, Y. Yazaki, K. Takarada, A. Yamashina (Tokyo, JP)
Effect of non-apical right ventricular pacing for left ventricular function A. Baimbetov, K. Ergeshov, S. Anartayev, K. Bizhanov (Almaty, KZ)
Predictors of super response to cardiac resynchronization therapy T. Segura De La Cal, R. Matia, A. Hernandez Madrid, E. Franco, J. Moreno, D. Rodriguez, C. Lazaro, J.L. Zamorano (Madrid, ES)
Ultrasound-guided axillary venous puncture for implantable cardiac devices is a safe technique with a short learning curve S.S. Bun, M. Eljamili, D.G. Latcu, A. Errahmouni, T. Delassi, N. Saoudi (Monaco, MC)
Procedural safety and long-term follow-up after pacemaker implantation in nonagenarians A. Loirat, D. Feneon, A. Behaghel, N. Behar, A. Le Helloco, P. Mabo, J.C. Daubert, C. Leclercq, R.P. Martins (Rennes, FR)
Combined score using clinical, electrocardiographic and echocardiographic parameters to predict outcome after cardiac
resynchronization therapy A. Bernard, L. Fauchier, S. Marechaux, A. Guiot, A. Reynaud, F. Schnell, C. Leclercq, P. Mabo, E. Donal (Tours, Lille and Rennes, FR)
Use of clinical follow-up and pacemaker memories to define predictors of complete atrio-ventricular block or sudden death after
balloon-expandable transcatheter aortic valve implantation. G. Viart, F. Anselme, E. Durand, A. Savoure, N. Auquier, H. Eltchaninoff (Rouen, FR)
The prognostic impact of electrocardiographic changes during therapeutic hypothermia in patients with resuscitated cardiac arrest M.H. Bae, C.Y. Kim, N.K. Kim, J.H. Kim, S.Y. Jang, S.H. Park, W.S. Choi, J.H. Lee, D.H. Yang, Y. Cho (Daegu, KR)
Mouth and nose cooling for brain protection in OHCA and stroke by CO2 adiabatic expansion on a pig model G.H. Fontaine (Paris, FR)
Mechanism of shock prevention using high rate detection in primary prevention ICD therapy F. Eberhardt, H. Bonnemeier, T. Kleemann, J. Brachmann, S. Fischer, F. Birkenhauer, J.O. Schwab (Cologne, Kiel, Ludwigshafen Am Rhein,
Coburg, Quedlinburg, Eschborn and Bonn, DE)
Ventricular stimulation for the risk stratification of sudden cardiac death in non-ischemic dilated cardiomyopathy patients: old tools
never die; they just fade away E. Kanoupakis, J. Fanourgiakis, E. Kallergis, H. Mavrakis, M. Vernardos, K. Roufas, S. Petousis, M. Touloupaki, P. Vardas (Heraklion, GR)
Risk stratification of ventricular tachycardia in post-infarct patients with left ventricular ejection fraction>35%: usefulness of
myocardial infarction scar assessment by magnetic resonance imaging N. Hammache, D. Voilliot, B. Brembilla-Perrot, F. Odille, M. Andronache, D. Mandry, N. Girerd, E. Aliot, N. Sadoul, C. De Chillou
(Vandoeuvre les Nancy, FR)
Impact of prolonged QRS duration and severe left ventricular dysfunction as a predictor of appropriate implantable
cardioverter- defibrillator therapy N. Matsumoto, M. Ogawa, T. Yasuda, J. Morii, Y. Nagata, Y. Hitaka, S. Imaizumi, A. Matsunaga, K. Saku (Fukuoka, JP)
Evaluating myocardial injury during ICD implantation using the upper limit of vulnerability versus standard defibrillation t
hreshold testing S. Hebsur, J. Hunter, K. Lewis, J.C. Hsu, G. Feld, U. Birgersdotter-Green (San Diego, US)
Surgery (Catheter ablation /except atrial fibrillation)
Efficacy of epicardial catheter ablation through subxiphoidal pericardiotomy guided by RMT for the treatment of recurrent ventricular
arrhythmias in patients with non-ischemic cardiomyopathy P1458
R. Prisecaru, L. Riahi, D. Stockman, Y. De Greef, P. Van Den Heuvel, B. Schwagten (Antwerp, BE)
Catheter ablation of ventricular ectopy: is rare too rare? P1455
J. Seiler, L. Roten, F. Noti, H. Tanner, N. Tran, A. Medeiros-Domingo, J. Fuhrer, H. Servatius (Bern, CH)
Implanted cardioverter defibrillator programming based on non invasive programmed stimulation after catheter ablation of ventricular
tachycardia P1456
G. Paglino, F. Baratto, M. Yamase, T. Oloriz, G. Santagostino Baldi, P. Vergara, A. Radinovic, P. Della Bella (Milan, IT)
Efficacy and safety of a new 8 mm ablation catheter with microelectrodes to ablate cavo-tricuspid isthmus dependent atrial flutter
and slow-fast atrioventricular nodal reentrant tachycardia P1457
V. Ducceschi, F. Maddaluno, C. Fiorentino, M. Santoro, G. Gregorio (Naples, Milan and Vallo Della Lucania, IT)
Ongoing need for cardiac pacing in a contemporary cohort of orthotopic heart transplant patients through one year of follow-up T. Farid, A.R. Moser, B. Austin, A. Magalski, A. Wimmer (Kansas City, US)
The influence of left ventricular midwall fibrosis on torsional mechanics. The implications for CRT. R.J. Taylor, F. Umar, E.L.S. Lin, A. Ahmed, W.E. Moody, W. Mazur, B. Stegemann, J.N. Townend, R.P. Steeds, F. Leyva (Birmingham, GB;
Cincinnati, US; Maastricht, NL)
More favorable electrical and mechanical reverse remodeling after cardiac resynchronization therapy with quadripolar versus
conventional bipolar lead S.J. Park, K.J. Chun, K.M. Park, Y.K. On, J. Huh, J.S. Kim (Seoul, KR)
Configuration of coronary veins in target area for cardiac resynchronization according to the systolic function R. Mlynarski, A. Mlynarska, K.S. Golba, M. Sosnowski (Katowice, PL)
Intra-procedural correlation of potential anatomic sites for LV lead placement and RV-LV measurement A. Schricker, G. Feld, J. Hsu, K. Lewis, J. Hunter, U. Birgersdotter-Green (San Diego, US)
Two new electrocardiographic intra- and interventricular dyssynchrony criteria improve cardiac resynchronization therapy outcome
prediction A. Vereckei, M. Kiss, Z.S. Szelenyi, E. Zima, V. Kutyifa, B. Merkely (Budapest, HU)
Multipoint pacing acutely induces better hemodynamics and QRS narrowing compared to conventional BiV. F. Zanon, E. Baracca, G. Pastore, L. Marcantoni, D. Lanza, C. Fraccaro, L. Roncon, D. Cavazzini, S. Aggio, F.W. Prinzen (Rovigo and
Adria (RO), IT; Maastricht, NL)
Correlation between clinical response to cardiac resynchronization therapy and changes in frequency spectra of the first heart sound
recorded with an endocardial acceleration sensor D. Kiblboeck, H. Hoellinger, E. Zeindlhofer, A. Winter, G. Eisserer, L. Pilgerstorfer, P. Siostrzonek, J. Reisinger (Linz, AT)
The jurdham procedure for endocardial cardiac resynchronization therapy: medium term follow-up. L. Delgado Elias, A. Negrete, A. Trainini, N. Lopez Cabanillas, J. Trainini, A. Fischer, S. Worley, M.S. Palacio, B. Elencwajg
(Buenos Aires, AR; Cali, CO; New York and lancaster, US)
Compound parameters of electrical propagation at implant identify target regions and areas of avoidance during cardiac
resynchronization therapy S. Ross, E. Kongsgaard, T. Edvardsen, T. Haaland, L.O. Gammelsrud, T. Fischer, R. Skaardal, H.H. Odland (Oslo, NO)
Pulmonary vascular resistence and transpulmonary gradient in non-responders to CRT T. Minarik, M. Fedorco, M. Taborsky (Ostrava and Olomouc, CZ)
Different ventricular arrhythmic outcome of cardiac resynchronization therapy-defibrillators in women A. Quesada Dorador, F. Arteaga, R. Romero-Villafranca, J. Martinez-Ferrer, L. Perez-Alvarez, J. Alzueta-Rodriguez, J. Garcia-Gerrero,
J.G. Martinez, X. Vinolas, J. Porres (Valencia, Alava, A Coruña, Malaga, Badajoz, Alicante, Barcelona and San Sebastian, ES)
Gender differences in CRT patients with surgically implanted epicardial leads L. Chen, H. Fu, S. Wong, Y. Cha, U. Birgersdotter-Green, V. Pretorius (San Diego and Rochester, US)
High recurrence rate of device-related adverse events following transvenous lead extraction procedure in CRT patients F. Regoli, M.G. Bongiorni, R. Rordorf, M. Santamaria, L. Segreti, V. De Regibus, G. Conte, M. Caputo, C. Klersy, A. Auricchio
(Lugano, CH; Pisa, Pavia and Campobasso, IT)
Immediate reimplantation after the extraction of infected cardiac implantable electronic devices (CIED) C. Salazar Ramirez, E. Gutierrez Carretero, A. De Alarcon Gonzalez (Malaga and Sevilla, ES)
Safety and tolerability of tilt testing and carotid sinus massage in the oldest old. G. Rivasi, M. Rafanelli, G. Toffanello, A. Ceccofiglio, F. Tesi, N. Marchionni, A. Ungar (Florence, IT)
Pause-dependent differences in RAAS activation in patients with vasovagal syncope. J. Gajek, D. Zysko (Wroclaw, PL)
Evaluation of military personnel at a dedicated syncope Center A. Naimushin, S. Laufer, M. Abu Hadba, D. Bar Lev, M. Glikson (Ramat Gan, IL)
Regional variation in ostial myocardial dimensions predicts sites of acute reconnection after left atrial appendage electrical isolation S. Panikker, R. Virmani, F. Kolodgie, J. Jarman, L. Mantziari, S.K. Haldar, J.P. Foran, V. Markides, T. Wong (London, GB; Gaithersburg, US)
Vernakalant facilitated electrical cardioversion - comparison of intravenous vernakalant and amiodarone for drug enhanced electrical
cardioversion of atrial fibrillation after failed electrical cardio A. Muessigbrodt, S. John, J. Kosiuk, S. Richter, G. Hindricks, A. Bollmann (Leipzig, DE)
Hypertrophic cardiomyopathy: survival assessment and identification of factors associated with the risk of sudden cardiac death S. Komissarova (Minsk, BY)
Does climbing eight thousands peaks influence on ECG and autonomic nervous system? G. Pytel, M. Kurdziel, J. Waclawski, A. Kurek, A. Kazik, K. Gierlaszynska, M. Gasior, B. Sredniawa (Zabrze, PL)
Comparative analysis of transmural dispersion of repolarization and the concentration of atrial natriuretic peptide (ANP)
in the plasma as an indicator of electrical instability in children with HCM V. Linyaeva, I.V. Leontieva (Moscow, RU)
Predictive value of deceleration capacity for risk stratification of sudden cardiac death in patients after myocardial infarction:
5-year data E. Okisheva, D. Tsaregorodtsev, V. Sulimov (Moscow, RU)
Evaluation of signal average electrocardiogram as a noninvasive outcome predictor of ventricular tachycardia catheter ablation
in a dedicated VT unit: initial single centre experience F. Melillo, T. Oloriz, M. Yamase, F. Guarracini, F. Baratto, N. Trevisi, M. Evangelista, P. Mazzone, G. Maccabelli, P. Della Bella (Milan, IT)
Multiscale sensitivity analysis in patient-specific models of cardiac electrophysiology C. Sanchez, M. Potse, F. Regoli, M.L. Caputo, G. Conte, T. Moccetti, E. Caiani, F. Prinzen, R. Krause, A. Auricchio (Lugano, CH; Milan, IT;
Right bundle branch block pattern in patients with previous myocardial infarction. D. Zysko, D. Timler, T. Grzebieniak, M. Obremska, P. Szyber, M. Rachwalik, J. Gajek, A. Fedorowski (Wroclaw and Lodz, PL; Malmo, SE)
Long-term monitoring of respiratory rate in patients with heart failure: the multiparametric heart failure evaluation in implantable
cardioverter defibrillator patients (MULTITUDE-HF) Study G.B. Forleo, L. Santini, M. Campoli, V. Ribatti, M. Malavasi, A. Scaccia, M. Menichelli, M. Lovecchio, G. Carreras, S. Valsecchi
(Rome, Viterbo, Sora, Frosinone, Milan and Rieti, IT)
Tbx18 overexpression improves function and alters gene expression in bradycardic subsidiary right atrial pacemaker tissue M.H. Choudhury, J. Yanni, S.J. Kakar, A.D.souza, P.A. Kingston, H. Dobrzynski, M.R. Boyett, G.M. Morris (Manchester, GB)
Variant rs2200733 on chromosome 4q25 confers increased risk of atrial fibrillation independently on traditional risk factors
in a Greek population N. Fragkakis, K.K. Kalinderi, A.F. Fotoglidis, K.K. Koskinas, D.K. Katritsis, K.L. Letsas, P.K. Kyriakou, V.S. Skeberis, L.F. Fidani, V.V. Vassilikos
(Thessaloniki, THESSALONIKI and Athens, GR)
Innervation relationship between cardiac ganglionated plexi and atria analyzed by neuronal tracing in canine hearts L. Lee, M.J. Cha, Y.J. Cho, E.K. Choi, S.E.I.L. Oh (Seoul, KR)
Inhibition of late INa suppresses the pro-arrhythmic but not the chronotropic effect of isoproterenol: comparison with a beta-blocker A. Dhalla, H. Ling, L. Chi, L. Belardinelli (Fremont, US)
Arrhythmogenic right ventricular dysplasia during pregnancy : retrospective study of 21 patients (W) P1505
E. Varlet, J. Nizard, G. Duthoit, V. Fressart, N. Badenco, X. Waintraub, T. Chastre, C. Maupain, F. Hidden-Lucet, E. Gandjbakhch (Paris, FR)
First ECG derivative method as a marker of ventricular arrhythmias in chronic alcoholics during acute alcohol withdrawal P1506
A.S. Gorbunova, S.Y.U. Levashov, E.G. Volkova (Chelyabinsk, RU)
The diagnostic value of positron emission tomography in patients with cardiac sarcoidosis K. Higuchi, K. Tachibana, H. Muramoto, A. Suzuki, Y. Onishi, S. Umezawa, A. Niwa, K. Hirao (Kanagawa and Tokyo, JP)
Preliminary evaluation of an educational program for critical nurses concerning QT interval prolongation to prevent Torsade de
Pointes P1508
S.L. Lo, H.S. Lo, S.J. Yeh, W.J. Cherng, S.H. Chen, F.C. Lin (Tauyuan, Taipei, Tau Yuan and Keelung, TW)
Acute procedural outcomes of percutaneous left atrial appendage occlusion (LAAO): a multicentre experience P1509
T.R. Betts, M. Leo, P. Kanagaratnam, D. Hildick-Smith, O. Segal, D. Todd, D. Fox, C. Pepper, J. Foran, T. Wong (Oxford, London, Brighton,
Liverpool, Manchester and Leeds, GB)
Structured multidisciplinary approach ensures optimal anticoagulation therapy in patients with atrial fibrillation. P1510
A.E. Albertsen, E.D. Monning, B.R.R. Nielsen, D.S. Moller (Viborg, DK)
Investigation on routine follow-up in heart failure patients with remotely monitored implanted cardioverter defibrillators systems C. Hansen, C. Loges, F. Birkenhauer, C. Weiss (Göttingen, Bad Friedrichshall, Eschborn and Lüneburg, DE)
Information for patients prior to consent for pacemaker or defibrillator implantation - fit for purpose? J.M. Mccomb, E.J. Shepherd (Newcastle upon Tyne, GB)
New EHRA Scientific Documents-1
Chairpersons: K.H. Kuck (Hamburg, DE); A.N. Hovhannesyan (Yerevan, AM)
We will present and discuss new EHRA Scientific Documents.
EHRA /HRS/APHRS joint document on VT.
Cardiac Arrhythmias in Acute Coronary Syndromes. EHRA/ACCA/EAPCI Position Paper
B. Gorenek (Eskisehir, TR)
Catheter Based Left Atrial Appendage Occlusion
Patient values and preferences in managing cardiac arrhythmias
D. Lane (Birmingham, GB)
Basic research has produced several novel, innovative approaches to antiarrhythmic therapy. New targets and strategies will be presented and
discussed in this session.
Opportunities to prevent sudden death in sports Chairpersons: S. Manola (Zagreb, HR); N.A.M. Estes (Boston, US)
K2P channel inhibition to suppress atrial fibrillation.
Mechanisms of LQTS. Is individualized therapy possible?
L. Crotti (Pavia, IT)
Is there a therapeutic role for microRNAs in heart rhythm disorders?
R. Caballero (Madrid, ES)
Suppression of arrhythmia by late sodium current inhibition.
R. Coppini (Florence, IT)
Emerging molecular strategies in antiarrhythmic therapy
Chairpersons: M. Vukmirovic (Cetinje, ME); J.R. Ehrlich (Frankfurt, DE)
New insights related to the prevention of sudden death in athletes
The incidental finding of post-myocarditis fibrosis on MR: how to proceed?
A. Wolak (Jerusalem, IL)
New insights from cardiac MR during uninterrupted exercise.
H. Heidbuchel (Hasselt, BE)
The place of AEDs and ICDs in competitive sports.
B. Olshansky (Iowa City, US)
Fighting sudden death in sports arenas.
L. Serratosa Fernandez (San Lorenzo De El Escorial, ES)
The art of the ECG. Part 1
Chairpersons: J. Farre (Madrid, ES); H.J. Wellens (Maastricht, NL)
The ECG is our daily "work horse". Although 110 years old new information about the value of the ECG continues to occur, requiring repeated
education to use the ECG optimally in our management of the cardiac patient. With the help of a voting system Dr. Farre and Dr. Wellens will test
your current knowledge and will go from there.
08:30 Discussants:.
J. Farre (Madrid, ES); H.J. Wellens (Maastricht, NL)
Prediction of response to crt and patient outcomes
Chairpersons: V. Kutyifa (Rochester, US); W.T. Abraham (Columbus, US)
08:30 Biventricular, left ventricular only and multipoint pacing in CRT patients: an acute hemodynamic comparison.
F. Zanon, E. Baracca, G. Pastore, L. Marcantoni, D. Lanza, C. Picariello, L. Roncon, S. Aggio, P. Galasso, F.W. Prinzen (Rovigo, IT;
08:39 Optimizing the LV pacing site by means of electrical delay and LVdp/dtmax may predict the clinical outcome in CRT patients:
results of one year follow-up
F. Zanon, D. Lanza, C. Fraccaro, L. Marcantoni, E. Baracca, G. Pastore, C. Picariello, L. Roncon, S. Aggio, F.W. Prinzen (Rovigo, IT;
08:48 Validation of a simple risk stratification tool for patients implanted with cardiac resynchronization therapy: the valid-crt
risk score
M. Gasparini, C. Klersy, C. Leclercq, M. Lunati, M. Landolina, A. Auricchio, M. Santini, G. Boriani, A. Proclemer, F. Leyva
(Rozzano, Pavia, Milan, Rome, Bologna and Udine, IT; Rennes, FR; Lugano, CH; Birmingham, GB)
08:57 Safety and outcome of left ventricular endocardial pacing: the 12 months results of the alternate site cardiac resynchronization
(ALSYNC) study
J.M. Morgan, M. Biffi, L. Geller, F. Ruffa, C. Leclerq, S. Tung, B.E.W. Gerritse, Z. Yang, R. Yee, P. Jais (Southampton, GB;
Bologna and Lecco, IT; Budapest, HU; Rennes and Bordeaux, FR; Vancouver and London, CA; Maastricht, NL; Minneapolis, US)
09:06 Cardiac re-synchronization therapy for infants with left bundle branch block caused by various etiologies.
H. Sakaguchi, Y. Hayama, A. Miyazaki, T. Hoashi, K. Kagisaki, H. Ohuchi (Suita, JP)
09:15 Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients
with primary prevention CRT-D.
F.A. Sebag, N. Lellouche, M.D.O.neil, M. Wright, C. Leclerq, C.A. Rinaldi (Rennes and Creteil, FR; London, GB)
09:24 Association of apical rocking with long-term major adverse cardiac events in patients undergoing cardiac resynchronization
A. Ghani, P.P.H.M. Delnoy, A. Adiyaman, J.P. Ottervanger, A.R. Ramdat Misier, J.J.J. Smit, A. Elvan (Zwolle, NL)
09:33 Prognostic value of epicardial strain amplitude at CRT left ventricular pacing site A. Laish-Farkash, V. Khalameizer, E. Fishman, A. Costa, Y. Shmayahu, A. Katz (Ashkelon and Rosh Haayin, IL)
09:42 Biventricular pacing increases left anterior descending artery flow by increasing the dominant backward-travelling
decompression (suction) wave in patients with left bundle branch block.
S.B.L. Claridge, Z. Chen, T. Jackson, J. Behar, M. Lumley, K. De Silva, R. Williams, J. Bostock, D. Perera, C.A. Rinaldi (London, GB)
09:51 Impact of collagen turnover markers on echocardiographic response and mortality after CRT-D implantation in TRUST-CRT
A. Sokal, R. Lenarczyk, O. Kowalski, K. Mitrega, S. Pluta, J. Stabryla-Deska, Z. Kalarus (Zabrze, PL)
Understanding the substrate in arrhythmias and its impact on outcome
Chairpersons: J.L. Merino (Madrid, ES); P. Geelen (Aalst, BE)
Characterization of the endocardial component of ventricular tachycardia reentrant circuits by postpacing interval
electroanatomical mapping P1536
O. Salvador, S. Castrejon, D. Filgueiras-Rama, M. Arceluz, E. Falconi, F. Cruz, C. Vazquez, R. Delgado, M. Ortega, J.L. Merino
Selective atrial vagal denervation guided by spectral mapping to treat advanced atrio-ventricular block.
E. Rivarola, C. Hardy, D. Hachul, E. Sosa, M. Scanavacca (Sao Paulo, BR)
Performance of the SA-VA difference to differentiate atrioventricular nodal reentrant tachycardia from atrioventricular
tachycardia in a large cohort
F. Akerstrom, M.A. Arias, F.J. Garcia-Fernandez, M. Pachon, R. Salgado, A. Puchol, L. Rodriguez-Padial (Toledo and Burgos, ES)
Is epicardial approach routinely required to the ablation of ventricular tachycardias in patients with non-ischaemic
cardiomyopathy?
G. Santagostino, T. Oloriz, F. Baratto, N. Trevisi, P. Della Bella (Milan, IT)
Critical progressive activation delay after premature stimulation is associated with polymorphic ventricular tachycardia
in non-ischemic cardiomyopathy: results from the Leiden NICM study
J. Venlet, S.R.D. Piers, S.F.A. Askar, G.F.L. Kapel, M. De Riva Silva, H.M. Siebelink, M.J. Schalij, D.A. Pijnappels, K. Zeppenfeld
(Leiden, NL)
Arrhythmogenic substrate characterization in patients with arrhythmogenic right ventricular cardiomyopathy undergoing
ventricular tachycardia ablation
C. Bisceglia, S. Kirubakaran, J. Silberbauer, T. Oloriz, N. Trevisi, F. Baratto, P. Della Bella (Milan, IT)
Arrhythmia substrate characterization in relation to survival and long-term outcomes of catheter ablation of ventricular
tachycardia in nonischemic dilated cardiomyopathy
B. Dinov, A. Schratter, V. Schirripa, L. Fiedler, A. Bollmann, S. Rolf, G. Hindricks, A. Arya (Leipzig, DE)
Number of beats in the transition zone with fixed SA interval determines accessory pathway location in atrioventricular
reentrant tachycardia
F. Akerstrom, M.A. Arias, M. Jensen-Urstad, M. Pachon, P. Insulander, A. Puchol, L. Rodriguez-Padial (Toledo, ES; Stockholm, SE)
Atrial fibrillation after radiofrequency catheter ablation of atrial tachyarrhythmias in adult patients after surgical repair
of congenital heart disease
T. Noda, M. Wada, I. Nakajima, K. Ishibashi, K. Miyamoto, H. Okamura, T. Aiba, S. Kamakura, K.F. Kusano (Suita, Osaka, JP)
Long-term outcome of intra-atrial reentrant tachycardia catheter ablation in adults with congenital heart disease. P1545
R. Peinado, O. Salvador, A.E. Gonzalez, J. Ruiz-Cantador, A. Vega, D.H. Garcia, M.A. Gonzalez-Vasserot, J.L. Merino,
A. Sanchez Recalde, J.M. Oliver (Madrid, ES)
Chairpersons: B. Gorenek (Eskisehir, TR); G. Hindricks (Leipzig, DE)
Atrial cardiomyopathies: definition, characterisation and clinical implication
How to set up a syncope unit.
R.A. Kenny (Dublin 8, IE)
Chronic kidney disease in the patient with cardiac rhythm disturbances or implantable electrical devices.
HRS/EHRA/APHRS/ SOLAECE Expert Consensus Statement on Optimal ICD Programming and Testing.
Cardiac resynchronisation therapy (CRT): difficult decisions in complex patients Chairpersons: A.S. Manolis (Glyfada-Athens, GR); M. Lunati (Milan, IT)
To approach CRT in very specific and complex settings
CRT in NYHA IV patients with/without inotropes.
R.L. Lenarczyk (Zabrze, PL)
CRT in chronic and terminal kidney disease.
F. Leyva-Leon (Sutton Coldfield, GB)
CRT in congenital heart disease.
M.J. Schalij (Voorschoten, NL)
CRT in neuromuscolar disorders.
F. Anselme (Rouen, FR)
Previous unsuccessful attempts of LV lead implantation: which approach for resynchronisation?
I. Kassai (London, GB)
Non-lethal arrhythmic challenges in athletes.
Joint session with EACPR
Chairpersons: H. Heidbuchel (Hasselt, BE); T. Balabanski (Sofia, BG)
Every electrophysiologist is confronted with these vexing questions. How to proceed in practice?
Investigation of ventricular extra-systoles in athletes
A. Malhotra (London, GB)
Therapeutic advice to the athlete with atrial fibrillation.
Left ventricular non-compaction in an athlete's heart: hallmark or risk?
The young athlete with asymptomatic preexcitation.
Discussants:.
Complications of af ablation: avoidance, recognition and management
Chairpersons: M. Didenko (Saint - Petersburg, RU); M. Scaglione (Asti, IT)
The incidence of silent cerebral thromboembolism in catheter ablation for atrial fibrillation using novel oral anticoagulants
versus therapeutic warfarin
A. Aso, T. Nakamura, M. Nishihara, T. Mori, K. Takenaka, K. Numaguchi, Y. Murasato, K. Hiyamuta (Fukuoka, JP)
Incidence and predictors of pericardial effusion during and immediately after catheter ablation of atrial fibrillation
Y. Murakawa, A. Nogami, M. Shoda, K. Inoue, S. Naito, K. Kumagai, Y. Miyauchi, T. Yamane, N. Morita, K. Okumura (Kawasaki,
Tsukuba, Tokyo, Osaka, Maebashi, Fukuoka, Hachioji and Hirosaki, JP)
May a clinical assessment predict left atrial appendage thrombi presence in patients undergoing atrial fibrillation transcatheter
ablation? A large retrospective experience 1562
M. Anselmino, L. Garberoglio, S. Gili, A. Battaglia, S. Frea, W. Grosso Marra, M. Morello, D. Castagno, M. Scaglione, F. Gaita
(Turin and Asti, IT)
Risk of left atrial appendage thrombus in patients scheduled for ablation for atrial fibrillation beyond the CHA2DS2VASc score 1563
A.A. Sikorska, J. Baran, E. Pilichowska-Paszkiet, M. Sikora-Frac, T. Krynski, R. Piotrowski, S.M. Stec, B. Zaborska, P. Kulakowski
(Warsaw and Rzeszow, PL)
Higher incidence of esophageal lesions after atrial fibrillation ablation related to the use esophageal temperature probes.
P. Mueller, F. Fochler, A. Szoelloesi, K. Nentwich, M. Roos, J. Krug, P. Halbfass, A. Schade, T. Deneke (Bad Neustadt an der Saale, DE)
The clinical course and management of periesophageal vagal nerve injury after catheter ablation of atrial fibrillation: lessons
from long-term follow-up.
M. Terasawa, K. Satomi, Y. Iwasaki, K. Takarada, Y. Tsunoda, S. Takahashi, Y. Yazaki, Y. Goseki, K. Uno, A. Yamashina (Hachiouji
and Sapporo, JP)
Low vulnerability of the esophagus for electroporation ablation
K.G.E.J. Neven, V.J.H.M. Van Driel, H. Van Wessel, R. Van Es, H.H. Fidder, A. Vink, P.A.F.M. Doevendans, F.H.M. Wittkampf
(Utrecht, NL)
Ablation of atrial fibrillation with uninterrupted NOAC treatment during ablation of atrial fibrillation is not associated with
severe peri- and postprocedural complications
C. Wunderlich, M. Christoph, Y. Huo, M. Forkmann, T. Gaspar, J. Salmas, M. Pohl, J. Mayer, C. Piorkowski (Dresden, DE)
Feasibility and safety of apixaban as compared to rivaroxaban for periprocedural anticoagulation in patients undergoing
catheter ablation for atrial fibrillation
A. Rillig, J. Plesman, T. Lin, C.H. Heeger, A. Metzner, E. Wissner, S. Mathew, F. Ouyang, K.H. Kuck, R.R. Tilz (Hamburg, DE)
The safety of catheter ablation for atrial fibrillation using open irrigation catheter in patients on chronic hemodialysis
Y. Furukawa, T. Yamada, T. Morita, S. Tamaki, Y. Iwasaki, M. Kawasaki, A. Kikuchi, T. Kondo, M. Fukunami (Osaka, JP)
Awards and Closing Ceremony
Chairpersons: K.H. Kuck (Hamburg, DE); G. Hindricks (Leipzig, DE)
Summary EUROPACE 2015.
Pioneer in clinical Electrophysiology Lecture
Cardiac pacing: more than 50 years of conceptual and technological breakthroughs.
20 000 Vies.
L. Gaborieau (Levallois Perret, FR)
Young Investigator Award & Moderated Posters Winners Announcement.
Announcement: training Fellowship winners.
Announcement: academic Research Fellowship winner.
Farewell address EHRA president.
Efficacy and safety of PVI with the multielectrode irrigated-tip nMARQ catheter P. Vergara, L. Capulzini, G. Paparella (Milan, IT; Brussels, BE)
Ablation for atrial fibrillation combined with left atrial appendage closure: three years follow-up data P1585
A. Alipour, M.J. Swaans, V.F. Van Dijk, J.C. Balt, M.C. Post, M.A.R. Bosschaert, B.J. Rensing, L.V.A. Boersma (Nieuwegein, NL)
A meta-analysis on additional CFAE ablation in atrial fibrillation patients: no benefit over simple pulmonary vein isolation. P1586
R.A. Providencia, P. Lambiase, N. Srinivasan, G. Babu, S. Ahsan, F. Khan, E. Rowland, A.W. Chow, M. Lowe, O. Segal (London, GB)
Characteristics of patients with early in-hospital recurrence after cather ablation for atrial fibrillation: Insights from the German
ablation registry (W) P1587
A. Sultan, J.L. Luker, D.A. Andresen, K.H.K. Kuck, E.H. Hoffmann, J.B. Brachmann, S.W. Willems, L.E. Eckardt, J.S. Senges, D.S. Steven
(Cologne, Hamburg, Munich, Coburg, Münster and Ludwigshafen, DE)
Objective, automated lesion annotation (VisiTag) during pulmonary vein isolation: Influence on acute isolation rates and lesion
characteristics P1588
S. Asbach, C. Lang, L. Trolese, C. Bode, F. Schluermann (Freiburg, DE)
Radiofrequency catheter ablation for redo procedures after pv isolation with the cryoballoon technique: analysis of pv conduction
recovery patterns and long-term outcome of two ablation strategies P1589
K. Kettering, F. Gramley (Frankfurt, DE)
Biatrial rotor ablation guided by FIRM basket map: initial single center experience. P1590
L. Vitali Serdoz, P. Halbfass, C. Mahnkopf, J. Brachmann (Coburg, DE)
Atrial fibrillation recurrence after catheter ablation of paroxysmal atrial fibrillation: is there a role for left atrial speckle tracking
A. Monteiro, A. Galrinho, M. Oliveira, L. Branco, P.S. Cunha, P. Rio, R. Pimenta, M.J. Ferreira, P. Sarmento, R.C. Ferreira (Lisbon, PT)
Non invasive risk stratification identifies populations at high and low risk for long-term recurrence after catheter ablation of
persistent atrial fibrillation (W) P1592
J. Luker, A. Sultan, D. Schreiber, S. Lezius, M. Frohlich, H. Servatius, B.A. Hoffmann, S. Willems, D. Steven (Cologne and Hamburg, DE;
Bern, CH)
Silent cerebral lesions (scl) post-ablation with open-irrigated multi-electrode radiofrequency catheters in paf patients: results
from a subpopulation of the revolution and remarqable trials P1593
M. Grimaldi, M. Duytschaever, J. Sussman, E.G. Daoud, J.B. Deville, D. Lakkireddy, R. Horton, V. Swarup, A. Wickliffe, P. Jais
(Acquaviva Delle Fonti, IT; Brugge, BE; Morristown, Columbus, Plano, Kansas City, Austin, Phoenix and Atlanta, US; Bordeaux-Pessac, FR)
Location of rotors in patients with atrial fibrillation:use of a novel body surface mapping system C. Lemes, S. Deiss, T. Maurer, A. Saguner, A. Tsyganov, M. Chmelevsky, F. Ouyang, A. Metzner, K.H. Kuck, E. Wissner (Hamburg, DE;
Moscow and Saint Petersburg, RU)
Validation of a novel implantable cardiac monitor for AF detection: the Detect AF study results G. Noelker, J. Mayer, L.H. Boldt, K. Seidl, V. Van Driel, T. Massa, M. Kollum, J. Brachmann, M. Boogmans, T. Lewalter (Bad Oeynhausen,
Dresden, Berlin, Ingolstadt, Frankfurt, Singen, Coburg and Muenchen, DE; Leyenburg, NL; Bruxelles, BE)
Vasospastic angina as both a risk factor for new-onset atrial fibrillation and a predictor of negative outcome in atrial fibrillation patients M.J. Cha, S.R. Lee, W.H. Lim, S.H. Kang, Y.J. Cho, I.Y. Oh, E.K. Choi, S. Oh (Seoul, KR)
Effect of right ventricular pacing site on occurrence of atrial fibrillation G. Pastore, F. Zanon, E. Baracca, S. Aggio, C. Picariello, D. Lanza, L. Marcantoni, M. Carraro, L. Conte, L. Roncon (Rovigo, IT)
Clinical characteristics of patients aged under 40 with lone atrial fibrillation M. Maruyama, T. Noda, M. Wada, I. Nakajima, K. Ishibashi, H. Okamura, K. Miyamoto, T. Aiba, S. Kamakura, K. Kusano (Osaka, JP)
P wave dispersion - a clinically useful parameter that does not exist. K. Zimmer, W. Przywara, J. Gajek (Wroclaw, PL)
A new concept: single shot isolation of the left atrial appendage using the 28mm cryoballoon P1594
S. Bordignon, A. Fuernkranz, L. Perrotta, A. Kostantionu, B. Schullte-Hahn, B. Nowak, B. Schmidt, K.R.J. Chun (Frankfurt a.M., DE)
ICE assisted radiofrequency ablation of paroxysmal atrial fibrillation-modern standard in elderly patients P1595
I. Skigin, I. Pyaterichenko, K. Shorokhov, E. Voytkovskaya, T. Elizarova, A. Abramov (Saint-Petersburg, RU)
Time-dependent development of respiratory acidosis during conscious sedation for pulmonary vein isolation (W) P1596
R.F. Feurich, J.R. Ehrlich, A. Fink, G. Buerkle (Wiesbaden, DE)
High incidence of low esophageal temperatures during second generation cryoballoon therapy for atrial fibrillation P1597
Pulmonary vein stenosis after pulmonary vein isolation using duty-cycled unipolar/bipolar radiofrequency ablation guided by
intracardiac echocardiography P1598
S. Asbach, F. Schluermann, L. Trolese, G. Pache, C. Bode, T. Krauss (Freiburg, DE)
Superior efficacy of pulmonary vein isolation with online contact force measurement persists after the learning period:
a prospective case control study P1599
M. Wolf, J.B. Saenen, W. Bories, H.P. Miljoen, C. Vrints, A. Sarkozy (Antwerp, BE)
The coronary sinus is an important extra-PV substrate of paroxysmal atrial fibrillation: evidence from serial inducibility testing P1600
Does left atrial electroanatomical remodeling involve the P-wave to left appendage time determined by noninvasive transthoracic
Y. Hori, S. Nakahara, N. Tsukada, A. Nakagawa, N. Nishiyama, T. Komatsu, S. Kobayashi, Y. Sakai, I. Taguchi (Koshigaya City, JP)
Incidence of dormant conduction after pulmonary vein isolation using second-generation cryoballoon: comparison with irrigated-tip
radiofrequency ablation (W) P1602
I. Watanabe, Y. Okumuya, K. Takahashi, A. Hirayama (Tokyo, JP)
Incidence and characteristics of conduction gaps after pulmonary vein isolation using the endoscopic laser ablation system P1603
A. Fuernkranz, M. De Lazzari, D. Dugo, S. Bordignon, L. Perrotta, J.K.R. Chun, B. Schmidt (Frankfurt/M, DE)
Long-term follow-up of ablation with multiple generations of duty-cycled phased radiofrequency ablation using a subcutaneous
monitoring device P1604
G. Rovaris, E. Piazzi, S. De Ceglia, G. Zanotto, A. Vincenti (Monza and Legnago, IT)
Impact of two different linear ablation strategies (inferolateral vs. superoseptal mitral isthmus) on left atrial function in patients
with persistent atrial fibrillation P1605
T. Daehne, M. Brunelli, M.-A. Secknus, A. Grosse, S. Raffa, A. Cima, A. Madaffari, M. Frommhold, J.C. Geller (Bad Berka, DE)
Impact of hypertension on anatomical change of left atrial wall and output needed for pulmonary vein isolation in patients
with atrial fibrillation P1606
M. Kamioka, H.S. Suzuki, Y.M. Matsumoto, M.N. Nodera, T.K. Kaneshiro, Y.K. Kamiyama, Y.T. Takeishi (Fukushima, JP)
Atrial tachycardias occurring after surgical treatment of atrial fibrillation: Electrophysiological analysis and ablation strategies R. Krausova, D. Wichterle, P. Peichl, J. Kautzner, J. Pirk (Prague, CZ)
Long-term outcomes after surgical ablation for atrial fibrillation in patients with continuous heart rhythm monitoring devices T. Hanke, U. Stierle, P. Ziegler, B. Graf, S. Klotz, H.-H. Sievers, E. Charitos (Luebeck, DE; Minneapolis, US)
Endocardial vs epicardial ablation of atrial fibrillation: effectiveness and left atrial flutter incidence A. Chasnoits, D. Goncharik, O. Kovalenko, V. Halianishcha, V. Sevrukevich, A. Zigalkovich, V. Barsukevich, L. Plaschinskaya, A. Savchenko,
A. Mrochek (Minsk, BY)
First experience with CARTOUNIVUTM used in combination with the nMARQ multipolar circular ablation catheter in atrial
fibrillation ablation S. Varanasi, S.H. Chin, S. Siddiqui, G.S. Chu, S.H.W. Man, R. Somani, A.J. Sandilands, P.J. Stafford, G.A. Ng (Leicester, GB)
Cryoablation of typical AVNRT: younger age and administration of bonus ablation favor long-term success P. Pieragnoli, A. Paoletti Perini, L. Checchi, G.C. Carrassa, P. Carrai, A. Michelucci, L. Padeletti, G. Ricciardi (Florence, IT)
Catheter ablation within the aortic sinus cusp for ventricular arrhythmia-A safety distance between the tip of ablation catheter
and coronary artery ostium E. Nakano, T. Harada, Y. Takagi, M. Yamada, M. Takano, T. Furukawa, Y. Akashi (Kawasaki, JP)
Implementation of maximum voltage gradient technique for ablation of typical atrial flutter with zero-fluoroscopy approach. S.M.S. Stec, K.J. Deutsch, D.K. Karbarz, B.P. Pasicka, M.K.S. Klank-Szafran, J.S. Sledz, M.M. Mazij, B.L. Ludwik, A.K. Kusak, J.S. Spikowski
(Rzeszow, Kielce, Radom, Wroclaw and Szczecin, PL)
Long term mortality in patients undergoing permanent cardiac pacing K. Mohee, J. Ghosh, J. Zhang, A.L. Clark, S. Thackray, J.G. Cleland (Hull, GB)
Long-term prognosis for ventricular pacing of patients with atrial fibrillation: over ten years and large cohort analysis A. Kamijima, K. Ishibashi, M. Wada, I. Nakajima, K. Miyamoto, H. Okamura, T. Noda, T. Aiba, S. Kamakura, K. Kusano (Suita, JP)
Feasibility, safety, and acute hemodynamic effect of a new approach for anti-bradycardia pacing: left ventricular septum pacing
by transvenous approach through the inter-ventricular septum M. Mafi Rad, Y. Blaauw, J.G.L.M. Luermans, M. Janssen, H.J. Crijns, F.W. Prinzen, K. Vernooy (Maastricht, NL)
Implantable cardioverter defibrillator (ICD) therapy following CRT-D implantation is less common in women (W) P1623
A.M. Killu, A. Grupper, A. Mazo, T. Webster, K. Brooke, D.O. Hodge, P.A. Friedman, S.J. Asirvatham, M.J. Glikson, Y.M. Cha
(Rochester and Rochester MN, US; Tel Hashomer, IL)
Absence of externalized conductors and electrical dysfunction in durata leads: results from a prospective, multicenter study P1624
D. Hayes, R. Freedman, J. Porterfield, L. Porterfield, J. Dinerman, R. Styperek, C. Machell, G. Kim, A. Curtis (Rochester, Salt Lake City,
Memphis, Huntsville, Rome, San Antonio, Sylmar and Buffalo, US)
Atrial preventive pacing increase cumulative incidence of atrial arrhythmias longer than 5 minutes in ICD patients A. Fontenla, R. Salguero, J.B. Martinez-Ferrer, A. Rodriguez, J. Fernandez Pastor, E. Garcia, N. Basterra, R. Romero,
J. Fernandez De La Concha, F. Arribas (Santa Cruz de Tenerife, Madrid, Alava, Malaga, Vigo, Pamplona and Badajoz, ES)
The subxiphoidal pacemaker with epicardial lead - a safe therapy for pacemaker dependent patients after device explantation
due to infection? V. Moeller, M. Seifert, F. Hoelschermann, C.H. Butter (Bernau bei Berlin, DE)
Role of positron emission tomography in the diagnosis of cardiac implantable electronic device infection J. Whitaker, H. Raju, A. Corrigan, N. Patel, S. Nordin, H. Chubb, M.O.neill, S. Barrington, C.A. Rinaldi (London, GB)
Is defibrillator back-up always needed at the end of service life of CRT-D? Insights from the DECODE registry. M.L. Narducci, E. Menardi, P. Ferrari, F. Quartieri, C. La Rosa, G. Stabile, M. Zoni Berisso, V. Carinci, M. Malacrida, F. Zanon
(Rome, Cuneo, Bergamo, Reggio Emilia, Taranto, Naples, Genoa-Sestri Ponente, Bologna, Milan and Rovigo, IT)
Serum markers of collagen turnover predict future shocks in ICD recipients with dilated cardiomyopathy on optimal treatment J. Fanourgiakis, E. Kanoupakis, E. Kallergis, H. Mavrakis, M. Vernardos, G. Mpantouvakis, A. Daskalakis, G. Chlouverakis, P. Vardas
(Heraklion, GR)
Primary prevention implantable cardioverter defibrillator: is battery replacement always needed? G. Dell'era, A. Degiovanni, E. Occhetta, A. Magnani, S. Gavazzoli, L. Plebani, P. Marino (Novara, IT)
High event rates support application of SCD HeFT criteria for primary prevention of sudden death in a multi-ethnic asian heart failure
cohort R. Cherian, P. Kojodjojo, D. Singh, W.T. Yeo, S.C. Seow, T.W. Lim (Singapore, SG)
Occurrence of supra-ventricular and ventricular arrhythmias in a current implantable cardioverter defibrillator population:
preliminary observations from the things registry D. Giorgi, V. Calvi, M. Bertini, V. Carinci, M. Iori, G. Bolognesi, M. Pastore, E. De Maria, D. Grassini, M. Biffi (Lucca, Catania, Ferrara,
Bologna, Ravenna, Piacenza, Fidenza, Carpi and Milan, IT)
Prevalence, methods, efficacy, and safety of radiofrequency ablation of focal atrial tachycardia arising from non-coronary sinus
of Valsalva in the aorta: a single centre experience. M. Toniolo, L. Rebellato, D. Muser, E. Daleffe, A. Proclemer (Udine, IT)
Correlation between the sudden jump-like increases of the AH interval induced during incremental atrial pacing and during
programmed atrial stimulation T.N. Shalganov, B.T. Kunev, M.K. Stoyanov (Sofia, BG)
10 year follow-up of patients treated by radiofrequency ablation for right ventricular outflow tract tachycardia/premature ventricular
contractions S. D Roervik, P.I. Hoff, J. Chen, E. Solheim, P. Schuster (Bergen, NO)
Efficacy and safety of different energy settings for cavotricuspid isthmus ablation in patients with typical atrial flutter A. Madaffari, K. Hanazawa, A. Grosse, T. Daehne, M. Frommhold, A. Cima, M. Brunelli, S. Raffa, J.C. Geller (Bad Berka, DE)
Post-procedural heart rate reduction predicts need for permanent pacemaker implantation after transcathether aortic valve
implantation in patients with atrial fibrillation G. Portugal, M. Oliveira, A. Abreu, L. Patricio, D. Cacela, P.S. Cunha, A. Lousinha, R. Ramos, S. Almeida, R. Ferreira
(Lisbon and Vila Franca de Xira, PT)
Exercise training improves functional capacity in pacemaker users G. Peixoto, E.G.D. Licariao, D. Lobo, C.E. Negrao, P.A. Oliveira, R.A. Teixeira, S.A.D. Nishioka, S.F. Siqueira, R. Costa, M. Martinelli
Optimization of coronary sinus lead placement by means of Right-to-Left Delay reduces QRS width and improves clinical outcome
of cardiac resynchronization therapy D. Solari, R. Carpi, F. Di Lorenzo, D. Oddone, P. Donateo, R. Mureddu, M. Brignole (Lavagna, IT)
How does scar affect the potential benefit of triventricular pacing over conventional CRT? P.R. Huntjens, J. Walmsley, P. Bordachar, S. Ploux, F.W. Prinzen, T. Delhaas, J. Lumens (Maastricht, NL; Bordeaux-Pessac, FR)
The effect of atrioventricular and ventriculo-ventricular delay optimisation on ventricular activation times T.A. Jackson, S. Claridge, J. Behar, R. Razavi, C.A. Rinaldi (London, GB)
The ability of preoperative cardiovascular magnetic resonance imaging to identify optimal target sites for transvenous left
ventricular lead placement A. Parikh, G.R. Hartlage, P.T. Strickland, E. Okene, F.M. Merchant, J.N. Oshinski, M.S. Lloyd (Atlanta, US)
A combined electroanatomic activation and voltage map discriminates patients with right bundle branch block who profit from
cardiac resynchronization therapy M. Zarse, H. Bogossian, A. Kloppe, D. Mijic, Z. Karosiene, H. Suleimann, F. Hasan, Q.S. Nguyen, J. Kolbe, B. Lemke (Lüdenscheid, Bochum
and Luedenscheid, DE)
Fragmented-QRS after receiving cardiac resynchronization therapy was strongly associated with ventricular arrhythmias or
sudden cardiac death M. Igarashi, H. Tada, H. Yamasaki, K. Kuroki, T. Machino, Y. Sekiguchi, Y. Noguchi, A. Nogami, K. Aonuma (Ibaraki, Fukui and Tsukuba, JP)
The impact of applied ECG criteria for diagnosing left bundle branch block on the outcome of cardiac resynchronization therapy K. Gladisova, P. Margitfalvi, M. Sasov, P. Hlivak, H. Cerna, A. Vachulova, M. Svetlosak, L. Urban, V. Bernat, R. Hatala (Bratislava, SK)
Comparison of conventional biventricular and triple site pacing on acute hemodynamic response. F. Zanon, G. Pastore, E. Baracca, L. Marcantoni, D. Lanza, C. Picariello, L. Roncon, S. Aggio, M. Rinuncini, F.W. Prinzen
(Rovigo, IT; Maastricht, NL)
Left ventricular endocardial stimulation in patients with atrial fibrillation using puncture of interventricular septum Y. Karpenko (Odessa, UA)
Lead dependent infective endocarditis analysis of survival after transvenous leads extraction procedure P1642
A. Polewczyk, W. Jachec, G. Opolski, M. Grabowski, M. Janion, A. Kutarski (Kielce, Zabrze, Warsaw and Lublin, PL)
Efficacy and safety of permanent epicardial leads implantation before leads extraction in pacemaker-dependent patients with infective
endocarditis: a single center experience P1643
L. Bontempi, F. Vassanelli, M. Cerini, A. Lipari, L. Inama, N. Ashofair, G.L. Bisleri, F. Rosati, C. Muneretto, A. Curnis (Brescia, IT)
Frequency and clinical impact of retained implantable cardioverter defibrillator material in heart transplant recipients P1644
J. Kim, M.S. Kim, M.S. Kim, G.B. Nam, K.J. Choi, Y.H. Kim, J.J. Kim (Seoul, KR)
Implantable loop recorder for unexplained syncope A. Bovin, J. Malczynski, D. Dalsgaard (Herning, DK)
Value of the combination of risk scales as triage in a syncope unit V. Leon Arguero, A. Gil Sanchez, R. Padron, E. Velasco, M. Martin, J.M. De La Hera, C. Corros, A. Garcia, C. Moris De La Tassa
(Oviedo, ES)
Atrioventricular block induced by tilt testing-a rare finding O.-A. Nastase, L. Mandes, M. Rac-Albu, C. Ginghina, R. Ciudin (Bucharest, RO)
Non-pharmacological interventions protect from malignant arrhythmias partially by targeting myocardial Cx43 in rodent model
of essential hypertension. N. Tribulova, T. Benova, B. Szeiffova-Bacova, J. Radosinska, C. Viczenczova, V. Knezl, J. Slezak (Bratislava, SK)
Ischemia prior to ventricular tachyarrhythmia does not affect survival in acute myocardial infarction patients treated with
a wearable cardioverter defibrillator R. Perumal, S. Szymkiewicz (Pittsburgh, US)
Increased periatrial adipose tissue is associated with left atrial dysfunction and can predict the development of stroke in patients
with atrial fibrillation H.-M. Tsao, W.-C. Hu, S.-A. Chen (Yi-Lan, Chung-Li and Taipei, TW)
The effect of patient geometry on the ECG in patients with heart failure and intraventricular conduction defects: an in-silico study U.C. Nguyen, M. Potse, F. Regoli, M.L. Caputo, G. Conte, S. Muzzarelli, T. Moccetti, F.W. Prinzen, R. Krause, A. Auricchio
(Maastricht, NL; Lugano, CH)
Incidence of pathological electrocardiographic findings and accordance of those with accepted normal ranges in the population
of first grade pupils K. Jubele, A. Knipse, O. Sesunaceva, A. Buls, O. Kalejs, A. Lejnieks (Riga, LV)
P-wave duration after cavotricuspid isthmus catheter ablation is associated with dilated left atrium and right atrial conduction time H. Watanabe, T. Kabutoya, T. Watanabe, Y. Imai, K. Kario (Tochigi, JP)
Impact of non-dipper hypertension on the ventricular electrical and mechanical dysfunction S.I. Im, K.I. Cho, H.S. Kim, J.H. Heo, T.J. Cha (Busan, KR)
Usefulness of external long-lasting ECG monitoring for the diagnosis of unexplained syncope and palpitation: Results of the
SYNARR-FLASH study E.T. Locati, M. Brignole, J.M. Ormaetxe, H. Tanner, M. Oliveira, M. Lopez-Gil, X. Sabate, N. Rivas, R. Willems, A. Moya
(Milan and Lavagna, IT; Bilbao, Madrid and Barcelona, ES; Bern, CH; Lisbon, PT; Leuven, BE)
Beta blockers assumption among patients implanted with cardioverter defibrillator do not reduce appropriate ICD shock. F. Santoro, P.L. Pellegrino, G.D.arienzo, L. Ziccardi, M. Caivano, D. Gianfrancesco, D. Montrone, G. Triggiani, N.D. Brunetti, M. Di Biase
(Foggia, IT)
Comparison between atropine and adrenaline for atrioventricular nodal reentrant tachycardia induction G. Cismaru, S. Gerguri, J. Asamoah, R. Rosu, L. Muresan, M. Puiu, G. Gusetu, D. Pop, P.A. Mircea, D. Zdrenghea (Cluj Napoca, RO)
Phenotype variability associated with andersen tawil syndrome E. Nof, R. Cherki, E. Burashnikov, G. Caceres, R. Beinart, M. Eldar, C. Antzelevitch, M. Glikson (Tel Hashomer, IL; Utica, US)
rs1805124 polymorphism of SCN5A gene and primary left bundle branch block A. Chernova, S.Y.U. Nikulina (Krasnoyarsk, RU)
Polymorphism of gene interleukin-6 is associated with atrial fibrillation in patients with COPD E.A.V. Volchkova, A.A.Z. Zateyshchikova, I.V.S. Shavrin, I.V.Z. Zotova, A.G.N. Nikitin, K.A.B. Brovkin, V.V.N. Nosikov,
D.A.Z. Zateyshchikov (Moscow, RU)
Biomarkers of cardiovascular stress in assessment the left atrial remodeling in patients with ischemic chronic heart failure with atrial
fibrillation D. Lashkul, V.D. Syvolap (Zaporizhzhya, UA)
Endomyocardial Biopsy from right ventricular in children with drug-refractory arrhythmias E.S. Vasichkina, H.R. Poghosyan, L.B. Mitrofanova, R.B. Tatarsky, D.S. Lebedev (Saint Petersburg, RU; Yerevan, AM)
Symptomatic premature ventricular complexes are associated with left ventricular outflow tract time velocity integral. J.Y. Kim, S.H. Kim, I.G. Song, T.S. Kim, J.H. Kim, S.W. Jang, M.Y. Lee, T.H. Rho, Y.S. Oh (Seoul, KR)
In the pigeon heart atrioventricular valve pacemaker myocytes are found exclusively in those sites where annulus fibrosus is present V. Prosheva (Syktyvkar, RU)
The effect of beta-blocker in modulating ventricular fibrillation inducibility and electrical restitution during sympatho-vagal interaction
in isolated rabbit hearts P1665
S.H. Chin, E. Wake, K.E. Brack, G.A. Ng (Leicester, GB)
Occurrence of ventricular and supraventricular arrhythmias in patients with severe pulmonary hypertension is associated
with abnormal heart rate turbulence, an indicator of sudden cardiac death. P. Bienias, M. Ciurzynski, O. Dzikowska-Diduch, Z. Rymarczyk, M. Roik, M. Kostrubiec, M. Kurzyna, A. Torbicki, A. Fijalkowska,
P. Pruszczyk (Warsaw, PL)
Takotsubo cardiomyopathy associated with cardiac device implantation T. Kondo, J. Miake, K. Ogura, M. Kato, K. Iitsuka, K. Yamamoto (Yonago, JP)
Study on ventricular arrhythmias in acute myocardial infarction M.T. Rahman (Dhaka, BD)
Particular reaction of blood pressure in young elite athletes in exercise stress test L. Makarov, N. Fedina, V. Komoliatova, D. Besportochny, I. Kiseleva (Moscow., RU)
ECG abnormalities in pericardial disease: association with arrhythmias and clinical signs T. Kudaiberdiev, G. Imanalieva, K. Tilemanbetova (Bishkek, KG)
Improved clinical outcomes with the use of new oral anticoagulants in aged patients with atrial fibrillation K.H. Lee, H.W. Park, N.S. Yoon, J.G. Cho, Y.K. Ahn, M.H. Jeong, J.C. Park, S.S. Kim (Gwangju, KR)
Clinical aspects in real life patients with atrial fibrillation and different oral anticoagulants B. Lurina, M. Kovalova, G. Rancane, I. Sime, G. Dormidontova, E. Miglane, B. Tilgale, O. Litunenko, A. Lejnieks, O. Kalejs (Riga, Jelgava,
Ventspils, Liepaja and Daugavpils, LV)
Incidence and survival of out-of-hospital cardiac arrest in the swiss canton ticino M. Caputo, R. Mauri, R. Burkart, C. Benvenuti, T. Moccetti, A. Del Bufalo, A. Gallino, C. Casso, C. Klersy, A. Auricchio (Lugano and
Breganzona, CH; Pavia, IT)
Painting by Françoise Persillon
Imprimé par Newméric
World Congress on Cardiac Electrophysiology
www.cardiostim.com
Invasive & Non-Invasive Electrophysiology - Catheter Ablation - Pacing & Defibrillation - Heart
Failure - Cardiac Imaging - Angiogenesis & Genetics - Emerging Cardiovascular Technologies
Dr Philippe Ritter - CARDIOSTIM
E-mail: [email protected]
Created by Jacques Mugica
Millions of people have atrial fibrillation this website can help to understand
What is Atrial Fibrillation?
What are the signs & symptoms?
How to live with Atrial Fibrillation?
www.afibmatters.org
www.fibrillation-auriculaire.org
www.vorhofflimmern-zaehlt.org
www.fibrillazioneatriale.org
www.fibrilacion-auricular.org
Aÿbmatters.org is supported in the form of an unrestricted educational grant by:
SESSION BY TOPIC
NAME/PAGE NUMBER
Ablation track (Traditional ablation & Ventricular tachycardia ablation)........................................................................................................................................................................................................................................................18, 23, 30, 35, 63, 71, 77, 98, 103
Arrhythmias in athletes.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................31, 134
(AF, AF ablation, Anticoagulation).........................................................................................................................................................................................................................................................................................................................................................17, 19, 22, 24, 29, 31, 34, 57, 62, 70, 76, 97, 102, 109, 114
(Genetics & Basic Electrophysiology)........................................................................................................................................................................................................................................................................................................................................................................................18, 23, 30, 35, 58, 63, 78, 99, 105, 111, 116, 131
(ICD - CRT)............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................17, 23, 30, 34, 57, 62, 71, 76, 97, 100, 103, 109, 115, 134
(ECG and eCardiology, Remote monitoring, ECG interpretation)..........................................................................................................................................................................................................................................19, 24, 31, 36, 58, 64, 72, 78, 110, 115, 132, 135
Nurses and Allied Professional track - (Nurse, Allied Professional, other)............................................................................................................................................................................................................................19, 25, 31, 36, 59, 64, 73, 78, 99, 105
Pacing track - (Cardiac Pacing, Lead management - extractions and recalls)....................................................................................................................................................................17, 22, 29, 34, 57, 62, 71, 73, 76, 97, 109, 114
Paediatric ...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................65, 73, 79
Pharmacology /cancer chemotherapy / Pregnancy.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................20, 25, 32, 37, 59
Registries and surveys..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................77, 98, 104, 110, 115
Satellite Symposia...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................27, 28, 61, 66, 67, 68, 81, 107, 108
Scientific documents and Guidelines...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................114, 131, 134
Special events........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................38, 74, 105, 112, 136
Special sessions ..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................22, 29, 61, 69, 70, 75, 102, 113
Syncope..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................99, 104, 110, 116
ESC Working Group on Cardiac Cellular Electrophysiology sessions............................................................................................................................................................................................................................................................18, 24, 31, 36, 48, 58, 63, 72, 77, 82
Young electrophysiologist / Women in electrophysiology....................................................................................................................................................................................................................................................................................................................................................................................................................................98, 104, 111, 116
Abstract sessions................................................................................................................................................................................................................................................................................................................................................................................................................................ 20, 26, 31, 37, 59, 65, 74, 80, 100, 106, 111, 112, 117, 132, 135
Moderated Poster sessions.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................21, 33, 60, 75, 101, 113, 133
Poster sessions............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................39, 42, 51, 82, 91, 119, 125, 137
CHAIRPERSONS & JUDGES
Abd El Wahab A.: 36
Abraham W.T.: 132
Aliyev F.: 23
Almendral Garrote J.M.: 26
Alonso Martin A.: 69
Anic A.A.: 78
Antoons G.: 58
Antz M.: 26
Arbelo E.: 98
Arenal Maiz A.: 21
Arentz T.: 72
Atie J.: 20
Auricchio A.: 68, 72, 107
Avraamides P.: 30
Balabanski T.: 134
Barbuti A .: 36
Baron Esquivias G.: 104
Bauer A.: 31
Behr E.: 30
Bezzina C.R.: 29
Biffi M.: 109
Birgersdotter-Green U.: 114
Blanc J.-J.: 60, 116
Blomstrom-Lundqvist C.: 22, 81, 110
Boersma L.V.A.: 22
Bollmann A.: 107
Bongiorni M.G.: 22, 27, 62, 77
Borggrefe M.: 18, 103
Braunschweig F.: 58, 64
Breithardt G.: 17, 66, 115
Breithardt O.A.: 113
Brugada Terradellas J.: 115
Camm A.J.: 29, 81
Cappato R.: 67
Capucci A.: 25
Casadei B.: 29, 111
Cazeau S.: 111
Charpentier F.: 36
Chen J.: 110
Christ T.: 18
Colosio S.: 19
Crijns H.J.G.M.: 74, 102
Curnis A.: 72, 108
Cygankiewicz I.: 24
Daubert J.C.: 103
Day J D.: 19
De Potter T.J.R.: 80, 98
Defaye P.: 67
Deharo J.-C.: 62, 108
Della Bella P.: 28, 71, 107, 113
Didenko M.: 135
DiFrancesco D.: 58, 111
Dobrev D.: 77
Doshi S.K.: 68
Duray G.Z.: 29, 113
Duytschaever M.: 75, 112
Eckart L.: 101
Efremidis M.: 35
Ehrlich J.R.: 111, 131
Eldar M.: 18, 106
Elders J.: 59
Ernst S.: 116
Estes N.A.M.: 131
Estner H.: 77
Farre J.: 132, 135
Fenelon G.: 63
Filippatos G.S.: 114
Fogelman R.: 65
Francis D.: 24
Gadler F.: 63
Gaita F.: 18
Galal W.: 34
Gasparini M.: 115
Geelen P.: 133
Geller L.A.: 98
Giannessi C.: 19
Gizurarson S.: 99
Glikson M.: 109, 117
Goette A.: 24, 32, 62, 75
Gold M.R.: 62
Goldenberg I.: 65, 97, 103
Gomez A.: 24
Gorenek B.: 134
Grace A.: 77
Grimaldi M.: 27, 102
Guedon-Moreau L.: 64
Halimi F.: 18, 37
Hamdan M.: 99
Haouala H.: 110
Hatala R.: 76
Hauer H.A.: 99
Haugaa K.H.: 59, 63
Healey J.: 23, 32
Hebe J.: 73
Heidbuchel H.: 134
Hindricks G.: 19, 29, 64, 66, 70, 102, 134, 136
Hinterbuchner L.: 105
Hocini M.: 66, 113
Hovhannesyan A.N.: 34, 131
Huikuri H.V.: 101
Israel C.W.: 17
Jaarsma T.: 31
Janousek J.: 65
Jordaens L.: 30
Jubele K.: 111
Kalman J.M.: 64
Karpenko Y.: 71
Katz A.: 78
Kennergren C.E.H.: 76, 107
Khachatryan A.: 37
Khoury M.: 99
Kirchhof P.: 57, 114
Kourtellaris P.: 25
Kuck K.-H.: 27, 31, 38, 57, 66, 70, 109, 117, 131, 136
Kutyifa V.: 65, 104, 132
Lamp B.: 60
Larsen J.M.: 71
Le Heuzey J.-Y.: 58
Leclercq C.: 67, 98, 114
Lendeckel U.: 111
Levy S.: 57
Leyva-Leon F.: 61, 73
Linde C.: 111, 115
Lip G.Y.H.: 73, 109, 114
Lobban T.: 99
Lombardi F.: 19
Love C.: 71
Lunati M.: 68, 134
Luria D.: 97
Mabo P.: 17
Magalhaes L.: 31
Makaryan Y.S.: 20
Malik M.: 31, 58
Malmborg H.: 59
Manola S.: 131
Manolis A.S.: 134
Mansour A.H.: 78, 105
Mansourati J.: 33, 100
Marin F.: 114
Marquie C.: 108
Mavrakis I.: 21
Meine M.: 107
Merino J.L.: 22, 103, 133
Merkely B.: 71, 104
Metzner A.: 100
Mitkowski P.: 17
Mont L.: 63, 97
Morgan J.M.: 75
Morichelli L.: 73
Mudd J.: 64
Murgatroyd F.D.: 34, 57
Pruvot E.: 105
Raffagnato P.: 25
Raviele A.: 76
Reddy V.: 29
Remme C.A.: 18
Revishvili A.S.: 36
Rienstra M.: 32
Rillig A.: 32
Ristic A.D.: 57
Ritter P.: 57, 105, 117
Romanov A.: 22
Rosenthal E.: 73
Roses Noguer F.: 79
Rostock T.: 97
Rueb N.: 80
Russo A.: 35
Okumura K.: 24
Oloriz T.: 77
O'neill M.: 76, 112
Oto A.: 116
Napolitano C.: 30, 35
Neuzil P.: 97
Ng G.A.: 33
Nielsen J C.: 74, 98, 115
Nof E.: 116
Norekval T.M.: 31, 36
Padeletti L.: 71
Papiashvili G.: 115
Pappone C.: 70
Piorkowski C.: 23, 28, 70
Platonov P.G.: 20
Ploux S.: 62
Poole J.: 59, 69
Porfili A.: 25
Potpara T.: 75
Pretorius V.: 22
Prinzen F.W.: 100, 105
Priori S.G.: 23, 110
Probst V.: 35
Proclemer A.: 98, 104
Walfridsson U.: 64
Wellens H.J.: 132, 135
Wolpert C.: 30, 106
Zaza A.: 72
Zeppenfeld K.: 37
Zizek D.: 34
Zupan I.: 23
Santini M.: 72
Sarkozy A.: 116
Scaglione M.: 135
Schalij M.J.: 20
Schilling R.: 62, 66
Schmidt G.: 19
Settergren M.: 109
Shen W.K.: 17, 104
Silberbauer J.C.: 61
Simmers T.A.: 27
Simonelli N.: 59, 99
Smith G.L.: 72
Sperzel J.: 97, 108, 117
Steinberg J.: 76
Stellbrink C.: 76
Sticherling C.: 30
Sutton R.: 110, 116
Vos M A.: 59
Vukmirovic M.: 131
Tagney J.: 73, 78
Tahirovic E.: 17
Teles R.: 109
Thiene G.: 58
Thomsen M.B.: 77
Tolosana J.M.: 100
Tondo C.: 67
Van Gelder I.C.: 37
Vardas P.E.: 34, 117
Vatasescu R.-G.: 79
Viskin S.: 23, 110
Volders P.G.A.: 24, 78, 105, 111
NAME/INDEX NUMBER
Abe H.: 1293
Abriel H.: 153, 553, 785
Acosta J.: 1149
Adler Y.: 544
Adragao P.P.: 16
Aguinaga Arrascue L.E.: 604
Alboni P.: 1225
Almendral Garrote J.M.: 1080, 1192, 148
Amara W.: 1223
Ammar S.: 14
Andreassi M.G.: 78
Ang R.: 1079
Anguera Camos I.: 10
Anselme F.: 1553
Anselmino M.: 129
Aquilina O.: 1096
Auricchio A.: 1104, 1187
Baratto F.: 1075
Baron Esquivias G.: 1295
Behar N.: 611
Behr E.: 218
Beinart R.: 691
Belardinelli L.: 152
Belhassen B.: 1285
Bellin M.: 155
Ben Gal T.: 167
Benditt D.G.: 1157
Berruezo Sanchez A.: 1099
Berul C.: 566
Betts T.R.: 667
Bezzina C.R.: 215
Biffi M.: 1185
Birgersdotter-Green U.: 1235, 674
Bisbal van Bylen F.: 1148
Bisceglia C.: 551
Blaauw Y.: 68
Blanc J.-J.: 1073, 1092
Blom N.: 793, 795
Blomstrom-Lundqvist C.: 1062, 1290, 812, 1574
Boersma L.V.A.: 641
Bogdan S.N.: 1085
Boink G.J.J.: 1298
Bongiorni M.G.: 1069, 1087, 117, 661
Bonnemeier H.: 1300
Bordachar P.: 1071
Borggrefe M.: 1270
Boriani G.: 1091, 1548, 715, 764, 781
Botto G.L.: 1074, 248, 663
Boveda S.: 642, 693, 711
Brachmann J.: 1156, 1287, 540, 619
Braunschweig F.: 560, 724
Breithardt G.: 135
Brignole M.: 1065, 1160, 678, 7
Brugada Terradellas J.: 1086, 1219, 1284, 792, 794
Brugada Terradellas R.: 1215
Burri H.: 1211, 224, 546, 761
Butter C.: 1067, 125, 697
Draoli N.: 100
Drew B.J.: 1165
Durante A.: 101
Duray G.Z.: 699
Duru F.: 1163
Duytschaever M.: 649
Echt D.: 1107
Eckardt L.: 660
Ehrlich J.R.: 11, 137
Eldar M.: 701
Elders J.: 621
Elliott P.M.: 610
Ellis E.C.: 1189
Ernst S.: 1084, 1164, 80
Caballero R.: 1519
Caiani E.G.: 561
Calovic Z.: 1197
Camm A.J.: 539, 646, 816
Cappato R.: 1131, 1274, 662
Capucci A.: 170
Casadei B.: 194, 712
Ceriotti C.: 1128
Cervellione R.: 35
Cha Y.-M.: 1303, 545
Chierchia G.B.: 814
Chinitz L.: 780
Chun K.J.: 640
Cleland J.G.F.: 1072, 1184
Clementy N.: 1186
Colosio S.: 102
Conte G.: 85
Coppini R.: 1520
Cowan J.C.: 1264
Crijns H.J.G.M.: 103
Crotti L.: 1518
Curnis A.: 1194
Daubert J.C.: 1289, 1571, 3, 664
Dawood D.: 106
de Chillou C.: 1144
de Groot N.M.S.: 171, 568, 725
De Potter T.J.R.: 669, 79
De Roy L.: 706
Defaye P.: 1190, 599, 657, 710
Deharo J.-C.: 1095, 1155, 226, 6, 679
Deisenhofer I.: 1301, 131, 151, 677
Delgado V.: 698
Della Bella P.: 1262, 132, 591
Demion M.: 787
Deneke T.: 1078
Derval N.: 595
Dickstein K.: 1279
DiFrancesco D.: 1297
Dobrev D.: 1161
Dobrzynski H.: 219
Doevendans P.A.F.M.: 1166
D'Onofrio A.: 616
Doshi S.K.: 666, 673
Faerestrand S.: 720
Farre J.: 1525, 1559
Fauchier L.: 1549, 537
Fazal I.A.: 564
Fedorowski A.: 1093
Figueiredo M.J.O.: 162
Finlay M.C.: 1171
Fitzpatrick A.P.: 1158
Fitzsimons D.: 228
Fogelman R.: 798, 800
Foran J.P.M.: 671
Francis D.: 1139, 1141
Friedman P.: 200, 4
Fynn S.P.: 211
Gaborieau L.: 1576
Gadler F.: 72, 763
Gaita F.: 1063
Galimberti P.: 592
Gasparini M.: 1128, 207, 209, 592
Gitt A.K.: 1281
Glikson M.: 1082, 1515, 250, 543, 1572
Goette A.: 1546, 644
Gold M.R.: 145, 234, 31
Goldenberg I.: 77
Gorenek B.: 1514
Goronja B.: 1292, 1294, 1296
Grimaldi M.: 127
Gronda E.: 1269
Guedon-Moreau L.: 675
Gustafsson F.: 124
Guy-Moyat B.: 708
Hamdan M.: 1159
Hatem S.: 139
Haugaa K.H.: 1234
Healey J.: 201, 203
Hebe J.: 626
Heidbuchel H.: 1522
Heinzel F.R.: 1229
Hendriks J.M.L.: 231, 721
Herrera Siklody C.: 676, 685
Herweg B.: 225
Hindricks G.: 1271, 617, 782, 1575
Hinterbuchner L.: 1100, 790
Hocini M.: 1263, 639, 719
Hoegh Petersen H. : 198
Hoffmann E.: 676
Hohnloser S.H.: 233
Hoke U.: 1228
Huikuri H.V.: 28
Imazio M.: 196, 542
Inoue K.: 95
Israel C.W.: 1212, 1288, 601
Jaarsma T.: 229, 624
Jais P.: 1106, 1193, 214, 704
Jalife J.: 593
Janousek J.: 728
January C.: 1266
Johansen J.B.: 165
Jung W.: 199, 714
Kaab S.: 136, 216, 98
Kalman J.M.: 1265, 212
Kassai I.: 1554
Kautzner J.: 605, 692, 766
Kenny R.A.: 1547
Khawaja M.Z.: 40
Kirchhof P.: 160, 30, 647
Kirkfeldt R.: 1088, 70
Klein H.U.: 75
Kletsiou E.: 622
Kloppe A.: 1196
Klug D.: 71
Knecht S.: 607, 754
Knops R.: 654
Kolb C.: 1231, 227
Kuck K.-H.: 122, 126, 246, 254, 643
Kuklik P.: 752
Kutarski A.: 597
Lambiase P.: 206, 208, 659
Landolina M.: 716
Lane D.: 1516
Lau D.H.: 166
Le Heuzey J.-Y.: 172
Leclercq C.: 1210, 658
Leenhardt A.: 17
Lenarczyk R.L.: 1550
Lettino M.: 718
Lewalter T.: 66
Leyva-Leon F.: 1551
Lieberman R.: 1214
Lim P.B.: 1191
Linde C.: 230, 249, 674, 683, 1570
Lip G.Y.H.: 161, 2, 645, 813, 96
Lobban T.: 789
Loh P.: 149
Lohr F.: 41
Lombardi F.: 559, 93
Love C.: 1068
Lunati M.: 713
Luzzi G.: 1066
Maack C.: 86
Maass A.H.: 42
Mabo P.: 614, 700
Madrid A.H.: 1221, 772
Maggioni A.P.: 193
Mahajan R.: 618
Mahnkopf C.: 1098
Malhotra A.: 1555
Malik M.: 251, 27, 92
Marijon E.: 1153
Marinskis G.: 5
Marrouche N.: 756
Martins R.P.: 138
Mastenbroek M.H.: 680
Maury P.: 702
Mazzone P.: 1129
Meine M.: 1183
Merino J.L.: 63, 64, 65, 1573
Merkely B.: 765
Michaud G.: 688
Mitsuhashi T.: 97
Mittal S.: 758
Mondesert B.: 1130
Monserrat L.: 608
Mont L.: 1064, 120, 142, 1556
Morgan J.M.: 1286, 143, 202, 204, 749, 750, 751
Morichelli L.: 38, 615
Morken I.: 168
Moya I Mitjans A.: 1227
Mudd J.: 723
Mullens W.: 1140, 1142
Murgatroyd F.D.: 681
Nakagawa H.: 1145
Napolitano C.: 1218, 83
Newham A.: 563
Ng G.A.: 128
Nof E.: 84
Nolan P.: 791
Norekval T.M.: 1102
Normand C.: 1278
O'Donnell D.: 1195
Olde Nordkamp L.R.A.: 146
Oldgren J.: 1204
Oloriz T.: 705
Olshansky B.: 1523
Ommen S.: 612
Oster J.: 558
Oto A.: 12
Ouyang F.: 1097
Ovsyshcher I.E.: 73
Ozcan E.E.: 1081
Packer D.L.: 1132
Padeletti L.: 248
Panhuyzen-Goedkoop N.M.: 1232
Pap R.: 213
Papadakis M.: 1162, 1557
Park C.I.: 707
Parkash R.: 1233, 694
Pathak R.: 684
Paul T.: 726
Pedersen S.S.: 1103, 147, 788
Pelargonio G.: 675
Penela D.: 1151
Petronio A.S.: 1208
Pinto F.J.: 247, 768
Piorkowski C.: 613, 650
Pison L.: 1222
Pohl M.: 1083
Potpara T.: 1206, 1220, 1276, 774
Pretorius V.: 759
Prinzen F.W.: 1172, 562
Priori S.G.: 154, 26
Proclemer A.: 771
Przibille O.: 1201
Quesada Dorador A.: 1070
Rafla S.M.: 1292, 1294, 1296
Reddy V.: 1076, 133, 34, 687, 690
Regoli F.: 757
Remme C.A.: 550
Ricci R.P.: 783
Richter S.: 547
Rinaldi C.A.: 695, 762
Rincon L.M.: 538
Ritter P.: 118, 140, 253, 602, 686
Rodriguez Font E.: 709
Rosenthal E.: 627
Roses Noguer F.: 727
Rowin E.J.: 609
Rueb N.: 569
Ruschitzka F.: 1135, 1137, 1268
Russo A.: 677
Saad E.: 163
Sacher F.: 1147, 767
Sadoul N.: 565
Saghy L.: 755, 81
Sala S.: 769
Sanders P.: 104, 1133
Sarkozy A.: 13
Savelieva I.: 1267, 195
Scanavacca M.: 606
Schaer B.A.: 603
Schalij M.J.: 1552, 1558
Scheinman M.M.: 134
Schilling R.: 590
Schmidt B.: 67
Schmidt G.: 158, 91
Schotten U.: 169, 594
Schreieck J.: 815
Schwartz J.: 20, 217
Schwerg M.: 1209
Sciaraffia E.: 773
Scott P.A.: 9
Serratosa Fernandez L.: 1524
Sheldon R.: 1226
Shen W.K.: 1224
Silberbauer J.C.: 703
Silva Ferreira A.: 197
Simmers T.A.: 121
Simonelli N.: 36
Singh J.: 1134, 1136
Sinnecker D.: 159, 94
Smeets J.L.R.M.: 1283
Sohail M.R.: 1188
Soldati E.: 600
Sora N.: 1129
Sperzel J.: 655
Stahlberg M.: 1090
Steffel J.: 1200
Steinbeck G.: 76
Steinberg B.A.: 541
Steinwender C.: 119
Stellbrink C.: 1280
Sticherling C.: 1273, 1277
Stuart A.: 625
Suleiman M.: 1154
Sutton R.: 1094
Tagney J.: 1167, 623
Tan V.H.: 1150
Tedrow U.: 1146, 1304
Thomas D.: 1299, 1517, 21
Tikkanen J.: 1216
Till J.: 19
Tjong F.V.Y.: 141
Todd D.: 1089
Tondo C.: 652, 653, 69
Torp-Pedersen C. : 1, 1203, 1513
Trevisi N.: 591
Tse H.-F.: 620
Tsiachris D.: 1077
Tzeis S.: 8
Ungar A.: 1291
Vahanian A.: 123
Valdivia H.: 775
Van Der Boon R.M.: 1207
Van Der Meer P.: 39
Van Der Werf C.: 18
Van Gelder I.C.: 105
Van Hare G.: 33
Van Tintelen P.: 549
Vanderheyden M.: 1230
Varma N.: 682
Vennekens R.: 784
Vernooy K.: 1169, 235
Viskin S.: 1282, 797, 799
Volders P.G.A.: 252
Vos M.A.: 157
Vranic I.: 1170
Vrints C.J.M.: 717
Walfridsson U.: 1101
Wang P.: 596, 753
Ward D.: 552
Wellens H.J.: 1525, 1559
Wiesfeld A.C.P.: 567
Wilkoff L.: 696, 760
Willems S.: 1205, 590
Wissner E.: 1105
Wolak A.: 1521
Wolpert C.: 1217
Worley S.: 1213
Wright D.J.: 548
Wright M.J.: 689
Xanthos T.: 1168
Zabel M.: 74
Zaza A.: 156, 786
Zeppenfeld K.: 1275, 628
Zoni-Berisso M.: 1152
Zorzin A.: 37
Aalto-Setala K.: P947
Abaecherli R.: 1240, 45
Abasolo D.: P1419
Abdelaziz W.: P489
Abdelwahab A.: P530
Abdelwahab A.M.: P1382, P878
Abe H.: P1118
Abecasis M.: 736
Abi-Saleh B.: P1446
Abramov A.: P1595
Abreu A.: P1631
Abriel H.: P436
Abu Hadba M.: P1392, P1490
Accogli M.: P384
Ackerman M.J.: 1108
Acosta J.: 572, P855
Acosta Martinez J.: 241
Acou W.: P1431
Adachi T.: P1413, P315
Adalet K.: 637
Adamopoulos S.: P340, P526
Adams V.: P468
Addawe M.: P498
Addonisio L.: P322, P996
Adel Mohamed Elamragy A.: P1382, P878
Adiyaman A.: 1532, P1375, P189, P283
Adjibodou B.: P483
Adler S.W.: P187, P302
Adragao P.: 730, 736, P458
Adrianov A.: P898, P908
Adrianov A.V.: P908
Agarwal S.C.: P488
Agelaki M.: P985
Aggio S.: 1526, 1527, P1479, P1580, P1640
Agoston G.: P829
Agresta A.: P588
Agricola E.: P1414
Aguinaga L.: P855
Agustin Fernandez-Cisnal A.F.C.: P486
Ahlouche F.: P478
Ahmed A.: P1474
Ahn M.S.: 43
Ahn Y.K.: P1418, P1671
Ahsan S.: P1586, P353, P887
Aiba T.: P1047, P1054, P1339, P1544, P1581, P1630,
Aichinger J.: P828
Airaksinen K.E.J.: P1016
Ait Messaoudene M.S.: P478
Aita S.: P459
Aizawa Y.: P1425, P837, P842
Akamatsu N.: P1118
Akasaka K.: P1406
Akashi Y.: P1612
Akbulak R.O.: P1438, P190, P479
Akchurin R.: P310
Akerstrom F.: P1538, P1543
Akhtar M.A.: P833
Akkaya E.: P838
Akoum N.: P258
Al Mogheer B.: P530
Alamanni F.: 808
Albenque J.P.: P321, P743, P988
Albenque J.-P.: P449
Alberio M.: P586
Albertini C.M.M.: 1317, P270
Albertsen A.E.: P1510
Aldama G.: P367
Aldhoon B.: P331, P850
Aleksandrov A.A.: P496
Alexeenko V.: P1419
Alexopoulos D.: P299
Alfano F.: P903
Algazzar A.: P489
Al-Hijji M.: 1108
Ali H.: P1449
Ali Z.: P910
Aliot E.: 636, P1461
Alipour A.: P1585
Allan A.: P424, P425
Allegue C.: 1177
Allgeier J.: 178, P260
Allison S.: P1252, P357
Almeida S.: P1631
Almendral J.: P456
Alonso Fernandez P.: P1254
Alonso P.: P186, P455, P848
Alqubany A.: 238
Al-Razo O.: P276
Al-Sharef O.: P498
Altamirano R.: P326
Altamura G.: P1353
Altan V.M.: P440
Alturki A.: P1329
Alvarez Calderon M.: P991
Alves L.B.A.: P270
Alves L.B.O.: 1317
Alves S.: 111
Alzueta J.: P338, P509
Alzueta-Rodriguez F.J.: 1318
Alzueta-Rodriguez J.: P1484
Amara W.: 110, 112
Amaya N.: P481, P852
Ambroso D.: P1258
Ammendola E.: P280, P339, P384, P487
Ammirati A.: P348
Amoroso G.: P903
Amraoui S.: P1390
Amuzescu B.: P933
An Y.: P512
Anartayev S.: P1467
Ando K.: P512
Andoh K.: P1383
Andrade J.: P467
Andrade J.G.: P856
Andrades M.: P1056
Andreev D.A.: P496
Andreini D.: P285
Andres A.: P186, P455, P848
Andres Lahuerta A.: P1254
Andresen D.A.: P1587, P265
Andreu D.: 241, 572, 805, P855
Andronache M.: 636, P1461
Ang R.: P833
Angelini A.: 1239
Angheben C.: P476, P500
Angoulvant D.: 108, P1058, P288, P533, P740
Anguera I.: P1038
Ansalone G.: P1372
Anselme F.: 1306, P1035, P1430, P1472
Anselmino M.: 1562, P1341, P1432
Anter E.: P745
Antolic B.: P1386, P454
Antonio N.: P58
Antoniucci D.: 1112, P1389
Antzelevitch C.: P1653
Aoki K.: P1422
Aonuma K.: 1319, 243, P1410, P1638, P268, P459,
Aoudia Y.: P478
Aoyama D.: P481, P852
Aoyama D.A.: P317
Aoyama Y.: 1248, 1250, P1002, P446, P453
Aparina O.: 1237
Apostolakis E.: P823
Ara F.: P377, P527
Arai K.: P844
Arai M.: P1346
Arakawa K.: P481, P852
Aranda Hernandez A.: P516
Arany A.: 1308
Arbelo E.: 805, P336
Arceluz M.: 1305, P1001, P1362, P1536, P326, P421
Arceluz M.R.: P417, P420
Ardito C.: P1338
Arena G.: P1338, P1429, P264
Arenal A.: P1049
Arenal Maiz A.: 629
Arentz T.: 178, P260
Arias M.A.: P1538, P1543
Arnar D.O.: 176
Arokiaraj M.A.R.K.: P1055
Aronsen J.M.: P437
Aronsen M.: P965
Arribas F.: P1625
Arsenescu Georgescu C.: P1052
Arsenos P.: P376
Arteaga F.: P1484
Arteaga R.B.: P328
Artemenko S.: 237, P966
Artukhina E.: P1454
Arya A.: 1309, P1331, P1356, P1428, P1542, P826,
Asamoah J.: P1657
Asano T.: P315
Asbach S.: P1588, P1598
Ashihara K.: P844
Ashofair N.: P1643, P975
Ashour Z.: P530
Asirvatham S.: P475, P864
Asirvatham S.J.: P1623
Askar S.F.: 1238
Askar S.F.A.: P1540
Aslanidi O.V.: 181
Aso A.: 1560
Aspelund T.: 176
Assad J.M.: 811
Assress K.: P1027
Asta J.: 1241, P1045
Atienza F.: P1049
Atkinson A.: P432
Attanasio P.: P1336, P1400, P375, P466
Audoubert M.: P1120
Auquier N.: P1472
Auricchio A.: 1528, P1030, P1486, P1503, P1661,
P1673, P284, P483, P881
Austin B.: P1018, P1473
Axelsson A.: P1411
Ayari A.: P1335, P1440
Aydin M.A.: P362, P510
Azam M.A.: 1241, P1045
Aziz S.: P1324, P1330
B Thomsen M.: P415
Baavour R.: P263
Babu G.: P1013, P1586
Babu-Narayan S.: P263
Babur Guler G.: P1439
Babuty D.: 108, 1117, P1058, P288, P533, P740
Baccillieri M.S.: P1258
Bacova B.: P1041
Bacsi A.: P1043
Badenco N.: P1505
Badimon L.: 557
Bae M.H.: 46, P1464
Bae M.H.: P484
Baek Y.S.: P1119, P1124
Baensch D.: P1380
Baig F.: P442
Baimbetov A.: P1467
Baiocchi C.: P339
Baker V.: P521
Balachandran R.: 245, P851
Balan G.H.E.: P1348
Balazova E.: P1024
Baldinger S.H.: 49
Balicer R.: P739, P967
Baligh E.: P530
Balla C.: P1449
Balsam P.: P1040
Balt J.: P444
Balt J.C.: P1585, P277
Balykova L.A.: P524
Banerjee A.: 108, P1058, P968
Bangueses R.: P493
Ban-Haim S.: P263
Bani R.: P1034
Banker R.S.: P259
Banyasz T.: P964
Baptista A.: 116, P1061
Baptista S.: P580
Bar Lev D.: P1490
Baracca E.: 1526, 1527, P1479, P1580, P1640
Baran J.: 1563, P1433, P993
Baranova E.I.: P368
Baranova V.: P966
Barata C.: P300
Baratto F.: 242, P1003, P1358, P1456, P1502, P1539,
P1541, P329
Barboi O.: P1348
Barbraud C.: P853
Barbuti A. :P400
Bardeleben S.V.: P1443
Bardhaj G.: P1351
Barile L.: 222
Barja L.D.: P505
Bar-Lev D.: P1387, P1392
Barnay C.: 110
Baro I.: P406
Barr G.S.: P62
Barrera Cordero A.: 629
Barrera-Cordero A.: 1318
Barrington S.: P1627
Barrio M.T.: P456
Barrio T.: P332, P334
Barros J.V.: P270
Barsukevich V.: P1609, P480
Bartholome A.: 1314
Bartkowiak-Sniatkowska A.: P1007
Bartolucci C.: P389
Bartus K.: P382
Barwad P.: P380
Bashir Y.: 732, P281, P587, P831, P978
Bassily E.: P1444, P465
Bastani H.: P1452
Basterra N.: P1625
Baszko A.: P1007, P482
Baszko A.B.: P1451
Batalov R.: P858
Battaglia A.: 1562, P1432
Bauer A.: P56
Bauersachs J.: P1051
Bautista C.: P1453, P902, P904
Baykaner T.: P267, P309
Bayrak D.F.: P518
Bazan V.: P460
Beard P.: 806
Beatty G.: P1042
Beau S.: P1012, P357
Beau S.L.: P1252
Bebarova M.: 777, P932
Becher H.: P501
Becker G.: P1039
Becker N.: P379
Beckler M.: P379
Beckmann B.M.: P1121
Beekman H.D.M.: P516, P892
Beekman J.: P930
Behaghel A.: P1470, P868, P987
Behar J.: 1534, P1027, P1028, P1635
Behar J.M.: P1033
Behar N.: P1470, P868, P987
Beheiry S.: P262
Behr E.R.: 1173, P1123, P1402
Beinart R.: P1387, P1653
Bejan Angoulvant T.: P533
Belardinelli L.: 1182, P1493
Belbachir N.: P406
Belenkov Y.N.: 1114
Beleveslis T.H.: 638
Bellazzi R.: P519
Belott P.H.: P488
Belotti G.: P585
Belshi X.H.: P369
Beltrami M.: P882
Belver A.: P1361
Belyaeva M.: P1048
Belyaeva O.D.: P368
Ben Mansour N.: P381
Benak A.: P1347
Bencsik G.: P1347, P829
Bender A.B.: P267
Bendini M.G.: P274
Benezet Penaranda J.: P1022
Benitah J.P.: P404
Benito B.: P1044, P1417, P460, P748
Benito E.: 571, 805
Benkouar R.: P478
Bennadji A.: 634
Bennett M.: P359
Bennink G.: P438
Benova T.: P1041, P1648
Benvenuti C.: P1673
Beregi J.P.: P999
Berezin A.: 577
Bergmann L.: P188
Berkowitsch A.: P838
Bernard A.: 108, P1058, P1471, P740
Bernardes A.: P300, P883
Bernat V.: P1639, P825
Bernier M.L.: P1329
Berruezo A.: 1320, 241, 571, 572, 805, P1453, P855,
Bertaglia E.: P1261, P1367, P588, P840
Bertini M.: P1255, P1368, P1622, P585
Berzina M.: 107
Besportochny D.: P1669
Beton O.: P885
Betts T.: P978
Betts T.R.: 109, P1509, P831
Betts T.R.: 732, P281, P587
Bhagirath P.: 578, P291
Bianchi B.: P436
Bianchi F.: P1432
Bianchi V.: P384
Bianco E.: P386
Biasucci L.M.: P1011
Bibikov V.N.: 735
Bieganowska K.: P495
Bienias P.: P1666
Biffi M.: 1529, P1255, P1368, P1370, P1622, P339,
P346, P352, P487, P494, P585
Bikova A.A.: P496
Bilge A.K.: 637
Bilinska M.: 114
Binkowski B.: P318
Birbach M.: P495
Birgersdotter-Green U.: 1108, P1463, P1477, P1485
Birkenhauer F.: P1459, P1511
Bisceglia C.: 802, P1541
Bisch L.: 575, P422
Bisleri G.: P471, P847
Bisleri G.L.: P1643, P975
Bittner A.: P326
Bizhanov K.: P1467
Blaauw J.: P350
Blaauw Y.: P1628, P355
Blanco Nuez M.: P820
Blann A.: P909
Blaschke F.: P1336, P375, P466
Blaszyk K.: 576
Blazquez J.A.: P276
Blessberger H.: P1021
Bloise R.: 1179, P519, P61
Blomstrom-Lundqvist C.: P284
Bobkowski W.: P1007, P482
Boczar K.: P1017, P888
Bode C.: P1588, P1598
Bode F.: P56, P584
Boehm M.: 180, 89, P412
Boem A.: P1015
Boersma E.: P1405
Boersma L.V.A.: P1369, P1379, P1585, P277, P444,
P62, P869
Bogdan S.N.: P1387
Bogers A.J.J.C.: P1405, P1407, P528, P900
Bogossian H.: P1257, P1416, P1637, P323
Boldt H.: P1400
Boldt L.H.: P1336, P1578, P375
Boldt L.-H.: P466
Bollmann A.: 1309, P1331, P1356, P1428, P1431,
P1496, P1542, P468, P826, P857, P889
Bolognese L.: 803
Bolognesi G.: P1622
Bolzan B.: P491
Bonet Basiero A.: P349
Bongard V.: 50
Bongianino R.: 1179
Bongiorni M.G.: P284, P285
Bongiorni M.G.: P1015, P1486, P346
Bonitta G.: P1449
Bonnemeier H.: P1459
Bonner M.: 1312
Bonner M.D.: P278
Bonnes J.L.: P365
Bontempi L.: P1429, P1643, P346, P471, P975
Bonzanni M.: P428
Boogmans M.: P1578
Booth C.R.P.: P330
Borbas J.: 1178, P1043
Borbas Z.: P432
Bordachar P.: P1390, P1391, P1634
Bordenave L.: P1390
Bordignon S.: P1594, P1603, P292
Borggrefe M.: 48, 579, 633, P1121, P583, P865
Boriani G.: 1528, 174, P1253, P1255, P1370, P352,
P354, P54
Bories W.: P1599
Boros A.M.: P1031
Borowik E.: P905
Borras R.: 241, P336
Bortoli B.A.: P839, P982
Bosa Ojeda F.: P1019
Bosch X.: 572
Bosschaert M.A.R.: P1585
Bossu A.: P516, P892, P930
Bostock J.: 1534, P1027
Bothner C.: P185
Botros M.: P452, P464
Bottio T.: 1239
Botto G.L. :P503
Boucek T.: 1245
Boudrifa A.: P478
Boule S.: P1376
Boumedien T.: P478
Bourgonje V.J.A.: P892
Boursier M.: 110
Bouvagnet P.: P439
Bouzeman A.: P879, P988
Boveda S.: 1306, 1316, P1430, P272, P584, P743,
Bovendeerd P.: P880
Bovin A.: P1645
Boyett M.R.: P432
Boyett M.R.: P1494
Brachmann J.: 115, 1316, P1459, P1578, P1590
Brachmann J.B.: P1587
Brack K.E.: P1665, P378
Bracke F.A.L.E.: P278
Brady P.B.: P1050
Brambilla R.: P1448
Branchitta G.: P1015, P285
Branco L.: P1591, P884
Brandenburg S.: P963
Branny M.: P473
Braunschweig F.: P275
Breckwoldt K.: P948
Breckwoldt K.A.J.A.: P949
Breedveld R.: P586
Brembilla-Perrot B.: 636, P1005, P1461
Brenes-Salazar J.B.S.: P1050
Breschi M.: P322, P996
Brette F.: P962
Briasoulis E.: P1404
Brieda M.: P490
Brignole M.: P1633, P1658
Brinza B.: P1052
Brisinda D.: P1355, P370, P529
Brockmeier K.: P438
Brodt C.: P308
Brooke K.: P1623
Brooks S.: P1334
Brouwer M.A.: P365, P485
Brouwer T.F.: P1369
Brovkin K.A.B.: P1655
Brown J.H.: P917
Bru P.: 112
Bruce C.: P864
Brueggemann A.: P379
Brugada B.R.: P1328
Brugada J.: 1177, 1320, 241, 571, 572, 805, P1453,
P855, P902, P904
Brugada P.: P305, P306, P451
Brugada R.: 1177, 1320
Bruguera J.: P748
Brunckhorst C.: 49
Brunelli M.: 1244, 177, P1605, P1617, P818, P971,
Brunet X.: P999
Brunetti N.D.: P1656
Brzozowski W.: 1111
Bucchi A.: P925
Budera P.: 1242
Bueno D.: P1044
Bueno-Orovio A.: P393
Buerkle G.: P1596
Buist T.: P189
Buist T.J.: P191
Bukart-Kuttner D.: P584
Bukowska A.: P1395, P1396
Bulava A.: P1435
Bulkova V.: 1245, P1060, P1427
Buller H.: 173
Buls A.: P1662
Bun S.S.: P1335, P1424, P1440, P1469
Bundgaard H.: P1411
Bunting E.: P876
Buonocore M.: 1179
Burashnikov E.: P1653
Burban M.: P272
Burel S.: P917
Burgos A.: 1305
Burgos F.: 1320
Burkart R.: P1673
Burke M.: P1369, P488
Burkhardt J.D.: P261, P262
Burkhoff D.: P583
Burri H.: P1600, P313, P314, P461
Burton F.: P424, P425
Buss G.: 575
Butorova E.: 1237
Butter C.: 1316, P284, P57, P583
Butter C.H.: P1626, P511
Buturak A.: P518
Bzukala I.: 1116, P513
Cabanas-Grandio P.: P334
Cabestrero De Diego A.: P349
Cabrera S.: P1044, P1417, P460, P748
Caccavale A.: P903
Caccavo V.: P990
Cacciani F.: P366, P395
Cacela D.: P1631
Caceres G.: P1653
Caglayan C.E.: P919
Cai C.H.I.: 1180
Cai X.J.: P430
Caiani E.: P1503
Caico S.I.: P503
Caivano M.: P1656
Cakal B.: P1439
Calabrese V.: P341
Caldwell J.: P955
Callegari S.: P1394, P366
Calo L.: P1253
Calo' L.: P1372, P341, P384
Calovic Z.: P1381
Calvi V.: P1409, P1622, P490
Calvino R.: P367
Calvo D.: P509
Calvo M.: 805
Calzolari V.: P861
Campagnolo R.: 1314
Campana A.: P1368, P487
Campari M.: P384, P588
Campistol J.: P904
Campoli M.: P1497
Campostrini G.: P939
Campuzano C.O.L.: P1328
Campuzano O.: 1177
Candeias R.: P458
Candelmo F.: P903
Cano O.: P186, P455
Cano Perez O.: P1254, P848
Cao M.: P1252, P357
Capodanno D.: P1409
Caponi D.: 804, P1341
Cappato R.: P1449, P62
Capucci A.: P490
Capulzini L.: P1584, P457
Caputo M.: P1486, P1673, P483
Caputo M.L.: P1503, P1661
Carbonell San Roman A.: P1057
Carbucicchio C.: 803
Carcouet A.: P406
Cardin C.: 50, 634, P1120
Carinci V.: P1618, P1622
Carlosena-Remirez A.: 571, 805
Carmo P.: 730, 736, P458
Carnero G.: P290
Carnevali L.: P1394, P366
Caro J.: 1305, P417, P420, P421
Carpi R.: P1633
Carpinteiro L.: P300, P883
Carrabba N.: 1112
Carrai P.: P1611
Carraro M.: P1580
Carrassa G.C.: P1611
Carreras G.: P1497, P584
Carrillo D.C.: P358
Cartei S.: P1034
Carvalho S.: 730
Carvalho S.A.L.O.M.E.: 736
Casabe H.: P290
Casaleggio A.: P394
Casares J.: P493
Casella M.: 1249, 803, P1350, P984
Casini S.: P944
Casis O.: 223
Casserly I.P.: P1343
Casso C.: P1673
Castagno D.: 1562
Castaldi B.: P490
Castella J.: 1177
Castellanos E.: P456
Castellanos Martinez E.: P332
Castrejon Castrejon S.: P1001, P1362, P421
Castrejon S.: P1536
Castro A.: P1011, P1353
Castro Urda V.: 629, P55
Castro-Beiras A.: P367
Catanzariti D.: P1338, P1429, P264, P476, P500
Cates J.: 1307, P258
Cattafi G.: P264
Cavaco D.: 730, 736, P458
Cavazzini D.: P1479
Cebron J.P.: 1306, P1430
Ceccofiglio A.: P1488, P363
Celestino-Soper P.B.S.: 1176
Celik A.I.: P919
Centeno A.: P367
Cerbai E.: P393
Cerini M.: P1643, P471, P975
Cerisano G.P.: P1389
Cerna H.: P1639, P825
Cerny J.: P1260
Cesar S.: 1177, P1453, P902, P904
Cgojeva I.: 107
Cha M.J.: P1492, P1579, P441, P841
Cha T.J.: P1664
Cha Y.: P1485
Cha Y.M.: 1108, P1623
Chabanne C.: P1008
Chae S.C.: P484
Chaigne S.: P416, P434, P435
Chaldoupi S.M.: P277
Chaldoupi S.-M.: P444
Champagne J.: P187, P302
Chan J.: P1366
Chapurnikh A.: P310
Charitos E.: P1608
Charlton S.: P289
Charpentier F.: P406, P917
Charron P.: P1398
Chasnoits A.: P1609, P480
Chastre T.: P1505
Chauvel R.: P1120
Chaykovskaya M.: 574, 579
Checchi L.: P1034, P1611
Checinski L.: P497
Cheggour S.: 110
Chekneva I.S.: 1114
Chemello D.: P1056
Chen C.J.: P839, P982
Chen D.Y.: P293
Chen J.: 236, P1616, P266
Chen L.: P1485
Chen P.S.: 1176
Chen S.-A.: 175, P1660
Chen S.H.: P1508
Chen T.H.: P293
Chen X.: P744, P832
Chen Z.: 1534, P1027
Chentir M.T.: P478
Cheong S.S.: P364
Cherian R.: P1621
Cherkashin D.: P310
Cherki R.: P1653
Cherng W.J.: P1508
Chernov V.: P1445
Chernova A.: P1654
Cherpak B.: 1243
Chi L.: P1493
Chia P.L.: P1366
Chiari E.: P847
Chiba Y.: P315
Chierchia G.B.: P305, P306, P451
Chigharoe U.: P900
Chiladakis I.: P875
Chiladakis J.: P299
Child N.: 734
Chilukoti R.: P1395
Chilukoti R.K.: P1396
Chin D.: P1388
Chin S.H.: P1610
Chin S.H.: P1388, P1665, P184, P316, P378
Chinitz L.: P271
Chisciotti V.M.: P363
Chizelle F.: P406
Chlouverakis G.: 570, P1619, P343, P344
Chlupova G.: P871
Chmelevsky M.: 574, P1583
Cho J.G.: P1418, P1671, P742
Cho K.I.: P1664
Cho Y.: 46, P1464, P484
Cho Y.J.: P1492, P1579, P441, P841
Chodor P.: P273
Choi E.K.: P1492, P1579, P441
Choi E.-K.: P841
Choi J.H.: P337
Choi J.Y.: P1378
Choi K.J.: P337
Choi K.J.: P1644, P901
Choi W.S.: 46, P1464
Chorro J.: P1361
Chouchoulis K.: P299, P875
Choudhury M.H.: P1494
Choudhury R.: 731
Chow A.: P887
Chow A.W.: P1586, P353, P515
Choy A.M.: P442
Choy J.: P501
Christ T.: P948
Christ T.O.R.S.T.E.: P949
Christensen G.: P437, P965
Christiansen M.: 1173
Christoph M.: 1251, 1567, P1046, P1344, P450
Christopoulos G.: 244, P998
Chrysostomakis S.: P344, P492
Chu G.S.: P1610
Chu G.S.: P1388, P184, P316
Chubb H.: 181, 809, P1322, P1323, P1324, P1330,
P1627, P311, P325, P472, P972
Chun J.K.R.: P1603
Chun K.J.: P292, P385
Chun K.J.: P1475
Chun K.R.J.: P1594
Ciaramitaro G.: P339
Ciccone M.M.: P1449
Ciconte G.: P305, P306, P451
Cihak R.: P331, P850
Cijevschi Prelipcean C.: P1348
Cima A.: 1244, 177, P1605, P1617, P818, P971, P977
Cipolletta L.: 1249, P1350, P463, P984
Cipriani M.: P354
Cismaru G.: P1657
Ciudin R.: P1647
Ciurzynski M.: P1666
Clague J.R.: P1354, P474
Claridge S.: P1028, P1033, P1635
Claridge S.B.L.: 1534, 734, P1027
Clark A.L.: P1629, P373
Cleland J.G.: P1629
Clementy N.: 108, P1058, P288, P533, P740
Clergue M.: P405
Clerx M.: P431
Cobb V.: P353, P887
Cocera Ortega L.: P946
Cohen M.: 1173
Colchester R.: 806
Colenso C.: P931
Colleran R.: P1343
Colman M.A.: 181
Combes N.: P743, P988
Combes S.: P743, P988
Comin-Colet J.: P1044
Condorelli G.: 1179
Connors S.: P1253
Conrad J.: P1036
Conradi L.: P362, P510
Constanstinescu A.A.: P1407
Constantin M.: P416, P434, P435
Constantinescu A.A.: P528
Conte G.: P1486, P1503, P1661, P306, P483
Conte L.: P1580
Conti S.: 1249, P1350, P1409, P307, P463, P984
Contreras Valdes F.: P745
Cook S.: 1173
Coppini R.: P393
Corbisiero R.: P1252, P357
Corciova F.: P1052
Cordeiro F.: 116, P1061
Corradi D.: P1394
Corrigan A.: P1627
Corros C.: P1646
Corsi P.: 1112, P1389
Cortez Dias N.: P883
Cortez-Dias N.: P300
Corzani A.: P1370
Coser A.: P500
Costa A.: P945, 1533
Costa F.: P580
Costa R.: 1317, P1029, P1632, P270, P335, P581,
Costello-Boerrigter L.C.: P830
Coulombe A.: P405
Courtheix M.: P1391
Cousin V.: P1376
Coyan F.: P917
Cramer M.J.: P350
Cranney G.: P359
Crevelari E.S.: 1317
Crijns H.: 174
Crijns H.J.: P1628, P257, P350, P355
Crijns H.J.G.M.: P294, P301, P443
Cristoforetti A.: 182
Cristovao J.: P58
Crockford C.: P377, P527
Cros C.E.: P409
Crosato M.: P280, P861
Crossley G.: P494
Crozier I.: P897
Crozier I.G.: P62
Cruickshank C.: P897
Cruz F.: P1536, P326, P417
Cruz P.F.: 1305, P1001, P1362, P420, P421
Csanady M.: 1178
Csanyi B.: 1178
Cuadrado E.: P1417
Cuko A.: P1381
Cunha P.: P884
Cunha P.S.: 111, P1631
Cunha P.S.: P1591, P835
Curnis A.: P1261, P1338, P1643, P264, P280, P341,
P354, P471, P847, P975
Curti M.: P483
Curtis A.: P1012, P1624
Cvek J.: P473
Cvijic M.: P1386, P454
Czajkowski M.: P360
Czyz K.: P1007, P482
D' Onofrio A.: P280, P384, P503, P588
D Roervik S.: P1616
Da Costa A.: 1316
Daehne T.: 1244, 177, P1605, P1617, P818, P971,
D'agostino C.: P341
Dahlstrom U.: P275
Dahme T.: P185
Dai C.: P1122
Dai Shimo D.R.: P1326
Daleffe E.: P1614, P54
Dalla Valle C.: P1367, P840
Dalla Vecchia E.: P1258
Dalsgaard D.: P1645
Daly M.: P897
Dandamudi G.: 1310, 1313, 1315, P1377, P1447,
Dang L.: P1042
D'angelo G.: 242
D'angelo G.D.: P361
Danielsen A.: P475
Danwade T.: 573
Daoud E.G.: P1593
D'arienzo G.: P1656
Darkner S.: P744, P832
Darwiche W.: P533
Daskalakis A.: P1619, P344
Dauber K.: P330
Daubert J.C.: P1008, P1470, P868, P987
Daubert J.P.: P309
Dave A.S.: 733
Davies D.W.: 811
Davlouros P.: P299
Dawson D.: P985
De Alarcon Gonzalez A.: P1487
De Ambroggi G.: P1449
De Asmundis C.: P305, P306, P451
De Boer M.J.: P365, P485
De Bono J.: P968
De Bortoli A.: 236, P266
De Caralt T.: 241, 572
De Ceglia S.: P1604
De Chillou C.: 636, P1461
De Cristofaro R.: P274
De Filippo P.: P264, P487
De Greef Y.: P1458, P997
De Groot N.M.S.: 578, P1405, P1407, P291, P528,
De Hooge J.: 578
De Jaegere P.: P1125
De La Hera J.M.: P1646
De Lazzari M.: P1367, P1603, P840
De Luca A.: P386
De Maria E.: P1255, P1622
De Mattia L.: P861
De Meester C.: P853
De Paula Van Der Steld L.: P1328
De Ponti R.: P1004
De Potter T.J.R.: P1351
De Regibus V.: P1486
De Riva Silva M.: 240, P1540
De Sensi F.: P1016, P322, P996
De Silva K.: 1534
De Simone A.: P503
De Sousa J.: P300, P883
De Teresa-Galvan E.: 1318
De Vito G.: P1448
De Vito R.: 804, P1341
De Vries A.A.: 1236
De Vries A.A.F.: 1181, 1238
De Wijs M.: P1405
De Wijs M.C.J.: P900
De Wijs M.J.C.: P1407
Debski M.: P347, P888
Dedroogh M.: P188
Defaye P.: 1306, 1316, P1430, P272, P584, P879,
Degiovanni A.: P1620
Deharo J.C.: P284
Deisenhofer I.: P867
Deiss S.: 574, P1357, P1583, P320
Del Bufalo A.: P1673, P483
Del Giorno G.: 1249, P1350, P384, P463, P984
Del Greco M.: P1372, P476, P500
Del Rosso A.: 1115
Delassi T.: P1424, P1469, P478
Delgado A.S.: 111
Delgado A.S.: P835
Delgado Elias L.: P1481
Delgado Espinosa A.: P820
Delgado R.: 1305, P1001, P1362, P1536, P326, P417,
Delhaas T.: P1634, P504, P880
Della Bella P.: 242, 51, 802, 808, P1003, P1358,
P1414, P1450, P1456, P1502, P1539, P1541, P329,
Dell'era G.: P1620
Dello Russo A.: 1249, 803, P1350, P307, P463, P984
Delnoy P.P.: P283
Delnoy P.P.H.M.: 1532, P1375, P189, P191, P869
Demir G.G.: P1439
Demir M.: P919
Demirel F.: P283
Dempsey C.: P931
Dempster J.: P396
Denegri M.: 1179
Deneke T.: 115, 1564, 244, P261, P462, P830, P854,
Deniz A.: P919
Deno D.C.: 245, P851
Deplagne A.: 110, P56
Derejko P.: 114
Derndorfer M.: P828
Derval N.: P287
Desai A.: P958
Desimone C.: P475, P864
Desjardins A.: 806
Desplantez T.: P416, P434, P435
Deubner N.: P838
Deutch K.: P482
Deutsch K.J.: P1451, P1613
Deveci O.S.: P919
Devidutta S.: P380
Deville J.B.: P1593
Deyab R.H.: P1382, P878
Dhalla A.: P1493
Dhillon O.: P521
Dhinoja M.: P833
Di Bacco L.: P471
Di Bernardo S.: 575, P422
Di Biase L.: P261, P262
Di Biase M.: P1656
Di Clemente F.: 804
Di Cori A.: P1015, P285
Di Donna P.: 804, P1341
Di Giovanni G.: P306
Di Grazia A.: P1409
Di Lorenzo F.: P1633
Di Mambro C.: P327
Di Monaco A.: P990
Di Pasquale E.: 1179
Di Prima A.: 242
Di Stolfo G.: P1261
Diab I.: P521
Diemberger I.: P1370, P352
Diener H.C.: P912
Diener H.-C.: P536
Dietrichs E.S.: P424
Dievart F.: P533
Dinerman J.: P1012, P1624
Ding L.: 1180
Dinh T.: P355
Dinov B.: P1356, P1431, P1542, P468, P857
Ditkivskyy I.: 1243
Dobrev D.: 557
Dobrovie M.: P1356
Dobrzynski H.: P1494, P432
Doerr L.: P379
Doesch C.: 48, 633
Doevendans P.A.F.M.: 1566, P836
Doevendans P.J.: P350
Doi A.: P1126, P1363
Doisne N.: P405
Domenichini G.: P521
Dompnier A.: 112
Donal E.: P1471
Donateo P.: P1633
Dorda M.: P1427
Dormidontova G.: P1672
Dovellini E.V.: 1112, P1389
Downar E.: 238
Doytchinova A.: 1176
Dragicevic E.: P379
Drago F.: P327, P348
Drozdov I.V.: P496
Drug V.L.: P1348
Druzhko M.S.: P333
D'souza A.: P1494
D'souza B.: P488
Dubner S.J.: P536, P912
Dubuc M.: 810, P187, P302, P856, P866
Ducceschi V.: P1457
Ducharme A.: P57
Dudink E.A.M.P.: P294, P443
Dudley S.C.: P916
Dugo D.: P1603, P292
Dujenet F.: P911
Dukkipati S.R.: P321
Duncker D.: P1010, P1051
Dunnink A.: P516, P892
Duparc A.: 50, 634, P1120, P56
Dupuis S.: P416, P434, P435
Duran O.: 631
Durand E.: P1472
Duray G.: P271
Duray G.Z.: 1311, P1379
Duru F.: 49
Duthoit G.: P1505
Duytschaever M.: 731, P1325, P1426, P1593
Dyrda K.: 810, P856, P866
Dyrda K.M.: P1371
Dzemeshkevich S.: P895
Dzeshka M.S.: P445, P447
Dzikowska-Diduch O.: P1666
E Molina C.: P959
Earley M.: P833
Earley M.J.: P521
Eberhardt F.: P1459
Ebrille E.: 804, P1341, P475
Eckardt L.E.: P1587, P265
Ector J.: 630
Edner M.: P275
Edroos S.A.: P498
Edvardsen T.: P1482, P589
Efimova E.: P1356
Efimova I.: P1445
Efimova N.: P1445
Efremidis M.: P376
Efremov E.: P1048
Efremov E.E.: P899
Eggen M.D.: P278
Egorov D.: P1401, P523, P898
Ehara N.: P983
Ehlermann P.: 48
Ehrlich J.R.: P1596
Eichenberger A.: P461
Eisenberger M.: P1435
Eisfeld J.: P933
Eisserer G.: P1480
Ejima K.: 737, P844
El Tallawi K.C.: P1446
Eldar M.: P1387, P1392, P1653
Elencwajg B.: P1481
El-Gendi H.: P498
Elizarova T.: P1595
Eljamili M.: P1424, P1469
Ellenbogen K.A.: 1310, 1313, 1315, P1447, P345,
Elsaesser A.: P536, P912
Eltchaninoff H.: P1472
Elvan A.: 1307, 1532, P1375, P189, P283, P869
Elvan A.R.: P191
Elvas L.: P58
Ene E.: P1025
Engels E.: P355
Engels E.B.: P1125, P1384
Engels M.C.: 1238
Enjuanes C.: P1044
Epicoco G.: P1449
Epstein A.E.: P488
Eremeeva M.V.: P893
Ergeshov K.: P1467
Erginel-Unaltuna N.: P518
Erglis A.: 107, P907
Ernst S.: P1354, P263, P474
Ernst Y.: 1314
Errahmouni A.: P1335, P1440, P1469
Escande W.: P1376
Eschenhagen T.: P948
Eschenhagen T.H.O.M.A.S.: P949
Escobedo C.: P1391
Espe E.K.S.: P965
Esposito F.: P588
Es-Salah-Lamoureux Z.: P938
Essebag V.: P1329, P187, P302
Evangelista M.: 242, P1502
Evertz R.: 1320
Evtushenko A.: P1445
Evtushenko V.: P1445
Exner D.: P494
Exposito V.: P514
Exposito-Garcia V.: P334
Ezzat V.: 238
Fabbri A.: P391
Faerestrand S.: P1259
Fageda A.: P460
Falconi E.: 1305, P1001, P1362, P1536, P326, P417,
Fallani F.: P352
Fanourgiakis J.: 570, P1460, P1619, P343, P344, P492
Farazi T.G.: P1252, P357
Farid T.: P1018, P1473
Faryan M.: P531
Fassini G.: 803, P984
Fassini G.M.: P307, P463
Fassini G.M.: 1249, P1350
Fastl T.: P472, P972
Fauchier L.: 108, P1058, P1471, P288, P533, P740,
Faustino M.: P580
Favaloro L.: P290
Fayad G.: P1376
Fedida J.: P1398
Fedina N.: P1669
Fedorco M.: P1483
Fedorowski A.: P1504
Feghali T.: P1446
Fehri W.: P381
Fehske W.: P183
Felblinger J.: 636
Feld G.: P1463, P1477
Feliciano J.: 111, P884
Feltl D.: P473
Feltrin G.: 1239
Feneon D.: P1470, P868, P987
Fenici R.: P1355, P370, P529
Feola I.: 1181
Fernandez A.: P290
Fernandez Cimadevilla C.: P493
Fernandez De La Concha J.: 629, P1625, P509
Fernandez Lozano I.: 629, P55
Fernandez Pastor J.: P1625
Fernandez-Armenta J.: 241, 572, P334, P855
Fernandez-Aviles F.: P1049
Fernandez-Pastor J.: 1318
Fernandez-Portales J.: P1038
Fernandez-Velasco M.: P951
Ferrari P.: P1618
Ferraris F.: P1341
Ferreira A.: 116, P1061
Ferreira C.: 116, P1061
Ferreira M.J.: P1591
Ferreira R.: 111, P1631, P884
Ferreira R.C.: P1591, P835
Ferrer Hita J.J.: P1019
Ferrero De Loma-Osorio A.: P1361
Ferretto S.: 1239, P1367, P840
Ferrieres J.: 50
Fertig N.: P379
Fetisova E.: 579
Feurich R.F.: P1596
Fiala M.: P1060, P1337, P1427, P473
Fidani L.F.: P1495
Fidder H.H.: 1566
Fiedler L.: P1542
Figueroa J.: P417, P420
Fijalkowska A.: P1666
Filgueiras-Rama D.: P1536
Fingrova Z.: 1245
Fink A.: P1596
Fink T.: P382
Finlay M.: P833
Finlay M.C.: 806, P1053
Fioravanti F.: P1355, P370, P529
Fioreli A.I.: 1317
Fiorentino C.: P1457
Fischer A.: P1481
Fischer J.: P1356
Fischer S.: P1459
Fischer T.: P1482, P589
Fishman E.: 1533
Fitton T.: P470
Flecher E.: P1008
Flore V.: 630
Floria M.: P1052, P1348
Florio C.: P953
Fochler F.: 1564
Fochler P.: P998
Fogarty T.J.: 811
Foldesi C.: 729
Foldesi C.S.: 1308
Foley P.W.X.: P587
Folkeringa J.R.: P301
Fons C.: P904
Fontaine G.H.: P1465
Fontenla A.: P1625
Fontes M.S.C.: 220
Foran J.: 109, P1509, P382
Foran J.P.: P1491, P312
Foresti S.: P1448, P1449
Forkmann M.: 1251, 1567, P1046, P1344, P450
Forleo G.: P1261, P1372, P341
Forleo G.B.: P1497
Forster T.: 1178, P1043, P829
Fotoglidis A.: P890
Fotoglidis A.F.: P1495
Fournet M.: P987
Fox D.: 109, P1509
Fraccaro C.: 1527, P1479
Fragakis N.: P376, P890
Fragkakis N.: P1495
Fraguas H.: P290
Francesci F.: P56
Franco D.: P367
Franco Diez E.: P1057
Franco E.: P1026, P1468
Franklin K.: P295
Frea S.: 1562
Frech S.: P933
Freedman R.: P1012, P1624
Freixa Pamias R.: P349
Fressart V.: P1398, P1505
Frey S.: P507
Friedman P.: 1108, P864
Friedman P.A.: P1623
Frisk M.: P437, P965
Frisoni J.: P352
Frohlich M.: P1592
Frolov A.V.: P1009
Fromentin S.: 110
Frommeyer G.: P323
Frommhold M.: 1244, 177, P1605, P1617, P818, P971,
Fry C.H.: P1419
Frykman V.F.: P863
Fu H.: P1485
Fuernkranz A.: P1594, P1603, P292
Fuhrer J.: 1110, P1455, P517
Fuji Y.: P1397
Fujii E.: P1333, P1436
Fujii K.: P255
Fujii S.: P1383, P1406
Fujimoto M.: P1437
Fujita S.: P1333, P1436
Fukamizu S.: 1248, 1250, P1002, P446, P453
Fukuda K.: P1425, P837, P842
Fukuda M.: P970
Fukuda T.: P970
Fukumoto K.: P837, P842
Fukunaga M.: P512
Fukunami M.: 1569, P296
Fukushima K.: P844
Fukuyama M.: 1175, P1397
Fumagalli S.: 174, P882
Funasako M.: P297
Furst K.: P479
Furukawa T.: P1612
Furukawa Y.: 1569, P1434, P296, P983
Fuse J.: P970
Gaba P.: P864
Gabbai D.: 174
Gabbarini F.: 804
Gaborit N.: P935
Gabrawi M.: P325, P472, P972
Gacon P.H.: P873
Gadula-Gacek E.: P414
Gafoor S.: P382
Gaido L.: P1432
Gaita F.: 1562, 804, P1341, P1432
Gajek J.: P1489, P1504, P1582, P497
Gal P.: 1307, P189, P191, P258
Galand V.: P987
Galasso P.: 1526
Galizio N.: P290
Gall N.: 635
Gallinghouse G.J.: P262
Gallino A.: P1673
Gallo C.: P1432
Galrinho A.: P1591, P884
Galuscan G.: 112
Galvan Z.: P467
Galvin J.: P1343, P894
Gambelli P.: P61
Gambino A.: 1239
Gamble J.H.P.: P281, P587
Gammelsrud L.O.: P1482, P589
Gammer V.: P1021
Gandalovicova J.: P1060
Gandjbakhch E.: P1398, P1505
Ganeeva O.N.: P496
Ganesha Babu G.: P887
Gangl C.: P846
Garan H.: P876
Garbade J.: P1356
Garberoglio L.: 1562
Garcia A.: P1646
Garcia Campo E.: P272, P334
Garcia D.H.: P1545
Garcia E.: P1625
Garcia Fernandez J.: P509, P991
Garcia Gonzalez M.J.: P1019
Garcia Quintana A.: P820
Garcia Seara J.: 1316
Garcia-Elias A.: P1044
Garcia-Fernandez F.J.: P1538
Garcia-Gerrero J.: P1484
Garcia-Piney E.: 631, P1038, P859
Garcia-Rubio J.: P493
Gardarsdottir M.: 176
Gardarsdottir V.A.: 176
Gardner E.A.: 811
Gargaro A.: P585
Garipov R.S.: P891
Garratt C.: P432
Garweg C.: 630
Gasior M.: P1499, P414
Gaspar T.: 1251, 1567, P1046, P1344, P450, P826
Gasparini M.: 1528, P280, P354, P54
Gatzoulis K.: P376
Gaudin D.: P188
Gaur N.: P398
Gavaruzzi G.: P352
Gavazzoli S.: P1620
Gaztanaga L.: P334
Ge Junbo D.R.: P1326
Geelen P.: P1351
Geelhoed B.: P817
Geller J.C.: 1244, 177, P1605, P1617, P818, P971,
Geller L.: 1529, P1031
Gentil-Baron P.: P1600, P313, P314, P461
George M.: P379
Georger F.: 110
Georgopoulos S.: P376
Geraschenko A.V.: 735
Gerdes C.: P279, P508
Gerdes J.C.: P1385
Gerguri S.: P1657
Gerosa C.: P1448
Gerosa G.: 1239
Gerritse B.E.W.: 1529
Gersak B.: P1360
Gersh B.J.: P1321
Ghani A.: 1532, P1375
Ghezelbash S.: 557
Ghoerbien S.: P291
Ghosh J.: P1629
Giacopelli D.: P861
Giammaria M.: P1261, P1372, P341
Gianfrancesco D.: P1656
Giannini G.: P386
Giannola G.: P346, P494
Giaretta V.: P1056
Gierlaszynska K.: P1499
Giese A.: P1395
Gil Sanchez A.: P1646
Giles R.: P359
Gili S.: 1562
Gill J.: 734
Gilles E.: P475
Ginghina C.: P1647
Ginks M.: 732, P281, P831, P978
Ginks M.R.: P587
Giofre' F.: P1368
Giorgi D.: P1622, P585
Girerd N.: P1005, P1461
Gislason G.H.: P53
Giudici M.: P874
Giudici M.C.: P328
Giudici V.: P490, P535
Giuliani I.: 1239
Giurlani L.: 1112, P1389
Gkouziouta A.: P340, P526
Gladisova K.: P1639, P825
Glikson M.: P1387, P1392, P1490, P1653
Glikson M.J.: P1623
Glover B.: P1343
Godot A.: P868
Goesaert C.: P853
Goessinger H.: P846
Goette A.: P1396
Goetze J.P.: P744
Goirigolzarri Artaza J.: P55
Golba K.S.: P1023, P1476, P499
Golcuk E.: 637
Gold M.R.: P1256
Goldemund D.: P1060
Goldenberg I.: 632, P1387
Goldsmith G.: P328
Golenischa V.: P480
Golitsyn S.: P1048
Golitsyn S.P.: 1237
Golovko A.: P926, P928
Gomes S.: P359, P467
Gomez A.M.: P404
Gomez F.: P474
Gomez F.P.: P1354
Gomez Juanatey A.: P336
Gomez-Pulido F.: 805
Goncharik D.: P1609, P480
Gonzalez A.E.: P1545
Gonzalez Cabeza E.: P1019
Gonzalez E.: P276
Gonzalez Enrriquez S.: P514
Gonzalez Ferrer J.J.: P1022
Gonzalez J.: P290
Gonzalez M.C.: P853
Gonzalez-Vasserot M.A.: P1545
Gorbunova A.S.: P1506
Gordeev O.: P898
Gorga E.: P847
Gosau N.: P362, P510
Goseki Y.: 1565, P1466
Goto E.: 738, P469, P980
Goto K.: P1423
Goto S.: P534
Gotte M.J.W.: 578, P291
Gottlieb L.A.: P913
Gould P.: P330
Goulet D.: P1371
Gourraud J.B.: 1117, P1120
Goya M.: P525
Grabowicz W.: P318, P905
Grabowski M.: P1642
Graf B.: P1608
Graf D.: 1174
Grajek S.: 576
Gramley F.: P1443, P1589
Granier M.: P999
Grapsa J.: P985
Gras D.: P494
Grassini D.: P1622, P585
Grauso M.: P405
Grazhdankin I.: 237
Grebmer C.: P867
Grecu M.: P1052, P1348
Green A.: P894
Greffier J.: P999
Gregorio G.: P1457
Greiss H.: P838
Griffith M.: P968
Grigoryan S.V.: P969
Grimaldi M.: P1593, P990
Grishin I.: P310
Groh W.J.: 1176
Grosse A.: 1244, 177, P1605, P1617, P818, P971,
Grossi S.: P1432
Grosso Marra W.: 1562
Grothoff M.: 807
Grove R.G.: P506
Grupper A.: P1623
Grycewicz T.: P318
Grzebieniak T.: P1504
Gschwendtner M.: P828
Guarnaccia V.: 1115
Guarracini F.: P1414, P1450, P1502, P361
Guasch E.: 571
Guastaferro C.: P490
Guclu-Geyik F.: P518
Gudnason V.: 176
Guerra P.: P856, P866
Guerrero L.U.I.S.: P1055
Guevara E.: P290
Guicheney P.: P405
Guillermo M.: P1393
Guinamard R.: P433, P439
Guiot A.: P1471
Guler E.: P1439
Gunes H.M.: P1439
Guo D.: 1182
Gupalo E.M.: P899
Gurevitz O.: P1387
Gusetu G.: P1657
Gusev K.: P963
Gutberlet M.: 807
Gutierrez Carretero E.: P1487
Gwechenberger M.: P846
Gwizdala A.: 576
Gyori G.: 1308
Haaland T.: P1482, P589
Haarbo J.: P282
Haber T.: P356
Haberka K.: P347, P888
Hachiya H.: 239, P1000
Hachul D.: P1537
Hadadi C.A.: P1447
Haddad G.: 112
Hadjis A.: P1329
Hadjivassilev S.: P833
Haegeli L.M.: 49
Haeley J.: P1329
Haertig J.: P356
Haest R.J.: P294
Haest R.J.P.: P443
Haggui A.: P381
Haghikia A.: P1051
Hagiwara N.: 737, P844
Haim M.: P739, P967
Haines D.E.: P992
Haissaguerre M.: 1117, P287
Hajlaoui N.: P381
Hakalahti A.H.: P979
Hakmi S.: P362, P510
Halbach M.: P57
Halbfass P.: 1564, 244, P1590, P462, P830, P854,
Haldar S.K.: P1491, P312
Halianishcha V.: P1609
Halimi F.: P1341
Halperin J.L.: P536, P912
Hama Y.: P1345, P989
Hammache N.: P1461
Han S.W.: P1378
Hanazawa K.: P1373, P1617
Hancox J.: P931
Hanis J.: P1435
Hanke T.: P1608
Hannes T.: P438
Hansen A.: P948
Hansen A.R.N.E.: P949
Hansen C.: P1511
Hansen J.: P832
Hansen P.S.: P979
Hanson B.: P286
Haouala H.: P381
Harada T.: P1612
Harari D.: P321, P449
Hardy C.: P1537
Harris L.: 238
Harrison J.: 809, P1324, P1330, P311
Hartlage G.R.: P1636
Haruna T.: P297
Hasan F.: P1637, P323
Hasebe N.: P1127, P1406, P372
Hasegawa K.: P481
Hasegawa K.H.: P317
Hasenfuss G.: P963
Hashiguchi N.: P1352
Hashimoto Y.: 1319, P582
Hatala R.: 1316, P1024, P1639, P825
Hatch F.: P1419
Hategan L.: 1178, P1043
Hatem S.: P1395, P1396
Hatzinikolaou-Kotsakou E.: 638
Haustein M.: P438
Haverkamp W.: P1336, P1400, P375, P466
Havranek S.: 1245
Hawkey S.: P442
Hayama Y.: 1530, 179, P1332, P1421, P974
Hayase J.: P267
Hayashi A.: 1247
Hayashi H.: P297
Hayashi K.: P1118
Hayashi Y.: P1126, P1363
Hayes C.: 732
Hayes D.: P1012, P1624
Hayman J.: 1311
Hayward M.: P286
Hebsur S.: 1108, P1463
Heeger C.: P320, P452
Heeger C.H.: 1568, P1342, P192, P464
Hegedus Z.: 1178, P1043
Hegyi B.: P964
Heijman J.: 557
Heitman L.H.: 1236
Hell S.: P963
Henmi R.: 737, P844
Henningsen K.: P744
Henningsson M.: P1323
Henrikson C.: P60
Heo J.H.: P1664
Herbots L.: P1349
Herman D.: 1242
Hermans M.: P365
Hermida J.S.: P1035
Hernandez Hernandez J.: P859
Hernandez J.: 631, P1038, P358
Hernandez Madrid A.: P1468
Hernandez Ojeda J.: P336
Hernandez Ortega E.: P820
Hernandez-Madrid A.: P1057
Hernandez-Torres F.: P367
Herring N.: P587
Hery T.: P1398
Hescheler J.: P438
Hesselink T.: P1597, P843
Hidden-Lucet F.: P1398, P1505
Higuchi K.: P1507, P525
Hilbert S.: 807
Hildick-Smith D.: 109, P1509
Hilfiker-Kleiner D.: P1051
Hillege H.L.: P817
Himi T.: P1345, P989
Hindricks G.: 1309, 807, P1331, P1356, P1428, P1431,
P1496, P1542, P468, P826, P857
Hindricks H.: P889
Hirai T.: P870
Hirao K.: 239, P1507, P525
Hirao K.H.: P303, P995
Hiraoka M.: 1248, 1250, P1002, P446, P453
Hirata K.: 1113
Hirayama A.: P1602, P324, P746
Hirose S.: P824
Hirose T.: P1346
Hiroshima K.: P512
Hisazaki K.: P481, P852
Hisazaki K.H.: P317
Hitaka Y.: 1246, P1462, P534
Hiyamuta K.: 1560
Hlivak P.: P1639, P825
H-Madrid A.: P1026, P338
Ho G.: P267
Hoashi T.: 1530
Hochadel M.H.: P265
Hocini M.: P287
Hodge D.: 1108
Hodge D.O.: P1623
Hoefer C.: P188
Hoellinger H.: P1480
Hoelschermann F.: P1626, P511
Hoenig S.: P1021
Hof T.: P433, P439
Hoff P.I.: 236, P1616, P266
Hoffman B.: P1426
Hoffmann A.: P531
Hoffmann B.A.: P1438, P1592, P190, P479
Hoffmann E.H.: P1587, P265
Hoglund N.: P295
Hohl M.: 180, 89, P412
Hohmann S.: P1010, P1051
Hojo R.: 1248, 1250, P1002, P446, P453
Holloman K.: P494
Holmes D.: P475
Homuth G.: P1395, P1396
Hood M.A.: P62
Hook B.G.: P470
Hooks D.: P897
Horakova Z.: P920, P932
Horduna I.: P474
Horduna I.S.: P1354
Hori Y.: 1247, P1601, P319, P845
Horie M.: 1175, P1397
Hortigon-Vinagre M.: P940
Horton R.: P1593
Horvath A.: P949
Horvath B.: P964
Hosek J.: P932
Hoshen M.: P739, P967
Hoskova I.: 1242
Hosoda J.: P1383
Hosoya N.: P821
Hossein-Foucher C.: P1035
Houben R.: P1325
Houthuizen P.: P1125
Houzarova Z.: P1060
Hovstad T.: P1259
Howlett P.J.: P1419
Hsu J.: P1477
Hsu J.C.: P1463
Hu W.C.: 175
Hu W.-C.: P1660
Hua W.E.I.: 1180
Huang B.: P1039
Hudnall J.H.: P1379
Hueb W.A.: P860
Huemer M.: P1336, P1400, P375, P466
Huh J.: P1475, P819
Huisman M.V.: P536, P912
Hunter J.: P1463, P1477
Hunter R.: P833
Hunter R.J.: P521
Huntjens P.R.: P1634
Hunuk B.: P305
Hunuk B.U.R.A.K.: P451
Huo Y.: 1251, 1567, P1046, P1344, P450, P826
Hurmusiadis V.: P1053
Hurtado A.: P276
Hussain W.: P312
Hussein A.: P910
Husser D.: 1309, P1428, P1431, P468, P889
Hussin A.: P494
Huth Ruwald A.C.: P53
Hwang J.K.: P385
Hyde E.: P1033
Ibarra S.: 733
Ibragimova A.G.: P893
Ichihara N.: 239, P1000
Ichikawa M.: 1175, P1397
Iesaka Y.: 239, P1000
Igarashi M.: 243, P1410, P1638, P268, P459
Iglesias A.: 1177
Igual B.: P455
Iitsuka K.: P1667, P973
Ijzerman A.P.: 1236
Ikeda T.: P1437
Ikegami Y.: P970
Iliceto S.: 1239, P1367, P840
Ilich I.L.: P891
Iliescu A.: P1052
Illikova V.: P1024
Im S.I.: P1664, P256
Imahashi M.: P1406
Imai M.: 737
Imai Y.: P1663
Imaizumi S.: P1462, P534
Imamura S.: P1332, P1421
Imanalieva G.: P1670
Inagawa K.: P970
Inama L.: P1643, P975
Infusino T.: P322, P996
Ingoglia G.: P418
Inoguchi K.: P315
Inoko M.: P297
Inokuchi K.: P1413, P383
Inoue K.: 1561, P255
Insulander P.: P1543
Ioannidis J.P.A.: P1321
Ioannou A.: P1013
Ionin V.A.: P368
Iorgulescu C.N.: P1025
Iori M.: P1622, P339
Iqbal S.M.: P906
Irfan G.: P305, P306, P451
Iriart X.: P1391, P1412
Ishibashi K.: P1339, P1544, P1581, P1630, P824
Ishida K.: P481, P852
Ishida M.: P821
Ishiguro M.: P1346
Ishikawa T.: P1383
Ishimura M.: P1352
Ismer B.: P356
Isobe M.I.: P303, P995
Isshiki T.: P1383
Ito M.: P1333, P1436
Itoh H.: P1397
Iturbe M.: P185
Ivanitskiy E.A.: P1374, P827
Ivyanskij S.A.: P524
Iwakura K.: P255
Iwasaki Y.: 1565, 1569, P296
Iwasawa J.: 239, P1000
Iwase K.: P870
Izquierdo De Francisco M.: P1361
Izumi C.: 179, P1332, P974
Jabr R.: P1419
Jachec W.: 1111, P1642
Jackson N.: 1241, 238, P1045
Jackson T.: 1534, P1027, P1033
Jackson T.A.: P1028, P1635
Jacon P.: P911
Jadidi A.: 178, P260
Jagathesan R.: P498
Jager P.L.: P191
Jain S.K.: P187, P302
Jais P.: 1529, P1593, P287, P849
Jalal Z.: P1391, P1412
Jamous A.: 1312
Jan M.: P1360
Jang S.W.: P1441, P1651
Jang S.Y.: 46, P1464, P484
Jangsangthong W.: 1238
Janion M.: 1111, P1642
Jansova H.: P1260
Janssen M.: P1628
Januska J.: P1337, P1427
Jarkovska D.: P410
Jarman J.: P1491
Jarman J.W.E.: P312
Jastrzebski M.J.: P1451
Jatsuk D.I.: P368
Jauker W.: P828
Jauvert G.: P272
Jdaida B.: P381
Jeevaratnam K.: 776
Jegere S.: P907
Jeilan M.: P1388
Jenei Z.S.: P1031
Jensen H.: P311
Jensen H.K.: P279
Jensen J.M.: P279
Jensen S.: P295
Jensen-Urstad M.: P1452, P1543
Jeong M.H.: P1418, P1671
Jespersen T.: 23
Jesus Jimenez-Lopez J.J.L.: P486
Ji Y.: P930
Jiang Y.O.N.G.: 1180
Jilesen D.: P485
Jimenez Diaz J.: P1022
Jimenez J.: P358
Jimenez-Candil J.: 631, P1038, P859
Jimenez-Lopez J.: P334
Jo U.: P337, P901
Joergensen O.D.: 113, P53
Johannessen A.: P832
Johansen J.B.: P282
Johansen J.B.: 113, P53
John I.: P377, P527
John R.M.: P187, P302
John S.: P1496, P468
Johnson W.B.: P494
Jones M.A.: 732
Jones P.W.: P1369
Jons C.: P53
Jordaens L.: P62
Jorge Perez P.: P1019
Jorgensen O.D.: P282
Jose Moreno-Arribas J.M.A.: P486
Joseph L.: P328
Josephson M.E.: P1321
Joshi S.: P380
Jouni M.: P936
Juan Benezet-Mazuecos J.B.M.: P486
Juan Fernandez-Armenta J.F.A.: P486
Juarez Prera R.A.: P1019
Jubele K.: P1662
Kaab S.: 115, P1121
Kaba R.A.: P377, P527
Kabutoya T.: P1663
Kacet S.: P1376
Kagawa Y.: P1333, P1436
Kageyama S.: P821
Kagisaki K.: 1530
Kahveci G.: P518
Kaik J.: P1403
Kaitani K.: 179, P1332, P1421, P974
Kaji S.: P983
Kajiyama T.: P1352
Kajurek K.: P1040
Kakar S.J.: P1494
Kakihara J.: P1126, P1363
Kalarus Z.: 114, 1535, P1253, P273
Kalejs O.: 107, P1662, P1672, P907
Kalinderi K.K.: P1495
Kalinin V.: 579
Kallergis E.: 570, P1460, P1619, P343
Kalogeropoulos A.: P875
Kamakura S.: P1339, P1544, P1581, P1630, P824
Kamal Z.: 1109
Kamdar R.: 635
Kamijima A.: P1630
Kamioka M.: P1357, P1606
Kamishita K.: P1345
Kamiyama Y.K.: P1606
Kammler J.: P1021
Kanaan J.: P1395, P1396
Kanadasi M.: P919
Kanagaratnam P.: 109, P1509
Kandinsky M.L.: P333
Kaneda M.: P1346
Kaneshiro T.K.: P1606
Kang I.S.: P819
Kang S.H.: P1579, P441, P841
Kanoupakis E.: 570, P1460, P1619, P343, P344, P492
Kapa S.: P475
Kapel G.F.L.: 240, P1540
Kaplunova V.Y.U.: 1114
Kapsali E.: P1404
Kaptsiukh T.M.: P1009
Kara T.: P864
Karai D.: P1403
Karaskov A.: 237, P966
Karavolias G.: P526
Karbarz D.K.: P1613
Kardos A.: 1308, 729
Karim R.: P1322, P1323, P1330, P311, P472, P972
Kario K.: P1663
Karolyi L.: P304
Karosiene Z.: P1257, P1637, P323
Karosine Z.: P1416
Karpenko Y.: P1641
Kasem-Suwan P.: P342
Kaseno K.: P317, P481, P852
Kashimura S.: P1425, P837, P842
Kasim M.: P423
Kassem H.: P530
Kastellanos S.: P1122
Kaszuba A.: P495
Kataria V.: P1325
Kato K.: 737, P1397, P844
Kato M.: P1667, P973
Katritsis D.G.: P1321, P966
Katritsis D.K.: P1495
Katritsis G.D.: P1321
Katsivas A.: P985
Katsouras G.: P990
Katsumata Y.: P1425, P837
Katta A.A.: P489
Katus H.A.: 48
Katz A.: 1533
Kaur G.: 1307, P258
Kaura A.: 635
Kautzner J.: P1260, P1607, P321, P331, P850
Kavet R.: P1371
Kawai H.: P1422
Kawaji T.: P1423
Kawamura I.: P453
Kawamura M.: P1359, P1413, P269, P315
Kawamura Y.: P1127, P1406, P372
Kawasaki M.: 1569, P296
Kawauchi T.S.: 1317, P270
Kaya H.: P885
Kaye G.: P330
Kayki Mutlu G.: P440
Kazik A.: P1499
Kebed D.K.: P1050
Keelan T.: P1343
Keilegavlen H.: P1259
Kekesi V.: P520
Kennergren C.: P284
Kerber S.: P981
Kesek M.: P295
Kettering K.: P1443, P1589
Kettlewell S.: P396
Khabarova N.V.: 1114
Khairy P.: P1371, P467, P856, P866
Khalameizer V.: 1533
Khalea S.: P910
Khalid R.: P992
Khalil M.: P438
Khamnagadaev I.A.: P891
Khan A.P.: 24
Khan F.: P1586, P353, P515
Kheir A.: P1011
Khiani R.: P587
Kholmovski E.: P258
Khoueiry Z.: P988
Khoury M.: P1446
Kiblboeck D.: P1480
Kidakoev Z.A.: P333
Kiedrowicz R.M.: P1322, P1323, P1324, P1330
Kietselaer B.L.: P294, P443
Kik C.: P1405, P1407, P528, P900
Kikuchi A.: 1569, P296
Kilicaslan F.: P1439
Kiliszek M.: P1040
Killu A.M.: P1623
Kim C.Y.: 46, P1464, P484
Kim D.H.: P1119, P1124
Kim E.K.: P256
Kim G.: P1012, P1624
Kim H.S.: P1664
Kim H.S.: 43
Kim J.: P1644, P337, P901
Kim J.S.: P256, P385
Kim J.Y.: P1441, P1651
Kim J.B.: 43
Kim J.H.: 46, P1441, P1464, P1651, P484
Kim J.J.: P1644
Kim J.S.: P1475, P742, P819
Kim J.W.: P364
Kim K.: P983
Kim K.S.: 43, P1378
Kim M.S.: P1644, P1644, P901
Kim N.K.: 46, P1464, P484
Kim S.H.: P1441, P1651
Kim S.S.: P1418, P1671, P742
Kim T.S.: P1441, P1651
Kim W.: 43
Kim W.Y.: P311
Kim W.S.: 43
Kim Y.H.: P337
Kim Y.R.: P337
Kim Y.H.: P1644, P901
Kim Y.N.: P1378
Kim Y.Y.: P488
Kimber S.: P501
Kimura M.: P297
Kimura T.: P1383, P1423, P1425, P837, P842, P896
Kimura Y.: P297
Kinch Westerdahl A.: P863
King B.: 238
Kingston P.A.: P1494
Kinoshita M.: P983
Kircanski B.: P872
Kircher S.: P1431
Kirkfeldt R.: 113
Kirkwood G.: P918
Kirste Y.: P1010
Kirubakaran S.: P1541
Kis Z.: 1308, 729
Kiseleva I.: P1669
Kiss M.: P1478
Kistamas K.: P964
Kitada M.: P1373
Kitamura T.: 1248, 1250, P1002, P446, P453
Kiuchi K.: P1422
Kiyakbaev G.K.: P1327
Kizilirmak F.: P1439
Klank-Szafran M.K.S.: P1613
Klausz G.: P1347, P829
Kleemann T.: P1459
Klemen L.: P454
Klersy C.: 1528, P1486, P1673, P483
Kloppe A.: P1637
Klossner N.: 1110
Klotz S.: P1608
Klug D.: 1117, P1035, P1376, P57, P879
Knecht S.: P1037, P1442
Knezl V.: P1041, P1648
Knight B.P.: P187, P302
Knipse A.: P1662
Knops P.: P1405, P1407, P528, P900
Knops R.E.: P1369, P62
Knott T.: P933
Knutsen T.M.: 1109
Knybel L.: P473
Ko E.: P1373
Kobayashi S.: 1247, P1601, P319, P845
Kobayashi Y.: P1352, P1359, P1413, P269, P315, P383
Kobori A.: P1434, P983
Kodama K.: P821
Koenig T.: P1010, P1051
Kogan Y.: 632
Koh K.W.: P910
Kohari M.: P1347
Kohl T.: P963
Kohno R.: P1118
Koivumaeki J.T.: P392
Kojodjojo P.: P1621
Kokov L.S.: P891
Kolb C.: P1380, P867
Kolbe J.: P1637
Kolios M.: P1404
Kollum M.: P1578
Kolodgie F.: P1491
Kolstad T.: 555
Komatsu T.: 1247, P1601, P319, P845
Komatsu Y.: P268, P287
Komissarova S.: P1498
Komiyama K.: 1248, 1250, P1002, P446
Komoliatova V.: P1669
Komurcu-Bayrak E.: P518
Kondo H.: 179, P974
Kondo T.: 1569, P1667, P296, P973
Kondracka A.: P1040
Konduracka E.: 1116, P513
Koneru J.N.: P522
Kong W.: P1420, P741
Kongsgaard E.: P1482, P589
Konofagou E.: P876
Konstantinidou M.: 638
Konstantinou A.: P292
Koopman P.: P1349
Korantzopoulos P.: P1404, P376, P823
Kornej J.: 1309, P1428, P1431, P468, P889
Korniat A.: P1398
Kornmayer M.: P867
Kornyei L.: P1043
Korolev S.V.: 735
Kosiuk J.: P1431, P1496
Koskinas K.K.: P1495
Kostantionu A.: P1594
Kostopoulou A.: P340, P526
Kostrubiec M.: P1666
Kosztin A.: P520
Kotecha D.: 173
Kottmaier M.: P867
Kourai K.: P512
Kouranloo K.: P1322
Kourlaba G.: P492
Koustrup T.: P1408
Koutalas E.: 1309
Koutsogiannis N.: P299
Kouvidis E.: P492
Kovalenko O.: P1609
Kovalev I.: P858
Kovalova M.: 107, P1672
Kovarikova D.: P1060
Kowalski M.K.: P506
Kowalski O.: 1535
Kowase S.: 1319, P268
Koyama Y.: P255
Kozhevnikova M.V.: 1114
Koziolova N.: P822
Kozluk E.: P1040
Kragten J.A.: P294, P443
Kranig W.: P506
Krasniqi N.: 49
Krause R.: P1030, P1503, P1661, P881
Krausova R.: P1607
Krauss T.: P1598
Kravchuk B.: 1243
Kreidieh B.: 733
Kremzer A.: 577
Krestianinov O.: 237
Kretov E.: 237
Kreuzhuber M.: P1331
Kristensen J.: P279
Krivolapov S.: P858
Kroener A.: P438
Kroll K.: P356
Kronborg M.B.: P282
Kronborg M.B.: P1385, P279, P508
Kroon W.: P1030, P881
Kropotkin E.: P1374, P827
Kruchina T.: P1401, P523, P898
Krueger S.: 809
Krug J.: 1564, 244, P854, P998
Krummen D.E.: P267, P309
Kruszelnicka O.: 1116
Krynski T.: 1563, P1433, P993
Kucejko T.: P318
Kucera J.P.: P942
Kucera P.: P1260
Kuck K.H.: 115, 1568, P1342, P1583, P192, P284,
Kuck K.-H.: 574, P1357, P320, P449, P452
Kuck K.H.K.: P1587, P265
Kucuksu Z.: P885
Kudaiberdiev T.: P1670
Kudoh Y.: P1006
Kudolo J.: P933
Kuehne M.: P1037, P1442, P507
Kuhelj D.: P1360
Kuiper H.R.M.: P448
Kukla P.K.: P1451
Kuklik P.: P1438, P190, P257, P448
Kulakowski P.: 1563, P1433, P993
Kulikov A.: P310
Kumagai K.: 1561, 738, P469, P980
Kumagai N.: 1246
Kumakura A.: P1047
Kumar C.: P1256
Kumar S.K.: P1366
Kunev B.T.: P1615, P477
Kuniss M.: P838
Kunitomi A.: P842
Kurdziel M.: P1499
Kurek A.: P1499, P414
Kuroda S.: P582
Kuroki K.: 243, P1410, P1638, P268, P459
Kurosaki K.: 1319, P268, P582
Kurushka T.V.: P1009
Kurzyna M.: P1666
Kus T.: P1039
Kusak A.K.: P1613
Kusano K.: P1339, P1581, P1630, P824
Kusano K.F.: P1544
Kuschyk J.: 48, 633, P583, P865
Kusha M.: 1241, P1045
Kutarski A.: 1111, P1642, P284, P360, P886
Kutinsky I.: P992
Kutyifa V.: P1478
Kuwahara T.: P1345, P989
Kuwahara T.K.: P303, P995
Kuznetsova M.V.: P496
Kwan J.: P1119, P1124
Kweon S.S.: P742
Kwon C.H.: P337
Kwon J.H.: P901
Kwon S.W.: P1119, P1124
Kypta A.: P1021
Kyriakou P.: P890
Kyriakou P.K.: P1495
Kyu K.: P1420
La Rosa C.: P1618
Laager V.: 1311, P1379
Ladewig D.: P475
Lagrenade I.: 108, P1058
Lahidheb D.: P381
Lai P.: 1241, P1045
Laish-Farkash A.: 1533
Lakkireddy D.: P1593, P261, P262
Lakshmanadoss U.: P992
Lal K.: P1322, P1323
Lalani G.G.: P267
Lam A.: 1110
Lambert H.: P321
Lambert T.: P1021
Lambiase P.: P1369, P1586, P286, P353
Lambiase P.D.: P1013, P515, P59
Lambrakos L.: P876
Lamoureux C.: 778
Landolina M.: 1528, P1011, P280, P346, P354, P54
Lane D.: 173
Lang C.: P1588
Lang C.C.: P442
Langbein A.: P304
Langialonga T.: P990
Lanters E.A.H.: P900
Lanza D.: 1526, 1527, P1479, P1580, P1640
Lanzillo T.: P903
Lapuerta Irigoyen J.A.: P493
Laroche C.: 174
Larraya F.: P326
Larreta B.: P1036
Larsson K.: P947
Lashkul D.: P1649
Latcu D.G.: P1335, P1424, P1440, P1469
Latypov R.: P310
Lau Y.C.: P909
Laufer S.: P1392, P1490
Laur O.: P1401, P523
Lawless M.: P918
Lawo T.: P583
Laynez Cerdena I.: P1019
Lazaro C.: P1468
Lazniak A.: P1007, P482
Le Bloa M.: 1117
Le Helloco A.: P1470, P868
Le Pennec-Prigent S.: P1008
Le Polain De Waroux J.B.: P853
Leao S.: 116, P1061
Leatham E.W.: P1419
Lebedev D.: P1032, P502
Lebedev D.S.: P1650
Lebedeva E.: P927
Lebedeva V.: P1032, P502
Leclercq C.: 1117, 1528, P1008, P1253, P1470, P1471,
Leclerq C.: 1529, 1531
Lecoq C.: P288
Lederer J.: P963
Lee C.K.: P364
Lee C.-L.: 175
Lee J.H.: 46, P1464, P484
Lee K.H.: P1418, P1671, P742
Lee L.: P1492
Lee M.J.: P1119, P1124
Lee M.Y.: P1441, P1651
Lee R.: P382
Lee S.C.: P256
Lee S.R.: P1579, P441, P841
Lee W.S.: P337
Lee Y.H.: P742
Lee Y.S.: P1378
Lefebvre F.: P404
Legal F.: P56
Leggio M.: P274
Lehnart S.E.: P963
Lehrmann H.: 178, P260
Leibowitz M.: P739, P967
Leinveber P.: P864
Leite L.: P58
Lejnieks A.: 107, P1662, P1672
Lekakis J.: P1122
Lelakowski J.: P1017, P347, P888
Lellouche N.: 1531
Lelong B.: P1008
Lematte E.: 50, 634
Lemes C.: P1357, P1583, P320, P452
Lemke B.: P1253, P1257, P1416, P1637, P323
Lemmens-Gruber R.: P906
Lenarczyk R.: 1535
Lencioni M.: P968
Lendeckel U.: P1395, P1396
Lennerz C.: P867
Lensi M.M.: P335, P581, P860
Leo M.: 109, P1509, P831, P978
Leon A.R.: P1369, P488
Leon Arguero V.: P1646
Leoni L.: 1239, P1338, P1429, P264, P840
Leontieva I.V.: P1500
Lerner D.J.: P60
Letsas K.: P376
Letsas K.L.: P1495
Levashov S.Y.U.: P1506
Leventopoulos G.: P862
Levesque S.: P467
Levi Y.: P1340
Levin D.: P442
Levine R.O.B.E.R.T.: P1055
Levorato D.: P1015
Lewalter T.: 115, P1578
Lewis K.: 1108, P1463, P1477
Leyva F.: 1528, P1474, P877, P968
Lezius S.: P1592
Li A.: P1402
Li G.: P298
Li J.: P745
Li S.: P494
Li Y.: P952
Liang M.: P1420
Liang X.: P298
Licariao E.G.D.: P1632
Lichtenberg L.: P183
Liebe V.: 48, P865
Lim H.S.: P351
Lim T.W.: P1621
Lim W.H.: P1579, P441, P841
Lima Da Silva G.: P300, P883
Lin A.C.: P494
Lin E.L.S.: P1474, P877
Lin F.C.: P1508
Lin Jiaxiong D.R.: P1326
Lin Jinyi D.R.: P1326
Lin L.S.: P293
Lin T.: 1568, P1342, P192, P464
Linde C.: P275
Lindemann C.: P818
Ling H.: P1493
Linyaeva V.: P1500
Linz D.: 180, 89, P412
Liotta C.: P1409
Lip G.: 173, 174
Lip G.Y.H.: 108, P1058, P288, P445, P447, P536,
Lipari A.: P1643, P975
Lipchenca I.: P1387
Lipinski W.: P495
Lipsett D.B.: P437
Lishmanov Y.: P1445
Lissoni F.: P339
Listopad O.V.: P368
Litchi C.F.: P917
Litunenko O.: P1672
Liu G.: 1182
Liu H.: P916
Liu J.: 1236
Liu M.: P916
Liu S.: P1379, P289
Liu T.: P298, P376, P823
Liu W.E.N.: 44
Liu X.: 90
Lloyd M.S.: P1636
Lo H.S.: P1508
Lo S.L.: P1508
Loaiza S.: P358
Lobo D.: P1632
Locatelli A.: P535
Locati E.T.: P1658
Lodola F.: 1179
Lodzinski P.: P1040
Loebe S.: P889
Logarzo E.M.I.L.I.O.: P505
Loges C.: P1511
Loirat A.: P1470
Lokhandwala Y.: P380
Lopez Cabanillas N.: P1481
Lopez Lluva M.T.: P1022
Lopez-Gil M.: P1658
Loricchio M.L.: P1353
Lorrain A.: P986
Losik D.: P966
Louch W.E.: P437
Lousinha A.: 111, P1631, P835, P884
Lovecchio M.: P1497, P274
Lovett E.: P57
Lowe M.: P1586, P353
Lowe M.D.: P515
Lozano-Velasco E.: P367
Lubberding A.F.: P415
Lubimceva T.: P1032, P502
Lubinski A.: P318, P905
Ludwik B.L.: P1613
Luermans J.G.L.M.: P1628, P355
Luis Martinez-Sande L.M.S.: P486
Luise R.: P56
Luker J.: P1438, P1592, P479, P994
Luker J.L.: P1587, P265
Lumens J.: P1634, P504, P880
Lumia G.: P1057
Lumley M.: 1534, P1027
Lunati M.: 1528, P1364, P1429, P346, P354, P54
Lund L.H.: P275
Lupo P.: P1449
Lurina B.: P1672
Luzi M.: P1255
Luzzi G.: P346
Lyasnikova E.: P1032, P502
Lynch S.A.: P894
Lynnes T.C.: 1176
Lyvet J.: P461
Ma C.S.: P536, P912
Maass A.H.: P62
Mabo P.: P1008, P1470, P1471, P584, P868, P987
Maca A.: P907
Macaluso G.: P272
Maccabelli G.: 802, 808, P1003, P1502
Macchi E.: P1394, P366
Machado Cesar L.A.: P860
Machell C.: P1624
Machino T.: 243, P1410, P1638, P268
Macle L.: 810, P467, P856, P866
Macquaide N.: P961
Madaffari A.: 1244, 177, P1605, P1617, P818, P971,
Madalosso M.: P490
Maddaluno F.: P1457
Madeira F.: P580
Madero S.: P332, P456
Madershahian N.: P57
Maesen B.: P257
Maffe' S.: P588
Maffessanti F.: P1030, P881
Mafi Rad M.: P1628, P350, P355
Magalhaes A.: P300, P883
Magalhaes P.: 116, P1061
Magalhaes S.: P300
Magalski A.: P1018, P1473
Maggioni A.: 174
Maggioni A.P.: P284
Maglia G.: P346
Magnani A.: P1620
Maguire P.J.: 811
Magyar J.: P964
Mahaina R.: P1392
Mahapatra S.: P449, P849
Mahapatra S.R.: P321
Mahfoudhi H.: P381
Mahmoud M.H.: P498
Mahnkopf C.: P1590
Maier L.S.: P917
Maines M.: P476, P500, P54
Mairesse G.H.: 1314
Majocchi B.: P307, P463
Makai A.: P1347
Makarov L.: P1669
Makarov L.M.: P524
Makaryan Y.S.: P969
Makiyama T.: 1175
Malacrida M.: P1011, P1618, P339, P487, P503
Malaczynska-Rajpold K.: 576
Malaescu G.: P1025
Malaspina D.: P1448
Malavasi M.: P1497
Malczynski J.: P1645
Malecka B.: P1017, P347, P888
Malhotra A.: P978
Malkina T.: P1048
Malkina T.A.: P899
Malovini A.: P519
Mamiya K.: P870
Man S.H.: P1388, P184, P316
Man S.H.W.: P1610
Manaka T.: 737, P1415, P844
Mandes L.: P1647
Mandry D.: 636, P1461
Manenti V.: P1005
Manganelli F.: P903
Mangani N.: P505
Maniadakis N.: P492
Manintveld O.: P1407
Manintveld O.C.: P528
Mankaryous G.: P877
Mann I.: 635
Manrique A.: P433
Mansour M.: P187, P302, P449, P849
Mansourati J.: 1117
Mantziari L.: P1354, P1491, P312, P474
Marcantoni L.: 1526, 1527, P1479, P1580, P1640
Marcelino S.: P314
Marcelot D.: P461
Marchand B.: 1314
Marchandise S.: P853
Marchionni N.: 174, P1488, P363
Marchlinski F.: P321
Marcu I.C.: P942
Marechaux S.: P1471
Margitfalvi P.: P1024, P1639, P825
Mari Lopez B.: P1019
Mariankowski R.: P513
Marie P.Y.: 636
Marijon E.: P879
Marini M.: P500
Marino P.: P1620
Marino V.: P307, P463
Marionneau C.: P917
Markides V.: P1491, P312
Marques L.: P580
Marques M.: 730
Marques P.: P883
Marquie C.: P1035, P1376
Marrouche N.F.: 1307, P258
Marshall H.: P968
Marstrand P.: P1411
Marszalec W.: P437
Martens E.: P1014
Marti Almor J.: P460
Marti-Almor J.: P1044, P1417, P748
Martignani C.: P1370, P352
Martin A.: 631, P859, P911
Martin D.: P357
Martin D.T.: P1252
Martin Gonzalez J.: P509, P991
Martin M.: P1646
Martinek M.: P261, P828
Martinelli M.: 1317, P1029, P1632, P270, P335, P581,
Martinez Brotons A.: P1361
Martinez Dolz L.: P186, P455
Martinez Ferrer J.: 629, P509
Martinez J.G.: P1484
Martinez-Dolz L.: P848
Martinez-Ferrer J.: P1484, P338
Martinez-Ferrer J.B.: P1625
Martino M.: P56
Martins R.P.: P1008, P1470, P868, P987
Martins S.A.M.: P1029
Maruyama M.: P1581
Marx M.: P846
Marynissen T.: 630
Marzi A.: 802, P1414, P1450, P361
Marziali A.: P1370
Marzo L.: P1453, P902, P904
Mase M.: 182
Massa R.: P1011
Massa T.: P1578
Massaro G.: P1370
Massaro R.: P341
Masse S.: 1241, 245, P1045, P851
Mastropietro M.: P861
Masuda K.: 243
Mata A.: P300
Matas M.: P336
Matejovic P.: 777, P932
Mateos Perez A.: P991
Mateus P.S.: 116, P1061
Mathew S.: 1568, P1342, P1357, P192, P320, P464
Matia Frances R.: P1026, P1057, P338
Matia R.: P1468
Matsuda H.: P375
Matsudo Y.: P1345, P989
Matsue Y.: 1319, P582
Matsumoto N.: 1246, P1462, P534
Matsumoto Y.M.: P1606
Matsumura A.: 1319, P582
Matsunaga A.: P1462, P534
Matsuoka M.: P1047
Matsuoka R.: P1346
Mattey-Prevot F.: P461
Mauel E.: 1314
Maupain C.: P1505
Maurer T.: 574, P1583, P320, P452
Mauri R.: P1673
Maurino I.C.: 1317, P270
Maurizi N.: P61
Maury P.: 1117, 50, 634, P1120
Mavrakis H.: 570, P1460, P1619, P343
May A.M.: P1050
Mayer J.: 1251, 1567, P1046, P1344, P1578, P450
Mayordomo Gomez S.: P991
Mayr H.: P1020
Mazic U.: P1360
Mazij M.M.: P1451, P1613
Mazo A.: P1623
Mazur W.: P1474
Mazza A.: P274
Mazzanti A.: P519, P61
Mazzone P.: P1003, P1414, P1450, P1502, P361
Mazzotti A.: P1370
Mc Cann C.: P1343
Mccomb J.M.: P1512
Mcdonnell P.: 1312
Mcglynn K.: P424
Mcgorrian C.: P894
Mcintyre W.F.: P1365
Mcspadden L.C.: P1381
Medallo J.: 1177
Medeiros-Domingo A.: 1110, P1455, P517
Medina Fernandez-Aceytuno A.: P820
Medina-Palomo C.: 1318
Meigas K.: P1403
Meijboom F.J.: P350
Meine M.: P350, P516
Melichercik J.: P356
Melillo F.: P1414, P1502, P361
Melissano D.: P490
Mellor G.: P1123
Melnikova O.P.: P1009
Melo G.: 1317, P270
Meloh H.: P375
Melton I.: P897
Memmi M.: P519
Menardi E.: P1011, P1618
Mendes M.: P458
Mendez Vargas C.: P1019
Menichelli M.: P1497
Merchant F.M.: P1636
Mercurio M.: P1353
Merino J.L.: 1305, P326
Merino J.L.: P1536, P1545, P417, P420
Merino Llorens J.L.: P1001, P1362, P421
Merkely B.: P1031, P1478, P520
Mesa J.M.: P276
Mesirca P.: P929
Messemer M.: P185
Messina F.: P1353
Messner P.: P999
Metzger J.: 1174
Metzner A.: 1568, P1334, P1342, P1357, P1583, P192,
Metzner K.: 554
Meurice J.: P1035
Meyer M.R.: P917
Mezentsev P.: P310
Mezni M.F.: P381
Miake J.: P1667, P973
Michalakeas C.: P1122
Michaud G.F.: P321
Michelucci A.: 1112, P1389, P1611
Mickelsen S.R.: P328
Miglane E.: P1672
Migliore F.: P1367, P840
Migliore M.: P394
Mihalcz A.: 1308
Mijic D.: P1257, P1416, P1637, P323
Mikhailov A.: P367
Miki K.: P870
Milan V.: P386
Milhem A.: 112
Miljoen H.P.: P1599
Miller J.M.: 1176, P309
Miller L.: P960
Milliez P.: P1035
Minami K.: 738, P469, P980
Minarik T.: P1483
Minarsch L.: P897
Minchole A.: P393
Minin S.: P1445
Minoshima A.: P1127
Minoura Y.: P1413, P383
Mintale I.: P907
Miracapillo G.: P1016, P322, P996
Miracle A.: P1026
Miragoli M.: P934, P1394, P366
Mircea P.A.: P1657
Miro Palau V.: P1254
Mironova N.: 1237, P1048
Mironova N.A.: P899
Mishima T.: P1339
Miszczak-Knecht M.: P495
Mitic G.: P1059
Mitkowski P.: 576
Mito S.: P834
Mitrega K.: 1535, P273
Mitrofanova L.B.: P1650
Mitrousi K.: P498
Miura K.: P970
Miyagi T.: 1113
Miyake A.: P1054
Miyamoto K.: P1006, P1339, P1544, P1581, P1630,
Miyamoto Y.: P1047
Miyauchi Y.: 1561
Miyazaki A.: 1530, P1047, P1054
Miyazaki S.: 239, P1000
Miyazawa K.: P1352
Miyazawa S.: 1250, P453
Miyoshi T.: P1054
Mizia-Stec K.: P531
Mizukami A.: 1319, P582
Mizuki T.: 737
Mizuno H.: 802, 808, P1003
Mlotek M.: 110
Mlynarska A.: P1023, P1476, P499
Mlynarski R.: P1023, P1476, P499
Moccetti T.: P1030, P1503, P1661, P1673, P483, P881
Moeller V.: P1626, P511
Moellmann H.: P838
Mohan M.: P442
Mohanty P.: P261, P262
Mohanty S.: P261, P262
Moharram M.A.: P489
Mohd Saad N.: P910
Mohee K.: P1629
Moiseev V.S.: P1327
Moisei R.E.: P1052
Molenaar M.M.D.: P1597, P843
Molenda L.: P473
Molgaard H.: P1408
Molina Lerma M.: P509
Moller D.S.: P1510
Molnar L.: P1031
Moltrasio M.: P307
Momiyama Y.: P970
Mondesert B.: P856
Mondoly P.: 50, 634, P1120
Monedero Campo J.: P991
Mongeon F.P.: P467
Monir G.: P1444, P465
Monney P.: P422
Monning E.D.: P1510
Mont L.: 1311, 1320, 241, 571, 572, 805, P271, P336,
Montagnier C.: 110, 112
Montdesert B.: 810
Monteforte N.: P519, P61
Monteiro A.: P1591, P835
Montnach J.: P406
Montrone D.: P1656
Moody W.E.: P1474
Moolgaonkar S.: P380
Moon B.: P849
Moon S.H.: P901
Morais C.: P580
Moran D.P.: P894
Morani G.: P1372, P280, P491
Morea G.: P386
Moreira J.I.: 116, P1061
Morello M.: 1562
Moreno Arribas J.: P334
Moreno J.: 1316, P1026, P1468, P272
Moreno Planas J.: P1057, P584
Moretti P.: P1004
Morgado F.: P458
Morgagni G.L.: P1255
Morgan D.: P851
Morgan J.M.: 1529, P488, P862
Morgan K.: P897
Morgan R.: 181
Mori T.: 1560
Morii J.: 1246, P1462, P534
Morini M.: P61
Morinigo J.: P1038, P859
Morinigo J.L.: 631
Moris De La Tassa C.: P1646
Morishita T.: P852
Morita N.: 1561
Morita T.: 1569, P296
Morka A.M.: P1451
Morosato M.: 804, P491
Morrice K.: P1351
Morris A.: 1307, P258
Morris D.A.: P466
Morris G.M.: P1494
Mortensen P.T.: P1385
Mortensen P.T.: P279, P508
Moscato A.: 1314
Moschos G.: 638
Moscoso Costa F.: 730, 736, P458
Moser A.R.: P1018, P1473
Moser J.M.: P1438, P190
Mosse C.A.: 806
Moszczynska-Stulin J.: P497
Motohashi Y.: P1373
Motwani R.: P380
Mougenot N.: P405
Mouws E.M.J.P.: P1405
Moya A.: P1658
Mpantouvakis G.: P1619, P492
Mrochek A.: P1609, P480
Muegge A.: P1416
Muehl A.: P1037, P1442
Mueller C.: 1240, 45
Mueller D.: P1380, P56
Mueller P.: 1564, 244, P462, P830, P854, P981, P998
Mueller-Burri S.A.: 49
Mueller-Ehmsen J.: P57
Muessigbrodt A.: P1496
Mugnai G.: P305, P306, P451, P491
Muhammad Z.: P910
Mullens W.: P1253
Muller H.: P314
Muneretto C.: P1643, P471, P847, P975
Munetsugu Y.: P1359, P1413, P269, P315, P383
Munoz-Garcia A.: 1318
Murakawa Y.: 1561
Murakoshi N.: P268, P896
Muramoto H.: P1507, P525
Muraoka Y.: P834
Murasato Y.: 1560
Murata K.: P821
Mureddu R.: P1633
Muresan L.: P1657
Murgatroyd F.: 635
Murrow J.: P986
Murzilli R.: P1030, P881
Muser D.: P1614
Mustapaeva Z.R.: P419
Muszkiewicz A.: P397
Muzzarelli S.: P1661
Myc J.: P382
Myftiu S.: P369
Myles R.: P425
Mzoughi S.: P381
Nabutovsky Y.: P1256
Nadziakiewicz P.: P414
Naegele H.: P583
Nagashima M.: P512
Nagata Y.: 1246, P1462, P534
Nagel A.: P356
Nagy I.: 1178, P1043
Nagy K.V.: P520
Nagy Z.: 729
Nahler A.: P1021
Naimushin A.: P1392, P1490
Nair K.: 238
Naito S.: 1561, 738, P469, P980
Najibi S.: P1036
Nakada A.: P446, P453
Nakagawa A.: 1247, P1601, P319
Nakagawa H.: 731
Nakagawa Y.: 179, P1332, P974
Nakagomi T.: P870
Nakahara A.: P845
Nakahara S.: 1247, P1601, P319, P845
Nakai K.: P1423
Nakajima I.: P1339, P1544, P1581, P1630, P824
Nakajima J.N.: P303
Nakajima K.: P1425, P837, P842
Nakajima N.J.: P995
Nakamura H.: 239, P1000
Nakamura K.: 738, P469, P980
Nakamura K.N.: P317
Nakamura T.: 1560
Nakamura Y.: P383
Nakanishi T.: P1006, P1415
Nakano E.: P1612
Nakano M.: 738, P469
Nakashima E.N.: P303, P995
Nakazato J.: 1113
Nalos L.: P408
Nam G.B.: P337, P1644, P901
Namdar M.: P1600, P313, P314, P461
Nanasi P.P.: P964
Nangeroni G.: P1432
Nanthakumar K.: 1241, 245, P1045, P851
Naoki N.A.: P317
Naperkowski A.: 1310, 1313, P1377, P1447, P345,
Napolitano C.: 1179, P519, P61
Narasimhan C.: 573
Narayan S.M.: P267, P309
Nardaia S.H.G.: P419
Narducci M.L.: P1368, P1618, P487
Naruse Y.: 1319, P582
Nas J.: P365, P485
Nasanova O.: P1445
Nastasa A.: P1025
Nastase O.-A.: P1647
Natale A.: P261, P262, P449
Nattel S.: P467
Nawada R.: P821
Ndjessan J.J.: P911
Nedios S.: 1309
Negrao C.E.: P1632
Negrete A.: P1481
Negroni S.: P1448
Nentwich K.: 1564, 244, P462, P830, P854, P998
Nentwich K.M.: P981
Nerbonne J.M.: P917
Neri P.: P535
Neshati Z.: 1238
Nessler J.: 1116, P513
Nesti M.: P1034, P882
Neuber C.: P948
Neuber C.H.R.I.S.T.: P949
Neuberger H.R.: 180
Neumann T.: P838
Neuwirth R.: P473
Neuzil P.: P1369
Neven K.G.E.J.: 1566, P836
Nevralova R.: P1427
Neyroud N.: P405
Ng G.A.: P1610
Ng G.A.: P1388, P1402, P1665, P184, P316, P378
Ng K.: P330
Nguyen D.H.: P1371
Nguyen D.Q.: P183
Nguyen Q.S.: P1637, P323
Nguyen U.C.: P1661
Nickel A.: 89
Nicolson W.B.: P1388, P1402
Nie Zhenning D.R.: P1326
Niebauer M.: P1012
Niederer S.: P1033, P472, P972
Nielsen B.R.R.: P1510
Nielsen J.C.: P1385, P282, P979, 113, P279, P508,
Nifontov S.E.: P368
Nigro G.: P490
Nihoyannopoulos P.: P985
Nijenhuis V.J.: P277
Nikitichev D.: 806
Nikitin A.G.N.: P1655
Nikolaidou T.: P373
Nikonova J.: P822
Nikulina S.Y.U.: P1654
Nilsson K.R.: P986
Ninios I.: P323
Nishihara M.: 1560
Nishimura T.: P1006, P1415
Nishioka S.A.D.: P1029, P1632, P335, P581, P860
Nishiura T.: P372
Nishiyama N.: 1247, P1425, P1601, P319, P837, P842,
Nishiyama T.: P1425, P837
Nishizaki M.: 1250, P1002, P446, P453
Nisizaki M.: 1248
Niwa A.: P1507
Niwa M.: P870
Nizard J.: P1505
Noack J.: P272
Nobre Menezes M.: P300, P883
Nobuyoshi M.: P1383
Noda T.: P1339, P1346, P1544, P1581, P1630, P824
Nodera M.N.: P1606
Noelker G.: P1578
Noergaard B.L.: P508
Nof E.: P1387, P1653
Nogami A.: 1319, 1561, 243, P1410, P1638, P268,
Noguchi Y.: P1638
Nogueira-Silva M.: P884
Nohr E.A.: P1385
Nohr E.A.: 113
Noimark S.: 806
Noonan B.: P894
Nordin S.: P1627
Norgaard B.L.: P279
Norseng P.A.: P965
Norton L.: P308
Nosikov V.V.N.: P1655
Notarstefano P.F.: 803
Noti F.: 1110, P1455, P517
Novak J.: P1013
Novak M.: P1060
Novak P.G.: P187, P302
Novakova T.: P871
Novelli V.: P519
Novik G.: P1401, P523
Novikov D.S.: P333
Nowak B.: P1594
Nowak S.: P531
Numaguchi K.: 1560
Nunez C.: P1361
Nunez J.: P1361
Nyns E.C.A.: 1238
O' Neill M.: 809, P1323, P1324, P1330, P1322
Obremska M.: P1504
Obsitnik B.: P1041
Occhetta E.: P1620
Ochi A.: P1413, P383
Oddone D.: P1633
Odgers L.: P351
Odille F.: 636, P1461
Odland H.H.: P1482, P589
O'donnell D.: P351
Ogawa K.: P1410, P383
Ogawa M.: 1246, P1462, P534
Oginosawa Y.: P1118
Ogura K.: P1667, P973
Oh I.Y.: P1579, P441, P841
Oh S.: P1579, P441, P841
Oh S.E.I.L.: P1492
Oh Y.S.: P1441, P1651
Ohkubo K.O.: P303, P995
Ohm O.J.: 236, P266
Ohm O.J.O.: P982
Ohm O.L.O.: P839
Ohno S.: 1175, P1397
Ohuchi H.: 1530, P1047
Oi M.: P1373
Ois A.: P1417
Ojala M.: P947
Oka T.: P255
Okajima K.: P1422
Okamoto K.: P870
Okamura H.: P1339, P1544, P1581, P1630, P824
Okano M.: P297
Okeie K.: P1437
Okene E.: P1636
Okisheva E.: P1501
Okumura K.: 1561
Okumura Y.: P324, P746
Okumuya Y.: P1602
Olague De Ros J.: P1254
Olague J.: P186, P455, P848
Olalla J.J.: P514
Olivares R.: 1305
Olivari Z.: P861
Oliveira M.: 111, P1591, P1631, P1658, P884
Oliveira M.M.: P835
Oliveira P.A.: P1632
Oliver J.M.: P1545
Olivier A.: P1005
Oloriz T.: 51, 802, P1003, P1358, P1456, P1502,
P1539, P1541, P361, P374
Omar R.: P910
Omaygenc M.O.: P1439
On R.: P1036
On Y.K.: P256, P385
On Y.K.: P1475, P819
Ondraskova L.: P1060
O'neil M.D.: 1531
O'neill J.O.: P894
O'neill M.: P1627, P311, P325, P472, P972
Onishi N.: 179, P1332, P1421, P974
Onishi Y.: P1413, P1507, P315, P383
Onodera T.: P821
Onuki T.: P1413, P315
Opacic D.: P930
Opel A.: P833
Opolski G.: 114, P1040, P1642
Oppizzi M.: P1414
Or J.: P1392
Oreto G.: P1004
Orihara Y.: P255
Orini M.: P286, P515
Ormaetxe J.M.: P1658
Oros A.: P892
Ortega D.F.: P505
Ortega M.: 1305, P1001, P1362, P1536, P326, P417,
Ortiz J.T.: 572
Ortiz M.: P332, P456
Orynchak M.A.: P1399
Osca Asensi J.: P1253, P1254, P186, P455
Osca J.: P848
Oshima S.: 738, P469, P980
Oshinski J.N.: P1636
Osmancik P.: 1242
Osswald S.: 1240, 45, P1037, P1442, P507
Ostiguy G.: P1371
Ostojic M.C.: P747
Oswald H.: P1010, P1051
Otahal B.: P473
Otsuji Y.: P1118
Ottervanger J.P.: 1532, P191
Otto T.: P304
Ouyang F.: 1568, P1342, P1357, P1583, P192, P320,
Owusu-Ansah A.: P498
Oza A.: P586
Ozawa J.: P1397
Ozhathil L.C.: P436
Ozmen C.: P919
Ozmen Yildiz P.: P919
Pacchia C.F.: 1307, P258
Pache G.: P1598
Pacholewicz J.: P414
Pachon M.: P1538, P1543
Padeletti L.: P1034, P1338, P1429, P1611, P264, P882
Padro Dalmau J.: P349
Padron R.: P1646
Paffoni P.: P588
Paglino G.: P1003, P1358, P1456, P329, P361
Pagliuca M.R.: P903
Pagourelias E.: P890
Paina M.: P924
Pajitnev D.: P838
Palacio M.S.: P1481
Palacios I.G.O.R.: P1055
Palazzo A.: P290
Palmisano P.: P384
Pandolfini L.: P1034, P882
Panfilov A.V.P.: P413
Pani A.: P1448
Panikker S.: 109, P1491, P312
Panteloglou D.: P1416
Paoletti Perini A.: P1611
Paolucci A.: P505
Pap R.: P1347, P829
Papadakis M.: P1123
Papadopoulos C.: P890, P985
Papakonstantinou I.: 806
Paparella G.: P1584, P457
Papavassiliu T.: 48, 633
Paperini L.: P1015, P285
Pappalardo F.: 242
Pappone C.: P1381
Paratsii O.: 1243
Parikh A.: P1636
Parisi Q.: P1368, P487
Park C.I.: 575, P422
Park H.S.: P1378, P484
Park H.W.: P1418, P1671, P742
Park J.C.: P1418, P1671
Park J.H.: P1119, P1124
Park K.M.: P385
Park K.M.: P1475, P256, P819
Park S.: P309
Park S.J.: P256, P385
Park S.D.: P1119, P1124
Park S.H.: 46, P1464
Park S.J.: P1475, P819
Park S.W.: P819
Parkhomenko D.: 1237
Parravicini U.: P588
Parreira L.: 730, 736
Partigulova A.: P310
Parwani A.S.: P466
Parwani A.S.: P1336, P1400, P375
Pascale P.: 575, P287, P422
Pasicka B.P.: P1613
Passini E.: P393
Pastore G.: 1526, 1527, P1479, P1580, P1640
Pastore M.: P1622
Patel A.: P259, P289
Patel K.: P59
Patel N.: P1627
Patricio L.: P1631
Patton K.K.: P488
Paulussen G.: P586
Pava L.F.: P358
Pavaci H.: P867
Pavin D.: 1306, P1430, P987
Pavlov P.: P462
Pavlovic N.: P1442
Pearman C.: P918
Peat R.: P1398
Pecha S.: P362, P510
Pecora D.: P503
Pedersen M.: P831
Pedersen M.E.F.: P978
Pedretti S.: P1364
Pedrosa A.A.A.: P1029, P335, P581
Pedrotti P.: P1364
Pego M.: P58
Pehrson S.: P744, P832
Peichl P.: P1607, P331, P850
Peinado R.: P1545, P332, P456
Peixoto G.: P1029, P1632, P335, P581, P860
Pelaez A.: P1361
Pellegrino P.L.: P1656
Peller M.: P1040
Pellet N.: P911
Pellicori P.: P373
Pelloni S.: 182
Pena-Hernandez J.L.: 1318
Penela D.: 1320, 241, 572, P855
Pepe J.: P1444, P465
Pepi P.: P503
Pepper C.: 109, P1509
Per Ivar P.I.H.: P839, P982
Perafan P.: P358
Perdiguero P.: 631, P1038, P859
Perea R.J.: 241, 571
Perego G.B.: P354
Perera D.: 1534, P1027
Peretto G.: 51, P374
Perez B.A.: P1044
Perez Escobar L.: P356
Perez L.: P509
Perez-Alvarez L.: P1484
Perge P.: P1031
Pernat A.: P454
Perrotta L.: P1594, P1603, P292
Perumal R.: P1659
Peters S.: 47, 52
Petersen H.H.: P282
Petersen H.H.: P53
Petix N.R.: 1115
Petkanych M.: 1243
Petousis S.: P1460, P343
Petru J.: P321
Petscher K.: P185
Petyt G.: P1035
Petzer E.: 635
Peyronnet R.: P957
Peytchev P.: P1351
Pfitzner R.: P888
Pham Trung C.: P55
Phlips T.: 731, P1325
Piantoni C.: P923
Piazzi E.: P1604
Picariello C.: 1526, 1527, P1580, P1640
Pieragnoli P.: P1034, P1611, P882
Pierantozzi A.: P487
Pieroni M.: 803
Pierre B.: P740
Piers S.R.D.: 240, P1540
Pietrucha A.Z.: 1116, P513
Pietrucha B.J.: 1116
Pijnappels D.A.: 1181, 1236, 1238, P1540
Pilgerstorfer L.: P1480
Pilichowska-Paszkiet E.: 1563, P1433
Pillois X.: P1391
Pilt K.: P1403
Pimenta D.: P1013
Pimenta R.: 111, P1591, P835, P884
Pimentel M.: P1056
Pindmaa M.: P1403
Pindor J.: P473
Pinto F.J.: P883
Pinto-Teixeira P.: P884
Pioner J.M.: P943
Piorkowski C.: 1251, 1567, P1046, P1344, P450,
Piot O.: P879
Piotrowski R.: 1563, P1433, P993
Pirk J.: P1607
Pirn P.: P1403
Pisano E.: P586
Pisano' E.: P1372
Pisano' E.C.L.: P490
Pison L.: P190, P257, P355
Pitak M.P.: P1451
Pitschner H.F.: P838
Pizzamiglio F.: 1249, 803, P1350, P984
Placidi S.: P348
Plante M.: P1371
Plaschinskaya L.: P1609
Plashchinskaya L.: P480
Platou E.S.: 1109
Plebani L.: P1620
Pleman J.: P1342
Plenge T.: P994
Plesman J.: 1568
Ploux S.: P1390, P1634
Pluijmert M.: P880
Plumb V.: P1012
Pluta S.: 1535
Po S.S.: P976
Podliesna S.: P399
Poels T.T.: P1125
Poghosyan H.R.: P1650
Poh K.K.: P1420
Pohl M.: 1251, 1567, P1046, P1344, P450
Pokawattana A.: P351
Pokushalov E.: 237, P966
Polasek R.: P1260
Polewczyk A.: 1111, P1642, P360, P886
Polewczyk A.M.: P360, P886
Polewczyk M.: P360, P886
Pollak S.: P1444, P465
Polonen R.P.: P947
Polovina M.: P1059, P747
Polyanskaya E.: P822
Pontaga N.: 107
Pop D.: P1657
Popescu M.: 174
Popov S.: P858
Porcellini S.: P1338, P1429, P264
Porres J.: P1484
Porres J.M.: P338
Porta Sanchez A.: 1241, 238, P1045
Porterfield J.: P1624
Porterfield L.: P1624
Portero V.: 556
Portugal G.: 111, P1631
Posadowska M.: P495
Posdziech V.: P887
Post M.C.: P1585
Potenza D.: P1368, P1372, P339
Potpara T.: P1059, P747
Potse M.: P1030, P1503, P1661, P881
Pott A.: P185
Poulsen S.H.: P279
Prajapati C.K.: P947
Prakash K.: P1123
Prat S.: 571
Pregowska K.: P495
Pretorius V.: 1108, P1485
Prillinger J.: P1256
Prinzen F.: P1503, P504, P880
Prinzen F.W.: 1526, 1527, P1125, P1384, P1479,
Prinzen F.W.: P1030, P1628, P1634, P1661, P350,
Prior J.: 575
Priori S.G.: 1179, P519, P61
Prisecaru R.: P1458, P997
Privalova E.V.: 1114
Priyantoro K.: P423
Priyantoro S.: P423
Probst V.: 1117, P1120
Proclemer A.: 1528, P1614, P354, P54
Prohaszka Z.: P1031
Proietti R.: P1329
Prolic Kalinsek T.: P1360
Pronicheva I.: P895
Prosheva V.: P427, P1652
Prosperi M.: P348
Providencia R.: P515, P58, P743, P887
Providencia R.A.: 1306, P1013, P1430, P1586, P353,
Prudat Y.: P942
Pruiti G.P.: P1409
Pruszczyk P.: P1666
Pruvot E.: 1174, 575, P422
Przywara W.: P1582
Ptaszek L.: P849
Pucci A.: P585
Puchol A.: P1538, P1543
Puererfellner H.: P828
Puertas C.: P1049
Pugazhendhi A.: P1377
Puiu M.: P1657
Pyaterichenko I.: P1595
Pyda M.: 576
Pye B.: P986
Pytel G.: P1499
Qaiyumi D.: P1336
Quadrini F.: P990
Quartieri F.: P1255, P1618, P585
Quesada Dorador A.: P1484
Raatikainen M.J.P.: P979
Raatikainen P.: P1253
Rabi Y.: P739, P967
Rabot C.: P1391
Rac-Albu M.: P1647
Rachwalik M.: P1504
Radcliffe E.: P918, P954
Radinovic A.: P1358, P1450, P1456, P329
Radosinska J.: P1041, P1648
Radovanovic N.: P872
Radu D.-A.: P1025
Raemmler C.: P304
Raepers M.: 1314
Rafael Peinado R.F.: P486
Rafanelli M.: P1488, P363
Raffa S.: 1244, 177, P1605, P1617, P818, P971, P977
Ragab A.: P55
Ragno E.: P903
Rahman M.T.: P1668, P532
Rahneva T.: P521
Raimondo C.: 804, P1341
Rajamani S.: P921, 1182
Rajani R.: P472, P972
Rajappan K.: 732, P281, P587, P831, P978
Raju H.: 1173, P1627
Ramanna H.: 578, P291
Ramdat Misier A.R.: 1532, P1375, P189, P191, P283
Ramdat Missier A.R.: P869
Ramirez Rodriguez A.M.: P820
Ramirez Rodriguez R.: P820
Ramos P.: P1044, P1417, P460, P748
Ramos R.: P1631
Rancane G.: P1672
Ranjan R.: P258
Rapacciuolo A.: P384, P503, P588
Rapedius M.: P379
Rapezzi C.: P1370, P352
Rappel W.-J.: P267
Rava L.: P348
Ravelli F.: 182
Ray D.: P968
Razali O.: P1379, P271
Razavi R.: 809, P1028, P1033, P1322, P1324, P1330,
Razavi R.M.: P1323
Reardon W.: P894
Rebellato L.: P1614
Rebo R.: P910
Reddy V.: P449
Reddy V.Y.: P321
Refaat M.: P1446
Regazzoli D.: P1414
Reges O.: P739, P967
Regoli F.: P1030, P1486, P1503, P1661, P483, P881
Reichenspurner H.: P362, P510
Reichlin T.: 1240, 45, P1037, P1442, P507
Reil J.C.: P412
Reinke T.: P1051
Reisinger J.: P1480
Reis-Pinheiro Y.: P853
Reithmann C.: 115
Rekik H.: P911
Remoli R.: P327
Rensing B.J.: P1585
Rensing B.J.W.M.: P869
Renzullo E.: P1004
Reppas E.: 638
Restrepo Cordoba M.A.: P55
Revishvili A.: P895
Revishvili A.S.H.: P1454, P419, P893
Reynaud A.: P1471
Reynolds D.: 1311, P1379, P271, P278
Rezus C.: P1348
Rho T.H.: P1441, P1651
Rhode K.: P311
Riahi L.: P1458, P997
Riahi S.: P282, P53
Ribatti V.: P1497
Ricci R.P.: P354, P54
Ricciardi D.: P1261
Ricciardi G.: P1034, P1611, P882
Richter B.: P846
Richter S.: P1331, P1356, P1496, P826
Rienstra M.: P817
Righi D.: P327
Rillig A.: 1568, P1342, P192, P464
Rinaldi C.A.: 1534, 734, P1027
Rinaldi C.A.: 1531, P1028, P1033, P1627, P1635,
Rinuncini M.: P1640
Rio P.: P1591
Risteski D.: 237
Ritter P.: 1311, P1379, P1390, P271, P278
Riva S.: 803, P307
Riva U.: P274
Rivard L.: 810, P856, P866
Rivarola E.: P1537
Rivas N.: P1658
Rivasi G.: P1488, P363
Rivaud M.: P914
Rivera Juarez A.R.: P1049
Rivolta I.: P403
Rizk H.H.: P1382, P878
Rizzetto R.: P404
Roberts P.R.: P862
Robles F.: P290
Roca J.: 1320
Rocca P.: P535
Rocchetti M.: P440
Rocha M.S.: P860
Rocha M.S.R.: P1328
Roderick P.J.: P862
Rodriguez A.: P1625
Rodriguez B.: P393
Rodriguez D.: P1468
Rodriguez Entem F.: P514
Rodriguez Garcia J.: P584
Rodriguez Gonzalez A.: P1019
Rodriguez Gonzalez E.: P55
Rodriguez Manero M.: P486
Rodriguez Munoz D.: P1057
Rodriguez Perez J.C.: 629
Rodriguez-Campelo A.: P1417
Rodriguez-Manero M.: P334
Rodriguez-Padial L.: P1538, P1543
Roeger S.: 48, 633, P583, P865
Rogers D.: P353
Roghi A.: P1364
Rohde L.E.: P1056
Roik M.: P1666
Rolando M.: 1316
Rolf S.: 1309, P1331, P1428, P1431, P1542, P826,
Rollin A.: 50, 634, P1120
Romano S.A.: P1409
Romanov A.: 237, P966
Romero I.: P1349
Romero R.: P1625
Romero-Villafranca R.: P1484
Ronchi C.: 88
Roncon L.: 1526, 1527, P1479, P1580, P1640
Roos M.: 1564, 244, P462, P830, P854, P981, P998
Roque J.: P1417
Rordorf R.: P1486, P346, P354, P54
Rosa Alba Abellas-Sequellas R.A.A.S.: P486
Rosati F.: P1643, P471, P847, P975
Ross S.: P1482, P589
Rosset S.: 1174
Rossetti G.: P1011
Rossi P.: P394
Rossi S.: P1394, P366
Rossillo A.: P54
Rosso R.: P1340
Rosu R.: P1657
Roten L.: 1110, P1455, P287, P517
Roth N.: P263
Rothman K.J.: P536, P912
Rotondi F.: P903
Rottbauer W.: P185
Rouet R.: P433
Roufas K.: P1460
Rougier J.S.: P436
Rousseau-Plasse A.: P584
Rousso B.: P583
Roux J.F.: P1329
Rovaris G.: P1448, P1604
Rowland E.: P1586, P353
Roy D.: 810, P467, P498, P866
Roy K.: P1354, P474
Rozen G.: P1392
Rubio J.: P1026, P338
Rudic B.: 48, 579, 633, P1121, P865
Rudomanova V.S.: P893
Rudzinski A.: 1116
Ruehmkorf K.: P188
Ruf S.: 89
Ruffa F.: 1529, P1448
Ruidavet J.B.: 50
Ruiz Granell R.: P1361
Ruiz Guerrero L.: P514
Ruiz-Cantador J.: P1545
Ruiz-Salas A.: 1318
Ruocco A.: P384
Rupar K.: P1360
Russo E.: P1350, P307, P984
Russo M.S.: P327
Rutherford L.: P442
Rutigliano L.: 1179
Ruud M.: P965
Rychlak R.: P513
Rydlewska A.: P1017
Rymarczyk Z.: P1666
Ryu K.: P1381
Rzaev F.G.: P419
Sabate X.: P1658
Sabbag A.: P1387
Sacconi L.: P429, P956
Sacher F.: 1117, P1120, P287, P849
Sadoul N.: 636, P1461, P879
Sadowski T.: 89
Sadron M.: 50, 634
Saeed Y.: P432
Saenen J.B.: P1599
Saggu D.: 573
Saghy L.: 1178, P1347, P829
Sagnol P.: 112
Saguner A.: P1583
Saguner A.M.: 49
Sahlin C.: P295
Sahu J.: P56
Sai E.: P1410
Said S.: 174
Saito K.: P1406
Saitoh Y.: P305, P306, P451
Saja E.: P369
Sakaguchi H.: 1530, P1047, P1054
Sakai Y.: 1247, P1601, P319, P845
Sakamoto M.: P970
Sakamoto N.: P1127, P1406, P372
Sakamoto S.: P1126, P1363
Saku K.: 1246, P1462, P534
Sakurada H.: 1248, 1250, P1002, P446, P453
Sala L.: 22
Salas J.: P332, P456
Salazar Ramirez C.: P1487
Saleh K.: P1021
Salerno-Uriarte J.A.: P1004
Salgado Aranda R.: P509, P991
Salgado R.: P1538
Salguero R.: P1625
Saliba W.: P449
Salle L.: P433, P439
Salmas J.: 1251, 1567, P1046, P1344, P450
Salvador A.: P186, P455, P848
Salvador O.: 1305, P1001, P1362, P1536, P1545,
Sammut E.: P1033
Samoilov A.S.: P333
Samoylenko I.V.: P496
Sanchez B.: P1049
Sanchez C.: P1503
Sanchez Chamero P.: P349
Sanchez Garcia M.: 629, P55
Sanchez J.: P261, P262
Sanchez P.: P855
Sanchez P.L.: 631, P1038, P859
Sanchez Recalde A.: P1545
Sanchez-Gomez J.M.: P1361, P334
Sanchez-Huete G.: P1026, P338
Sanchez-Molero O.: 1177
Sancho Tello M.J.: P186, P455
Sancho-Tello De Carranza M.J.: P1254
Sancho-Tello M.J.: P848
Sandhu P.: P1036
Sandilands A.J.: P1610, P184, P316
Sangrigoli R.: P187, P302
Sanjay R.K.: P388
Santagostino Baldi G.: 242, P1358, P1456
Santagostino G.: 51, P1539, P329, P374
Santamaria M.: P1486, P339, P503
Santinelli V.: P1381
Santini A.: 1112
Santini L.: P1261, P1372, P1497, P341
Santini M.: 1528
Santoro A.: P1004
Santoro F.: P1656
Santoro M.: P1457
Santos J.X.: P1029
Santos P.: 730, 736, P458
Santucci L.M.: P348
Sanz Sanchez J.: P1254
Sanzo A.: P1004
Saoudi N.: P1335, P1424, P1440, P1469
Sapelnikov O.: P310
Saporito D.: P1255, P1368, P585
Saputo F.A.: P327
Saricam E.: P885
Sarkozy A.: P1599
Sarmento P.: P1591
Sarquella Brugada G.: 1177, P1453, P902, P904
Sartor L.: P276
Sasaki R.: P1406
Sasaki T.: 738, P469, P525, P980
Sasaki Y.: P1434, P983
Sasov M.: P1024, P1639, P825
Sassara M.: P1011
Sato N.: P1127, P1406, P372
Satomi K.: 1565
Saushkina Y.: P1445
Savarese G.: P322
Savchenko A.: P1609, P480
Saviano M.: P1381
Savic J.: P1059
Savoure A.: P1472
Sax B.: P520
Saxena P.: 25
Sayer J.: P498
Saygi S.: P1452
Sazonova Y.S.: P496
Scaccia A.: P1497
Scaglione M.: 1562, 804, P1341, P1432
Scanavacca M.: P1537
Scavee C.: P853
Schade A.: 1564, 244, P462, P830, P854, P981
Schaeffer B.: P1438, P190
Schaeffter T.: 809, P1324, P311
Schaer B.: P1037, P1380
Schaer B.A.: P507
Schaerf R.: P1036
Schaffer B.: P479
Schalij M.J.: 1181, 1238, 240, P1540
Scharf G.: P1042
Scharfe F.: P304
Scheel O.: P933
Scheer P.: P871
Scherr D.: P287
Schiebelling J.: 178, P260
Schilling R.: 811, P833
Schilling R.J.: 806, P521
Schimpf R.: 579, 633, P865
Schirripa V.: P1542
Schlaepfer J.: 575
Schleinkofer D.: P1252, P357
Schluermann F.: P1588, P1598
Schmidt B.: P1594, P1603, P292
Schmiedl J.: P468
Schmitt R.: 244, P998
Schmitz D.: P1253
Schnell F.: P1471
Schoene K.: P826
Scholten M.F.: P1597, P843
Scholz L.: P192
Schoonderwoerd B.A.: P301
Schotten U.: 89, P190, P257, P448
Schratter A.: P1542
Schreiber D.: P1438, P1592, P190, P479, P994
Schricker A.: P1477
Schricker A.A.: P267
Schullte-Hahn B.: P1594
Schulze-Bahr E.: P1121
Schurmann P.: 733
Schuster P.: 236, P1616, P266
Schuster P.S.: P839, P982
Schwab J.O.: P1459
Schwagten B.: P1458, P997
Schwappach B.: P963
Schwarz S.: P1021
Sciarra L.: P1338, P1429
Scott P.: 635
Sebag F.A.: 1531
Secknus M.-A.: P1605
Sedlacek K.: P1260
Sedov V.P.: P496
Seewoester T.: 1309
Segal O.: P1509, P1586, P353
Segal O.R.: P515
Segreti L.: P1015, P1486, P285
Segura De La Cal T.: P1057, P1468
Seidl K.: P1578
Seifer C.M.: P1365
Seifert M.: P1626, P511
Seiler C.: P517
Seiler J.: 1110, P1455, P517
Sejersted O.M.: P437
Sekaran A.: P972
Sekiguchi Y.: 243, P1410, P1638, P268, P459
Sekihara T.: P297
Sellal J.M.: P1005
Selmi W.: P1412
Semmler V.: P867
Senatore G.: P1261, P341
Senges J.: 115
Senges J.S.: P1587, P265
Seniuk W.: 576
Senni M.: P57
Senoo K.: 173
Seow S.C.: P1621
Sepp R.: 1178, P1043
Sepsi M.: P871
Sergi D.: P586
Sergi E.: P386
Servatius H.: 1110, P1455, P1592, P479, P517
Sesunaceva O.: P1662
Severgnini M.: P386
Severi S.: P390, P1016, P322, P393, P996
Sevrukevich V.: P1609
Sgoifo A.: P1394, P366
Shah A.J.: P287
Shah D.: P1600, P313, P314, P449, P461
Shah M.: P308, P380
Shah M.J.: P488
Shakaryants G.A.: 1114
Shalganov T.N.: P1615, P477
Shanks M.: P501
Shantsila E.: P445, P447
Sharf T.: P1048
Sharf T.V.: P899
Sharka I.: P369
Sharma P.: P522
Sharma S.: P1123
Shastri S.: P380
Shavarov A.A.: P1327
Shavrin I.V.S.: P1655
Shchekina N.V.: P524
Sheikh N.: P1123
Sheldon R.S.: P1039
Sheldon T.: 1311, P271
Shelke A.: 573
Shepherd E.J.: P1512
Sheppard M.: 1173
Shestak A.: 579, P895
Shi G.B.: P916
Shi L.B.: 236, P266, P839, P982
Shilova Y.: P822
Shimane A.: P1422
Shimizu S.: 738, P469, P980
Shimizu W.: P1047
Shimotakahara J.: 1113
Shin D.H.: P364
Shin M.H.: P742
Shin S.H.: P1119, P1124
Shinoda Y.: P1410
Shiode N.: P834
Shiomi Y.S.: P317
Shirokova A.A.: P524
Shizuta S.: P1383, P1423
Shkolnikova M.A.: P891
Shkoza A.: P369
Shlyakhto E.V.: P368
Shmayahu Y.: 1533
Shoda M.: 1561, 737, P1006, P1415, P844
Shorokhov K.: P1595
Shuvalova Y.U.: P310
Siciliano M.: P1367, P840
Siddiqui S.: P1388, P1402, P1610, P184, P316
Sideris A.: P376
Sidorova M.: P1048
Siebelink H.M.: P1540
Siedz J.: P482
Sieira J.: P306
Sierpinski R.: 114
Sievers H.-H.: P1608
Sievert H.: P382
Sigmund E.: P828
Sigurdsson S.: 176
Sikora-Frac M.: 1563, P1433
Sikorska A.: P1433, P993
Sikorska A.A.: 1563
Siland J.E.: P817
Silberbauer E.: 635
Silberbauer J.: 802, P1003, P1541
Sill B.: P362, P510
Silva E.: P1351
Silva K.R.: 1317, P270
Silva M.N.: P835
Silva T.: P835
Silvano M.: P840
Silvello D.: P1056
Silvestre G.: P491
Silvestre J.: P276
Silvetti M.S.: P348
Silvietti S.: 242
Simantirakis E.: P344, P492
Sime I.: 107, P1672
Simek J.: 1245
Simeonidou E.: P1122
Siminelakis S.: P823
Simmers T.A.: P278
Simon R.D.B.: P515
Simons G.R.: P60
Sims J.: P289
Simurda J.: 777, P932
Simurdova M.: 777, P932
Sinagra G.: P386
Singh D.: P1621
Singh J.P.: P1384
Singh N.: P437
Sinha A.M.: P1014
Sinkovec M.: P454
Siontis K.C.: P1321
Siostrzonek P.: P1480
Siot P.H.: P272
Siqueira S.F.: P1029, P1632, P335, P581, P860
Sisk S.: P60
Sitges M.: 1320
Sitzy J.: P1344, P450
Sivakumaran S.T.: P501
Sjaastad I.: P437, P965
Skaardal R.: P1482, P589
Skeberis V.: P890
Skeberis V.S.: P1495
Skigin I.: P1595
Skinner J.: 1173
Sknouril L.: P1427
Skretteberg P.T.: 1109
Slawuta A.: P497
Sledz J.S.: P1451, P1613
Slezak J.: P1041, P1648
Smeets J.L.R.M.: P365, P485
Smishlyaev K.: P1445
Smit J.J.J.: 1532, P1375, P189, P191, P283, P869
Smith G.: P425
Smith G.L.: P396, P424
Smolny N.: P466
Soares A.: 730, 736
Soboleva A.V.: P368
Sobotkova S.: P1060
Soejima K.: P1379, P271
Soesanto A.M.: P423
Sohail M.R.: P60
Sohal M.: P1033, P1390
Sohn G.H.: P364
Sohn J.: P1378
Sokal A.: 1535
Solari D.: P1633
Soldati E.: P1015, P285
Soldatov Y.U.O.: P524
Solheim E.: 236, P1616, P266
Solheim E.S.: P839, P982
Soltan G.: P489
Soltysinska E.: P415
Som Z.: 729
Somani R.: P1610, P184, P316
Sommer A.: P279, P508
Sommer P.: 1309, 807, P1331, P1356, P1428, P826,
Song I.G.: P1441, P1651
Song J.Y.: P819
Sonoda K.: P1397, P324
Sontis N.: P823
Sora N.: 802, P1414, P1450, P361
Sorbo A.R.: P1355, P370, P529
Sorgente A.: P1449
Sorrel J.: 178, P260
Sorto C.: P514
Sosa E.: P1537
Sosnowski M.: P1023, P1476, P499
Sossalla S.: P963
Soszynska M.: P1433
Sotomi Y.: P255
Sottas V.: P436
Sousa P.: P743, P988
Spadacini G.: P1004
Speerschneider T.: P415
Sperzel J.: P586
Spikowski J.S.: P1613
Spinar J.: P1337, P1427, P871
Spitzer S.G.: P304
Sporton S.: P833
Sprada B.: P1007
Squasi P.: P861
Sredniawa B.: P1499, P273
Sridevi C.: 573
Srinivasan N.: P1586
Srinivasan N.T.: P515, P59
Stabile G.: P1368, P1618, P280, P503, P588
Stabryla-Deska J.: 1535
Stach K.: 633, P865
Stafford P.J.: P1610, P184, P316
Stahlberg M.: P275
Stallmeyer B.: P1121
Stams T.R.G.: P892
Starek Z.: P864
Stauvroulaki M.: P343, P344
Stavrakis S.: P976
Stec S.: 114, P1433, P482, P993
Stec S.M.: 1563
Stec S.M.S.: P1451, P1613
Steeds R.P.: P1474
Steen T.: 1109
Steffel J.: 49
Stegemann B.: P1474, P877
Steinbach M.: 112
Steinberg J.S.: P966
Steinborn F.: P462
Steiner H.: 1176
Steingisser A.: 1312
Steinwender C.: P1021, P1379, P271
Stengl M.: P411
Stenin I.: 237
Stenzel G.: 809
Stephansen C.: P508
Stepinska J.: 114
Stevanello C.: P857
Steven D.: P1438, P1592, P190, P479, P994
Steven D.S.: P1587, P265
Stevenhagen Y.J.: P1597, P843
Sticherling C.: 1240, 45, P1037, P1380, P1442, P507
Stierle U.: P1608
Stirna V.: P907
Stockburger M.: 1316, P584
Stockburger M.O.: P272
Stockman D.: P1458, P997
Stoelzle-Feix S.: P379
Stojanov P.: P872
Stokke M.K. :P407
Stoller M.: P517
Stone M.: P978
Stoodley M.: P968
Stoyanov M.K.: P1615, P477
Straka Z.: 1242
Strelnieks A.: 107
Strelnikov A.: P966
Strickland P.T.: P1636
Stroker E.: P305, P451
Stromberg K.: 1311, P271
Stukalova O.: 1237
Stukalova O.V.: P899
Sturmer M.: P1039
Stutz R.: P1381
Styperek R.: P1624
Suddendorff S.: P475
Suerder D.: P1030, P881
Suffee N.: P1395, P1396
Suffredini S.: 221
Sugiyama E.: P1127
Sugiyama H.: P1423, P821
Sugumar H.: P351
Sukhacheva T.V.: P893
Suleimann H.: P1637
Sulimov V.: P1501
Sulo E.: P369
Sulo G.: P369
Sultan A.: P1438, P1587, P1592, P265, P479, P994
Sumitomo K.: P372
Sun L.Z.: 236, P266
Sun S.L.Z.: P839, P982
Sunthorn H.: P1600, P313, P314, P461
Sussman J.: P1593
Sutton R.S.: P863
Suwa K.: 737
Suzuki A.: P1507, P525
Suzuki H.S.: P1606
Suzuki M.: 1319, P582
Suzuki N.: P870
Svendsen J.H.: P744, P832
Svennblad B.: P275
Sveshnikov A.V.: 735
Svetlosak M.: P1024, P1639, P825
Svintsova L.: P858
Swaans M.J.: P1585
Swarup V.: P1593, P309, P57
Swissa M.: 632
Syam N.: P436
Syed F.: P475, P864
Syrkin A.L.: P496
Syvolap V.D.: P1649
Szeiffova-Bacova B.: P1648
Szelenyi Z.S.: P1478
Szentandrassy N.: 87, P964
Szeplaki G.: P1031
Szilagyi J.: P1347, P829
Szilagyi S.Z.: P1031
Szili- Torok T.: 1308
Szloszarczyk B.: P513
Szoelloesi A.: 1564, 244, P981
Szoelloesi G.A.: P462, P830, P854
Szoelloessi A.: P998
Szucs G.: P520
Szumowski L.: 114
Szwedzinska A.: P318
Szyber P.: P1504
Szydlo K.: P531
Szydlowski L.S.: P1451
Szymkiewicz S.: P1659
Taborsky M.: P1483
Tachibana K.: P1507
Tada H.: P1638, P481, P852
Tada H.T.: P317
Tadros R.: 810
Tafciu E.: 1239
Taggart P.: 734, P286
Taghji P.: 731
Taguchi I.: 1247, P1601, P319, P845
Taieb J.: 110, 112
Tajiri K.: P896
Tajstra M.: P414
Takagi K.T.: P303, P995
Takagi M.: P1126, P1363
Takagi T.: 239, P1000
Takagi Y.: P1612
Takahashi A.T.: P303, P995
Takahashi K.: P1373, P1602, P324, P746
Takahashi S.: 1565
Takahashi T.: 1113
Takano M.: P1612
Takarada K.: 1565, P1466
Takatsuki S.: P1425, P837, P842
Takeishi Y.T.: P1606
Takenaka K.: 1560
Takeuchi D.: P1006, P1415
Takeuchi R.: P821
Takeuchi T.: P1127, P372
Takigawa M.: P303, P995
Talajic M.: 810, P467, P866
Talib A.: P1406, P372
Tamaki S.: 1569, P296
Tamburino C.: P1409
Tamura T.: P1373
Tanabe Y.: P1127, P372
Tanaka I.: P297
Tanaka K.: P255
Tanaka M.: P1373
Tanaka N.: P255
Tanaka T.: P870
Tandogan I.: P885
Taniguchi H.: 239, P1000
Taniguchi Y.: P1422
Tanihata S.: P1346
Tanimoto K.: P970
Tanimoto Y.: P1425, P842
Tanner H.: 1110, P1455, P1658, P517
Tanos D.: P890
Tatarsky B.: P1401, P523
Tatarsky R.B.: P1650
Tavernier R.: 731, P1325, P1426
Tay E.: P1420, P741
Tay G.S.: P910
Taylor R.J.: P1474, P877
Tebbenjohanns J.: P188
Teh A.: P351
Teixeira R.A.: P1029, P1632, P335, P581, P860
Teixeira T.: 730, 736
Tejedor A.: P1049
Tejima T.: 1248, 1250, P1002, P446
Tempio D.: P1409
Temple I.: P432
Ten Berg J.M.: P277
Teodorovich N.: 632
Teplenin A.S.: 1181
Teranishi J.: P1422
Terasawa M.: 1565
Tercedor L.: P855
Teres C.: P314
Termosesov S.A.: P891
Ternus B.T.: P1050
Tesi F.: P1488, P363
Teslinova L.: P908
Tespili M.: P535
Teutsch C.: P536, P912
Tewfik E.: P1039
Tfelt-Hansen J.: 1173
Thackray S.: P1629
Thale J.T.: P506
Tham M.: P1366
Thambo J.B.: P1391, P1412
Thanassoulis G.: P1329
Thannhauser J.: P365
Theilade J.: P1411
Theodorakis G.: P340, P526
Theuns D.A.: P1369
Theuns D.A.M.J.: P62
Thibault B.: 810, P1371, P856, P866
Thomas U.: P379
Thomson E.: 634
Thudt K.: P1020
Tilemanbetova K.: P1670
Tilgale B.: P1672
Tilz R.: P1357, P320, P452
Tilz R.R.: 115, 1568, P1342, P192, P382, P464
Timler D.: P1504
Timmermans K.: P586
Tinica G.: P1052
Tlili G.: P1390
Todd D.: 109, P1509
Toffanello G.: P1488, P363
Tolosana J.M.: 805, P336
Toman O.: P1337, P1427
Tomasi C.: P1368, P585
Tomasi L.: P491
Tomassoni G.: P309
Tomaszewski A.: 1111
Tondo C.: 1249, 803, P1338, P1350, P1429, P264,
Toniolo M.: P1614
Toquero Ramos J.: P55
Torbicki A.: P1666
Torrado M.: P367
Torrinha C.: P515
Toso E.: P1432
Touhoku S.: P512
Touhy S.: P894
Touloupaki M.: P1460, P343, P344, P492
Townend J.N.: P1474
Townsend R.R.: P917
Toyofuku M.: P1373
Toyohara K.: P1006, P1415
Toyoshima Y.: P255
Trafford A.W.: P918
Trainini A.: P1481
Trainini J.: P1481
Tran N.: P1455, P517
Treede H.: P362, P510
Trevisi N.: P1003, P1414, P1502, P1539, P1541
Tribout L.: P1391
Tribulova N.: P1041, P1648
Triggiani G.: P1656
Tritto M.: P1004
Trivedi C.: P261, P262
Troisi F.: P990
Trolese L.: P1588, P1598
Tronchin A.: P861
Trukshina M.: P1032, P502
Trusinskis K.: P907
Tsai P.-H.: 175
Tsao H.-M.: 175, P1660
Tsaregorodtsev D.: P1501
Tschabrunn C.: P745
Tsiachris D.: 802, P1003
Tsukada N.: 1247, P1601, P319, P845
Tsunoda Y.: 1565
Tsyganov A.: 574, 579, P1583
Tueluemen E.: 633
Tulumen E.: 48, P1121, P865
Tundo F.: P307, P463
Tung S.: 1529
Turakhia M.: P308
Turakhia M.P.: P1256
Turgeon A.: P1371
Turi-Kovats N.: P520
Turreni F.: P1353
Turrini P.: P1258
Tveita T.: P424
Twerenbold R.: 1240, 45
Uchida E.: P383
Ueberham L.: P468
Ueda M.: P1352
Ullrich N.D.: P942
Ulman M.: P347
Umar F.: P1474, P877
Umemura S.: P1383
Umezawa S.: P1507
Ungar A.: P1488, P363
Uno K.: 1565
Urban L.: P1639, P825
Urbanek P.: 114
Uribe Heredia N.G.: P1022
Uusimaa P.: P979
Uzui H.: P481, P852
Uzui H.U.: P317
Uzun A.: P948
Vachulova A.: P1639, P825
Vaczi K.: P426, P964
Vado A.: P1011, P1261, P280, P487
Vaidya V.V.: P1050
Vaikhanskaya T.: P1009
Vakalyuk I.I.: P1399
Valderrabano M.: 733
Valdivia C.: P402
Valente B.: 111, P835
Valenti R.: P1389
Valenzuela C.: P401
Valeron D.: P474
Valerone D.: P1354
Valles E.: P1044, P1417, P460, P748
Valsecchi S.: P1497, P274
Valzania C.: P352
Vampola S.P.: P267
Van De Kemp P.: P1405, P1407, P528, P900
Van Den Heuvel P.: P1458, P997
Van Der Graaf A.W.M.: 578, P291
Van Der Harst P.: P817
Van Der Heyden M.A.G.: P930
van der Linde H.J.: 779, P950
Van Deursen C.J.M.: P1384
Van Dijk V.F.: P1585, P869
Van Dongen E.: P291
Van Driel V.: P1578
Van Driel V.J.H.M.: 1566, 578, P291, P836
Van Es H.W.: P869
Van Es R.: 1566
Van Ettinger M.J.B.: P1405, P528, P900
Van Gelder I.C.: P817
Van Hoeyweghen R.: P1325
Van Hunnik A.: P257, P448
Van Opstal J.M.: P1597, P843
Van T Sant J.: P350
Van Tran N.: 1110
Van Veldhoven J.P.: 1236
Van Wessel H.: 1566, P836
Vanberg P.: 1109
Vandekerckhove Y.: 731, P1325, P1426
Vandenberk B.: 630
Vandersickel N.V.: P413
Vanduynhoven P.: P1349
Varanasi S.: P1610
Varanasi S.S.: P1388, P184, P316
Vardas P.: 570, P1460, P1619, P343, P344, P492
Varela M.: 181
Varga A.: P829
Vargas D.: P1393
Vargiu S.: P1364
Varkevisser R.: P516, P892, P930
Varlet E.: P1505
Varotto L.: P461
Varounis C.: P1122
Varro A.N.D.R.A.S.: P949
Vasconcelos H.: P580
Vasichkina E.S.: P1650
Vaskovskiy V.A.: P893
Vasquez C.: P417, P420
Vassanelli C.: P491
Vassanelli F.: P1643, P975
Vassilikos V.: P890
Vassilikos V.V.: P1495
Vasylechko M.M.: P1399
Vatasescu R.G.: P1025
Vatta M.: 1176
Vaz E.: P458
Vazquez C.: P1536, P421
Vazquez Lopez Ibor J.: P55
Veeger N.: P301
Veerman C.: P937
Vega A.: P1545
Vegh E.M.: P1384
Vegh E.M.: P520
Vejlstrup N.: P1411
Velagic V.: P305, P451
Velasco E.: P1646
Veltmann C.: 633, P1010, P1051, P1121
Venier S.: 810, P856, P866
Venkat M.: P380
Venlet J.: 240, P1540
Ventura M.: P58
Venuti A.: P1355, P370, P529
Vereckei A.: P1478
Vergara P.: P1358, P1456, P1584, P329, P457
Verheule S.: P448, P930
Verlato R.: P1258, P1338, P1429, P264
Verma A.: P1329
Vermond R.A.: P817
Vernardos M.: P1460, P1619, P343, P344
Vernooy K.: P1125, P1384, P1628, P350, P355, P880
Vettor G.: 1249, P1350, P463, P984
Viani S.: P285
Viani S.M.: P1015
Viart G.: P1472
Vicedomini G.: P1381
Vicente Bertomeu-Gonzalez V.B.G.: P486
Vichare S.: P380
Viczenczova C.: P1041, P1648
Vigil P.: P493
Viigimae M.: P1403
Vijayaraman P.: 1310, 1313, 1315, P1377, P1447, P345,
Vijgen J.: P1349
Villacastin Dominguez J.C.: 629
Villard E.: P1398
Villejoubert O.: P740
Villuendas R.: 1320
Vincenti A.: P1448, P1604
Vink A.: 1566, P836
Vinogradova I.: P1401, P523, P898, P908
Vinolas J.: P338
Vinolas Prat X.: 629
Vinolas X.: P1484, P509
Vinther M.: P53
Virmani R.: P1491
Viscardi L.: P535
Viskin S.: P1340
Viswanathan K.: 1241, 238, P1045
Viswanathan M.: P309
Vitali Serdoz L.: P1590
Vitulano N.: P990
Vlachos K.: P376
Vlahos A.P.: P1404
Vock P.: P1020
Voigt N.: 557
Voilliot D.: 636, P1461
Volchkova E.A.V.: P1655
Volkova E.G.: P1506
Volkova Y.: P891
Vollert I.: P948
Vollert I.N.G.R.A.: P949
Von Olshausen G.: P867
Von Werder A.: P188
Vorobyoff A.S.: 735
Voros G.: 630
Vos M.A.: P516, P892, P930
Voytkovskaya E.: P1595
Vrazic H.: P867
Vrints C.: P1599
Vukicevic M.: P1059
Wachter R.: P57
Waclawski J.: P1499
Wada M.: P1339, P1544, P1581, P1630, P824
Wada T.: P1006
Wagner E.: P963
Waintraub X.: P1505
Wake E.: P1665, P378
Wake M.: 1113
Walmsley J.: P1634, P504
Walsh K.: P1343
Wang H.-H.: 175
Wang M.: P930
Wang P.J.: P309
Wang S.H.: P293
Wang W.Y.C.: P839, P982
Wang X.: P298
Wang Y.C.: 236, P266
Wang Y.Y.: P404
Ward D.: P894
Ware J.: 1173
Warita S.: P1346
Wasniewski M.: 576
Wasserstrom J.A.: P437
Watanabe H.: P1663
Watanabe I.: P1602, P324, P746
Watanabe M.: 1181
Watanabe N.: P1413, P315, P383
Watanabe R.: P1346
Watanabe T.: P1663
Watanabe Y.: P821
Webb J.: P1033
Weber R.: 178, P260
Webster D.: 732
Webster T.: P1623
Weijs B.: P294, P443
Weinmann T.: P304
Weiss C.: P1511
Weiss R.: P1369
Weiss S.: 809
Wellens H.J.J.: 51, P374
Wenling L.: 44
Westra S.W.: P365, P485
Whitaker J.: 809, P1322, P1323, P1324, P1330, P1627,
Wichterle D.: 1245, P1260, P1427, P1607, P331, P850
Wickliffe A.: P1593
Wierschke S.: P933
Wietholt D.: P583
Wijers S.C.: P516, P892
Wijffels M.C.E.F.: P277, P444
Wijntjens G.W.M.: P355
Wildberger J.E.: P294, P443
Wilde A.: 1173
Wilke S.: P183
Willems R.: 630, P1658
Willems S.: 115, P1426, P1438, P1592, P190, P257,
Willems S.W.: P1587, P265
Williams R.: 1534, P1027
Williams S.: P325, P472, P972
Williams S.E.: P311
Williams S.E.: 809, P1324, P1330
Williamson B.: P992
Wilson D.G.: P862
Wimmer A.: P1018, P1473
Winter A.: P1480
Winter D.: P1381
Winter S.: P828
Winum P.F.: P999
Wirth K.: 180, P412
Wissner E.: 1568, 574, P1342, P1357, P1583, P192,
Wissocque L.: P1376
Wita M.: P531
Witt C.T.: P1385
Witte O.A.: P1375
Wittkampf F.H.M.: 1566, P836
Wnuk M.: 1116, P513
Wnuk-Wojnar A.: P531
Wohlmuth P.: P452
Wolber T.: 49
Wolf J.: P864
Wolf M.: P1599
Wolff E.W.: P506
Wolke C.: P1395, P1396
Wollert H.-G.: P1395, P1396
Wollmann C.G.: P1020
Wolpert C.: P1121
Wong K.: P978
Wong K.C.K.: 732
Wong R.: P1420
Wong S.: P1485
Wong T.: P1491, P1509, P312, P382
Wong T.R.: 109
Wong W.: P992
Wonko E.: P318
Woo J.S.: 43
Woo S.I.: P1119, P1124
Worden N.E.: P328
Workman A.J.: P396
Worley S.: P1481
Worsnick S.A.: P1377
Wozniak-Skowerska I.: P531
Wranicz K.: 114
Wredlert C.: P1452
Wright M.: 1531, P472
Wright M.J.: P1322, P1323, P1324, P1330
Wunderlich C.: 1251, 1567, P1046, P1344, P450
Wutzler A.: P1336, P1400, P375
Wutzler A.S.: P466
Wystrach A.: P1014
Xiong Q.: P909
Xu D.Z.: P896
Yagasaki H.: P1346
Yagi N.: 1113
Yagishita D.: 737, P844
Yahata M.: P1423
Yakovleva M.: 574, 579
Yaksh A.: P1405, P1407, P528, P900
Yakubov A.: 237
Yalagudri S.: 573
Yalin K.: 637
Yamada M.: P1612
Yamada S.: P1422
Yamada T.: 1569, P296
Yamada W.: P970
Yamamoto K.: P1667, P973
Yamamoto M.: P1345, P1437, P989
Yaman M.: P885
Yamane T.: 1561, P983
Yamao K.Y.: P303, P995
Yamasaki H.: P1638
Yamase M.: P1358, P1456, P1502, P329
Yamashina A.: 1565, P1466
Yamauchi Y.: 239
Yang D.H.: 46, P1464, P484
Yang S.: P930
Yang Z.: 1529
Yanni J.: P915, P1494, P432
Yano T.: 738, P469, P980
Yao Y.: 1180
Yasaka Y.: P1422
Yasuda T.: 1246, P1462, P534
Yazaki Y.: 1565, P1466
Yee R.: 1529
Yeh S.J.: P1508
Yeo W.T.: P1621
Yildirim Y.: P362, P510
Yildiz I.: P919
Yilmaz M.B.: P885
Yin K..: 1180
Yip J.: P1420, P741
Yokoi K.: P1422
Yokokawa M.: P481, P852
Yokokawa M.Y.: P317
Yoo S.Y.: P364
Yoon J.W.: P1119, P1124
Yoon N.S.: P1418, P1671, P742
Yoshiyama M.: P1126, P1363
Yousefian O.: 1108
Ypey D.L.: 1181
Yu Z.: 1236
Yucel H.: P885
Yue A.: P862
Yui Y.: P1410
Yulzari A.: P449
Yun J.P.: P901
Yuniadi Y.: P423
Yusupov A.A.: P1327
Yutsuki Y.: P1373
Zabek A.: P1017, P347, P888
Zaborska B.: 1563, P1433
Zabunova M.: 107, P907
Zagari D.: P1004
Zagkli F.: P875
Zahradnikova Jr A.: P404
Zakke I.: P907
Zakliczynski M.: P414
Zaklyazminskaya E.: 579, P895
Zaltsberg S.: P838
Zamiri N.: P1045
Zamorano Gomez J.L.: P1057, P1026, P1468
Zamora-Rodriguez V.: P941
Zaniboni M.: P366, P395
Zanon F.: 1526, 1527, P1261, P1372, P1479, P1580,
Zanotto G.: P1604
Zardini M.: P1255
Zarse M.: P1257, P1416, P1637, P323
Zaslavskaya E.L.: P368
Zateyshchikov D.A.Z.: P1655
Zateyshchikova A.A.Z.: P1655
Zauner F.: P1010
Zawada-Rapacz K.: P318
Zaza A.: P440
Zdarska J.: 1242
Zdrenghea D.: P1657
Zecchin M.: P386
Zedira A.: P999
Zeemering S.: P257, P448
Zei P.: P308
Zei P.C.: 811
Zeindlhofer E.: P1480
Zeljko H.M.: P862
Zembala M.: P273, P414
Zemmoura A.: P1390
Zeppenfeld K.: 1181, 240, P1540
Zhang Chunyu D.R.: P1326
Zhang E.: 806
Zhang J.: P1629, P373
Zhang Q.: P298
Zhang S.: P1049, P1252, P357
Zhang S.H.U.: 1180
Zhang Y.: P931
Zhou G..: 44
Zhou Y.: 44
Ziacchi M.: P1255, P1370, P346, P352
Zibell K.: P351
Ziccardi L.: P1656
Ziegler P.: P1608
Zigalkovich A.: P1609
Zima E.: P1031, P1478, P520
Zimerman A.: P1056
Zimerman L.I.: P1056
Zimmer K.: P1582
Zingarini G.: P487
Zint K.: P536, P912
Zipoli A.: 1115
Zizek D.: P1386, P454
Zoni Berisso M.: P1618
Zorlu A.: P885
Zorzi A.: P840
Zorzin Fantasia A.: P386
Zotova I.V.Z.: P1655
Zucchelli G.: P1015, P285
Zucchetti M.: 1249
Zumhagen S.: P1121
Zupan I.: P1386
Zwiers K.: P1407, P528
Zykov K.: P1048
Zysko D.: P1489, P1504
The European Heart Rhythm Association presents:
The EHRA White Book 2015
The Current Status of Cardiac Electrophysiology
in ESC Member Countries
K.-H. Kuck, G. Hindricks, L. Padeletti, P. Raatikainen, D.O. Arnar
Albania . Algeria . Armenia . Austria . Azerbaijan . Belarus . Belgium . Bosnia & Herzegovina . Bulgaria . Croatia
Cyprus . Czech Republic . Denmark . Egypt . Estonia . Finland . France . Georgia . Germany . Greece . Hungary
Iceland . Ireland . Israel . Italy . Kazakhstan . Kosovo . Kyrgyzstan . Latvia . Lebanon . Libya . Lithuania . Luxembourg
Macedonia, FYR . Malta . Moldova . Montenegro . Morocco . Netherlands . Norway . Poland . Portugal . Romania
Russian Federation . San Marino . Serbia . Slovakia . Slovenia . Spain . Sweden . Switzerland . Syria . Tunisia . Turkey
Ukraine . United Kingdom
The first step towards
Equal Access to Therapy
ESC B
EHRA/
The EHRA White Book 2015 was made possible with the aid of
an unrestricted educational grant from BIOTRONIK SE & Co. KG
Scarica le Linee Guida AIAC 2013 sulla FA
Presentazione standard di PowerPoint
Pubblicazioni 2007 - LABORATORIO ANALISI E DIAGNOSTICA
Lo screening delle cardiopatie fetali
seminario kacem - Bujinkan Dojo Prato
FIRENZE > THE MALL DIRECT BUS - BUSITALIA
scarica il calendario manifestazioni 2016
THIRD SUNDAY OF EASTER – APRIL 19, 2015 Announcements
ardissino 2016 - conoscere e curare il cuore 2007
2020 © doczz.it
Riguardo a noi | DMCA | Abuso